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Abstract
Towards reducing variations in infant mortality and
morbidity: a population-based approach
David Field,1* Elaine Boyle,1 Elizabeth Draper,1 Alun Evans,1
Samantha Johnson,1 Kamran Khan,2 Bradley Manktelow,1
Neil Marlow,3 Stavros Petrou,2 Catherine Pritchard,4 Sarah Seaton1
and Lucy Smith1
1Department of Health Sciences, University of Leicester, Leicester, UK
2Warwick Medical School, University of Warwick, Coventry, UK
3Institute for Women’s Health, University College London, London, UK
4Public Health, NHS Leicester City, Leicester, UK
*Corresponding author df63@le.ac.uk
Background: Our aims were (1) to improve understanding of regional variation in early-life mortality rates
and the UK’s poor performance in international comparisons; and (2) to identify the extent to which late
and moderately preterm (LMPT) birth contributes to early childhood mortality and morbidity.
Objective: To undertake a programme of linked population-based research studies to work towards
reducing variations in infant mortality and morbidity rates.
Design: Two interlinked streams: (1) a detailed analysis of national and regional data sets and
(2) establishment of cohorts of LMPT babies and term-born control babies.
Setting: Cohorts were drawn from the geographically defined areas of Leicestershire and
Nottinghamshire, and analyses were carried out at the University of Leicester.
Data sources: For stream 1, national data were obtained from four sources: the Office for National
Statistics, NHS Numbers for Babies, Centre for Maternal and Child Enquiries and East Midlands and South
Yorkshire Congenital Anomalies Register. For stream 2, prospective data were collected for 1130 LMPT
babies and 1255 term-born control babies.
Main outcome measures: Detailed analysis of stillbirth and early childhood mortality rates with a
particular focus on factors leading to biased or unfair comparison; review of clinical, health economic and
developmental outcomes over the first 2 years of life for LMPT and term-born babies.
Results: The deprivation gap in neonatal mortality has widened over time, despite government efforts to
reduce it. Stillbirth rates are twice as high in the most deprived as in the least deprived decile. Approximately
70% of all infant deaths are the result of either preterm birth or a major congenital abnormality, and these
are heavily influenced by mothers’ exposure to deprivation. Births at < 24 weeks’ gestation constitute only
1% of all births, but account for 20% of infant mortality. Classification of birth status for these babies varies
widely across England. Risk of LMPT birth is greatest in the most deprived groups within society. Compared
with term-born peers, LMPT babies are at an increased risk of neonatal morbidity, neonatal unit admission
and poorer long-term health and developmental outcomes. Cognitive and socioemotional development
problems confer the greatest long-term burden, with the risk being amplified by socioeconomic factors.
During the first 24 months of life each child born LMPT generates approximately £3500 of additional health
and societal costs.
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Conclusions: Health professionals should be cautious in reviewing unadjusted early-life mortality rates,
particularly when these relate to individual trusts. When more sophisticated analysis is not possible, babies
of < 24 weeks’ gestation should be excluded. Neonatal services should review the care they offer to babies
born LMPT to ensure that it is appropriate to their needs. The risk of adverse outcome is low in LMPT
children. However, the risk appears higher for some types of antenatal problems and when the mother is
from a deprived background.
Future work: Future work could include studies to improve our understanding of how deprivation
increases the risk of mortality and morbidity in early life and investigation of longer-term outcomes and
interventions in at-risk LMPT infants to improve future attainment.
Funding: The National Institute for Health Research Programme Grants for Applied Research programme.
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Plain English summary
This report describes the results of research carried out over 5 years to understand why some babies aremore likely to die or suffer damage at birth. We did this by:
l looking in great detail at the national information about births and deaths of babies
l looking at how well babies born between 4 and 8 weeks before their due date are managed both
immediately after birth and then up to 2 years.
We found that babies born in poorer areas were much more likely to die before their first birthday because
more babies were born too soon or were born with a very severe abnormality. When we looked in more
detail, we found that women from poorer areas were more likely than women from affluent areas to
continue a pregnancy when the baby has a severe abnormality rather than to opt for a termination. We
also found that some of the differences in death rates between areas in England were because deaths of
babies born very early are recorded differently.
People often think that babies born between 4 and 8 weeks early generally do well, but we found that:
l they often need help around birth
l they are more likely to have problems as they grow up than babies born at term (40 weeks)
l these babies are more likely to experience problems with development if their parents are poor
l each of these babies costs society almost £3000 more than a typical baby born at term.
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Scientific summary
Background
Mortality rates in the first year of life have fallen over the past 30 years in the UK. However, there remains
wide variation in infant mortality rates throughout the UK and the rates also remain relatively high
compared with economically similar countries. As a result, the UK government developed a NHS target to
reduce socioeconomic inequalities in infant mortality. A review of this target found large knowledge gaps
with no adequate explanation of why infant mortality rates vary widely across the UK. In parallel, there
has been an increase in the number of babies delivered at late preterm (34–36 weeks) and moderately
preterm (32–33 weeks) gestations. Limited and largely retrospective data from outside the UK suggest that
these babies experience significant early mortality and morbidity, and are at an increased risk of adverse
developmental outcomes compared with babies born at term. However, their impact on the NHS is
unknown. In particular, it is not known how differences in obstetric and neonatal practice and
socioeconomic deprivation contribute to long-term child development and whether or not there are
potentially modifiable factors for reducing mortality and morbidity in this population.
Rationale and objectives
Our overall aim was to undertake a programme of inter-related population-based studies to work towards
reducing variations in infant mortality and morbidity. This work focused attention on two key areas:
1. improving understanding of the socioeconomic inequalities in infant mortality rates
2. establishing the impact of late and moderately preterm (LMPT) birth on mortality and morbidity and the
extent to which these can be reduced.
The rationale and objectives for these two streams of work are as described below.
Understanding inequalities in cause-specific infant mortality
The limitations of all-cause mortality analyses meant that it is not clear how the widening deprivation gap
is influenced by changes in the underlying trends for specific causes of death. The objectives of our work
were to identify the main causes of neonatal mortality and stillbirth associated with socioeconomic
inequalities, to explore the reasons underlying these cause-specific inequalities in mortality and to improve
comparisons of mortality between health regions accounting for variations in case mix.
The Late And Moderately Preterm Birth Study
There was a paucity of prospective studies of LMPT birth that enabled investigation of the impact of
early-life factors on long-term developmental outcomes. We therefore carried out a population-based
prospective cohort study with the objectives of defining the impact of socioeconomic factors on LMPT birth
rates, the impact of birth at 32–36 weeks’ gestation on neonatal and postnatal services and the impact
of a range of socioeconomic, obstetric and neonatal factors on infant health and developmental outcomes
at 2 years of age.
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Methods
Understanding inequalities in cause-specific infant mortality
We explored socioeconomic inequalities in cause-specific mortality in four ways.
Socioeconomic inequalities in cause-specific neonatal mortality
We undertook a cause-specific analysis of neonatal mortality using data on all neonatal deaths and live
births in England between 1 January 1997 and 31 December 2008. In order to calculate socioeconomic
inequalities in neonatal mortality at an area level we utilised the Index of Multiple Deprivation (IMD).
Poisson regression models were used to estimate the relative deprivation gap (comparing mortality in the
most deprived and least deprived deciles) in rates of neonatal mortality (overall and by specific cause) and
to estimate the proportion of the deprivation gap in overall neonatal mortality explained by each cause.
Socioeconomic inequalities in cause-specific stillbirth rates
To understand whether or not national socioeconomic inequalities are similar for neonatal mortality and
stillbirth, we undertook a cause-specific analysis of all stillbirths and live births in England between
1 January 2000 and 31 December 2007. Similarly, we utilised the IMD to calculate area-level socioeconomic
inequalities in stillbirth rates. Poisson regression models were used to estimate the relative deprivation gap
(comparing mortality in the most deprived and least deprived deciles) in rates of stillbirth (overall and by
specific cause) and to estimate the proportion of the deprivation gap in overall neonatal mortality
explained by each cause.
Exploring the reasons underlying cause-specific inequalities in mortality
In order to understand how socioeconomic inequalities in neonatal mortality relating to congenital
anomalies arose, we undertook an analysis of data from a large UK congenital anomaly register.
We analysed data on nine selected congenital anomalies with poor prognostic outcome that were
audited as part of the UK fetal anomaly screening programme. All pregnancies with an end date between
1 January 1998 and 31 December 2007 were included in the analyses. We explored socioeconomic
variation throughout the pathway including the overall risk of the anomalies in utero, the rate of
termination of pregnancy, the rate of stillbirth, the rate of live birth with an anomaly and neonatal
mortality associated with an anomaly.
Improving comparisons of mortality between health regions
The aim of this work was to improve comparisons of mortality between health regions by understanding
variations in the classification of births at < 24 weeks’ gestation as either a live birth or a fetal loss. At the
primary care trust (PCT) level, we combined national data on live and stillbirths by gestational age between
1 January 2005 and 31 December 2008 with information on late fetal losses of 22+0–23+6 weeks.
These data allowed a comparison of the proportion of births at < 24 weeks’ gestation registered as live
born between PCTs and the impact on PCT-level infant mortality rates of excluding these extremely
preterm infants.
Late And Moderately Preterm Birth Study
We explored the impact of LMPT birth through a prospective population-based study of infants born at
32–36 weeks’ gestation.
Recruitment of the cohort
Between September 2009 and December 2010, all mothers who were resident in a geographically defined
area of Leicestershire and Nottinghamshire and delivered singletons at 32–36 weeks’ gestation were eligible
to participate in the study with their babies. A group of babies born at term (≥ 37 weeks’ gestation) during
the same time period and in the same geographical region was also recruited as a control group. All multiple
births at or beyond 32 weeks’ gestation were eligible to participate. This resulted in a cohort of 1146 babies
born late or moderately preterm and 1258 babies born at term. Data collection for mothers included
information relating to general medical and obstetric history, antenatal care, labour and delivery.
SCIENTIFIC SUMMARY
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Impact of socioeconomic factors on preterm birth
Mothers were interviewed using a semistructured questionnaire to obtain sociodemographic details and
information about lifestyle, living and working conditions and antenatal health. These data were used
to clarify the contribution of socioeconomic deprivation in LMPT birth and assess whether or not area-level
deprivation effects are explained by individual socioeconomic factors.
Neonatal outcomes
Data were collected about the infants’ clinical course until hospital discharge, including length of stay,
types of care, interventions and investigations, including the need for resuscitation at delivery, neonatal
unit (NNU) admission and respiratory support. Information was obtained about common and important
neonatal morbidities such as jaundice, hypoglycaemia, hypothermia and feeding difficulties.
Health and developmental outcomes at 2 years of age
Data were collected at 2 years of age via a parent-completed questionnaire. This comprised items to assess
general health, respiratory function, neurosensory (vision, motor and hearing) function and standardised
measures to assess cognitive development (Parent Report of Children’s Abilities – Revised), behaviour
problems and socioemotional competence (Brief Infant and Toddler Socioemotional Assessment). The
prevalence of adverse health, respiratory, cognitive and behavioural outcomes in LMPT children compared
with term-born control infants was assessed using risk ratios both before and after adjustment for
important confounders. Socioeconomic and neonatal predictors of adverse neurodevelopmental outcomes
among children born LMPT were also explored.
Economic costs of late and moderately preterm birth
Neonatal and maternal data collection forms captured a comprehensive profile of resources used by each
infant until final hospital discharge or death. Data relating to infants’ utilisation of resources use over the
first 2 years of life were collected via parent-completed questionnaires administered when the infants were
6 months, 1 year and 2 years of age. Resource inputs were valued using a combination of primary
research, based on established accounting methods, and data collated from secondary national tariff sets.
Cost comparisons were carried out using Student’s t-test for LMPT infants compared with term-born
controls. Regression modelling was used to estimate the relationship between gestational age at birth and
total costs over the first 2 years.
Key findings
Understanding inequalities in cause-specific infant mortality
l Although there was an absolute decrease in neonatal mortality over the period 1997–2007, the relative
deprivation gap (ratio of mortality in the most deprived decile to that in the least deprived decile)
increased, with the percentage of excess deaths associated with deprivation increasing from 32% in
1997–9 to 51% in 2003–5.
l Almost 80% of the relative deprivation gap in all-cause mortality was explained by premature birth and
congenital anomalies.
l Rates of stillbirth were twice as high in the most deprived decile as in the least deprived, and this wide
gap did not diminish over time. Unexplained antepartum stillbirths accounted for 50% of this
deprivation gap.
l Although rates of severe anomalies and method of detection were similar for all deprivation groups,
the rate of termination after antenatal diagnosis of a congenital anomaly was lower in the most
deprived areas than in the least deprived areas (63% vs. 79%).
l Because of the socioeconomic variation in rates of termination for congenital anomaly the rate of
neonatal deaths associated with a congenital anomaly was 98% higher in the most deprived areas,
explaining the patterns seen in the national mortality study.
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l Wide between-PCT variation existed in the classification of extremely preterm births (< 24 weeks) and,
consequently, the percentage of infant deaths arising from these births ranged from 20% to 80%.
l Excluding births at < 24 weeks led to significant changes in infant mortality rankings of PCTs indicating
that infant death rates in PCTs in England are significantly influenced by variation in the registration
of births when viability is uncertain.
The Late And Moderately Preterm Birth Study
l Women from the most deprived areas were 49% more likely to have a LMPT baby. After adjusting for
individual-level socioeconomic factors, there was no significant association between area deprivation
and LMPT birth.
l Infants born at 32–36 weeks’ gestation were significantly more likely to require resuscitation at
delivery, admission to a NNU and respiratory support than those born at ≥ 37 weeks’ gestation.
l Neonatal morbidities, including jaundice, hypothermia, hypoglycaemia and feeding difficulties, were more
common in LMPT infants than in term-born infants and LMPT infants were less likely to receive breast milk.
l Neurosensory impairments were significantly more common in children born LMPT than in control
infants (1.6% vs. 0.3%). However, cognitive impairment conferred the greatest long-term burden of
deficit and was present in 16% of LMPT children, compared with 10% of control children [adjusted
relative risk 1.42, 95% confidence interval (CI) 1.08 to 1.86].
l Children born LMPT were at increased risk of delayed socioemotional development, mild respiratory
problems and poorer general health compared with term-born peers after adjustment for confounders.
l Socioeconomic deprivation, male sex, maternal hypertensive disease, antenatal recreational drug use
and not receiving breast milk by neonatal hospital discharge were independent predictors of
neurodevelopmental disability following LMPT birth.
l Late and moderately preterm birth was associated with significant additional costs during the period of
the initial hospitalisation and over the first 2 years of life: the mean cost difference was £3507 (95% CI
£3009 to £4160) to discharge, which increased to £3562 (95% CI £2897 to £4287) for resource
utilisation up to 2 years.
Conclusions
This programme of research studies has led to key findings relevant to reducing inequalities in
infant mortality that have important implications for policy and practice, as well as future
research recommendations.
Implications for policy and practice
1. Commissioners and others responsible for clinical governance should exercise greater caution when
reviewing unadjusted early-life mortality rates, particularly when these relate to individual trusts.
2. When more sophisticated analysis is not possible, it is prudent at least to exclude babies born at
< 24 weeks’ gestation from analyses. Variation in mortality rates between areas relating to terminations
for congenital anomaly should be recognised.
3. Neonatal services should review the care they offer to babies born late or moderately preterm to ensure
that it is appropriate for their needs and the identified risks faced by this group.
4. Women considering delivery of their baby at 32–36 weeks’ gestation should be counselled that there is
a small increased risk of developmental problems. The risk is higher among those with greater
socioeconomic risk and when hypertension is the indication for early delivery.
5. The nature of the developmental problems affecting these babies appears to be primarily cognitive,
social and emotional, and this is most prevalent in children from a relatively deprived background.
6. Provision of paediatric services for the assessment, follow-up and support for infants born LMPT should
be tailored to their gestation-specific needs and reflect the difference in developmental problems seen
between these children and those born very preterm.
SCIENTIFIC SUMMARY
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Recommendations for future research
As a result of this programme of work, a range of new research questions emerged, and funding to
pursue some of these has already been sought or is already in place:
1. Understanding the choices of different groups of women when dealing with a pregnancy in which a
major congenital anomaly has been identified to ensure that the reported socioeconomic variations in
rates of termination do not arise from systematic differences in the delivery of services.
2. Understanding decision-making regarding the interpretation of signs of life at the limit of viability in
order to standardise the implementation of guidelines and reduce the impact of the variation.
3. Longer-term follow-up of the LMPT cohort to determine how early cognitive problems evolve over time
and whether there is developmental plasticity in this group. This will also enable assessment of whether or
not delays in early socioemotional development manifest as behaviour problems or peer relationship
difficulties later in childhood.
4. Evaluation of the efficacy of early parenting interventions for improving cognitive and socioemotional
development in the LMPT population.
5. Development, implementation and evaluation of potential follow-up schemes for children born late or
moderately preterm and their families.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
DOI: 10.3310/pgfar04010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 1
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Field et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
xxix

Chapter 1 Background
Choice of topic
At the time that this programme grant was conceived, in 2007, the intention was to improve
understanding of some of the key contributors to the high rates of early childhood morbidity and mortality
in the UK. This broad aim remains relevant as, although progress has been made in the intervening years,
these same themes appeared in the 2012 Chief Medical Officer’s (CMO’s) report published in
October 2013.1
When planning the research it was clear that it would not be possible to target all of the factors that
contribute to early childhood mortality and morbidity, but our intention, and the linking theme of the
work, was to focus on important areas of practice and/or policy in which knowledge and understanding
were lacking. Therefore, the original application was focused on three topic areas.
Perinatal and early childhood mortality rates
Although UK stillbirth, neonatal and infant mortality rates had generally reduced over previous decades,
it was clear that there were wide health inequalities in these rates across the country2 and overall stillbirth
rates had demonstrated much more limited change.3 Furthermore, it was recognised that UK rates for each
of these measures were high compared with those in similar developed countries.4
Premature birth was known to be the major component of both neonatal and infant mortality, accounting
for approximately 50% of neonatal deaths,2 with very preterm birth (< 33 completed weeks’ gestation)
account for most of the deaths. Previous data from our group demonstrated that rates of delivery of
< 33 weeks were particularly high in the UK, and we also found that rates of very premature birth doubled
when the least deprived areas of the country were compared with the most deprived.5 However, at
the start of this programme there was little information about the extent to which variation around the
country was explained by differences in other causes of early death such as congenital anomaly or, indeed,
other aspects of how and where premature infants were managed.
Late and moderately preterm birth
Late and moderately preterm (LMPT) birth is defined as birth between 32 and 36 completed weeks’
gestation. At the time of our application this area was largely unstudied in the UK and yet, numerically,
LMPT babies remain the largest group of preterm babies.6,7 In particular, we did not know whether or
not deprivation had the same influence on these babies or if most of them were born because it was
considered safer to end a pregnancy in which some complication had arisen. Perhaps more importantly,
we knew little about the degree to which these babies contributed to early childhood mortality and
morbidity. Better understanding of the risks attached to delivery at this gestation was seen as important in
helping families and clinicians in the management of high-risk pregnancies in which delivery between
32 and 36 weeks’ gestation was seen as an option.
Our third stream of work was intended to explore the use of biochemical markers to identify women early
in pregnancy who were at high risk of preterm delivery. This stream was considered unlikely to deliver
benefit to the NHS within 3–5 years [a prerequisite for National Institute for Health Research (NIHR)
programme grants] and hence this stream was not funded.
Therefore, the report of the programme that follows describes the outputs from two streams of work.
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Stream 1
This stream was designed to focus on an analysis of stillbirth and early childhood mortality rates, with the
aim of improving understanding of the different influences on these rates in the UK. The work relied
heavily on both routine data and more specialist data collected for other purposes.
Stream 2
This stream focused on the contribution of the group of babies born at 32–36 weeks’ gestation to both
early mortality and morbidity. This work was based on a cohort of babies born LMPT and a random set of
term-born control infants.
Developments during the course of the programme grant
In terms of the work focused on early childhood mortality, developments/new information during the course
of the programme reinforced the need for more detailed studies to take place. In particular, in the years
leading up to 2010 the NHS had a key target of reducing the health inequalities in infant mortality by
10%.8 Despite this, health inequalities were widening at the time this programme commenced. A lack of
understanding of the major influences on both neonatal and infant mortality was identified at a Department
of Health workshop as one of the major difficulties in achieving the target. Therefore, even if one sets aside
the huge importance to individuals and communities in reducing neonatal and infant mortality, there remains
a need to understand the public health and societal influences that lead to both the UK’s relatively high rates
of death in early life and the associated health inequalities. In particular:
1. the scale of the impact of deprivation on the published rates
2. the effect of cultural and religious differences between communities which, for example, could
influence the management of antenatally identified severe congenital anomalies
3. the extent to which public health interventions could influence particular causes of death (such as
sudden infant death syndrome).
Without such an understanding it was simply not possible to develop a rational approach to reducing
perinatal and early childhood mortality rates.
During the period of the programme grant, a range of studies focusing on LMPT babies were published
from around the world, but particularly in the USA, where such babies were growing in number. However,
most of these studies were small and retrospective and without the opportunity to combine data about
antenatal events, neonatal course and subsequent development. Certainly no such studies have emerged
from the UK.
New questions did arise, in particular regarding the extent to which LMPT births contribute to the overall
burden of morbidity resulting from prematurity. Routine data from Scotland9 demonstrated a link to an
increased incidence of special educational need in babies born LMPT, but it remained unclear whether
this was a generic risk attached to all babies born at these gestations or whether the affected babies
represented a specific subset that could be identified (and potentially targeted for intervention) in the
antenatal or neonatal period.
Therefore, the aims and objectives of the programme, which are set out at the start of the report from
each stream, remained both topical and relevant.
BACKGROUND
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Chapter 2 Understanding inequalities in
cause-specific infant mortality (stream 1)
Aim
The aim of stream 1 was to understand the recent widening inequalities in infant mortality rates (death in
the first year of life) by exploring cause-specific mortality, gestation and deprivation.
Objectives
Original objectives
1. To investigate if excess infant deaths related to prematurity have increased in more deprived areas.
2. To investigate how inequalities in cause-specific infant, neonatal and perinatal mortality have changed
over time.
3. To explore health inequalities in neonatal and perinatal mortality among very preterm infants and to
identify whether or not service use varies with deprivation.
4. To explore risk factors for mortality in the neonatal and perinatal period.
5. To develop newly defined cause-specific mortality targets for primary care trusts (PCTs) accounting for
variations in case mix.
Deviations from the original planned research
The original research plan focused on one of the key determinants of inequality in neonatal mortality:
deaths related to immaturity, including detailed analyses of these deaths to improve understanding of the
reason(s) for these inequalities using detailed regional data. Results from early analyses indicated that
another key element of the socioeconomic inequalities associated with infant mortality is congenital
anomalies. Deaths as a result of a congenital anomaly accounted for the largest proportion of the
deprivation gap in neonatal mortality attributable to a single cause, and also represented a significant
proportion of the deprivation gap in stillbirths. It seemed clear that understanding how these inequalities
related to congenital anomalies arose was key to implementing effective public health interventions to
reduce socioeconomic inequalities in infant and neonatal mortality. The objectives of the study were,
therefore, modified in order to allow a detailed exploration of the underlying reasons behind these issues,
looking particularly at the impact of variations in patterns of termination of pregnancy for congenital
anomaly on rates of stillbirth, live birth and neonatal mortality. It was felt that this should take higher
priority, as little research has been undertaken in this area. The presence of the East Midlands and South
Yorkshire Congenital Anomalies Register (EMSYCAR) within the same research team facilitated this analysis.
As a priority, our research planned to look at adjusting infant mortality rates at a local level for differences
in case mix, particularly socioeconomic deprivation. This was intended to aid policy-makers and
commissioners working in PCTs to reliably assess how they compared with other regions with broadly
similar population case mix and hence assess whether or not appropriate packages of care could be
implemented in their region to improve outcomes. However, it was apparent on close inspection of the
data when embarking on this work that there were major differences in the reporting of live births of
infants aged 22 and 23 weeks’ gestation. Based on international research, variations in birth registration
practices have been shown to have a major influence on infant mortality rankings and there was clearly a
need to assess the scale of this issue in the UK in order that ‘real’ variations in performance could be
separated from those arising as a result of artefactual/administrative differences. Therefore, it seemed
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essential to explore the available data for the UK on the variation in the registration of births of infants at
22 and 23 weeks of gestation and the impact of this variation on infant mortality.
Amended objectives
1. To investigate socioeconomic inequalities in cause-specific neonatal mortality rates in England (study 1).
2. To investigate socioeconomic inequalities in cause-specific stillbirth rates in England (study 2).
3. To explore the reasons underlying cause-specific inequalities in mortality (study 3).
4. To improve comparisons of mortality between health regions accounting for variations in case mix
(study 4).
Study 1: investigating socioeconomic inequalities in cause-specific
neonatal mortality in England
Background
Despite overall improvements in mortality and neonatal care, in the UK 17 babies die just before, during
or just after birth every day, with around 6500 deaths per year.10 Wide socioeconomic inequalities exist in
stillbirth and neonatal mortality, with significantly higher rates in the most deprived areas of England.11 The
UK government made major attempts to tackle socioeconomic inequalities in infant mortality by setting a
public service agreement target in 2003 to reduce the relative deprivation gap in England and Wales by
10% by 2010.8 However, the deprivation gap in all-cause mortality, rather than narrowing, showed
evidence of widening.12 The limitations of all-cause mortality analyses meant that it was not clear how this
widening gap was influenced by changes in the underlying trends in specific causes of death.
Preterm birth is the main cause of neonatal and infant mortality, accounting for two-thirds of neonatal
deaths in England.2 Rates of very preterm birth have increased over time in the UK and internationally5,13
and, as these rates are generally higher in more deprived areas of the UK,5 it is likely that this is associated
with an increase in the absolute numbers of excess deaths relating to deprivation. Such an effect clearly
has the potential to result in a widening of the health inequalities in infant mortality. Therefore, this
research was designed to unpick the socioeconomic inequalities in all-cause mortality, by exploring
cause-specific trends over time, and identify major potentially modifiable risk factors for mortality.
This study provided a detailed exploration of socioeconomic inequalities in infant and neonatal mortality in
England using routinely available data sets.
Objective
To investigate socioeconomic inequalities in cause-specific neonatal and infant mortality in England.
Methods
Description of data sets utilised
In order to achieve this objective, analyses utilised data at a national level to explore health inequalities in
cause-specific infant, neonatal and perinatal mortality. As this study was based on routinely collected data
that were anonymised, there was no requirement for ethics approval. The study focused on the 12-year
period of 1 January 1997 to 31 December 2008 and utilised several national data sets.
National (England) data: mortality
Individual-level data on all neonatal deaths (death before 28 days of life) of singleton infants born to
mothers resident in England between 1 January 1997 and 31 December 2008 came from the Centre for
Maternal Child Enquiries (CMACE; www.cmace.org.uk), which until 2011 collected neonatal mortality data
as part of its national perinatal mortality surveillance work, funded by the National Patient Safety Agency.
Originally, CMACE and its predecessor organisation collected data for all stillbirths and infant deaths;
UNDERSTANDING INEQUALITIES IN CAUSE-SPECIFIC INFANT MORTALITY (STREAM 1)
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however, from 1 January 2004, CMACE data collection was limited to stillbirths and neonatal mortality,
although data for late fetal losses at 22 and 23 weeks’ gestation were collected until 3 December 2006. The
cessation of collection of postneonatal mortality data prevented analyses of infant mortality for the whole
12-year period. However, sensitivity analyses were undertaken using information on infant mortality in
1997–2003 to assess the differences in patterns between neonatal and infant mortality. Data included
cause of death, type of death (i.e. stillbirth, late fetal loss, neonatal death or postneonatal death), gestation,
date of birth, mother’s age, sex of the infant, birthweight, ethnic group, multiplicity and the mother’s lower
super output area (LSOA) of residence an area used in the 2001 and 2011 UK censuses,14 covering around
1500 households. Only neonatal and postneonatal deaths with a valid LSOA were included; otherwise, no
deprivation score could be assigned, but this excluded only 1% of deaths.
Classification of causes of deaths
For the national data on mortality, a local CMACE co-ordinator initially classified deaths using the
extended Wigglesworth hierarchical classification system.15 A CMACE regional manager then checked
them with reference to post-mortem and coroner’s reports, when available. Finally, CMACE carried out
central cross-validation checks to ensure consistency.
In this report, for neonatal deaths (i.e. live births ending in a death before 28 days of life) and
postneonatal deaths (deaths up until 1 year of life) the Wigglesworth classification has been used but has
been expanded for deaths caused by immaturity, on the basis of gestational age at birth (< 24 weeks,
24–27 weeks and 28–36 weeks). Accidental deaths were grouped with ‘other specific conditions.’
Unfortunately, because of the changes in the classification systems used by CMACE over the time period,
1997–2008, neonatal death data classified by Wigglesworth cause of death (Box 1) were available only
from 1997 to 2007, as in 2008 CMACE implemented a new cause of death classification that was not
comparable with previous years of data. Therefore, for analyses involving cause of death, 11 years of data
were available (1997–2007) but, for analyses of overall mortality, 12 years of data were available.
BOX 1 Classification of cause of death for neonatal and postneonatal deaths for England
Neonatal and postneonatal causes of death (based on Wigglesworth’s
classification system15)
Congenital anomaly.
Intrapartum event.
Immaturity (< 24 weeks).
Immaturity (24–27 weeks).
Immaturity (28–36 weeks).
Infection.
Accidents and other specific causes.
Sudden infant death.
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Denominator data: live births
Ideally, individual-level birth denominator data were required from the NHS Numbers For Babies (NN4B)
project. This data set was established in 2005 and part of the financial rationale for its implementation was
to provide denominator live-birth data, including gestational age (not previously available in England) for
easy access by researchers. However, this aim had not been achieved and the data set was not routinely
available in a timely manner. Additionally, because of confidentiality issues, data for analysis were not
available at the individual level and linkage and so, unfortunately, were not usable for these analyses. After
a lengthy period of unproductive negotiation, a decision was made to resort to using Office for National
Statistics (ONS) birth registrations for calculating mortality rates. As no gestational age information is
included in these data, this limited the detailed analyses of issues relating to prematurity. Furthermore, as a
result of regulatory stipulations associated with access to ONS data, it was not possible to obtain individual-level
data on live births. Birth data were, therefore, obtained in two separate ways in order to facilitate the
different analyses to be undertaken. First, the number of live births by year of birth and LSOA of residence
were obtained to enable the calculation of mortality rates by LSOA. These data allowed exploration of
trends over time. A second data set, used primarily for study 3, was obtained from the ONS on live births
with additional information on birthweight, mother’s age, sex and multiplicity of birth. These data were
available only in an aggregated form providing data for deprivation deciles of LSOAs across England.
Measurement of socioeconomic deprivation
Previous government targets in England and Wales measured the relative deprivation gap by using a
classification of socioeconomic group based on the father’s occupation.12 This excluded both infants whose
parents had never worked and those who were solely registered by the mother. This led to the exclusion
of a significantly at-risk group. Consequently, this method of measurement of socioeconomic group is
inadequate. Ideally, individual measures of socioeconomic deprivation would have been used. However,
as the overall aim of this programme was to utilise routine data to assess and monitor socioeconomic
inequalities, an area-level measure of deprivation was chosen to fulfil this role. Therefore, socioeconomic
inequalities were measured by using the Index of Multiple Deprivation (IMD) for 200416 at the LSOA level.
This measure of multiple deprivation is made up of seven domain indices at the LSOA level, which relate to
(1) income deprivation; (2) employment deprivation; (3) health deprivation and disability; (4) education;
(5) skills and training deprivation; (6) barriers to housing and services; and (7) living environment deprivation
and crime. LSOAs are the smallest areas for which these deprivation data are available; although some
degree of heterogeneity exists within them, the small size of the areas (only 1500 residents) limits this.
All LSOAs in England were ranked by deprivation score. They were then weighted by its population of
births (using the live-birth denominator data) and divided into 10 groups with approximately equal
populations of births in each from 1 (least deprived) to 10 (most deprived). Thus, when calculating
mortality rates, if stillbirth or neonatal mortality was the same for all deprivation groups, a similar number
of neonatal deaths would be expected in each of the 10 groups. This approach offered the potential
not only to monitor mortality but also to allow targeted interventions at an area level in the future.
Data linkage
The national infant mortality and stillbirth data were provided with LSOA codes. The IMD 200416 was then
linked to the mortality data matching on LSOA code, facilitating the linkage to the LSOA-level ONS birth
denominator data set by LSOA-level code. The second, more detailed ONS births data set was linked using
deprivation decile, multiplicity of birth, mother’s age, sex of the baby and the PCT of residence at birth.
Statistical analyses
The aim of these analyses was to explore the deprivation gap in neonatal and infant mortality over time,
first at an all-cause level and then by specific cause to unpick the key causes of death that related to
socioeconomic inequalities in mortality. In order to explore trends by socioeconomic deprivation neonatal
mortality rates for each cause of death by deprivation decile and time period were calculated. Analyses
were undertaken solely for singleton births in this study because, in relation to multiple births, a variety of
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factors (such as differential access to fertility treatment) affects the rate at which multiple births occur and,
in addition, multiple births are associated with both a higher mortality rate and additional specific causes
of death.
Exploring the deprivation gap
Poisson regression models17 were used to assess trends in mortality by deprivation decile over time, fitting
separate models for all-cause mortality and each specific cause of neonatal mortality. Previous UK targets
for reducing socioeconomic inequalities in infant mortality8 have been based on the relative deprivation
gap identified in 2003. In the work carried out within this programme, in order to co-ordinate with the
national targets, the relative deprivation gap was measured by fitting a linear trend between deprivation
decile and mortality, and calculating the mortality rate ratio between the most deprived and least deprived
deciles which is similar in approach to the relative index of inequality.18 Significant change in the relative
deprivation gap over time was assessed by fitting a separate deprivation effect for each time period.
Reductions in neonatal mortality over time were explored by relative change (percentage reduction in
mortality rate by deprivation decile).
Investigating both the relative and absolute deprivation gap can provide a better understanding of time
trends in socioeconomic inequalities. For example, if a condition is relatively common, a small relative gap
may be associated with a large absolute difference in rates. Adjusting for the underlying prevalence can
ignore important changes in the absolute deprivation gap. Therefore, absolute changes in stillbirth
and neonatal mortality over time by deprivation decile (difference in neonatal mortality per 10,000 births
by deprivation decile) were calculated to assess improvements in mortality. The delta method was used to
calculate confidence limits.19 Excess mortality associated with deprivation was estimated as a percentage by
separately applying the stillbirth rate and neonatal mortality rate in the least deprived decile to the total
population divided by the total number of deaths observed. The proportion of the deprivation gap for both
all-cause stillbirth and all-cause neonatal mortality explained by each cause for each time period was
calculated. For each specific cause, the neonatal mortality rates in the least deprived decile and the most
deprived decile for each time period were calculated using the Poisson regression models. The absolute
difference between these two rates was calculated and expressed as a proportion of the absolute
difference in rates for all causes combined.
Results
Deprivation gap in all-cause neonatal mortality over time
Between 1997 and 2007, a total of 18,524 neonatal deaths of singleton infants were notified to CMACE
All-cause neonatal mortality decreased over time from 31.4 per 10,000 live births (1997–9) to 25.1 per
10,000 live births (2006–7), but this differed by deprivation group. In absolute terms, rates were
significantly higher in the most deprived areas (Table 1). Between 1997–9 and 2006–7 rates decreased
more in the least deprived decile than in the most deprived decile (most deprived decile, 7.4 fewer deaths
per 100,00 births; least deprived decile, 5.6 fewer deaths per 10,000 births). However, the relative
reduction in mortality over time was smaller in the most deprived decile (17%) than in the least deprived
decile (26%), leading to a widening of the deprivation gap. Table 2 details the regression equation for
all-cause mortality. In 1997–9 infants risk of neonatal death in the most deprived decile was twice that in
the least deprived [mortality rate ratio 2.08, 95% confidence interval (CI) 1.92 to 2.27], and this gap
widened significantly over time, reaching a peak of 2.68 in 2003–5 before slightly narrowing to 2.35 in
2006–7. Consequently, the percentage of excess deaths associated with deprivation increased over
the time period from 32.3% (1997–9) to 51.0% (2003–5) and then decreased to 37.5% (2006–7).
Consequently, there was no evidence of an overall reduction over the time period to achieve the relevant
NHS targets.
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TABLE 1 Observed neonatal mortality rate per 10,000 live births by deprivation decile and year of birth, and
estimated reduction in mortality per 10,000 births from 1997–9 to 2006–7 (based on Poisson regression model)
Cause of
death
Deprivation
decile
Mortality per 10,000 live births
Reduction in mortality from 1997–9 to
2006–7
1997–9 2000–2 2003–5 2006–7
Relative change,
% (95% CI)
Absolute change
per 10,000 births
(95% CI)
All causes Least deprived 20.8 18.3 16.9 14.9 26.1 (18.9 to 32.7) 5.55 (3.89 to 7.21)
Most deprived 46.4 46.6 43.5 35.9 16.7 (10.4 to 22.6) 7.41 (4.49 to 10.32)
Cause-specific deaths
Congenital
anomaly
Least deprived 5.7 3.9 4.0 4.1 31.3 (16.9 to 43.3) 1.60 (0.81 to 2.39)
Most deprived 12.4 12.4 10.5 10.5 9.5 (–4.6 to 21.7) 1.05 (–0.45 to 2.56)
Intrapartum
events
Least deprived 2.4 2.7 3.1 2.2 15.6 (–9.4 to 34.9) 0.45 (–0.23 to 1.13)
Most deprived 3.6 2.5 3.2 2.6 29.4 (9.9 to 44.6) 1.17 (0.37 to 1.96)
Immaturity
< 24 weeks’
gestation
Least deprived 2.6 3.5 2.9 2.7 1.9 (–22.4 to 21.4) 0.06 (–0.58 to 0.69)
Most deprived 8.6 10.7 11.2 9.3 –4.0 (–22.0 to 11.3) –0.35 (–1.76 to 1.07)
Immaturity
24–27 weeks’
gestation
Least deprived 4.9 3.4 3.1 2.7 44.7 (31.4 to 55.4) 2.19 (1.44 to 2.94)
Most deprived 9.9 8.0 7.4 6.1 35.1 (22.9 to 45.4) 3.24 (2.00 to 4.48)
Immaturity
28–36 weeks’
gestation
Least deprived 1.0 1.1 0.8 0.5 56.8 (32.3 to 72.4) 0.81 (0.42 to 1.21)
Most deprived 3.0 1.8 2.4 0.9 60.4 (42.3 to 72.8) 1.63 (1.03 to 2.23)
Infection Least deprived 1.8 1.4 1.3 1.2 24.6 (–1.9 to 44.3) 0.49 (–0.02 to 0.99)
Most deprived 3.7 4.2 3.7 3.1 –5.2 (–33.0 to 16.8) –0.20 (–1.11 to 0.72)
Accidents and
other specific
causes
Least deprived 1.8 0.9 1.0 0.8 10.7 (–24.5 to 35.9) 0.17 (–0.32 to 0.66)
Most deprived 2.8 3.2 2.6 2.4 7.2 (–23.0 to 29.9) 0.19 (–0.53 to 0.91)
Sudden infant
death
Least deprived 0.3 0.9 0.3 0.4 6.8 (–69.0 to 48.6) 0.03 (–0.21 to 0.27)
Most deprived 1.4 1.3 1.1 0.5 40.3 (6.9 to 61.7) 0.62 (0.11 to 1.14)
Adapted from Smith et al.20 © 2010, British Medical Journal Publishing Group, under the terms of the Creative Commons
Attribution Non-Commercial Licence (CC BY-NC 2.0), which permits use, distribution and reproduction in any medium,
provided the original work is properly cited, the use is non-commercial and is otherwise in compliance with the licence.
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Deprivation gap in specific-cause neonatal mortality over time
The next step was to explore these deaths in more detail by investigating the cause-specific mortality.
Immaturity was the most common cause (45.4%), followed by congenital anomalies (24.5%), intrapartum
events (10.8%), infection (9.8%), accidents and other specific causes (7.1%), and sudden infant deaths
(3.0%). The number of deaths increased with increasing deprivation for each cause, although the
magnitude of this increase varied by cause. With the exception of deaths due to immaturity of < 24 weeks’
gestation, neonatal mortality fell over time for all causes, with the greatest falls seen for immaturity of
24–27 and 28–36 weeks’ gestation.
For five of the eight causes of death [congenital anomalies, immaturity (< 24 weeks and 24–27 weeks),
infection and accidents and other specific causes], there was a larger relative fall in mortality over time in
the least deprived decile than in the most deprived decile, although this was only statistically significant
for congenital anomalies (Table 3). For these causes and immaturity (28–36 weeks) the trend in the
deprivation gap over time was similar to all-cause neonatal mortality, with an initial two- to threefold ratio
deprivation gap in 1997–9 (neonatal mortality rate ratio range 1.70–2.98) which increased up to 2003–5
(range 2.17–4.14) followed by a slight narrowing in 2006–7 (range 1.72–3.16) (see Table 3). The widest
deprivation gap was seen for death due immaturity of < 24 weeks’ gestation, with the risk of death in the
most deprived decile in 1997–9 being threefold that in the least deprived decile; the increased risk of death
rose to over fourfold in 2003–5 and fell again slightly to threefold in 2006–7. As the absolute mortality did
not fall over this time period, this widening of the deprivation gap led to the deaths due to immaturity
of < 24 weeks’ gestation representing a larger proportion of all deaths in 2006–7 (21.7%) than in
1997–9 (16.9%).
Rates of intrapartum death and sudden infant death showed fell more among the most deprived decile
than in the least deprived, leading to a non-significant narrowing of the deprivation gap in mortality of
these causes. However, these deaths constituted only 13.5% of deaths, and their impact on all-cause
mortality was small. Deaths due to intrapartum events showed the narrowest deprivation gap (ranging
from 1.15 to 1.37 across the time period). Consequently, the reduction in deaths if the rates seen in the
least deprived decile were applied across all deciles was small, ranging from 6.8% to 14.8%. In contrast,
the deprivation gap for sudden infant deaths was the widest seen for any specific cause in 1997–9
(mortality rate ratio 3.62). This showed a non-significant decrease over time to 2.32 in 2006–7. Sudden
infant deaths would have been reduced by over half in 1997–9 if mortality rates for the least deprived
decile were applied to the whole population, compared with a reduction of just over one-third in 2006–7.
TABLE 2 Regression equation for Poisson regression model for all-cause neonatal mortality rates
(exponential form)
Variable Coefficient SE 95% CI
Constant 0.002 < 0.001
Year (2000–2) 0.85 0.035 0.78 to 0.92
Year (2003–5) 0.77 0.032 0.71 to 0.84
Year (2006–7) 0.74 0.035 0.67 to 0.84
Deprivation decile 2.08 0.089 1.92 to 2.27
Deprivation decile year (2000–2) 1.22 0.076 1.08 to 1.37
Deprivation decile year (2003–5) 1.29 0.081 1.14 to 1.46
Deprivation decile year (2006–7) 1.13 0.081 0.98 to 1.30
SE, standard error.
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Graphical approach to understanding the deprivation gap
In order to best convey the cause-specific socioeconomic inequalities in mortality, a graphical approach was
chosen. Figure 1 demonstrates the percentage of the deprivation gap in all-cause neonatal mortality explained
by each specific cause. The width of the bands is directly related to the proportion of the deprivation gap
in neonatal mortality that each cause accounts for. This graph clearly demonstrates that deaths due to
immaturity (babies of < 24, 24–27 and 28–36 weeks’ gestation) and congenital anomalies explain the
majority of the deprivation gap in all-cause mortality. Thus, all deaths due to immaturity and congenital
anomalies combined accounted for 77% of the deprivation gap in 1997–9, rising to a peak of 81.9% in
2003–5 and then declining again to 79% in 2006–7. This increase in the proportion of the deprivation gap
explained by prematurity and congenital anomalies was due to a combination of a widening deprivation
gap in mortality for these causes, the high proportion of deaths due to these causes and a lack of decline in
mortality due to immaturity at < 24 weeks. The remaining causes (sudden infant death, intrapartum events,
infection, accidents and other causes) account for only 20% of the deprivation gap. Their reduced impact
is partially related to their relatively smaller contribution to overall mortality, but also the narrow deprivation
gap in mortality for intrapartum deaths. The percentage of the gap explained by sudden infant deaths fell
over time from 5% (1997–9) to 2.5% (2006–7).
TABLE 3 Neonatal mortality rate ratio comparing the most deprived decile with the least deprived decile by time
period and cause of death (based on Poisson regression model)
Cause of death
1997–9,
mortality rate
ratio (95% CI)
2000–2,
mortality rate
ratio (95% CI)
2003–5,
mortality rate
ratio (95% CI)
2006–7,
mortality rate
ratio (95% CI)
Test for interaction
between deprivation
and year
All causes 2.08
(1.92 to 2.27)
2.53
(2.32 to 2.77)
2.68
(2.45 to 2.93)
2.35
(2.10 to 2.63)
p= 0.0004
Cause-specific deaths
Congenital
anomaly
2.16
(1.82 to 2.56)
2.92
(2.43 to 3.51)
3.06
(2.54 to 3.70)
2.85
(2.27 to 3.58)
p= 0.0264
Intrapartum
events
1.37
(1.07 to 1.76)
1.15
(0.87 to 1.53)
1.21
(0.94 to 1.56)
1.15
(0.82 to 1.61)
p= 0.7817
Immaturity
< 24 weeks’
gestation
2.98
(2.42 to 3.67)
3.28
(2.66 to 4.05)
4.14
(3.40 to 5.06)
3.16
(2.47 to 4.04)
p= 0.1217
Immaturity
24–27 weeks’
gestation
1.88
(1.57 to 2.25)
2.49
(2.03 to 3.06)
2.38
(1.94 to 2.92)
2.21
(1.68 to 2.91)
p= 0.1779
Immaturity
28–36 weeks’
gestation
1.88
(1.35 to 2.62)
1.74
(1.16 to 2.59)
3.22
(2.10 to 4.95)
1.72
(0.93 to 3.18)
p= 0.1393
Infection 1.92
(1.45 to 2.54)
2.66
(2.00 to 3.53)
2.17
(1.57 to 3.00)
2.68
(1.88 to 3.83)
p= 0.3333
Accidents and
other specific
causes
1.70
(1.23 to 2.35)
2.29
(1.65 to 3.18)
2.71
(1.92 to 3.83)
1.77
(1.18 to 2.65)
p= 0.1987
Sudden infant
death
3.62
(2.15 to 6.07)
2.47
(1.49 to 4.07)
2.08
(1.26 to 3.43)
2.32
(1.14 to 4.73)
p= 0.4806
Adapted from Smith et al.20 © 2010, British Medical Journal Publishing Group, under the terms of the Creative Commons
Attribution Non-Commercial Licence (CC BY-NC 2.0), which permits use, distribution and reproduction in any medium,
provided the original work is properly cited, the use is non-commercial and is otherwise in compliance with the licence.
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Sensitivity analyses
Sensitivity analyses of infant mortality rates (1997–2003) showed extremely similar trends in the deprivation
gap over time for all-cause mortality and death from each specific cause, but deprivation gaps for individual
causes of death tended to be higher than for neonatal mortality overall. In 1997–9, sudden infant deaths
explained 20% of the deprivation gap in all-cause infant mortality, but this declined to 8% by 2003.
In contrast, immaturity and congenital anomalies accounted for 53% of the deprivation gap in 1997–9,
increasing to 73% in 2003, similar to the percentage seen in neonatal mortality. Hence, although the
percentage of infant deaths due to each cause differed from neonatal deaths in 1997–9, over time the
patterns became increasingly similar as immaturity and congenital anomalies played a greater role.
Conclusions
Key findings
l As there was a decrease in neonatal mortality over the period 1997–2007, the relative deprivation gap
(the ratio of mortality in the most deprived decile to that in the least deprived decile) increased,
particularly for deaths related to congenital anomalies and immaturity.
l Almost 80% of the relative deprivation gap in all-cause mortality was explained by premature birth and
congenital anomalies.
Limitations and strengths
Availability of death data
This work focused on neonatal mortality, as data on gestation-specific postneonatal deaths after 2003
were not available. However, patterns in infant mortality in 1997–2003 were extremely similar to those
seen for neonatal mortality, with a slightly wider deprivation gap.
Individual-level socioeconomic data
No routine data on individual risk behaviour, lifestyle, health and ethnicity were available for the mothers
included in this work. Inevitably this has limited the extent of the conclusions that can be drawn and has
the potential to have introduced a degree of confounding. For example, epidemiological work using
individual-level data has shown wide differences in stillbirth rates associated with maternal smoking during
pregnancy, hypertension and maternal obesity. Neonatal deaths are also known to be more common in
sole registrations. The lack of individual-level data also meant that it was not possible to identify women
who had had more than one neonatal death over the time period. However, while women who had had a
neonatal death were more likely to have a recurrence, the proportion of neonatal deaths that were likely
to have shown this pattern was low and, therefore, negligible in terms of our findings.
Despite these caveats, provided the results are treated with caution and trends are not extrapolated
beyond the time period under study, our methods are relatively straightforward and provide a way for
health service planners to monitor the latest trends in mortality.
Implications for policy and practice
Although targets were set to reduce inequalities in infant mortality by 2010 in the UK,8 the deprivation
gap did not narrow. Cause-specific analyses provide more detailed information, highlighting the
contribution of each causal group and the impact of interventions or changes in society over time.
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In the absence of cause-specific analyses various identifiable actions were recommended in England and
Wales to reduce the deprivation gap in infant mortality by the target 10% (Dr Marilena Korkodilos,
Specialist Public Health Services at Public Health England, 2010, personal communication). These are, in
order of magnitude of anticipated reduction:
1. increasing breastfeeding rates and reducing obesity in the routine and manual group
2. reducing rates of smoking during pregnancy
3. alleviating overcrowded housing
4. reducing teenage conceptions.
However, while these were all laudable aims, it seems clear from the work presented here that, unless
interventions target specifically the risk of very premature birth and potentially lethal congenital
abnormalities, the impact on the deprivation gap is likely to be minor. For example, even accounting for
the higher rates of infant mortality due to sudden infant death compared with neonatal mortality, based
on our findings the contribution to the total mortality gap is simply too small to have a significant impact.
The situation is somewhat different for smoking, as there is evidence to suggest that smoking is an
important factor in the aetiology of preterm birth and, as a consequence, infant mortality.21 The potential
impact of reducing obesity and teenage pregnancy is less clear, in terms of existing evidence. However,
smoking, obesity and teenage pregnancy have all been the subject of longstanding public health
campaigns of limited success and the UK suggested goals required major behavioural changes. Our lack of
understanding about the everyday environmental influences on the risk of preterm birth and major
congenital abnormalities appears to be a significant impediment to the development of a rational strategy
for diminishing the influence of deprivation on measures of early childhood mortality. Research has
previously demonstrated the importance of immaturity in the UK compared with other European
countries22 and the March of Dimes has highlighted the problem in global terms.13 Tackling the wide
deprivation gap among those less born at than 24 weeks’ gestation is likely to be achievable not through
further progress in neonatal care but only through prevention. The need for a greater understanding of
the mechanistic link between deprivation and prematurity is a major research priority, which would then
allow a focus on primary preventative strategies to reduce the rate of prematurity itself. Our lack of
understanding about the influence of health inequality in relation to major congenital anomalies deserves
no less attention.
These findings point to ways in which our understanding of the social influences on early childhood
mortality rates in particular localities might be improved, for example:
l The annual cause-specific mortality should be measured and overall neonatal and infant mortality rates
should be reviewed. Cause-specific analyses provide much greater insight into socioeconomic
inequalities in neonatal mortality on a global level, thus facilitating each country’s/area’s understanding
of its early childhood mortality rates and identifying appropriate interventions for prioritisation.
l The use of the father’s occupational class to assess socioeconomic group should be avoided, as this
excludes single mothers from analyses, a significant at-risk group. Area-level deprivation measures offer
an inexpensive and quick way to continue monitoring inequalities. However, the collection of, and
timely access to, comprehensive individual-level information for neonatal deaths and denominator data
would be a further improvement.
l Improved data linkage between large routine data sets such as NN4B would facilitate considerable
improvement in the research related to socioeconomic inequalities in infant mortality.
l Greater focus should be placed on the influence of preterm birth and congenital anomalies in
neonatal mortality.
l Strategies for reducing socioeconomic inequalities should focus on the prevention of preterm birth
rather than improvements in neonatal care, particularly for babies born before 24 weeks’ gestation.
DOI: 10.3310/pgfar04010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 1
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Field et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
13
Recommendations for future research
l There is a great need for a greater understanding of the mechanistic link between deprivation and
prematurity. In order to reduce socioeconomic inequalities in neonatal mortality rates, there needs to
be a shift in focus from targeting risk factors that have a minimal effect on prematurity rates to major
primary prevention strategies for preterm birth.
l The methods proposed here for monitoring inequalities in neonatal mortality provide a quick and
straightforward way of monitoring socioeconomic inequalities in the future. However, the collection of,
and timely access to, comprehensive individual-level information for neonatal deaths is required to
confirm the findings at an individual level.
Study 2: investigating socioeconomic inequalities in cause-specific
stillbirth in England
Background
Although there have been considerable improvements in health care in developed countries, stillbirth
remains a common adverse pregnancy outcome,23 and in the UK rates have been particularly high.24 This
issue appears to be intractable and, in contrast to the improvements seen in neonatal mortality, there has
been little or no reduction in rates of stillbirth over time.3 This has led to an increase in the contribution
of stillbirths to perinatal mortality. Consequently, stillbirth is a major public health burden that is frequently
overlooked, since stillbirths are often excluded from international comparisons of maternal and
infant health.25,23
This burden has not affected all groups alike. Socioeconomic inequalities in stillbirth rates have been
found in the UK and internationally,24,26,27 with women in deprived areas at higher risk of stillbirth. These
deprivation differences persist even after adjusting for factors such as attendance at antenatal appointments
or previous reproductive history.28 Inequalities in stillbirth in England and Wales have existed for many years
and research based on data from 1981–92 showed no signs of them diminishing.29
Little is known about the differences in the deprivation gap by specific causes of stillbirth in the UK.
Stillbirths are an extremely diverse group, with a variety of possible causes potentially resulting in a
stillbirth. Consequently, identifying specific causes of stillbirth is extremely difficult. However, stillbirth is
known to be linked to factors such as placental abruption, congenital anomalies and intrapartum events.
It has been noted that the deprivation gap is different for different causes of neonatal mortality20 and
it is likely that this is also true for stillbirths. Neasham et al.30 investigated the extended perinatal mortality
rate and noted that increased deprivation was associated with increased mortality as a result of
non-chromosomal anomalies. Guildea et al.27 noted a deprivation gap in unexplained antepartum stillbirths.
However, these and other studies have been based on relatively small populations and addressed a limited
number of causes.
In the UK, the Stillbirth and Neonatal Death Society (SANDS) has campaigned for further research into
stillbirth, and in particular the extent to which deprivation is a risk factor for stillbirth.31 As discussed above,
successive UK governments have made major attempts to tackle socioeconomic inequalities in infant
mortality culminating with the setting of a public service agreement target in 2003 to reduce the relative
deprivation gap in England and Wales by 10% by 2010.8 However, these targets neglected the issue
of socioeconomic inequalities in stillbirth. Furthermore, the boundaries between early neonatal deaths and
stillbirth are in many cases extremely blurred. There has been no recent evidence relating to the effect of
deprivation on the overall stillbirth rate or indeed whether or not the deprivation gap has changed over
time. An analysis of socioeconomic inequalities in stillbirth in England using routinely available data sets in
conjunction with the analyses of neonatal deaths allowed a more detailed picture of socioeconomic
inequalities in relation to early-life mortality.
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Objective
The aim was to investigate socioeconomic inequalities in cause-specific stillbirth rates in England.
Methods
Description of data sets utilised
In order to achieve these objectives, analyses utilised national-level data to explore health inequalities in
cause-specific stillbirths. As this study was based on routinely collected data that were anonymised, there
was no requirement for ethics approval. The study focused on the 12-year period between 1 January 1997
and 31 December 2008, and utilised several national data sets.
Individual-level data on all singleton stillbirths (infants born at ≥ 24 weeks’ gestation and showing no signs
of life at birth) born to mothers resident in England between 1 January 1997 and 31 December 2008
were obtained from the CMACE, which had collected neonatal mortality and stillbirth data as part of its
national perinatal mortality surveillance work funded by the National Patient Safety Agency until 2012.
Data included cause of death, gestation, date of birth, mother’s age, sex of the infant, birthweight, ethnic
group, multiplicity and mother’s place of residence (LSOA). Only stillbirths with a valid LSOA were included
as, otherwise, no deprivation score could be assigned, but this excluded only 1% of deaths.
Classification of causes of deaths
For the national data on stillbirth, a local CMACE co-ordinator initially classified deaths using the obstetric
(Aberdeen) classification system32 for stillbirths (Table 4). A CMACE regional manager then checked them
with reference to post-mortem and coroner’s reports when available. Finally, CMACE carried out central
cross-validation checks to ensure consistency.
Several of the rarer classification groups of the obstetric (Aberdeen) classification system were combined.
As so many deaths were in the unexplained antepartum deaths category, these were then divided on the
basis of birthweight (≤ 10th percentile or > 10th percentile), resulting in nine categories (see Table 4).
Similar to the situation for neonatal deaths, data on stillbirths, with information on cause of death
according to the Aberdeen classification, were available for only 8 years (i.e. from 1 January 2000 to
31 December 2007).
Denominator data: live births
The ONS birth registrations were combined with CMACE data on stillbirths to obtain a denominator of all
births, used for calculating stillbirth rates. As there is no gestational age information in these data, this
limited the detailed analyses of prematurity. As discussed in the analyses of neonatal deaths, birth data
were obtained on the number of live births by year of birth and LSOA of residence in order to calculate
mortality rates by LSOA. This allowed exploration of trends over time.
Measurement of socioeconomic deprivation
The same methodology was used for measuring socioeconomic deprivation as in the analyses of neonatal
deaths, utilising routine data to assess and monitor socioeconomic inequalities. The IMD for 200416 at
the LSOA level enabled allocation of a deprivation score to all infants with a valid postcode. These data
were obtained from the ONS.
As for the analyses of neonatal deaths, all LSOAs in England were ranked by deprivation score. The LSOAs
were then weighted by their population of births (using all births as a denominator) and divided into
10 groups with approximately equal populations of births in each from 1 (least deprived) to 10 (most
deprived). Thus, when calculating mortality rates, if stillbirth rates were the same for all deprivation groups,
a similar number of stillbirths would be expected in each decile.
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Data linkage
National stillbirth data were provided with LSOA codes. The IMD 200416 was then linked to the mortality
data matching on LSOA code. These data were then linked to the LSOA-level ONS birth denominator data
set by LSOA-level code.
Statistical analyses
First, analyses were undertaken at an all-cause level and then by specific cause to identify the key causes
of death that related to socioeconomic inequalities in stillbirth. In order to explore trends by socioeconomic
deprivation, stillbirth rates were calculated for each cause of death by deprivation decile and time period.
Analyses were undertaken for singleton births only, as, in relation to multiple births, a variety of factors
(such as differential access to fertility treatment) affect the rate at which multiple births occur and, in
addition, it is known that multiple births are associated with both a higher mortality rate and additional
specific causes of death.
TABLE 4 Classification of cause of death for stillbirths for England
Category Comprised deaths due to
Congenital anomalies Neural tube defects
Other anomalies
Pre-eclampsia Pre-eclampsia without antepartum haemorrhage
Pre-eclampsia complicated by antepartum haemorrhage
Antepartum haemorrhage Antepartum haemorrhage with placenta praevia
Antepartum haemorrhage with placental abruption
Antepartum haemorrhage of uncertain origin
Mechanical Cord prolapsed or compression with vertex or face presentation
Other vertex or face presentation
Breech presentation
Oblique or compound presentation, uterine rupture, etc.
Maternal disorder Maternal hypertensive disease
Other maternal disease
Maternal infection
Miscellaneous Isoimmunisation because of rhesus or other antigens
Neonatal infection
Other neonatal infection
Specific fetal condition
Unexplained antepartum (SGA) Unexplained antepartum (birthweight ≤ 10th percentile)
Unexplained antepartum (not SGA) Unexplained antepartum (birthweight > 10th percentile)
Unclassifiable Unclassified
Missing
SGA, small for gestational age.
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Exploring the deprivation gap
As for the analyses of neonatal mortality, Poisson regression models were used to assess trends in mortality
by deprivation decile over time,17 fitting separate models for all-cause mortality and each specific cause of
death for stillbirths. As discussed, UK targets for reducing socioeconomic inequalities in infant mortality8
were based on the relative deprivation gap, to avoid the influence of the underlying prevalence. The
relative deprivation gap was assessed by fitting a linear trend between deprivation decile and mortality
and calculating the mortality rate ratio between the most deprived and least deprived deciles, which is
similar in approach to the relative index of inequality.18 Significant change in the relative deprivation gap
over time was assessed by fitting a separate deprivation effect for each time period. Reductions in stillbirth
over time were assessed by calculating the relative change (percentage reduction in stillbirth rate by
deprivation decile).
Once again the absolute change in the outcome (in this case stillbirth) was calculated over time by
deprivation decile to assess improvements in mortality. The delta method was used to calculate confidence
limits.19 Excess mortality associated with deprivation as a percentage was estimated by separately applying
the stillbirth rate in the least deprived decile to the total population and dividing that by the total number
of stillbirths observed. The proportion of the deprivation gap in all-cause stillbirth rates explained by each
cause was calculated for each time period. Then for each specific cause, the stillbirth rate was estimated in
the least deprived decile and the most deprived decile for each time period by using the regression models.
The absolute difference in these two rates was then calculated and expressed as a proportion of the
absolute difference in rates for all causes combined.
Results
Deprivation gap in all-cause stillbirth rates over time
From 2000 to 2007, 21,472 singleton stillbirths were reported to CMACE; of these, LSOA was missing in
120 (0.6%) and cause of death was missing or unclassifiable in 919 (4.3%), leaving 20,433 for analyses.
First, the overall rate of stillbirth over time and by deprivation was assessed (Table 5). The overall stillbirth
rate was 4.4 per 1000 births and there was no evidence of a change in stillbirth rate over time (2000–3
rate, 4.4 per 1000; 2004–7, 4.4 per 1000; p= 0.80). The total number of stillbirths in each deprivation
decile increased as deprivation increased, with the number in the most deprived decile approximately
double that in the least deprived. Women from the most deprived decile were twice as likely to experience
a stillbirth of any cause than those from the least deprived (rate ratio 2.1, 95% CI 2.0 to 2.2; p< 0.0001).
There was no evidence that this changed over time.
Deprivation gap in cause-specific stillbirth rates
Looking at stillbirths by cause of death (Table 6) revealed that antepartum deaths of unknown cause
accounted for the highest percentage of stillbirths [59.2%: 21.3% small for gestational age (SGA); 37.9%
not SGA] followed by antepartum haemorrhage (13.0%); maternal disorders (9.1%); congenital anomalies
(7.8%); pre-eclampsia (4.2%) and mechanical issues during labour (2.4%). The remaining 4.3% were due
to miscellaneous or unclassified reasons and were excluded from the Poisson regression analyses.
TABLE 5 Regression equation for Poisson regression model for all-cause stillbirth mortality rates
Variable Coefficient SE 95% CI
Constant 0.0004 < 0.001
Year (2004–7) 0.991 0.029 0.94 to 1.05
Deprivation decile 2.117 0.068 1.99 to 2.25
Deprivation decile year (2004–7) 0.999 0.045 0.91 to 1.09
SE, standard error.
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There was no evidence of trends of increasing or decreasing rates of stillbirth over time for any specific
cause (Table 7); however, the deprivation gap varied by cause. Mechanical issues during labour was the
only specific cause for which there was no evidence of a deprivation gap [relative risk (RR) 1.2, 95% CI 0.9
to 1.5]. All other causes of stillbirth showed a significant deprivation gap, varying from a 1.7- to a 3.1-fold
difference. The widest deprivation gap was seen for deaths due to antepartum haemorrhage; women from
the most deprived decile were 3.1 (95% CI 2.8 to 3.5) times more likely to experience stillbirth of this
cause than those from the least deprived decile. Wide deprivation gaps were also seen for deaths due to
TABLE 7 Observed rates of stillbirth per 10,000 births by deprivation decile and year of delivery and estimated
change in mortality over time (based on Poisson regression model) with 95% CIs
Cause of death
Deprived
decile
Rates of stillbirth per 10,000
births (95% CI)
Change in mortality from 2000–3 to
2004–7 (95% CI)
2000–3 2004–7
Absolute change
per 10,000 births
Relative
change (%)
All stillbirths
(N= 20,433)
Least deprived 29.3
(28.1 to 30.5)
29.3
(26.0 to 32.9)
–0.3 (–2.0 to 1.4) 1.0 (0.9 to 1.0)
Most deprived 61.9
(59.9 to 64.0)
61.2
(59.3 to 63.2)
–0.7 (–3.5 to 2.2) 1.0 (0.9 to 1.0)
Cause-specific stillbirths
Congenital anomalies
(n= 1667; 8.1%)
Least deprived 2.0
(1.8 to 2.4)
1.7
(1.1 to 2.6)
–0.1 (–0.5 to 0.4) 1.0 (0.8 to 1.2)
Most deprived 6.3
(5.6 to 7.0)
5.2
(4.6 to 5.8)
–1.1 (–2.0 to -0.2) 0.8 (0.7 to 1.0)
Pre-eclampsia (n= 894;
4.4%)
Least deprived 1.4
(1.2 to 1.7)
1.4
(0.8 to 2.5)
–0.2 (–0.6 to 0.2) 0.9 (0.7 to 1.1)
Most deprived 2.8
(2.4 to 3.3)
2.4
(2.1 to 2.9)
–0.4 (–1.0 to 0.2) 0.9 (0.7 to 1.1)
Antepartum haemorrhage
(n=2773; 13.6%)
Least deprived 3.3
(2.9 to 3.7)
3.1
(2.2 to 4.3)
–0.2 (–0.7 to 0.3) 0.9 (0.8 to 1.1)
Most deprived 10.5
(9.7 to 11.4)
9.2
(8.5 to 10.1)
–1.2 (–2.4 to –0.1) 0.9 (0.8 to 1.0)
Mechanical (n= 512;
2.5%)
Least deprived 0.9
(0.7 to 1.2)
0.7
(0.3 to 1.4)
0.2 (–0.2 to 0.5) 1.2 (0.8 to 1.6)
Most deprived 1.3
(1.0 to 1.6)
1.1
(0.9 to 1.4)
–0.2 (–0.5 to 0.2) 0.9 (0.6 to 1.2)
Maternal disorder
(n= 1946; 9.5%)
Least deprived 2.5
(2.2 to 2.8)
2.2
(1.5 to 3.2)
0.5 (–0.03 to 1.0) 1.2 (1.0 to 1.4)
Most deprived 5.9
(5.3 to 6.6)
6.1
(5.5 to 6.7)
0.2 (–0.7 to 1.1) 1.0 (0.9 to 1.2)
Unknown antepartum
(SGA) (n= 4554; 22.3%)
Least deprived 6.0
(5.5 to 6.6)
6.1
(4.7 to 7.8)
–0.2 (–0.9 to 0.6) 1.0 (0.9 to 1.1)
Most deprived 14.9
(13.9 to 16.0)
14.7
(13.7 to 15.7)
–0.2 (–1.6 to 1.2) 1.0 (0.9 to 1.1)
Unknown antepartum
(not SGA) (n=8087;
39.6%)
Least deprived 13.5
(12.6 to 14.3)
15.2
(12.7 to 18.3)
–0.3 (–1.5 to 0.8) 1.0 (0.9 to 1.1)
Most deprived 20.9
(19.7 to 22.1)
23
(21.9 to 24.2)
2.1 (0.5 to 3.8) 1.1(1.0 to 1.2)
Adapted from Seaton et al.33 © 2012, British Medical Journal Publishing Group, under the terms of the Creative Commons
Attribution Non-Commercial Licence (CC BY-NC 2.0), which permits use, distribution and reproduction in any medium,
provided the original work is properly cited, the use is non-commercial and is otherwise in compliance with the licence.
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congenital anomalies (rate ratio 2.8, 95% CI 2.4 to 3.3) and maternal disorders such as hypertension (RR
2.2, 95% CI 1.9 to 2.5). The deprivation gap was wider for stillbirths of infants who were SGA (RR 2.5,
95% CI 2.3 to 2.7) than for those who were not SGA (RR 1.7, 95% CI 1.5 to 1.8; p= 0.26) (see Table 4).
The percentage excess deaths of all causes related to deprivation was 33%, suggesting in total one-third
more stillbirths were observed than would have been expected if the stillbirth rate for all deprivation
groups were the same as that for the least deprived decile.
Graphical approach to understanding the deprivation gap
Again, in order to best illustrate the cause-specific socioeconomic inequalities in stillbirth, a graphical
approach was chosen. Figure 2 demonstrates the percentage of the deprivation gap in all-cause stillbirth
mortality explained by each specific cause estimated from the Poisson regression models. This figure
highlights that those deaths due to unexplained antepartum events account for 50% of the deprivation gap.
Although, overall, among unexplained antepartum deaths, the proportion of infants who were SGA were
smaller than the proportion who were not (22.3% SGA and 39.6% not SGA), the SGA group explains more
of the deprivation gap. This is because the deprivation gap was wider for stillbirth infants who were SGA
(RR 2.5, 95% CI 2.3 to 2.7) than for those who were not SGA (RR 1.7, 95% CI 1.5 to 1.8). There was no
evidence of a change in the proportion of the deprivation gap explained by any of the different causes over
time, which can be seen by the lack of change in the gradient of the lines representing each specific cause.
Mechanical causes are seen to constitute a very small, insignificant proportion of the deprivation gap.
Conclusions
Key findings
l Rates of stillbirth were twice as high in the most deprived decile as in the least deprived.
l This wide gap remained constant over time and was not diminishing.
l There was a significant deprivation gap for most specific causes of stillbirth.
l Unexplained antepartum stillbirths accounted for 50% of the deprivation gap.
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FIGURE 2 Proportion of the deprivation gap in all-cause stillbirth rates explained by each cause of death over time.
Reproduced from Seaton et al.33 © 2012, British Medical Journal Publishing Group, under the terms of the Creative
Commons Attribution Non-Commercial Licence (CC BY-NC 2.0), which permits use, distribution and reproduction
in any medium, provided the original work is properly cited, the use is non-commercial and is otherwise in
compliance with the licence.
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Limitations and strengths
Classification of deaths
A limitation of much stillbirth research, including this work, is that many stillbirth classifications, such as the
obstetric (Aberdeen) classification,32 classify the majority of stillbirths as occurring for unknown reasons and
hence further analysis to improve understanding is restricted. Alternative classifications of these deaths
were not available for this work as for the time period under study national routinely collected data in
England used only the Aberdeen classification for stillbirth. There are currently 35 published classification
systems for stillbirth,25 many relying on advanced diagnostics that are not globally available. These systems
are not comparable and there has been a strong case made to have one universal system for all countries.34
Consequently, there has been a call for a consensus on definitions and classifications in order to better
understand the causes of stillbirth.24 Alternative systems, such as the classification of stillbirth by relevant
condition at death (ReCoDe)35 or the Cause of Death and Associated Conditions (CODAC)36 classification,
provide a possible cause of death for approximately 85% of stillborn infants, providing greater insight to
guide those developing interventions to reduce future mortality.
Individual-level socioeconomic data
As discussed in the analyses of neonatal deaths, data on individual risk behaviour, lifestyle, health and
ethnicity were not available for the mothers included in this work as it has been in other research.
Inevitably, this has limited the extent of our conclusions and has the potential to have produced a degree
of confounding. For example, epidemiological research using individual-level data has shown wide
differences in stillbirth rates associated with maternal smoking during pregnancy24 and maternal obesity.37
Stillbirths are also known to be more common in sole registrations.38 In women from deprived areas of
Scotland, maternal smoking status accounted for 38% of the inequalities seen in stillbirths.21 The lack of
individual-level data also meant that it was not possible to identify women who had more than one
stillbirth over the time period. However, as women who have had a stillbirth are more likely to have a
recurrence, the proportion of stillbirths that are likely to show this pattern is low and, therefore, negligible
in terms of our findings.
Despite this, provided the results are treated cautiously and trends are not extrapolated beyond the time
period under study, our methods are relatively straightforward and provide a way for health service
planners to monitor up-to-date trends in stillbirth.
Implications for policy and practice
Cause-specific analyses provide more detailed information, highlighting the contribution of each causal
group to deprivation differentials and the impact of interventions or changes in society over time.
Recent reductions in the stillbirth rate in other high-income countries24 suggest that there exist modifiable
risk factors and that by the introduction of targeted interventions, an improvement in stillbirth rates could
be seen, in particular the early identification of close monitoring of fetal movements.39 Maternal smoking
may be targeted successfully to impact on the rate of stillbirths, but effective tools to reduce maternal
obesity and rates of teenage pregnancy are currently lacking.40 Smoking, obesity and teenage pregnancy
have all been the subject of longstanding public health campaigns of limited success and the UK
suggested goals require major behavioural changes.
Some practical measures could help in improving our understanding of the role of deprivation in relation
to stillbirth:
l Cause-specific socioeconomic inequalities in stillbirth should be monitored annually.
l Avoid the use of the father’s occupational class to assess socioeconomic group, as this excludes single
mothers from analyses, a significant at-risk group. Area-level deprivation measures offer an inexpensive
quick way to continue monitoring inequalities.
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l Improved data linkage between large routine data sets such as NN4B would facilitate considerable
improvement in the research related to socioeconomic inequalities in infant mortality.
l The implementation of an improved, internationally adopted, classification system would enhance the
ability to identify other modifiable risk factors. In addition, such a system would facilitate the
implementation of appropriate targets and interventions and reduce the proportion of stillbirths
assigned to unknown causes.
Recommendations for future research
l The lack of change in stillbirth rates in the UK and the persistent wide socioeconomic inequalities
highlights the need for further research to understand this intractable problem.
l Assessment of the impact of recent professional recommendations on the classification of births after
24 weeks’ gestation known to have died earlier as ‘late fetal losses’.
Study 3: exploring the reasons underlying cause-specific
inequalities in mortality – congenital anomalies
Background
Socioeconomic inequalities in deaths associated with congenital anomaly
Following the national work on understanding socioeconomic inequalities in neonatal mortality and
stillbirth, it became apparent that a key area of concern was the widening gap in socioeconomic
inequalities in neonatal mortality relating to congenital anomalies. Deaths as a result of a congenital
anomaly accounted for the largest proportion of the deprivation gap in neonatal mortality due to a single
cause, and also represented a significant proportion of the deprivation gap in stillbirths. Understanding
how these inequalities relating to congenital anomalies arose seemed key to implementing effective public
health interventions to reduce socioeconomic inequalities in infant and neonatal mortality.
Socioeconomic inequalities in congenital anomalies have been demonstrated in the rates of stillbirth and
perinatal, neonatal and infant mortality.20,30,41,42 Research had shown an increasing risk of non-chromosomal
anomalies with increasing deprivation, in contrast to a decreasing risk of chromosomal anomalies.43 This last
finding was predominantly a result of the increased risk of chromosomal anomalies with increasing
maternal age. However, the influence of socioeconomic deprivation along the pathway from antenatal
detection to delivery and possible neonatal mortality was not fully understood because of the lack of clearly
defined standardised data in the antenatal period. Countries that have introduced the use of prenatal
diagnostic techniques and access to termination of pregnancy because of congenital anomaly have reported
large reductions in neonatal mortality rates, in contrast to those countries with more restrictive policies on
pregnancy termination.44–47 Nevertheless, the impact of these secondary preventative measures might vary
with socioeconomic deprivation in terms of access to, and timing of, antenatal detection services through to
the provision of information, the interpretation of risk, and the consequent decision-making regarding
continuation or termination of a pregnancy.
Evidence in this area is sparse. A systematic review of UK studies showed no evidence of social inequalities
in the uptake of prenatal screening,48 whereas research in Northern Ireland,49 where there is no provision
of termination services, showed inequalities in both the offer and the uptake of screening. Further research
suggested that socioeconomic differentials in decision-making following antenatal detection are a result of
maternal age differences.50 The term ‘congenital anomaly’ covers a very wide spectrum from the relatively
minor to those with an exceptionally poor prognostic outcome and it is secondary preventative measures
targeted at the latter that have the potential to improve infant mortality rates.
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A detailed analysis of regional data was undertaken to identify the underlying reasons behind the
inequalities seen in the analyses of neonatal mortality and stillbirth. Data were used from a large
population-based congenital anomaly register in England (EMSYCAR) covering about 10% of the births in
England and Wales, for 1998–2007, to investigate socioeconomic inequalities in the risk of congenital
anomalies with a poor prognosis from antenatal diagnosis to end of pregnancy. The impact of variations in
rates of termination of pregnancy for congenital anomaly on rates of stillbirth, live birth and neonatal
mortality associated with congenital anomaly were explored to aid understanding of the reasons for the
widening socioeconomic inequalities in neonatal and infant mortality in England.
Objective
The objective was to explore the reasons underlying cause-specific inequalities in mortality.
Methods
Description of data sets
Regional data: congenital anomalies incidence and mortality
The EMSYCAR currently covers about 74,000 births annually (about one-tenth of all births in England and
Wales), with around 2200 reported cases per year. The region covered by the register can be seen in
Figure 3. Data for Northamptonshire, which joined the register only in 2003, were excluded, leaving a
geographical area with about 60,000 births annually.
This register is population based and includes all structural and chromosomal congenital anomalies in
fetuses and infants of mothers living within the region at the time of delivery. It includes live births,
stillbirths (from 24 weeks’ gestation), spontaneous fetal loss (before 24 weeks’ gestation) and termination
of pregnancy for fetal anomaly at any gestational age. The register uses multiple sources of case
ascertainment from within the care pathway, including antenatal ultrasonography, antenatal screening,
delivery reports, birth notifications, pathology, cytogenetics, clinical genetics and paediatric surgery.
FIGURE 3 English counties covered by the EMSYCAR.
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All reported anomalies are coded in accordance with the International Classification Of Diseases, Tenth
Edition (ICD-10). Information on maternal age and ethnicity, mother’s postcode of residence at delivery,
end date of pregnancy and gestation at delivery were available from data collected by the register. The
study included fetuses with an anomaly with an end of pregnancy date between 1 January 1998 and
31 December 2007. These data were linked to the ONS birth registrations and the Confidential Enquiry
into Maternal and Child Health (CEMACH) data by LSOA to look at morbidity and mortality. Ideally,
analyses would be based on the mother’s postcode at conception, but this was not available from the
register. Analyses were therefore based on the mother’s postcode at delivery. To assess the potential
impact of changes in the mother’s residence through the pregnancy on the observed socioeconomic
inequalities, deprivation at antenatal detection and delivery was assessed separately for those fetuses for
which this information was available (i.e. fetuses detected in the antenatal period when the mother opted
to continue with the pregnancy).
Classification of congenital anomalies
The focus of the study was to investigate how socioeconomic inequalities arise along the care pathway from
antenatal detection to delivery. Serious congenital anomalies were defined as those incompatible with life
or associated with severe morbidity and for which screening systems are in place, leading to a precise
antenatal diagnosis that allows parents to make an informed decision about continuation of the pregnancy.
As a starting point, therefore, the 11 anomalies identified by the Fetal Anomaly Screening Programme
(FASP)51 in the UK were used (Table 8). Two anomalies were excluded – cleft lip and gastroschisis – as they
were much less likely to have a poor prognostic outcome. Only those anomalies associated with a unique
ICD-10 code and for which there is a high level of certainty about an adverse prognosis were included.
Nine anomalies met these criteria: two chromosomal anomalies (trisomy 13 and trisomy 18) and seven
non-chromosomal anomalies (anencephaly, spina bifida, hypoplastic left heart, bilateral renal agenesis,
lethal skeletal dysplasia, diaphragmatic hernia and exomphalos). For the majority of these, the FASP
definition of the anomaly was directly related to an ICD-10 code. However, for cardiac anomalies this was
much more difficult, as one ICD-10 code could relate to a less certain prognosis. Hypoplastic left heart was
chosen as it is the main cardiac anomaly diagnosed antenatally for which prognosis is clear and recognised
to be poor. In the case of fetuses registered with a chromosomal diagnosis, any coexisting congenital
anomalies were considered as secondary to the underlying chromosomal problem, rather than separate
non-chromosomal anomalies, as such associations are well established. Additional information on antenatal
detection was obtained from the register on these selected anomalies, including the method and timing of
diagnosis. An anomaly was deemed to be ‘antenatally detected’ if the date of detection of the exact, or a
closely related, anomaly predated delivery or the date of detection of an antenatal soft marker related to
the anomaly present at delivery predated the date of delivery. Ethnicity [classified into four groups: white
British, Asian or Asian British (Indian), Asian or Asian British (Pakistani) and other or missing] was included in
the regression models to assess whether or not the inclusion of ethnic group attenuated any observed
socioeconomic inequalities in the rate of antenatal detection and termination of pregnancy.
Sensitivity analyses were undertaken to look at outcomes of pregnancy for anomalies not in the selected
severe group to assess whether or not any major severe anomalies with poor outcome were being omitted
from the analyses. These additional cases of congenital anomaly demonstrated exceptionally low rates of
termination of pregnancy and neonatal mortality (see Table 8). Although 60% of pregnancies affected by
the nine severe anomalies selected ended in a termination of pregnancy, only 13% of all pregnancies with
other registered anomalies ended in termination. Furthermore, although 80% of pregnancies affected by
the selected anomalies ended in a neonatal death, this was true for only 20% of pregnancies affected
by all other registered anomalies. Evidently, these 20% of neonatal deaths are attributable to severe
anomalies, such as cardiac anomalies, that are less well specified, but for the purpose of this analysis the
nine anomalies specified here were deemed to be the most cohesive group.
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Denominator data: live births
The birth denominator data, as used in the exploration of national trends in infant mortality, of ONS birth
registrations by year of birth and LSOA of residence, were used in order to calculate mortality rates by
LSOA. This allowed us to explore trends over time for the geographical region covered by the EMSYCAR
data defined by PCT boundaries. Live births with additional information on birthweight, mother’s age, sex
and multiplicity of birth were obtained from the ONS. These had to be obtained in an aggregated form
and so deprivation deciles of LSOAs across England were specified and data were obtained on the number
of live births by decile of deprivation, year of birth and PCT.
Data linkage
The regional data included postcode of the mother’s residence at registration of the congenital anomaly.
These were linked to LSOA codes which enabled linkage with both the IMD 200416 and the
ONS birth denominator data set.
Statistical analyses
A range of rates along the pathway from diagnosis of an anomaly in the antenatal period to birth and
survival/death were calculated (selected anomalies refers to the nine selected FASP anomalies as defined
in Table 8):
l rate of selected anomalies in utero (all cases of selected anomalies whether identified in the antenatal
period or at birth) (denominator: total live births, stillbirths and known late fetal losses and terminations
of pregnancy, i.e. those registered with a fetal anomaly)
l rate of antenatal detection (denominator: all cases of selected anomalies)
l rate of termination of pregnancy because of fetal anomaly (denominator: antenatally detected cases)
l rate of fetal loss or stillbirth with an anomaly (denominator: total live births, stillbirths, and known late
fetal losses, i.e. those registered with a fetal anomaly)
l rate of live births with an anomaly (denominator: total live births)
l rate of neonatal mortality of infants with an anomaly (denominator: total live births).
Analyses were undertaken at the individual case (fetus or baby) level. Poisson regression models17 were
used to assess trends in the six outcome measures described above by deprivation decile over time. The
time period was divided into two sections: 1998–2002 and 2003–7. Data on terminated pregnancies and
fetal losses before 24 weeks’ gestation were available only when they were associated with a congenital
anomaly. Only these terminations and late fetal losses were included in the denominators for calculation
of rates of anomalies in utero. Models were fitted for all anomalies combined and then separately for
chromosomal and non-chromosomal anomalies. Interactions were explored to assess the change in the
effect of deprivation over time. Maternal age (< 20 years, 20–24 years, 25–29 years, 30–34 years and
> 35 years) was then included in the models to assess its influence on any observed socioeconomic
inequality. Confidence limits were obtained using the delta method.19
The effect of gestational age at detection of anomaly on termination of pregnancy was also assessed.
Gestational age group was classified based on the standard timings of antenatal testing into four bands:
≤ 17 weeks’, 18–21 weeks’, 22–23 weeks’ and ≥ 24 weeks’ gestation.
In order to assess whether or not patterns in outcome of pregnancy by deprivation for the nine selected
anomalies were similar to those for all registered anomalies, sensitivity analyses were undertaken using
data on all registered congenital anomalies.
Results
There were 1712 separate registrations of the nine anomalies between 1998 and 2007, of which 1695
had full postcode and maternal age information (99%). These 1695 registrations represented 1472 fetuses
with one of the nine selected anomalies and a further 107 fetuses with two or more of the nine
anomalies, making 1579 fetuses in total (see Table 8).
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Antenatal detection rates varied according to the type of congenital anomaly, ranging from 97% for
anencephaly to 77% for diaphragmatic hernia. Of those antenatally detected, over 80% of pregnancies
with a diagnosis of anencephaly, bilateral renal agenesis, trisomy 13 or trisomy 18 ended in termination and
less than 6% of fetuses with these anomalies were live born and survived the neonatal period. Pregnancies
in which the fetus was diagnosed with diaphragmatic hernia were least likely to be terminated (24%), but
such fetuses accounted for one-quarter of the observed neonatal deaths relating to the nine anomalies. Just
one in five fetuses with one of the nine selected anomalies were live born and survived the neonatal period,
compared with four out of five for all other registered anomalies. Exploring the number of cases by ethnicity
showed that, of fetuses with an anomaly, 84% (1159) were classified as ‘white,’ with the second largest
ethnic groups being Pakistani (Asian or Asian British) (4%, 53 fetuses), and Indian (Asian or Asian British)
(3%, 47 fetuses). Unfortunately, birth data were not available by ethnic group, but, according to census
data for the register area, 2% of those aged 0–15 years were classified as Pakistani and 3% as Indian.
Socioeconomic inequalities following diagnosis of a congenital anomaly
Table 9 demonstrates that there was no evidence of a difference in the overall rate of registrations of the
nine anomalies by deprivation (rate ratio comparing the most deprived decile with the least deprived decile
1.05, 95% CI 0.89 to 1.23). In 86% of cases, the anomaly was detected during the antenatal period and,
similarly, there was no evidence that this varied with deprivation (rate ratio 0.99, 95% CI 0.84 to 1.17)
or ethnicity (p= 0.913). However, termination of pregnancy when an anomaly was detected antenatally
was substantially less common in the most deprived decile (63%) than in the least deprived decile (79%;
rate ratio 0.80, 95% CI 0.65 to 0.97), and this finding was similar after adjusting for maternal age
differences (rate ratio 0.79, 95% CI 0.65 to 0.97) but slightly attenuated after adjusting for differences in
termination rates by ethnicity (rate ratio 0.86, 95% CI 0.70 to 1.05). This was because, although rates of
termination were similar for mothers classified as white British (71%) and Indian (Asian or Asian British)
(71%), they were considerably lower for Pakistani (Asian or Asian British) mothers (42%).
These socioeconomic variations in termination of pregnancy for congenital anomaly impacted greatly on
socioeconomic inequalities in the rate of fetal loss, stillbirth and live birth associated with an anomaly and
also subsequent neonatal death. Considering all of the selected anomalies combined, rate of stillbirth or
fetal loss was 20% higher in the most deprived decile than in the least deprived decile while the rate of
live birth was 61% higher and the rate of neonatal mortality was 98% higher. After adjusting for maternal
age differences, socioeconomic inequality widened, with women of a similar age from the most deprived
decile being 57% more likely to experience fetal loss or stillbirth, 85% more likely to give birth to a live
infant and 123% more likely to have a baby who subsequently died in the neonatal period.
TABLE 9 Rate of pregnancies associated with anomaly, rate of antenatal detection, and outcome of pregnancy by
deprivation before and after adjustment for maternal age based on Poisson regression model for all
anomalies combined
Outcome measure
All selected anomalies (n= 1579)
Unadjusted RRa (95% CI) Adjusted RRa (95% CI)
Registered cases per 10,000 births 1.05 (0.90 to 1.23) 1.22 (1.04 to 1.44)
% of all cases detected antenatally 0.99 (0.84 to 1.17) 0.99 (0.84 to 1.18)
% terminations in cases detected antenatally 0.80 (0.65 to 0.98) 0.79 (0.64 to 0.98)
Stillbirth or fetal loss per 10,000 births 1.20 (0.74 to 1.97) 1.57 (0.93 to 2.63)
Live birth per 10,000 live births 1.61 (1.21 to 2.15) 1.85 (1.36 to 2.50)
Neonatal deaths per 10,000 live births 1.98 (1.20 to 3.27) 2.23 (1.31 to 3.78)
a Figures are rate ratios for deprivation gap (most deprived decile vs. least deprived decile), adjusted for year of birth.
Adapted from Smith et al.52 © 2011, British Medical Journal Publishing Group, under the terms of the Creative Commons
Attribution Non-Commercial Licence (CC BY-NC 2.0), which permits use, distribution and reproduction in any medium,
provided the original work is properly cited, the use is non-commercial and is otherwise in compliance with the licence.
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Exploring inequalities by type of anomaly
When looking at chromosomal and non-chromosomal anomalies separately (Table 10), the effect of
deprivation differed, with women from the most deprived decile at increased risk of having a fetus with
a non-chromosomal anomaly (rate ratio 1.41, 95% CI 1.17 to 1.70), but at reduced risk of a fetus with a
chromosomal anomaly (rate ratio 0.52, 95% CI 0.39 to 0.69), compared with women from the least
deprived decile. The greater risk of chromosomal anomalies was the result of differences in maternal age
distribution between pregnant women from the most deprived and least deprived areas (women in the
most deprived decile accounted for 25% of pregnant women > 35 years of age, whereas women in
the least deprived decile accounted for 64% of this age group). As expected, the risk of chromosomal
anomalies increased with increasing maternal age [women aged > 35 years were nearly five times more
likely to carry a fetus with a chromosomal anomaly than younger mothers (rate ratio 4.96, 95% CI 4.12
to 5.98)]. In contrast, there was no evidence of a difference in the rates of non-chromosomal anomalies
with maternal age (rate ratio 1.01, 95% CI 0.86 to 1.20). The age-adjusted RR for chromosomal
anomalies showed no evidence of a difference in rate depending on deprivation level (rate ratio 0.85,
95% CI 0.63 to 1.15).
Despite these differences in registrations of chromosomal and non-chromosomal anomalies, the
socioeconomic differences in antenatal detection rates and terminations of pregnancy were similar for both
chromosomal and non-chromosomal anomalies. There was no evidence of a difference in antenatal detection
rates with deprivation for either chromosomal (rate ratio 0.96, 95% CI 0.70 to 1.31) or non-chromosomal
anomalies (RR 1.00, 95% CI 0.82 to 1.23). The socioeconomic differences in rates of termination of pregnancy
seen for chromosomal and non-chromosomal anomalies when considered separately were similar to
those seen for all anomalies combined.
In contrast, the rate of live birth associated with a non-chromosomal anomaly was 64% higher in the most
deprived decile than in the least deprived decile and neonatal mortality was 130% higher. Socioeconomic
inequalities for chromosomal anomalies appeared slightly narrower and were not statistically significant.
TABLE 10 Rate of pregnancies associated with anomaly, rate of antenatal detection, and outcome of pregnancy
by deprivation before and after adjustment for maternal age based on Poisson regression model for chromosomal
and non-chromosomal anomalies
Outcome measure
Non-chromosomal anomalies (n= 1118) Chromosomal anomalies (n= 461)
Unadjusted RRa
(95% CI)
Adjusted RRa
(95% CI)
Unadjusted RRa
(95% CI)
Adjusted RRa
(95% CI)
Registered cases per
10,000 births
1.41 (1.17 to 1.70) 1.43 (1.17 to 1.74) 0.52 (0.39 to 0.69) 0.85 (0.63 to 1.15)
% of all cases detected
antenatally
1.00 (0.82 to 1.23) 1.01 (0.82 to 1.24) 0.96 (0.70 to 1.31) 0.97 (0.70 to 1.35)
% terminations in cases
detected antenatally
0.84 (0.66 to 1.08) 0.82 (0.64 to 1.06) 0.82 (0.57 to 1.17) 0.82 (0.56 to 1.19)
Stillbirth or fetal loss per
10,000 births
2.47 (1.26 to 4.86) 2.57 (1.26 to 5.24) 0.47 (0.22 to 1.00) 0.85 (0.38 to 1.86)
Live births per 10,000
live births
1.64 (1.20 to 2.24) 1.78 (1.28 to 2.48) 1.50 (0.74 to 3.04) 2.21 (1.05 to 4.64)
Neonatal deaths per
10,000 live births
2.30 (1.25 to 4.23) 2.32 (1.22 to 4.42) 1.44 (0.60 to 3.47) 2.04 (0.81 to 5.14)
a Figures are rate ratios for deprivation gap (most deprived decile vs. least deprived decile), adjusted for year of birth.
Adapted from Smith et al.52 © 2011, British Medical Journal Publishing Group, under the terms of the Creative Commons
Attribution Non-Commercial Licence (CC BY-NC 2.0), which permits use, distribution and reproduction in any medium,
provided the original work is properly cited, the use is non-commercial and is otherwise in compliance with the licence.
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The rate of live birth with a chromosomal anomaly was 50% higher in most deprived decile than in the
least deprived decile (compared with 64% in the case of non-chromosomal anomalies) and neonatal
mortality were 44% higher (compared with 130% in the case of non-chromosomal anomalies). However,
adjusting for the wide maternal age differences increased the socioeconomic inequality for chromosomal
anomalies to 121% increased risk for a live birth with an anomaly and to 104% for a neonatal mortality
associated with an anomaly.
Sensitivity analyses
Sensitivity analyses were also undertaken to compare the pattern of deprivation with outcome of pregnancy
for all 13,580 registered cases of anomaly. This analysis showed a similar pattern to that for the nine selected
anomalies with a poor prognosis. There was an increase in the risk of an anomaly among women from the
most deprived areas (rate ratio 1.25, 95% CI 1.19 to 1.32) and a substantially lower rate of terminations
(rate ratio 0.55, 95% CI 0.48 to 0.62), resulting in an increased rate of live birth (rate ratio 1.48, 95% CI
1.39 to 1.58) and neonatal death (rate ratio 1.98, 95% CI 1.49 to 2.63) associated with an anomaly.
Conclusions
Key findings
l Rates of severe anomalies and method of detection were similar for all deprivation groups.
l Rates of termination after antenatal diagnosis of a congenital anomaly were lower in the most deprived
areas than in the least deprived.
l This resulted in wide socioeconomic inequalities in live-born infants with a congenital anomaly and
subsequent neonatal mortality.
Strengths and limitations
Classification of congenital anomalies
Alternative definitions of anomalies with a poor prognostic outcome could affect the results seen here.
However, our sensitivity analyses of all registered cases of congenital anomaly showed similar findings to
analyses of the nine selected anomalies. The work focused on those anomalies with a high detection rate
through the fetal anomaly screening programme. The socioeconomic differences in the risk of live-born
infants with an anomaly and neonatal deaths might be less marked for anomalies that are not routinely
detected before birth as the differential rates of termination will not play a part. Other anomalies, such as
Down syndrome, rely on accessing additional blood tests and amniocentesis for detection and have much
lower rates of associated mortality. Such conditions might show greater socioeconomic inequalities in live
births associated with an anomaly as there is greater potential for variation in access to screening and
differences in interpretation of risk and, consequently, an increased likelihood of socioeconomic differences
in decisions to terminate a pregnancy. Data from antenatal detection through to outcome of pregnancy
are not available nationally in the UK or many other countries. Here, the work utilised the largest of the
regional congenital anomaly registers in England, a large population-based register that covers 10% of
England and Wales. As 10 years of data were explored, this covered around 600,000 births and provides
detailed information from antenatal detection through to information on terminations, birth outcomes and
neonatal mortality unavailable elsewhere. Although coverage of the UK population is incomplete, the data
held by the nine regional registers that do exist are of the highest quality, and, since the demise of the
National Congenital Anomaly System, are now the only source of information available for monitoring the
incidence of congenital anomalies across the UK.
Although we have shown here that women of Pakistani (Asian or Asian British) ethnicity have much lower
rates of termination than white British or Indian (Asian or Asian British) women, we were unable to
investigate the important issues of religious beliefs and the acceptability of termination of pregnancy.
Nevertheless, the ethnic differences seen here could partially reflect different attitudes to termination with
religion. There is also discord in opinion within groups, and it is important that neither ethnicity nor
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religion is taken as a proxy for attitudes towards termination of pregnancy. Differences could be as a result
of variations in the communication of risk and timing of detection as well as cultural or religious
differences between ethnic groups.
Implications for policy and practice
Although this work concentrated on a specific region of the UK, it is likely that these results are generalisable
to the whole of the UK. The FASP aims to ensure consistent provision across the UK, although there may be
some variation between centres in the antenatal detection rates of the selected anomalies and differences
in uptake of screening programmes. This is unlikely to impact substantially on socioeconomic differences in
behaviour following detection of a suspected anomaly. In England, Scotland and Wales secondary
prevention of anomalies through access to termination of pregnancy is available to all. Internationally,
this is not universally the case, as access to termination of pregnancy varies, but these findings may be
mirrored in countries with a similar policy to that of England on the termination of pregnancy.
The use of prenatal diagnostic techniques and access to termination of pregnancy for fetal anomaly has
reduced neonatal mortality internationally, but this research has demonstrated that these secondary
prevention measures have had a knock-on effect of an increase in the socioeconomic inequality in mortality.
Going forward, comparisons of infant mortality rates between regions would be improved by taking into
account of the variation in rates of termination of pregnancy for severe congenital anomaly since this will
impact greatly on observed crude mortality rates. National monitoring of socioeconomic variations in
congenital anomalies would facilitate evaluation of services and this may be possible following the
introduction (in England) of the planned national congenital anomaly register.
Recommendations for future research
l It is vital that variations in congenital anomalies arising through the secondary prevention programmes
based on screening and the uptake of termination of pregnancy do not detract from the importance of
reducing inequalities in anomalies through primary prevention prior to conception as highlighted by
Dolk.53 Further research into the links between non-chromosomal anomalies and deprivation needs to
be undertaken in order to identify primary prevention interventions.
l A decision to continue a pregnancy associated with a serious congenital anomaly should not be
thought of as a flawed choice and may relate to societal and cultural norms. However, it is important
that the reported socioeconomic variations in rates of termination do not arise from systematic
differences in the delivery of services such as access to timely detection services, communication of
mortality and morbidity risk by health professionals and access to a termination of pregnancy. Future
research into the reasons underlying the socioeconomic variations in continuation of pregnancies
associated with serious congenital anomalies is needed.
Study 4: improving comparisons of mortality between
health regions
Background
The aim of this work was to explore how targets could be developed for PCTs to account for the variation
in population case mix. In the UK, the role of improving infant mortality has fallen to local commissioners
(currently Clinical Commissioning Groups, but at the time of this work PCTs had this responsibility), who
are responsible for health-care provision at a population level. PCT-level infant mortality rates have been
compared with peer PCTs to adjust for variation attributable to risk factors such as socioeconomic
deprivation, ethnicity and maternal age. Attention has then focused on whether or not the substantial
residual variation results from the effectiveness of local antenatal or neonatal services, with calls for
public health interventions to lower rates among PCTs perceived to be performing poorly. The intention
of this work was to use information on socioeconomic deprivation, age profile, ethnicity and other
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factors54 to adjust crude infant mortality rates so that PCTs could be compared in a more appropriate
manner and targets for reducing inequalities could be better assessed. One initial plan to look at these
data was by gestational age, and it was immediately apparent that the numbers of deaths at < 24 weeks’
gestation varied greatly between PCTs, despite extremely similar case-mix profiles.
At an international level, variations in birth registration practices have been shown to have a major
influence on infant mortality rankings55,56 and there is a need to distinguish between ‘real’ variations and
those arising from artefactual differences. Registration disparities mainly relate to births of uncertain
viability when definitions of late fetal death and live birth are particularly complicated. Changes in views on
the limit of viability have led to increases in registered live births of < 24 weeks’ gestation. However,
survival of these infants remains poor57–60 and they impact greatly on mortality rates, accounting for 20%
of neonatal deaths in England. Situations in which significant differences exist in the interpretation of what
constitutes a live birth between countries comparisons may be of limited value as standard published infant
mortality rates include only live births and, in England, in particular, there is no legal requirement to
register fetal deaths before 24 weeks’ gestation.
As became apparent from the PCT-level data, variation was evident between regions and the implications
of this were unknown but likely to be similar to the impact seen at an international level, rendering
comparisons between PCTs of infant mortality rates of limited value. Therefore, before such between-region
comparisons were made, any differences resulting from variation in registration practices needed to be
taken into consideration,61 and this research aimed to assess the best methods for achieving this.
Objective
The aim was to improve comparisons of mortality between health regions accounting for variations in case mix.
Methods
Description of data sets
Birth denominator data
As discussed in the analysis of neonatal deaths, access to the NN4B data set was extremely difficult, but
for this work, data finally became available from the NN4B birth notifications data set, which includes all
live birth and stillbirth registrations by gestation at birth. These detailed birth notification data commenced
in 2005 and were available only for 2005–8 for this study. Owing to confidentiality issues, only aggregated
data are made available several years after the time period of coverage. PCT-level data on all registered
births and linked infant deaths (death before 1 year of life) in England by gestational age bands
(< 24, 24–27, 28–32, 33–36 and ≥ 37 weeks) were obtained.
Four of the 151 PCTs were excluded because of high levels of missing gestational age data in the NN4B
data set (13–82% missing, n= 14,917; 0.3% overall).
Infant deaths and late fetal loss data
The NN4B data were linked to ONS data on infant deaths for the period 2005–6. Additional CMACE data
used in the national study of mortality on all neonatal deaths were also used here, including information
on late fetal losses – babies born with no signs of life at 22+0–23+6 weeks’ gestation. From 24+0 weeks’
gestation these births would be certified and legally registered as a stillbirth; however, babies born with no
signs of life at earlier gestations are not certified and, consequently, there is no legal registration process
and so they are not included in the ONS births or deaths data. CMACE also collected national data on
deaths at 22 and 23 weeks’ gestation until 31 December 2006, when data collection ceased. As
information on late fetal losses was not available for the whole 4-year period covered by the NN4B data,
an estimate was made based on doubling the numbers seen in 2005–6, but sensitivity analyses based on
2003–6 were also undertaken, and these suggested that there had been little change in the number of
late fetal losses over time by PCT.
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Data linkage
The ONS and NN4B data were linked by ONS to form a complete births and deaths data set. The late fetal
loss data were then linked by PCT to provide PCT-level data on all registered births and linked infant
deaths (death before 1 year of life) in England by gestational age (< 24, 24–27, 28–32, 33–36 and
≥ 37 weeks) for the period 1 January 2005 to 31 December 2008.
Statistical analyses
Very preterm birth rates
The aim of the work was to assess whether or not the proportion of live births by gestational age was
similar across different PCTs. Registration of births in the UK is based on gestational age and not
birthweight, so gestational age cut-off points for viability were used. Variation in delivery outcome and
rate of very preterm birth (≤ 32 weeks’ gestation) were explored between PCTs using:
l the gestation-specific birth rate for live-born infants (denominator: all live births)
l the gestation-specific birth rate for all infants (denominator: all live and stillbirths and late fetal deaths)
l the gestation-specific percentage of infants registered as live (denominator: gestation-specific live births
and stillbirths/late fetal deaths).
For each measure, the median, interquartile range (IQR) and 90% percentile range were calculated by
gestational age and PCT. Binomial regression models were fitted with PCT included as a random effect to
compare the variation in gestation-specific rates between PCTs. These models enable the exploration of
between-PCT variation in excess of that expected by chance, accounting for differences in sample size.
The standard deviation (SD) of the random effect for PCTs was compared across different gestational ages,
with a lower SD suggesting greater homogeneity between PCTs. Models were then adjusted for maternal
age and ethnicity based on census data and socioeconomic deprivation, measured using the area-level
IMD 2007 (population-weighted average of LSOAs in each PCT).
Infant mortality
The next step was to assess the impact of the variation in registration of births at > 24 weeks’ gestation on
infant mortality rates. The median, IQR and 90% percentile range for the proportion of infant deaths at
< 24 weeks’ gestation were calculated by PCTs to assess variation in the contribution of these deaths to
overall infant mortality. For each PCT, standard infant death rates were calculated (denominator: all live
births) and then recalculated excluding births for which clinical decision-making was most prone to
variation (births < 24 weeks’ gestation). Sensitivity analyses excluding births < 28 weeks’ gestation were
also undertaken. For each PCT, the absolute change in infant mortality and the change in rank before and
after excluding preterm births < 24 weeks’ gestation were calculated. Changes in infant mortality were
compared between PCTs with a high (≥ 50%) or low (< 50%) percentage of preterm births < 24 weeks’
gestation registered as live born.
Results
Variation in preterm birth rates
There were 2,535,855 live births, 13,112 stillbirths and 2382 estimated late fetal deaths across the 147
PCTs. First, the live-birth rate was assessed by gestational age to assess how the rate of preterm live birth
varied between PCTs. Rates of extremely preterm births (< 24 weeks’ gestation) varied widely between PCTs
(Figure 4). Binomial regression models confirmed this pattern of variation between PCTs (SD between PCT
variation < 24 weeks, 0.29; 24–27 weeks, 0.17; 28–32 weeks, 0.11) (see Figure 4), with the rate of
extremely preterm birth being six times higher in the top 5% of PCTs than in the lowest 5% (90th percentile
range 0.31 to 1.91 per 1000 births). In the older gestational age groups, this variation decreased, with a
twofold and 1.5-fold difference at 24–27 and 28–32 weeks’ gestation, respectively (90th percentile range:
24–27 weeks, 2.48 to 5.26; 28–32 weeks, 10.24 to 15.75). This pattern was confirmed by binomial
regression models with decreases in the between-PCT SD with increasing gestation (SD between PCT
UNDERSTANDING INEQUALITIES IN CAUSE-SPECIFIC INFANT MORTALITY (STREAM 1)
NIHR Journals Library www.journalslibrary.nihr.ac.uk
32
variation < 24 weeks, 0.38; 24–27 weeks, 0.18; 28–32 weeks, 0.11). After adjusting for socioeconomic
deprivation, ethnicity and the age distribution of women in the PCT, the between-PCT variation was
reduced for the more mature births but remained high in the extremely preterm group.
The next stage was to assess how the inclusion of fetal deaths and stillbirths affected the variation in the
live-birth rate by gestational age. Including fetal deaths in the overall rate of very preterm birth (total births
including fetal deaths) produced a reduction in the between-PCT variation in preterm births < 24 weeks’
gestation but little change at later gestations (see Figure 4). Binomial regression models confirmed this
pattern of variation between PCTs (< 24 weeks, 0.29; 24–27 weeks, 0.17; 28–32 weeks, 0.11).
The proportion of births recorded as live showed an increase with increasing gestational age from 52.6%
at < 24 weeks’ gestation to 73.9% at 24–27 weeks’ gestation and 91.9% at 28–32 weeks’ gestation, as
would be expected as survival improves with increasing gestation (Figure 5). However, the variation at
< 24 weeks’ gestation was wide with a 90% percentile range of 26.3% to 79.5%; that is, in the lower
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FIGURE 5 Median, IQR and 90% percentile range for the percentage of preterm births registered as live-born
by gestational age for PCTs (log-scale). Reproduced from Smith et al.62 © 2013, BMJ Publishing Group Ltd and
the Royal College of Paediatrics and Child Health, under the terms of the Creative Commons Attribution
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5% of PCTs, around one-quarter of births were registered as live-born compared with over three-quarters
in the upper 5% of PCTs. This variation reduced considerably with increasing gestation as seen in Figure 5
(90% percentile of range 24–27 weeks, 64.4% to 82.9%; 28–32 weeks, 88.5% to 95.4%). Binomial
regression models again confirmed this pattern of decreasing between-PCT variation in the percentage of
births registered as live-born with increasing gestation. Adjusting for PCT population characteristics
resulted in little change in the between-PCT variation for all gestational age groups.
Impact of extremely preterm births on infant mortality rates
The overall infant mortality rate was 4.78 per 1000 live births (n= 12,083). This varied widely between PCTs
from 2.34 to 8.93 per 1000 births. Despite making up only 1% of births, 19.5% of infant deaths arose from
births < 24 weeks’ gestation. Between PCTs this varied considerably (90% percentile range 6.7% to 31.9%).
First, the impact of preterm births < 24 weeks on the actual rate of infant mortality was assessed.
Comparing the overall infant mortality rate with the infant mortality rate excluding preterm births
< 24 weeks’ gestation (Figure 6) showed a decrease in infant mortality of more than 1 death per 1000
births after exclusion of preterm births < 24 weeks’ gestation in 60 out of the 147 PCTs. Of these, 83%
registered more than half of preterm births < 24 weeks’ gestation as live-born. Conversely, of those
87 PCTs which had a smaller decrease in infant mortality (≤ 1 death per 1000 births), only 43% had
registered over half of preterm births < 24 weeks’ gestation as live-born.
Second, as infant mortality rates are often used to rank PCTs’ performance, the impact of births at
< 24 weeks’ gestation on rankings of infant mortality rates was assessed. After excluding preterm births at
< 24 weeks’ gestation (Figure 7), PCTs that registered fewer than half of preterm births of < 24 weeks’
gestation as live-born fell a median of 12 places whereas those that registered at least half of births as
live-born improved by a median of 4 places.
Sensitivity analyses
Sensitivity analyses excluding infants < 28 weeks’ gestation showed similar findings. Further analyses using
estimates of late fetal deaths, based on 1997–2006 data, showed a stronger relationship between the
percentage of births registered as live-born < 24 weeks’ gestation and changes in both infant mortality
rates and ranks when excluding births < 24 weeks’ gestation. Although missing gestational age data may
be more common in earlier gestations, analyses assuming that the rate of missing data was 100 times
higher in the earliest gestational age group (< 24 weeks) had little effect on the results.
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Conclusions
Key findings
l Wide between-PCT variation existed in extremely preterm birth (< 24 weeks’ gestation) rates.
l Consequently, the percentage of infant deaths arising from these births varied.
l Exclusion of births < 24 weeks’ gestation led to significant changes in infant mortality rankings of PCTs.
l Infant death rates in PCTs in England are influenced by variation in the registration of births for which
viability is uncertain.
Limitations and strengths
The variation in the rate of live births at < 24 weeks’ gestation and the proportion of births registered as
live-born may reflect true underlying differences in the extremely preterm birth rate and fetal death rate
between PCTs. However, after adjusting for underlying aetiological differences such as socioeconomic
deprivation, ethnicity and maternal age, wide variation between PCTs persisted in this early gestational age
group. Furthermore, it was not possible to attribute such between-PCT variation to any reported approach
to care or improved overall outcomes in particular hospitals around England. These are the first analyses
exploring variation in the registration of < 24-week gestation births and deaths and their impact on infant
mortality in the UK. By utilising national data collected in a validated, systematic way, it provides a large
reliable data set to assess variation between regions across England.
Implications for policy and practice
This work demonstrates that registration differences impact on within-country comparisons, as well as
those between countries. In order to make direct comparisons in mortality, be it at international, regional
or unit level, detailed validation and standardisation is essential to ensure that ‘like-with-like’ comparisons
are being made, distinguishing ‘real’ variation from ‘artefacts’ that arise from reporting and registration
differences. A standardised approach to the collection, calculation and presentation of mortality rates
would reduce artefactual differences.
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Despite improvements in care, variations in outcomes persist. Differences in management strategies and
decisions regarding viability by a range of health-care professionals present at delivery are likely to be
responsible for the wide variations in delivery outcome of extremely preterm infants. Such variation in
management is likely to reflect not policy at the commissioner level but rather the approach of individual
hospitals and their clinical teams. In the UK, the World Health Organization (WHO) definition of a live birth
based on signs of life irrespective of gestational age is generally accepted for registration purposes.
However, there are practical difficulties in interpreting true signs of life as well as subjective differences in
judgements about the best outcome for parents. In the USA, where the WHO definition is accepted,
research shows that nearly one-third of physicians include gestational age in their personal criteria for
defining a live birth with definitions ‘open to subjective interpretation’.
Decisions over registration greatly affect parents in the UK, as late fetal deaths (< 24 weeks of gestation) are
not officially registered. Following the death of a live-born baby of any gestation or stillbirth after 24 weeks’
gestation, all parents are entitled to a birth and death certificate, to maternity/paternity leave and pay,
to child benefit for 8 weeks and to means-tested assistance with funeral expenses, and mothers receive free
prescriptions and dental care for 1 year; in addition, the case will be referred to a coroner for investigation.
In comparison, following a late fetal loss, parents will be eligible for none of these benefits. This is likely
to have financial impacts since extremely preterm birth is considerably higher in socioeconomically deprived
areas. There may also be emotional impacts related to these babies not being formally registered as births
and deaths. This issue was highlighted by a House of Commons debate exploring the introduction of birth
certificates for stillbirths (from 24 weeks’ gestation), lobbied for by parents.63
It would seem sensible that, when comparing localities, infant and neonatal mortality rates are calculated
excluding births less than 24 weeks’ gestation to ensure that ‘like-with-like’ comparisons are being made.
However, this would mean the exclusion of up to one-third of infant deaths in some areas and ultimately it
would seem wise to work towards reducing the variation in the registration of extremely preterm infants
in England.
Since 2013, the national perinatal mortality surveillance system in the UK has aimed to collect data on all
deaths (including babies born dead) at 22 and 23 weeks’ gestation. This step should not only improve our
ability to investigate within-country differences in early-life mortality rates but also allow for direct
international comparisons, particularly across Europe, where the vast majority of countries use the WHO
definition of birth and register all pregnancy outcomes from 22 weeks’ gestational age. Such an approach
would seem sensible for all developed countries.
Recommendations for future research
l Research into understanding how this variation arises and standardising the implementation of
guidelines regarding viability of infants of < 24 weeks’ gestational age is needed in order to tackle this
variation and reduce its impact on both mortality rate comparisons and inequalities in parents’ access
to benefits.
l Detailed understanding is needed of the potential emotional impact on parents of certifying babies at
22 and 23 weeks’ gestation as neonatal deaths or fetal losses so that guidelines can be introduced to
ensure that all parents are treated in the most appropriate way at this difficult time.
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Chapter 3 The Late And Moderately preterm
Birth Study
Background and rationale to the application
Introduction
The risks of very preterm birth (before 32 weeks’ gestation) have been extensively reported. It is well
recognised that delivery at this very early stage of pregnancy is associated with substantial neonatal
morbidity and mortality and with adverse long-term outcomes for the child.64–67 Very preterm birth has,
therefore, been the main focus of perinatal research for many years. In contrast, babies born between
32 and 36 weeks’ gestation have been understudied and, indeed, almost overlooked by researchers until
recent years. As such, there is a relative paucity of data about the outcomes of these larger and more
mature preterm infants. LMPT infants (32–36 weeks’ gestation) constitute a much larger group than very
preterm infants, representing 6–7% of all births and around 75% of preterm births. In England and Wales,
this represents around 40,000 babies each year.68 Births in this group have increased disproportionately in
recent years. In the USA, the years between 1990 and 2006 saw preterm births rise by more than 20%,
from 7.3% to 9.1%, with the greatest rise being seen in births between 34 and 36 weeks’ gestation.
Numbers of births at gestations below 34 weeks had increased by only 10%.69
Increasing rates of LMPT births are likely to be influenced by a number of factors. These were not well
understood, but it seemed reasonable to suppose that both increasing numbers of spontaneous deliveries
and increasing obstetric intervention for maternal and fetal complications at this gestation might have
contributed. The assumption, although untested, that late preterm infants were at much lower risk of
significant morbidity than were babies born at < 32 weeks’ gestation may have led to a trend towards
earlier intervention in pregnancies complicated by maternal pregnancy-related illness. In addition, improved
obstetric care at earlier gestations allowed prolongation of some pregnancies in which early delivery was
threatened to a stage when the risk of neonatal morbidity was perceived to be smaller (i.e. > 32 weeks).
It seemed plausible, therefore, that the number of infants falling within this gestational age group might
increase even further with obstetric intervention focused on minimising the risk of stillbirth close to term
and reducing neonatal morbidity.
In the UK, at the time when this study was planned, there was no routine collection of perinatal or
neonatal data for babies born at ≥ 32 weeks’ gestation and these infants were not routinely followed up
after discharge from neonatal hospital care. There was a widely held belief that the outcomes for preterm
infants born closer to term did not differ substantially from those of term-born infants. However, evidence
was emerging to suggest that this might not be true. It became clear that prospective, comprehensive data
collection for infants born LMPT was needed to clarify factors that contribute to preterm birth at these
gestations and to provide contemporaneous information about outcomes of LMPT infants to inform
parents and clinical management.
Terminology
Until 5–10 years ago, little attention was paid to standardising terminology relating to birth at 32–36 weeks’
gestation. Historically, such infants were often referred to as ‘near-term’, but other expressions, such as
‘moderate’, ‘mild’ and ‘marginally’ preterm, were also commonly used. In response to rapidly rising preterm
birth rates and in order to better acknowledge the needs of this group, a workshop, sponsored by the
National Institutes for Health (NIH) USA, was held (Optimizing Care and Outcome of the Near-term Pregnancy
and Near-term Newborn Infants: a summary of the workshop sponsored by the National Institute of Child
Health and Human Development).70 This suggested that the use of ‘near-term’ should be abandoned, as this
description did not adequately reflect the immaturity of these preterm infants and implied a greater degree of
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development than was appropriate. It was recommended that ‘late preterm’ should be used to denote birth
between 34+0 and 36+6 weeks’ gestation. Some discrepancies in terminology remain, but there is now a
greater consistency within the published literature. Late preterm birth has been accepted as birth between
34+0 and 36+6 weeks’ gestation. Although there has been no such consensus for a classification of birth
between 32+0 and 33+6 weeks, ‘moderately preterm’ is now commonly used. We chose to adhere to these
definitions, which are used throughout this report. When we describe issues relevant to the whole group we
use the abbreviation LMPT.
Aetiology of late and moderately preterm birth
No single cause has been identified to explain why preterm birth occurs. Risk factors for delivery at very
preterm gestations have been more extensively studied than those at more mature preterm gestations. A
number of associations have been found that are thought to predispose women to deliver prematurely.71–73
With respect to late and moderate prematurity, it was not known whether risk factors would be similar to
those associated with very preterm birth or whether different influences may be important.
Maternal infection
Maternal systemic, genital and urinary tract infection and inflammation have been causally linked to
preterm birth.74,75 The risk of infective complications increases with pre-labour premature rupture of the
membranes. Maternal chorioamnionitis has been implicated as a factor contributing to the poor
neurodevelopmental76 and neurological77 outcomes in affected neonates. However, the proportion of
pregnancies complicated by infection at later preterm gestations is unknown.
Socioeconomic deprivation
Material or social deprivation refers to a variety of conditions experienced by people who lack certain
resources in relation to others in the community.18 Material, social and financial deprivation, educational
disadvantage and poor access to health-care services are often closely linked. Areas of interest with respect
to preterm birth have been the impact of living conditions and working conditions, including physical
aspects of work.78 These and other experiences that result in stress are thought to contribute to preterm
delivery in the extremely preterm group, with rates of preterm birth in the most deprived women rising to
almost twice those of the least deprived.5 Poor dental health is a common problem in socioeconomically
deprived populations.79 Maternal oral health has been shown to be important for overall health and
periodontal disease during pregnancy has been associated with adverse pregnancy outcomes.80,81 Much of
the research linking socioeconomic status with preterm birth has been carried out with respect to extreme
prematurity.5,82 The influence of socioeconomic deprivation in women delivering at later preterm gestations
remains unexplored.
Lifestyle
Many aspects of lifestyle are closely linked to levels of material and financial deprivation. Lack of access to
financial resources can limit the choice of lifestyle and ability to access education and health care, making it
extremely difficult to separate material and behavioural issues. A number of elements of maternal lifestyle
during pregnancy may have either positive or adverse effects on the fetal growth or development in utero
and may influence rates of congenital anomaly. Although results of studies are conflicting, stress during
pregnancy and, in particular, during the early stages of pregnancy is also thought to be an important risk
factor for adverse pregnancy outcomes.83 Such stress may be related either to pregnancy-specific anxieties84
or to life events. Stress responses are frequently linked to financial poverty as people living in poverty have
fewer resources, both financial and psychological, with which to respond to major life events.
Other key issues potentially associated with preterm birth and adverse fetal development reflect lifestyle
choices such as risk-taking behaviours including smoking,85 excessive alcohol intake,86,87 recreational drug
use88 and dietary intake. Women are encouraged to eat a ‘healthy’ diet during pregnancy. There is
evidence from research to suggest that a cholesterol-lowering, or Mediterranean-style, diet reduces the risk
of preterm delivery.89–92 Women at lower risk were those who ate fish at least twice a week, used olive or
rapeseed oil, ate five or more portions of fruit and vegetables a day, ate meat at most twice a week and
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drank no more than two cups of coffee a day.90 However, others have shown no such association.
Maternal caffeine intake during pregnancy has, in itself, been associated with an increased risk of
spontaneous abortion.93,94 The UK Foods Standards Agency recently reassessed its recommendations, and
suggested that caffeine intake should be no more than 200mg per day (approximately two cups of coffee
or tea) because of an increased risk of fetal growth restriction (FGR).95 The impact of these factors of
maternal lifestyle has not been assessed with respect to LMPT birth.
Obstetric intervention
Expectant management of complications allows prolongation of pregnancy to a gestation at which
morbidity due to major problems of prematurity lessens on the basis that, at some point, the balance of
risk shifts in favour of delivery. As survival of infants born at > 34 weeks’ gestation is similar to that of
those born at term, 34 weeks appears to have been adopted as the point at which the threshold for
delivery changed for many obstetricians. There is, however, only limited objective evidence to support
clinical practice for many aspects of obstetric management in threatened labour and delivery at
later gestations.
Antenatal corticosteroids
Research on the use of antenatal corticosteroids (ANSs) to prevent lung disease of prematurity has focused
on very preterm deliveries and these drugs are recommended for use only up to 34 weeks’ gestation.
Despite some evidence to suggest neonatal benefit even in term deliveries,96 and guidance suggesting that
they may be considered in threatened preterm labour beyond 34 weeks, the use of ANSs in late preterm
deliveries is rare.
Tocolytic agents
The use of tocolytic agents is closely linked to attempts to prolong pregnancy in order to allow
administration of steroids at earlier gestations. The use of these medications beyond 34 weeks’ gestation is
not recommended.97
Pre-labour premature rupture of membranes
The Royal College of Obstetricians and Gynaecologists’ recommendations state that delivery should be
considered when rupture of the membranes occurs at 34 weeks’ gestation or later.98 This recommendation
was based on the increased risk of development of chorioamnionitis with expectant management. Only a
limited number of studies have addressed this question, and more research is required to determine the
optimal time of delivery.
Maternal complications
Pregnancy-induced hypertension and pre-eclampsia are the most common complications of pregnancy.
Delivery at 34 weeks’ gestation or later has been recommended in severe cases,99 but data suggest that
women with mild disease are also more likely to be delivered in the late preterm period.100
Previous delivery by caesarean section
Rates of caesarean section (CS) have been increasing in both the UK and the USA. Vaginal delivery after
previous CS carries additional risks for both mother and baby101,102 and concerns about safety have led to a
decline in both the number of obstetricians offering a trial of labour and the number of mothers taking up
this option. Most obstetricians delivered such women at 36–37 weeks’ gestation, but no clear guidelines
existed indicating the optimal time for delivery.
Maternal medical conditions
There are a number of maternal chronic conditions (e.g. essential hypertension, diabetes, renal disease or
connective tissue disorders) that may adversely affect either mother or fetus as pregnancy progresses.
The contribution of such conditions to the proportion of late preterm births had not been fully elucidated,
but it seems likely that the combination of late preterm birth with maternal morbidity will substantially
increase the risk for newborn morbidity compared with term-born infants.103
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Intrauterine growth restriction
An estimated fetal weight below the 10th percentile for gestational age is associated with some chronic
maternal medical conditions, placental disorders and fetal conditions such as chromosomal abnormalities
and viral infections. Timing of delivery depends on both maternal and fetal condition; expectant
management with close fetal monitoring is indicated and pregnancy is usually prolonged until at least
34 weeks unless monitoring indicates significant fetal compromise. However, the optimal timing for
delivery for those who find continuous fetal monitoring reassuring has not been determined.
Oligohydramnios
Lower than expected volumes of amniotic fluid can occur because of a number of different pathologies,
placing the fetus at increased risk. Close monitoring of the pregnancy is indicated, but the optimal
management in the late preterm period has not been defined.
Multiple gestations
The incidence of twin and higher-order multiple pregnancies has increased, partly because of the
increasing use of treatments for infertility. Multiple births are more likely to occur in the late preterm
period because of higher rates of spontaneous preterm labour and complications of pregnancy.104
According to data from the USA, the average gestational age at delivery of twins is 35.3 weeks and of
triplets is 32.2 weeks.105 There is evidence of increased risk of fetal death with increasing gestation in both
monochorionic and dichorionic pregnancies.106–108 At the time that this work was planned, the role of
elective delivery in the LMPT period in multiple pregnancies was yet to be clarified.
Neonatal morbidity
Although they generally experience less severe and shorter-lived acute morbidities in the neonatal period
than their more preterm counterparts, evidence is mounting to suggest that LMPT infants are at increased
risk of a number of important neonatal conditions compared with term-born infants. These include
respiratory distress,109 temperature instability,110 hypoglycaemia,111 jaundice112 and feeding difficulties.113
These morbidities are likely to lead to longer initial hospital stays, and researchers in both the USA114 and
the UK115 have also demonstrated that hospital readmission is more likely in this group of babies than in
term-born infants.
Respiratory disease
As infants born at < 32 weeks’ gestation are at the highest risk of respiratory disease associated with
prematurity, data reporting on rates and types of respiratory complications in more mature preterm infants
were relatively sparse and there were no UK studies addressing this. Rubaltelli et al.109 reported that the
rate of any respiratory distress among infants born at 33–34 weeks’ gestation in Italian neonatal units
(NNUs) was 20.6% and among those born at 35–36 weeks was 7.3%, compared with 0.6% in babies
born at > 37 weeks. Wang et al.110 compared outcomes of infants born at 35–36 weeks’ gestation
between 1997 and 2000. In this study, 28.9% of late preterm infants experienced respiratory distress,
compared with 5.3% of term-born infants. Similar results were reported by Escobar et al.116 in 2006, with
rates of 22.1%, 8.3% and 2.9% at 34, 35 and 36 weeks’ gestational age, respectively, in a retrospective
review of the Kaiser Permanente cohort of babies in the USA. In this study, infants born at 35 weeks’
gestation were nine times more likely to be ventilated than those born at 38–40 weeks; infants born
at 36 weeks were five times more likely to require ventilation. A retrospective single-centre study reported
ventilation rates of 30%, 33% and 23%, at 34, 35 and 36 weeks’ gestational age, respectively.117
Hypothermia
Temperature control and prevention of hypothermia form a part of routine newborn management.
Wang et al.110 found that 10% of late preterm infants required active management for hypothermia
compared with term-born infants. Laptook and Jackson111 demonstrated increased susceptibility to cold
stress in infants born at 34–37 weeks’ gestation. Temperature instability may be the presenting feature of
other illness such as sepsis, but the frequency of, and factors associated with, hypothermia in LMPT infants
in the UK has not been determined.
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Hypoglycaemia
Hypoglycaemia is commonly encountered in neonatal care. The level of blood glucose that constitutes
significant hypoglycaemia likely to impact on outcome is controversial for both term-born and preterm
infants.118,119 However, prevention of hypoglycaemia and its potential adverse neurodevelopmental effects
is recognised as an important part of neonatal management.120 Studies addressing hypoglycaemia in
moderately and late preterm infants were few, but, in a retrospective review of records of more than 7000
infants, Wang et al.110 observed hypoglycaemia three times as often in infants born at 35–36 weeks’
gestation as in term-born infants.
Feeding difficulties
Feeding represents one of the most basic skills that an infant must acquire in the neonatal period before
discharge from hospital. Difficulties with feeding may influence length of hospital stay, early weight gain,
glycaemic control and risk of infection. Sleepiness, difficulty with latching onto the breast and poor
co-ordination of sucking and swallowing are all common causes of delay in establishing normal oral
feeding in LMPT infants.113 Wang et al.110 found that 27% of late preterm infants, compared with 5% of
term-born infants, required intravenous (i.v.) fluid administration. A substantial number, particularly those
unable to feed enterally because of other conditions, may require a period of parenteral nutrition (PN).
Although this may be necessary to meet nutritional requirements, it carries associated risks related to the
PN itself and increased incidence of catheter-related infection with central venous line placement. As a
result of the challenges of establishing breastfeeding in preterm infants, it is possible that mothers of such
infants may be more likely to abandon breastfeeding than those delivering at term, although it is known
that breast milk is the most appropriate nutrition for a newborn baby. Methods of feeding in LMPT babies
at discharge from hospital and post discharge have not specifically been studied.
Jaundice
Prematurity places infants at an increased risk of hyperbilirubinaemia and the associated bilirubin
encephalopathy (kernicterus) that can result from extremely high levels of serum bilirubin (SBR). It had
been suggested that a trend towards earlier postnatal discharge of healthy newborn babies has led to an
increased risk of severe jaundice secondary to postdischarge feeding difficulties and reduced monitoring in
the first few days of life. In a study of hospital readmissions in the neonatal period,121 jaundice was one of
the most common reasons for readmission; late preterm infants required readmission more frequently than
did term-born infants. Bhutani et al.112 studied cases reported to the Pilot Kernicterus Registry in the USA
and found that late preterm babies were overrepresented in this registry, with breastfeeding being a
significant risk factor.
Mortality
Worryingly, the observed risk of increased morbidity, as discussed above, seemed also to be associated
with higher mortality rates in this group of infants than in those born at term. In 2000, Kramer122 assessed
the contribution of ‘mild and moderate preterm birth’ to infant mortality and concluded that these infants
had a high RR of death during infancy. Published infant mortality data for 2002 in the USA105 show that
the mortality rate among babies born mild or moderately preterm is three times that of term-born infants.
This was confirmed by Tomashek et al.,123 who found that early and late neonatal mortality were,
respectively, six and three times higher, and infant mortality three times higher, among preterm infants
than that of term-born infants. A substantial number of early deaths in both groups were related to
congenital anomalies, but differences persisted even after exclusion of infants with anomalies.
Neurodevelopmental outcomes
A small number of published studies suggest that surviving LMPT infants may be at risk of significant later
neurodevelopmental impairment. Results of a prospective follow-up study of 24 infants in 1987 indicated
that preterm infants born between 34 and 36 weeks’ gestation had increased psychomotor developmental
problems and, in particular, language difficulties when compared with term-born control children at 4 years
of age.124 In the UK, Huddy et al.125 sought to quantify poor outcomes at school age among 176 infants
born between 32 and 35 weeks’ gestation. Their results, based on parent and teacher reports, suggested
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that up to one-third of these infants had educational problems and required additional help at school.
Hyperactivity was noted by both parents and teachers in 8% of the group and was associated with poor
school performance. Using routinely collected maternal and infant data, the authors identified an
association between early respiratory illness and poor school outcome. However, loss to follow-up in this
study was substantial (34%), suggesting that the results might not represent the most reliable estimate of
the true incidence of difficulties.
Other researchers studied outcomes of preterm infants deemed to be at low risk of neurodevelopmental
impairment. Pasman et al.126 studied 44 low-risk infants born at 25–34 weeks’ gestation and found that
the subgroup of infants born between 31 and 34 weeks performed less well on neuropsychological testing
than their term-born counterparts. Pietz et al.127 assessed neurodevelopmental outcomes at 7 years of age
in low-risk infants with birthweights of > 1000 g who were apparently normal during infancy. Although
rates of severely subnormal test results were low in this group, there was an increased frequency of
moderately subnormal performance. Caravale et al.128 published results of 3- to 4-year follow-up of
30 neurologically normal children born between 30 and 34 weeks’ gestation. Compared with term-born
controls matched for age, sex and parental educational and occupational status, these infants achieved
significantly lower scores for tests of intellectual development, perceptual and motor abilities, language
abilities, memory and attention.
Growth in infancy and childhood in infants born late or moderately preterm
Poor postnatal growth is well recognised in extremely preterm infants129 and is often characterised in terms
of failure to achieve growth rates that would be expected for intrauterine development.130
Little is known about nutrition and growth in relation to later development of LMPT babies. A study of
postnatal growth in infants born at 30–34 weeks’ gestation suggested that intrauterine growth rates are
rarely achieved in this group.131 Pietz et al.127 examined growth parameters in low-risk preterm infants at
20 months and 7 years of age. They found that more children in the preterm group than in the control
group had weight, height and head circumference below the ninth percentile at 7 years. The proportion of
children with weight below the third percentile increased significantly between the ages of 20 months
and 7 years. Dodrill et al.132 examined the long-term oral sensitivity and feeding skills in 20 low-risk infants
born between 32 and 37 weeks’ gestation compared with matched full-term control infants. They found
statistically significant differences between the groups at 11–17 months corrected age, with preterm
infants showing delay in development. This delay was greater in infants who had received longer periods
of nasogastric feeding.
The economic costs of late and moderately preterm birth
It is well recognised that preterm birth places a significant financial burden on parents, families and the
health and educational services. Given the increased neonatal morbidity that is apparently experienced by
LMPT infants, it seems likely that the cost of initial birth hospitalisation will be significantly higher for LMPT
infants than for term-born infants.133 The public health and economic impact of much larger numbers of
survivors with less obvious physical, neuropsychological, educational and behavioural difficulties than those
seen in extremely preterm infants should not be underestimated. Compared with infants born at term,
it had been suggested that LMPT infants will have additional health-care needs and have more hospital
admissions during childhood.134 Among 263,000 infants born in California between 1992 and 2000,
15% of preterm infants required readmission to hospital in the first year of life, with infants born at
35 weeks’ gestation accounting for 25% of the total cost. Increased postdischarge health-care service
utilisation had been seen in studies of very preterm infants in the UK.134,135 As health-care costs are often
ongoing in infants of any gestation with long-term problems, it seems likely that the need for special
educational support in the LMPT gestational age group might be substantial and may not previously have
been fully recognised.
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The need for further research
As outcomes of LMPT babies are thought to be similar to those of term-born babies, clinical management
of these infants is similar to that of infants born at ≥ 37 weeks’ gestation. Following publication in 2000,
by Kramer et al.,122 of the first findings of increased mortality in LMPT infants, there was a substantial
upsurge in research interest between 2004 and 2006 in babies born at LMPT gestations. The results all
pointed to an association between LMPT birth and outcomes that were worse than those of term-born
infants. However, these studies were, for the most part, small and of a retrospective design and there was
little consistency between them with respect to the gestational ages of the children studied. In addition,
published studies were carried out in North America, with few European data and no UK data available.
Researchers were beginning to question the accepted clinical approach to the care of such infants and
calling for enhanced neonatal care, surveillance and follow-up in this group, similar to that which is routine
in infants born extremely preterm. Given the much larger numbers of LMPT babies, this would present a
considerable additional burden on health-care resources. There was, therefore, a clear and pressing need
for large, contemporary studies to clarify outcomes for LMPT infants and to determine if and how these
differ from those of term-born babies. As available data were then limited principally to retrospective
reviews of large data sets, prospective work with the potential to identify antenatal and perinatal risk
factors for LMPT birth was needed. In addition, further research was required to determine whether or
not certain groups of babies might be at particularly high risk and if these groups might be amenable to
targeted intervention to improve their outcomes. Although costs associated with preterm birth in general
have been studied, there is little information available that specifically highlights the financial burden for
parents and society that is attributable to early and ongoing support of infants born LMPT.
Aims and objectives of the Late And Moderately preterm
Birth Study
Overall aim
The study aimed to clarify factors contributing to preterm delivery at 32+0–36+6 weeks’ gestation and to
provide current information about outcomes of infants born at this gestation.
Specific objectives
Specific objectives were as follows:
1. to clarify the relative contributions of infection, deprivation, maternal lifestyle and obstetric intervention
to LMPT birth
2. to inform the development of guidelines for the management of complicated pregnancies at
32–36 weeks’ gestation
3. to quantify early mortality and morbidity associated with late and moderate prematurity compared with
that of control infants born at ≥ 37 weeks’ gestation
4. to identify perinatal or neonatal interventions with the potential to improve neonatal outcomes at
hospital discharge and reduce infant mortality in infants born at 32–36 weeks’ gestation
5. to evaluate health-care needs and use of health-care resources in infants born at 32–36 weeks’ gestation
6. to estimate the economic costs of moderate and late prematurity, in order to inform and guide
planning and configuration of children’s services.
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Key questions and focused objectives
In order to meet the above objectives, we developed a number of more focused areas for study and key
questions. These questions led to a series of focused objectives that are described in the relevant sections
of this report. Some of these questions were relevant for more than one of the specific objectives.
1. To clarify the relative contributions of infection, deprivation, maternal lifestyle and obstetric intervention
to LMPT birth:
i. What are the pre-pregnancy characteristics of mothers who delivered their babies at
LMPT gestations?
ii. What are the differences in characteristics between mothers delivering at LMPT gestations and those
who deliver at ≥ 37 weeks’ gestation?
iii. Which factors are likely to place women at higher risk of delivering LMPT?
iv. What is the contribution of socioeconomic deprivation in LMPT birth, and are area-level deprivation
effects explained by individual socioeconomic factors?
v. What are the differences between the outcomes of LMPT infants born to mothers who had
non-spontaneous onset of labour with those whose mothers had spontaneous onset of labour?
2. To inform the development of guidelines for the management of complicated pregnancies at
32–36 weeks’ gestation:
i. What are the frequency and type of pregnancy-related complications affecting women who go on
to deliver at LMPT gestations?
ii. What are the differences in pregnancy-related complications between women delivering at LMPT
gestations and those delivering at term?
iii. What are the frequencies of assisted reproductive techniques, obstetric investigations and
interventions in women delivering at LMPT gestations and how do these compare with those in
women delivering at term?
iv. What is the number of women having medical intervention for delivery prior to the onset of labour
at LMPT gestations, compared with those at term?
3. To quantify early mortality and morbidity associated with late and moderate prematurity compared with
that of control infants born at ≥ 37 weeks’ gestation:
i. What are the characteristics at birth of singletons and multiples born at LMPT gestations?
ii. How do characteristics of LMPT babies at birth differ from those of babies born at ≥ 37 weeks’ gestation?
iii. What is the incidence of congenital anomalies among LMPT babies compared with those born at
term and what type of anomalies occur in this population?
iv. How does mortality and morbidity associated with late and moderate prematurity compare with that
of control infants born at ≥ 37 weeks’ gestation?
4. To identify perinatal or neonatal interventions with the potential to improve neonatal outcomes at
hospital discharge and reduce infant mortality in infants born at 32–36 weeks’ gestation:
i. Which factors are likely to place women at higher risk of delivering LMPT?
ii. What are the differences between the outcomes of LMPT infants born to mothers who had
non-spontaneous onset of labour with those whose mothers had spontaneous onset of labour?
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5. To evaluate health-care needs and use of health-care resources in infants born at 32–36 weeks’ gestation:
i. What are the health and respiratory outcomes of children born LMPT at 2 years of age?
ii. What is the prevalence of cognitive and neurodevelopmental disability among children born LMPT?
iii. What are the neonatal risk factors for neurodevelopmental disability at 2 years of age among
children born LMPT?
iv. What is the impact of LMPT birth on behavioural outcomes at 2 years of age?
6. To estimate the additional economic costs of moderate and late prematurity, in order to inform and
guide planning and configuration of children’s services:
i. What are the economic costs between birth and initial hospital discharge associated with moderate
and late prematurity?
ii. What are the economic costs between birth and 2 years associated with moderate and
late prematurity?
iii. How are the economic costs associated with moderate and late prematurity distributed across sectors?
iv. What other factors, clinical and sociodemographic, constellate with moderate and late prematurity in
estimations of economic costs?
Study methods
Study participants
Eligibility
Our original plan was for recruitment to take place over a 1-year period between September 2009 and
August 2010. All mothers who were resident in a geographically defined area of Leicestershire and
Nottinghamshire and delivered babies at 32+0–36+6 weeks’ gestation were eligible to participate in the
study with their babies. There were no exclusion criteria. We also identified a group of babies born at term
(≥ 37 weeks’ gestation) during the same time period and geographical region that would be recruited as
a control group.
However, towards the end of the proposed 12-month recruitment period it became apparent that the
target sample size of 800 singleton births in each group was unlikely to be met. An extension of
the recruitment period was agreed with the ethics committee and recruitment continued until
31 December 2010.
Participating centres
We used a population-based design for the study to allow evaluation of the risks and outcomes within a
regional population. The geographical area covered by the study comprised rural and urban populations,
as well as a diverse range of ethnicities and a wide socioeconomic spectrum. This avoided the bias
introduced in hospital-based studies, which often leads to recruitment of a study population with artificially
elevated risk compared with the population as a whole. Within the chosen geographical area around
Leicester and Nottingham, there were four hospitals and one community birth centre that provided
maternity services to the population. Two hospitals in Nottingham provided all levels of neonatal care,
from intensive care to low-dependency or ‘special’ care, with a total of approximately 10,000 deliveries
annually. In Leicester, where there are also approximately 10,000 deliveries in total each year, one hospital
provided both neonatal intensive and low-dependency care while the other provided low-dependency care
only. In each of the two cities a single team of consultant neonatologists working across the two hospital
sites provided medical management of neonatal care. Therefore, although infants were cared for in four
separate geographical locations, for the purposes of delivery of neonatal care, these could be regarded as
two neonatal centres. Both centres were regional referral units for women with complicated pregnancies
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and/or neonates with postnatal problems requiring higher-level care. The community birth centre within
the region catered for around 250 deliveries per year. The deliveries here that were included were to
low-risk women in whom there had been no complications of pregnancy. In addition, a proportion of the
lowest-risk pregnancies were represented by deliveries at home.
Definition of geographical boundaries for recruitment
For the purposes of this study a geographical area covered by these hospitals was defined that maximised
the number of participants in the study but minimised the number of residents who would deliver in other
units not participating in the study (Figure 8). The region covered by the study was well known to the
researchers and has previously been the setting for a number of successful population-based
research studies.
Data were obtained from the ONS for the hospital of birth for babies born in 2007 to mothers living in
the postcode areas NG (Nottingham) and LE (Leicester). Based on these data, for each postcode sector
(e.g. LE1 6) the percentage of births delivering at the five maternity units participating in the study was
calculated. A cut-off point was then determined for the minimum percentage of births to occur in the five
participating maternity units that would give at least 85% of all births in the total included area occurring
in these units, that is to say that a cut-off point of 85% would mean that at least 85% of all births in each
included postcode sector would deliver at one of the five participating delivery sites. The percentage of
Derbyshire
Derby
Nottinghamshire
Nottingham
Lincolnshire
Rutland
Leicestershire
Staffordshire
Staffordshire
Northamptonshire
Leicester
FIGURE 8 Map of area of residence for eligibility for recruitment into the Late And Moderately preterm Birth Study.
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all births in the included area delivering to those five sites was actually much higher than this cut-off point
as nearly all women living in close proximity to a participating hospital deliver there.
Based on these estimates, and the aim of including around 2000 singleton infants in the study, a cut-off
point of 85% was decided on. This equated to 96.8% of births for the included postcode sectors actually
occurring in the five participating hospitals, increasing to 99.2% when home births were included: that is,
only 0.8% of births occurred in maternity units other than the five participating in the study.
Sample size
The sample size was based on detecting differences in rates of cognitive impairment and early
rehospitalisation between the study and control groups of infants from singleton pregnancies. School-age
follow-up of children in the EPICure study used a group of classroom controls,136 among whom the rate of
cognitive impairment was 2%. There are no data for rates of cognitive impairment in moderately preterm
infants in the UK. It was estimated that a rate of 5% cognitive impairment in our study group would be
clinically relevant and justify targeted intervention in children’s health and education services. Oddie et al.115
found that the rate of rehospitalisation in the first month of life in babies born at 35–37 weeks’ gestation
was 6%, compared with 3% among term-born infants. A sample size estimation based on these figures
predicted that recruitment of 800 singleton infants per group would allow detection of this difference in
cognitive function with 90% power and in rehospitalisation with 80% power at the 5% significance level.
To allow for potential non-consent and loss to follow-up, we decided to try to recruit 1000 singleton LMPT
infants and 1000 singleton term-born infants.
In 2007, there were approximately 17,000 singleton births in the selected study area in Leicestershire and
Nottinghamshire. Assuming that the proportion of births at 32+0–36+6 weeks’ gestation is 6–7%, it was
anticipated there would be around 1000–1200 LMPT singleton births in 1 year. A minimum recruitment
rate of 80% would give the required sample size.
Multiple births
To ensure inclusion into the study of sufficient term-born infants from multiple pregnancies it was decided
to include all births at 32+0 weeks’ gestation or greater resulting from multiple pregnancies.
Selection of singleton control infants
Potential term-born control babies were identified using a pseudo-random sample of births obtained from
ONS births data for 2007. For a random sample of 1000 births for the study area, ONS supplied
information on the day of the week of birth, month of birth and place of delivery. A date and time of birth
were then assigned to each of the births in this sample using known dates and time for births in
Leicestershire obtained from the Child Health Registers for Leicester and Leicestershire and Rutland PCTs.
These data were adjusted for day of the week to ensure an appropriate sampling of babies born at the
weekend, as non-urgent induction of labour and CSs are more likely to be undertaken on a weekday.
This method overcomes the bias that may occur if more naive sampling methods are used, for example
selecting the next term birth to occur at the maternity unit after a LMPT birth.137,138 Such sampling methods
would be likely to result in oversampling of high-risk term-born infants as these tend to be delivered in the
sample places and at the same times as LMPT births; for example, no births would have been sampled
from the midwifery-led unit.
Twelve births in the sample were excluded as they occurred at centres other than the five maternity units
included in the Late And Moderately preterm Birth Study (LAMBS) or at home. Therefore, the 988 controls
were used plus an additional 12 sampled from the 988 to make a pseudo-sample of 1000 controls.
The list of potential control singleton births was then passed to the study midwives.
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The birth to be included in the study was the first birth recorded at or after the time stated on the sample
list. If there was uncertainty over which birth should be included because more than one birth occurred at
the same time, then the NHS numbers of the mothers were examined and the infant included was the one
born to the mother with the lowest final digit of NHS number. For example, if there were two eligible
births to mothers with NHS numbers 2365892145 and 6523674352, then the mother with the latter
number would be included. If the last digits were identical, then the next digit to the left would be used
until there was a difference.
Recruitment to Late And Moderately Preterm Birth Study
Timing of recruitment
We aimed to recruit both study and control infants during their initial hospital stay following delivery. The
length of this stay varied considerably depending on the gestational age and clinical condition of the baby
at birth and the condition of the mother. In all centres, it was common for term-born infants to be
discharged home at 6–12 hours following delivery if there was no medical indication for either mother or
baby to remain in hospital. Infants at the lower end of the gestational range required admission to a
NNU and longer hospital stays.
At the time of recruitment, the mothers were either on the delivery suite or on a postnatal ward
depending on the anticipated length of hospital stay. If any mother was too sick to give consent in the
period following delivery, this process was delayed until the obstetrician caring for her was happy that she
was in a fit condition to be approached for consent.
Identification of eligible mothers and infants
Clinical staff on the delivery suite of each participating hospital identified infants born at 32–36 weeks’
gestation and informed a member of the research team. The research midwives referred each day to the
list of dates and times on which to base recruitment of the control infants in order to identify the next
infant born at ≥ 37 weeks’ gestation eligible to be recruited to the control group.
Consent
The Derbyshire NHS Research Ethics Committee (REC) approved the study design and methods. A team
of six midwives who worked collaboratively across the centres carried out recruitment to the study. A
research midwife attempted to approach all eligible mothers within the first 24 hours after the birth to
provide them with an information sheet and obtain written informed consent for their participation.
Mothers who were discharged before this initial contact could be made to present the study were
contacted by a member of the clinical staff and, when possible, a home visit by a research midwife was
arranged. The midwife obtained informed consent at this visit.
Written consent was obtained from parents of study and control infants for the following:
l interview with a research midwife and completion of a maternal lifestyle questionnaire
l collection, retention and analysis of pregnancy, perinatal and neonatal data
l permission to send follow-up questionnaires at 6, 12, 18 and 24 months following the child’s birth.
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Development of the Late And Moderately preterm Birth
Study documentation
Parent information leaflets were designed to be given to parents by the research midwives following a
verbal explanation of the study aims and methods. As relevant information for parents differed between
the LMPT and term groups, two different leaflets were developed. In addition, our intention to recruit all
eligible births, including stillbirths, necessitated the development of separate leaflets for bereaved parents.
There were, therefore, four separate parent information leaflets. Those for bereaved parents were printed
in a different colour from those for parents of live-born infants, to minimise the likelihood of error in
distribution of the information. Similarly, separate consent forms for participation were developed for live
births and stillbirths.
Data at recruitment and at all follow-up stages of the study were collected via a series of paper data
collection forms. These comprised:
l maternal interview questionnaire
l maternal data collection form
l neonatal data collection form
l 6-month follow-up parent questionnaire
l 12-month follow-up parent questionnaire
l 2-year follow-up parent questionnaire.
When possible, data were collected using items or scales that had been previously validated in other
settings (e.g. national census, prior research studies). When this was not possible, specific questions were
developed for the study following review of the relevant published literature. At the 2-year follow-up, all
measures included were validated assessment tools; as such, these are not included in an appendix given
copyright restrictions.
As the East Midlands is home to an ethnically diverse population, information sheets were also translated
to into the most commonly encountered languages: Hindi, Urdu, Punjabi, Gujarati, Polish, French and
Arabic. These versions were stored electronically to be accessible whenever they were needed for a
potential participant.
Staff appointment and training
Midwives working on the LAMBS were interviewed, appointed and began their employment 4 months prior to
the planned commencement of the study. This lead-in period was designed to allow ample time for new
members of staff to obtain required permissions, complete induction and undergo appropriate study-specific
training. Training was provided by the study principal investigator and project manager and included the
following: good clinical practice training, familiarisation with study sites and clinical documentation,
introduction to research methods, background information about neonatal research, prematurity and
published data specifically addressing LMPT birth; and familiarisation with LAMBS documentation, safety issues
and procedures related to research in the community and interview techniques. A period of observed data
collection and practice interviews was included prior to the start of the study.
Accompanying manuals for each of the data collection forms were developed that were intended as
guidance for those collecting data. These were provided to the research midwives in order to (1) standardise
methods of data collection by ensuring that all those collecting data interpreted the questions in the same
way and (2) to provide clear guidance in areas where uncertainty in interpretation was most likely to occur.
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Data collection for the Late And Moderately preterm
Birth Study
Perinatal data collection
Baseline data about all live births, stillbirths and neonatal deaths on delivery suite occurring at 32–36 weeks’
gestation were obtained from records of admissions and deliveries in each participating centre. Individual
participant study data were extracted from medical notes by the research midwives and recorded using
neonatal and maternal data collection forms (see Appendices 1 and 2).
Data relating to mothers’ general medical history, past obstetric history, antenatal care, labour and delivery
were extracted from the mothers’ maternity records. Data relating to the neonatal stay for well term-born
and late preterm infants who required no neonatal medical input were also obtained from the mothers’
maternity records. For infants who received medical care, either on the NNU or on the postnatal ward,
neonatal medical and nursing records were consulted to extract data about the infant’s clinical course until
hospital discharge.
In addition to obtaining data from medical records, research midwives interviewed each consenting mother
using a semistructured questionnaire (see Appendix 1) to obtain sociodemographic details and information
about her lifestyle, living and working conditions and antenatal health.
Follow-up data collection
After discharge from neonatal care, follow-up data were collected using a series of postal questionnaires.
These were sent for parents to complete and return when the children reached 6 and 12 months of
chronological age and 2 years corrected age (2Y-CA). Prior to sending all postal correspondence, infants
were traced via the NHS Patient Demographic Service to ensure that they were alive and to obtain current
contact details. Freepost envelopes were provided for parents to return questionnaires. A second copy of
the questionnaire was mailed 2–3 weeks later if the study centre had not received a
completed questionnaire.
Six months
The questionnaire at 6 months comprised items to assess their child’s use of health-care services, child-care
costs and mothers’ general health (see Appendix 2). Questionnaires were posted to parents within 1 week
of the date on which their child attained 6 months of age.
Twelve months
At 12 months of age, the same questionnaire was sent to obtain further longitudinal data relating to the
use of health-care and social care services, with additional questions to determine whether or not the
child had achieved key developmental milestones (see Appendix 3). Similar to the 6-month follow-up,
questionnaires were mailed to parents within 1 week of the date on which their child reached 12 months
of age and a second copy of the questionnaire was mailed 2–3 weeks later if a completed questionnaire
had not been returned. However, at this follow-up, data were collected using a hierarchical mixed-mode
approach. Parents who had not responded to two postal questionnaires were contacted by telephone,
e-mail or text message to confirm that they had received the questionnaire and to offer the option to
complete it as a telephone interview. Non-responders to postal questionnaires were therefore routinely
offered the option of a telephone interview when contact could be made. At this time, parents were also
given the opportunity to complete the 6-month questionnaire during the same telephone interview if this
had not previously been returned. Up to three attempts were made to contact each family by telephone,
e-mail or text message.
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Two years
At 2 years, the child’s age at follow-up was corrected for prematurity. Data relating to health and
neurodevelopmental outcomes were again collected using a hierarchical mixed-mode approach. Parents
were mailed a questionnaire to complete 7–10 days prior to the day on which their child reached 2 years
of age, corrected for prematurity. If the questionnaire was not received 10 days post 2Y-CA, parents were
contacted by telephone, e-mail or text message to remind them to complete the questionnaire and to
offer the option to complete it over the telephone at a time convenient to them. In addition, at this
follow-up stage, a system for online completion of questionnaires was established to improve response rates.
An identical format of the questionnaire was programmed online using SurveyMonkey® (SurveyMonkey,
Palo Alto, CA, USA) and, if this option was selected, parents were e-mailed a web link to the questionnaire to
be completed at their convenience. If parents could not be contacted by telephone, text or e-mail and the
questionnaire had not been received 2 weeks post 2Y-CA, a second postal questionnaire was sent. A final
attempt was made 1–2 weeks later to contact parents by telephone, text or e-mail to offer a telephone
interview or online completion. A maximum of three attempts were made to contact each family by
telephone, e-mail or text message.
Minimising loss to follow-up
To maintain parents’ interest in the study and minimise participant attrition, parents were sent a study
newsletter when children were 6, 12 and 18 months of age and children were sent a first and second
birthday card. Children were also sent a sticker activity sheet to play with while their parent completed the
questionnaire. Partway through the study, a Facebook group (Facebook, Inc., Menlo Park, CA, USA) was
also established in order to retain contact with the cohort. In order to protect the privacy of participants in
the study, a closed group was established whereby parents could only join after confirming personal
details held on study records. Parents were sent information about how to join the Facebook group with
routine study communications. Questionnaire data were not collected via Facebook, but the private
message system was used to maintain contact with families and send reminders to complete questionnaires.
Regular updates and news about the study were also posted to members of the LAMBS Facebook group to
maintain interest in the study. The Facebook link was included in all communication with parents of children
in the study to remind them of the group’s existence. All communications via Facebook received an
individual response from a member of the LAMBS research team. It was suggested that parents could post
photographs or updates to the Facebook page to encourage participation and dialogue with the study team
and other study families.
Data management and analyses
Data entry and management
A custom-made database was developed for initial study recruitment. This database was employed by
study administrative staff throughout the study period to ensure that participant records were up to date
at all stages of the study. Records of recruitment were cross-checked with birth registers in each maternity
unit. This database was also used to monitor and record method of completion and receipt of
follow-up questionnaires.
Further databases were developed for entry of data relating to each of the study data collection forms
and parent questionnaires. All data were independently double entered into a computer database and any
ambiguous data items were clarified by further review of the medical records. Implausible values were
highlighted during data cleaning and checked.
Statistical analyses
All statistical analyses were undertaken using Stata 13 (StataCorp LP, College Station, TX, USA). Statistical
significance was set at the 5% level for all analyses and no adjustment was made for multiple testing.139
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In all tables categorical variables are presented as n (%) and continuous variables are presented as either
means (SD) or medians (range).
The potential predictive effects of mothers’ and babies’ characteristics on the probability of being born
LMPT were quantified using estimated odds ratios (ORs), with 95% CIs and p-values.
Summary statistics of clinical outcomes are presented by study group, multiplicity and whether or not
labour was spontaneous. Relative risks were estimated for each outcome by Poisson regression, with
95% CIs calculated using robust standard errors (SEs).140,141
Odds ratios were used to estimate the association between the potential predictors and the probability of
being born LMPT as this part of the study had a case–control design and, therefore, the direct estimation
of RRs was not possible.142 The investigation of clinical and neurodevelopmental outcomes, however,
had a cohort study design, which allowed the estimation of RRs.
Non-response at the 2-year follow-up was investigated separately for term-born and LMPT children. The
risk of non-response was calculated using Poisson regression with robust SEs for a variety of maternal and
infant characteristics. For the categorical health, developmental and behavioural outcomes, the risk of the
poor outcome occurring was investigated. RRs with 95% CIs were presented for the risk of the poor
outcome in the LMPT compared with the term-born group. When not accounted for in the developmental
score, adjustments were also made for sex of child, corrected age and socioeconomic status. When
adjustment resulted in separation, this has been noted and estimates are not provided.
For continuous outcomes [measured using the Parent Report of Children’s Abilities – Revised (PARCA-R)
and Brief Infant and Toddler Social–Emotional Assessment (BITSEA) scores], the mean difference with
95% CI between the term-born and LMPT children is presented using a linear model. Adjustments have
been made for corrected age, socioeconomic status and sex of child.
Univariable associations with neurodevelopmental disability for LMPT children were calculated. The
multivariable model was constructed by selecting the variables with a p-value of < 0.2 in the univariable
analysis, excluding the IMD quartile because of its correlation with the socioeconomic score, into a model
selection procedure using backwards stepwise selection. The final model chosen was that in which all
included variables had a p-value of < 0.05.
Socioeconomic risk index
To facilitate exploration of the independent effect of preterm birth on developmental outcomes it was decided
to devise a composite socioeconomic risk index (SES Index) based on the definition of socioeconomic risk
outlined here and the socioeconomic risk factors identified. This was to enable adjustment for important social
and economic factors that are known to influence cognitive and behavioural development. Similar indices have
been used to adjust for social and economic factors in other studies exploring neurodevelopmental outcomes
following preterm birth. Table 11 highlights the contribution of each risk factor to the composite score.
Mother’s education was predominantly measured using the highest qualification from degree level to no
qualifications, but was combined with information on age at leaving full-time education when this information
was missing. Risk was scored as low risk (score= 0, degree or higher), mild risk [score= 1, advanced levels
(A levels)], moderate risk [score= 2, General Certificate of Secondary Education (GCSE) grades A–C] and high
risk (score= 4, GCSE grades D–G or none of the above). Occupation was also scored on this four-level scale,
based on the National Statistics Socio-economic Classification (NS-SEC) gradings (see Table 11).
In addition, receipt of benefits was used as a proxy measure for assigning risk status for mothers who
were unemployed and self-rated as looking after family, as such a large proportion of the population were
looking after the family and did not state a previous occupation. Cohabiting status, car ownership and
home ownership were scored at two levels: low risk (score= 0) and moderate (score= 2). A total score
across the five variables was computed ranging from 0 to 12, which was then used to classify level or risk.
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Maternal age was not included in the SES Index score as this is intrinsically linked with highest educational
qualification and occupational status, thus placing young mothers at particularly high risk and older
mothers at low risk.
Tertiles of risk were then calculated:
1. low risk= SES Index score of 0–2
2. moderate risk= SES Index score of 3–5
3. high risk= SES Index score of ≥ 6.
Exploratory analyses showed that, using these classifications, approximately one-third of mothers fell into
each risk category. Overall, for 12 mothers data were missing for one of the variables, so for these the
missing item was imputed with the mean of the remaining four variables for that child. For only one
mother was more than one item missing, and thus this mother was excluded from analyses using the
SES Index.
Study population
All births
Recruitment until the end of the original planned recruitment period comprised 685 LMPT singleton births
and 730 singleton term-born births. Figure 9 shows final recruitment to the study and survival to discharge
of recruited infants. During the 15-month extended period of recruitment, there were 20,321 births at or
beyond 37 weeks’ gestation within the relevant geographical area and 1376 births between 32 and
36 weeks’ gestation. LMPT births accounted for 6.3% of all births during the study period.
TABLE 11 Factors constituting the SES Index
Socioeconomic
risk aspect Indicator
Risk level
Low (score= 0) Mild (score= 1)
Moderate
(score= 2) High (score=3)
Education Mother’s highest
educational qualification
If missing or unknown
substitute with age at
end of continuous
education
Degree or
equivalent
(≥ 19 years)
A Level or
equivalent
(18–21 years)
GCSE grades A–C
or equivalent
(16–17 years)
GCSE grade D
or below or
equivalent
(< 16 years)
Occupation Mother’s occupational
status (NS-SEC analytic
class)
If ‘looking after family’
coded based on benefit
claims
Managerial,
professional or
administrative
occupations
Intermediate,
supervisory or
small-employer
occupations
Looking after
family (not
claiming benefits)
Routine or
semiroutine
occupations
Unemployed or
never worked
Looking after
family (claiming
income support/
Jobseeker’s
Allowance)
Social support Cohabiting status Living with a
partner
– Not living with a
partner
–
Income Car ownership Access to at
least one car in
the household
– No household
access to car
–
Wealth Home ownership Owns home or
has mortgage
– Rents/part rents/
rent free
–
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All 1376 births at LMPT gestations were eligible to participate and the control selection process identified
1590 term births within the study period that were eligible. Attempts were made to approach mothers of
all these eligible infants, both live born and stillborn, to invite them to participate in the study. A total
of 1146 out of 1376 (83%) LMPT and 1258 out of 1590 (79%) term births were included.
Singleton births
Singleton births accounted for 83.5% of all LMPT births during the study period and for 98.5% of births at
≥ 37 weeks’ gestation. Mothers of 1149 LMPT infants and 1192 term-born singleton infants were eligible
for recruitment to the study and, of these, 938 (81.6%) and 982 (82.5%), respectively, agreed
to participate.
Multiple births
Babies from multiple gestations accounted for 16.5% of LMPT births and for 1.5% of all births at ≥ 37 weeks’
gestation. In contrast to the recruitment of singletons, when eligible term births were sampled from the
complete population of term singleton births, in the case of multiples, all those born at term were eligible as
previously stated. Mothers of 226 LMPT and 298 term-born multiples were eligible to participate and, of
these, 208 (92%) LMPT and 276 (92.6%) term-born babies were recruited.
Stillbirths
There were 36 stillbirths at LMPT gestation and seven stillbirths in the randomly selected group of
deliveries at term. Of these, 16 were recruited to the LMPT group and three to the term-born group.
Non-participation
A record was maintained of numbers of women who declined to participate in the study. This record
comprised only those data that were required to identify potential recruits (gestation, postcode and
whether or not the pregnancy resulted in a live birth or stillbirth). When the reason for non-participation
was articulated, the research midwife documented this.
Live births
Of all mothers of live-born infants, 210 (15.6%) in the LMPT group and 328 (20.7%) in the term group
either declined participation or were unable to be contacted by the clinical staff following discharge from
hospital. A reason for non-participation was given by 118 (56%) of the LMPT group and by 191 (58%) of
the term group. The most common reason in both groups was a lack of interest in the research, which
was the reason given by 45% of LMPT mothers and 36% of mothers delivering at term.
Stillbirths
As might be expected, mothers of stillborn infants were less likely to agree to participate in the study:
55% of mothers of preterm stillborn infants declined to participate, as did 57% of mothers of stillborn
infants born at term. Many of these mothers did not wish to hear about or engage in research after this
distressing experience, although most indicated that they were willing to be contacted at a later date.
Therefore, in most cases, a period of time was allowed to elapse before the research midwives attempted
to approach these women. For those who wished to speak to a research midwife shortly after their
delivery, every effort was made to offer support and, when necessary, practical advice at this time.
Mothers who had given permission to contact them after discharge were telephoned at least 2 weeks
after the delivery and were not approached again if they declined at this time.
Deaths
There were six deaths in the postnatal period prior to discharge home. Of these, five were in LMPT group
and one was in the term-born group. There were two further deaths following discharge from hospital:
one term-born infant died before the 6-month follow-up and a further preterm infant died between
6 months and 1 year.
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Characteristics of mothers delivering at late and moderately
preterm gestations
Objectives
For singleton and multiple gestation pregnancies:
l to describe pre-pregnancy characteristics of mothers who delivered their babies at LMPT gestations
l to compare characteristics of mothers delivering at LMPT gestations with those who delivered at
≥ 37 weeks’ gestation
l to describe characteristics of babies born at LMPT gestations
l to compare characteristics of LMPT babies at birth with those of babies born at ≥ 37 weeks’ gestation
l to determine the incidence and type of congenital anomalies among LMPT babies compared with those
born at term.
Methods
Data obtained from mothers’ obstetric and delivery records were used, together with information gathered
from mothers at the time of interview post delivery.
Measures
Obstetric data
Data collection focused on exploration of the impact of key sociodemographic factors on the incidence of
LMPT birth and on outcomes of newborn infants. We studied the distribution of pre-pregnancy health
factors, including body mass index (BMI) at the time of booking for antenatal care, pre-existing chronic
health problems, diabetes mellitus and hypertension. We also looked at previous obstetric history,
including whether or not this was the first pregnancy and if the mother had experienced a previous
preterm birth.
Maternal interview data
The maternal interview (see Appendix 1) involved collection of sociodemographic data from all mothers.
This included information on mothers’ age, ethnicity, civil status, occupation during pregnancy, working
patterns and conditions, education, socioeconomic status and lifestyle.
The highest maternal educational qualification was classified into four categories: (1) degree or higher;
(2) A levels; (3) GCSE grades A–C; and (4) GCSE grades D–G or none of the above. Occupations were
classified into eight analytic classes which were collapsed into managerial or professional (classes I and II);
intermediate occupations (classes III–V); routine and semiroutine occupations (classes VI and VII); and
unemployed, retired and students (class VIII).
Mothers’ occupational status was classified using the NS-SEC (ONS143), with mothers who reported that
they looked after their family full time classified separately. Other economic information obtained
comprised receipt of means-tested benefits, access to a car, home ownership, self-reported financial status
and information about day-to-day financial hardship. These were combined into the composite working
condition risk score described above.
Data collected relating to mothers’ health comprised self-reported chronic health conditions.
Socioeconomic factors included maternal lifestyle and risk-taking behaviour including the use of tobacco,
alcohol or recreational drugs.
Delivery and neonatal data
Data collection included mode of delivery, gestation, birthweight, gender, FGR and the occurrence of
major chromosomal or structural congenital anomalies. Mode of delivery included spontaneous vaginal
delivery; assisted vaginal delivery, which included all instrumental deliveries with either cephalic or breech
THE LATE AND MODERATELY PRETERM BIRTH STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
56
presentation; and CSs and whether or not this was preceded by labour. Deliveries in which vaginal
instrumental delivery was attempted, but the baby was ultimately delivered by a CS were classified as CS.
FGR was defined using a customised weight percentile of calculator [Gestation Related Optimal Weight
(GROW) Customised Centile Calculators, v5.16; Gestation Network LTD, Birmingham, UK].
There is no universally accepted definition of a major congenital anomaly. For the purposes of this study,
major structural and chromosomal anomalies were classified by clinical consensus and with reference to
the classifications used by the EMSYCAR.
Results
There were 923 mothers who gave birth at LMPT gestation and 980 who gave birth at term to singleton
infants recruited to the study. In terms of multiple births, 103 mothers whose pregnancy ended in delivery
at LMPT gestation and 138 that delivered their babies at ≥ 37 weeks’ gestation joined the study.
The characteristics of mothers of all LMPT and term-born singleton infants participating in the LAMBS are
shown in Table 12 for singleton births and in Table 13 for multiple births. These tables include those
whose babies were born with major structural and/or chromosomal congenital anomalies. Maternal
characteristics were compared between the LMPT and term groups.
Maternal age and ethnicity
The distribution of ages of mothers at the time of delivery was similar between groups, with the majority
(57.3%) of mothers of singleton infants being between 25 and 35 years of age. Compared with the
reference group (aged 25–29 years), much smaller proportions of teenage mothers and older mothers
(> 35 years) delivered at LMPT gestations, but these differences did not reach statistical significance. No
particular age band was associated with increased odds of delivering a singleton baby at LMPT gestation.
The odds of LMPT delivery were significantly increased in mothers of multiple births delivering at
< 20 years of age, but the numbers of these women were extremely small, with only one in the
term group.
The majority of the mothers of infants in both LMPT (71.6%) and term (77.5%) groups were of white
British origin. Women of Asian and Asian British origin formed the next largest group, comprising 18.5%
of mothers delivering LMPT and 14.5% of those delivering at ≥ 37 weeks’ gestation. The odds of these
women delivering LMPT babies were significantly increased (OR 1.38, 95% CI 1.08 to 1.77; p= 0.01)
compared with those of white origin. Odds of LMPT delivery were also increased in women of mixed racial
origin, although the number of these women in the cohort were small (1.9% and 3.3% for LMPT and
term births, respectively).
Maternal socioeconomic characteristics
Living as part of a couple was associated with significantly lower odds of delivering a singleton LMPT infant
than was being a single parent (OR 0.69, 95% CI 0.54 to 0.88; p< 0.01). The number of mothers whose
relationships were consanguineous was small, but similar in both groups of singleton births. Similar
analysis was not possible for multiple pregnancies as there were only five mothers who were in
consanguineous relationships.
With respect to maternal education, comparisons between levels of education were against the reference
group comprising those women who had attained the highest level of educational qualification (degree or
equivalent). When compared with this group, all those with lower levels of education had significantly
increased odds of delivering at LMPT gestation. There was an inverse relationship between mothers’
highest education level and odds of LMPT birth, with the lowest educational group being at highest risk.
A similar pattern was seen for mothers having multiple births, with those in the lowest educational group
having significantly increased odds of delivering LMPT (OR 2.64, 95% CI 1.21 to 5.80; p= 0.015).
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TABLE 12 Characteristics of mothers of all live-born singleton infants
Characteristic Term LMPT
OR (95% CI) for
LMPT p-value
n (%) 980 (51.5) 923 (48.5) – –
Age at time of baby’s birth (years), n (%)
< 20 55 (5.6) 51 (5.5) 0.94 (0.62 to 1.42) 0.76
20–24 187 (19.1) 186 (20.2) 1.01 (0.77 to 1.31) 0.97
25–29 266 (27.1) 263 (28.5) Baseline –
30–34 278 (28.4) 266 (28.8) 0.97 (0.76 to 1.23) 0.79
≥ 35 194 (19.8) 156 (16.9) 0.81 (0.62 to 1.07) 0.14
Unknown 0 (0.0) 1 (0.1) – –
Ethnicity, n (%)
White 759 (77.5) 661 (71.6) Baseline –
Mixed 19 (1.9) 30 (3.3) 1.81 (1.01 to 3.26) 0.046
Asian or Asian British 142 (14.5) 171 (18.5) 1.38 (1.08 to 1.77) 0.01
Black or black British 48 (4.9) 49 (5.3) 1.17 (0.77 to 1.77) 0.50
Chinese or other ethnic group 11 (1.1) 12 (1.3) 1.25 (0.54 to 2.86) 0.59
Missing 1 (0.1) 0 (0.0) – –
Cohabitation, n (%)
Living as part of a couple 849 (86.6) 755 (81.8) 0.69 (0.54 to 0.88) < 0.003
Single 130 (13.3) 168 (18.2) Baseline –
Unknown 1 (0.1) 0 (0.0) – –
Consanguineous relationship, n (%)
Yes 26 (2.7) 23 (2.5) 0.94 (0.53 to 1.66) 0.83
No 951 (97.0) 896 (97.1) Baseline –
Missing 3 (0.3) 4 (0.4) – –
Highest educational qualification, n (%)
Degree or equivalent – codes 4 and 5 333 (34.0) 245 (26.5) Baseline –
A level or equivalent – code 3 227 (23.2) 224 (24.3) 1.34 (1.05 to 1.72) 0.02
GCSE grades A–C or equivalent – code 2 252 (25.7) 262 (28.4) 1.41 (1.11 to 1.80) 0.005
GCSE grade D or below or equivalent –
codes 1 and 0
164 (16.7) 190 (20.6) 1.57 (1.20 to 2.06) 0.001
Unknown 4 (0.4) 2 (0.2) – –
Occupational status during pregnancy, n (%)
Managerial and professional – codes 1 and 2 285 (29.1) 220 (23.8) Baseline
Intermediate – codes 3, 4 and 5 201 (20.5) 180 (19.5) 1.16 (0.89 to 1.52) 0.28
Routine and manual – codes 6 and 7 150 (15.3) 132 (14.3) 1.14 (0.85 to 1.53) 0.38
Never worked or unemployed – code 8 117 (11.9) 150 (16.3) 1.66 (1.23 to 2.24) 0.001
Looking after family – code 9 219 (22.4) 236 (25.6) 1.40 (1.08 to 1.80) 0.01
Missing 8 (0.8) 5 (0.5) – –
BMI at booking, n (%)
Normal 478 (48.8) 479 (51.9) Baseline –
Underweight 37 (3.8) 49 (5.3) 1.32 (0.84 to 2.07) 0.22
Overweight 240 (24.5) 225 (24.4) 0.94 (0.75 to 1.17) 0.56
Obese 184 (18.8) 126 (13.7) 0.68 (0.52 to 0.89) 0.004
Not known 41 (4.2) 44 (4.8) – –
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TABLE 12 Characteristics of mothers of all live-born singleton infants (continued )
Characteristic Term LMPT
OR (95% CI) for
LMPT p-value
Previous preterm delivery, n (%)
Yes 51 (5.2) 175 (19.0) 4.26 (3.07 to 5.91) < 0.001
No 929 (94.8) 748 (81.0) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Primigravida, n (%)
Yes 371 (37.9) 361 (39.1) 1.06 (0.87 to 1.28) 0.56
No 609 (62.1) 561 (60.8) Baseline –
Unknown 0 (0.0) 1 (0.1) – –
Any chronic health problem, n (%)
Yes 306 (31.2) 360 (39.0) 1.41 (1.16 to 1.71) < 0.001
No 674 (68.8) 563 (61.0) Baseline –
Unknown 0 (0.0) 0 () – –
Smoking during pregnancy, n (%)
Yes 204 (20.8) 252 (27.3) 1.44 (1.16 to 1.78) 0.001
No 776 (79.2) 666 (72.2) Baseline –
Unknown 0 (0.0) 5 (0.5) – –
Recreational drug use during pregnancy, n (%)
Yes 12 (1.2) 19 (2.1) 1.69 (0.82 to 3.51) 0.16
No 967 (98.7) 904 (97.9) Baseline –
Unknown 1 (0.1) 0 (0.0) – –
SES Index, n (%)
Low risk 365 (37.2) 283 (30.7) Baseline –
Medium risk 292 (29.8) 270 (29.3) 1.19 (0.95 to 1.50) 0.13
High risk 323 (33.0) 370 (40.0) 1.48 (1.19 to 1.84) < 0.001
Missing 0 (0.0) 0 (0.0) – –
Alcohol in pregnancy, n (%)
Yes 416 (42.5) 367 (39.8) 0.89 (0.74 to 1.08) 0.23
No 563 (57.5) 555 (60.1) Baseline
Unknown 1 (0.1) 1 (0.1) –
Pre-pregnancy diabetes, n (%)
Yes 8 (0.8) 32 (3.5) 4.36 (2.00 to 9.52) < 0.001
No 972 (99.2) 891 (96.5) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Pre-pregnancy hypertension, n (%)
Yes 11 (1.1) 26 (2.8) 2.55 (1.25 to 5.20) 0.01
No 969 (98.9) 897 (97.2) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
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TABLE 13 Characteristics of mothers of all live-born multiple births
Characteristic Term LMPT
OR (95% CI) for
LMPT p-value
n (%) 138 103 – –
Age at time of baby’s birth (years), n (%)
< 20 1 (0.7) 10 (9.7) 14.00 (1.68 to 116.49) 0.015
20–24 16 (11.6) 9 (8.7) 0.79 (1.68 to 2.07) 0.63
25–29 35 (25.4) 25 (24.3) Baseline –
30–34 41 (29.7) 37 (35.9) 1.26 (0.64 to 2.49) 0.50
≥ 35 45 (32.6) 22 (21.4) 0.68 (0.33 to 1.41) 0.30
Unknown 0 (0.0) 0 (0.0) – –
Ethnicity, n (%)
White 105 (76.1) 84 (81.6) Baseline –
Mixed 4 (2.9) 3 (2.9) 1.25 () 0.93
Asian or Asian British 17 (12.3) 9 (8.7) 0.66 () 0.35
Black or black British 12 (8.7) 5 (4.9) 0.52 () 0.24
Chinese or other ethnic group 0 (0.0) 1 (1.0) a a
Unknown 0 (0.0) 1 (1.0) a a
Cohabitation, n (%)
Living as part of a couple 126 (91.3) 89 (86.4) 0.50 (0.21 to 1.19) 0.12
Single 10 (7.3) 14 (13.6) Baseline –
Unknown 2 (1.6) 0 (0.0) – –
Consanguineous relationship, n (%)
Yes 5 (3.6) 0 (0.0) a a
No 133 (96.4) 103 (100.0) a a
Highest educational qualification, n (%)
Degree or equivalent – codes 4 and 5 67 (48.6) 38 (36.9) Baseline –
A level or equivalent – code 3 31 (22.5) 21 (20.4) 1.19 (0.60 to 2.36) 0.61
GCSE grades A–C or equivalent – code 2 25 (18.1) 23 (22.3) 1.62 (0.81 to 3.24) 0.17
GCSE grade D or below or equivalent –
codes 1 and 0
14 (10.1) 21 (20.4) 2.64 (1.21 to 5.80) 0.015
Unknown 1 (0.7) 0 (0.0) – –
Occupational status during pregnancy, n (%)
Managerial and professional – codes 1 and 2 55 (39.9) 40 (38.8) Baseline –
Intermediate – codes 3, 4 and 5 20 (14.5) 12 (11.7) 0.83 (0.36 to 1.88) 0.65
Routine and manual – codes 6 and 7 23 (16.7) 16 (15.5) 0.96 (0.45 to 2.04) 0.91
Never worked or unemployed – code 8 7 (5.1) 15 (14.6) 2.94 (1.10 to 7.89) 0.032
Looking after family – code 9 33 (23.9) 20 (19.4) 0.83 (0.42 to 1.66) 0.60
Unknown 0 (0.0) 0 (0.0) – –
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TABLE 13 Characteristics of mothers of all live-born multiple births (continued )
Characteristic Term LMPT
OR (95% CI) for
LMPT p-value
BMI at booking, n (%)
Normal 68 (49.3) 56 (54.4) Baseline –
Underweight 4 (2.9) 5 (4.9) 1.52 (0.39 to 5.92) 0.55
Overweight 38 (27.5) 21 (20.4) 0.67 (0.35 to 1.27) 0.22
Obese 24 (17.4) 12 (11.7) 0.61 (0.28 to 1.32) 0.21
Not known 4 (2.9) 9 (8.7) – –
Previous preterm delivery, n (%)
Yes 3 (2.2) 8 (7.8) 3.79 (0.98 to 14.66) 0.054
No 135 (97.8) 95 (92.2) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Primigravida, n (%)
Yes 51 (37.0) 39 (37.9) 1.04 (0.61 to 1.76) 0.89
No 87 (63.0) 64 (62.1) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Any chronic health problem, n (%)
Yes 45 (32.6) 34 (33.0) 1.02 (0.59 to 1.75) 0.95
No 93 (67.4) 69 (67.0) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Smoking during pregnancy, n (%)
Yes 23 (16.7) 26 (25.2) 1.69 (0.90 to 3.18) 0.10
No 115 (83.3) 77 (74.8) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Recreational drug use during pregnancy
Yes 0 (0) 4 (3.9) a a
No 137 (99.3) 99 (96.1) a a
Unknown 1 (0.7) 0 (0.0) – –
SES Index, n (%)
Low risk 71 (51.5) 44 (42.7) Baseline –
Medium risk 37 (26.8) 24 (23.3) 1.05 (0.55 to 1.98) 0.89
High risk 30 (21.7) 35 (34.0) 1.88 (1.02 to 3.48) 0.044
Missing 0 (0.0) 0 (0.0) – –
Alcohol in pregnancy, n (%)
Yes 80 (58.0) 67 (65.1) 0.73 (0.43 to 1.25) 0.25
No 57 (41.3) 35 (34.0) Baseline –
Unknown 1 (0.7) 1 (1.0) – –
continued
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For occupational status during pregnancy, comparisons were made against the reference group of
managerial and professional occupations. Compared with this group, all other groups had increased odds
of delivering LMPT infants, and these differences were statistically significant in the case of those who
had never worked or were unemployed (OR 1.66, 95% CI 1.23 to 2.24; p= 0.001), and in women
who reported that they were looking after their family on a full-time basis (OR 1.40, 95% CI 1.08 to 1.81;
p= 0.01). Within the group of multiple births, those who had never worked or were unemployed had
increased odds of LMPT delivery (OR 2.94, 95% CI 1.10 to 7.89; p= 0.032)
Using the derived SES Index, as described previously, the odds of delivering LMPT were increased within
the high-risk socioeconomic group compared with the low-risk group (OR 1.48, 95% CI 1.19 to 1.84;
p< 0.001). Although the pattern was similar for multiple births, the difference between the high- and
low-risk groups was of more marginal statistical significance (p= 0.044).
Maternal lifestyle
The majority of women in both study groups had a BMI within the normal range. Compared with those
with booking weight within the normal range, however, those women whose weight fell within the obese
range were less likely to deliver a LMPT baby (OR 0.68, 95% CI 0.52 to 0.89; p= 0.004). This was not the
case for multiple births.
Smoking during pregnancy was associated with increased odds of delivery at LMPT gestation (OR 1.44,
95% CI 1.16 to 1.78; p= 0.001) in singleton but not in multiple pregnancies. The number of women who
reported the use of recreational drugs was very small, but in this study this did not carry any increased risk
of LMPT delivery. Alcohol use in pregnancy was also not associated with increased odds of LMPT delivery
in either singleton or multiple pregnancies.
Previous preterm birth and pre-pregnancy health
Nineteen per cent of mothers of LMPT singleton infants had experienced a previous preterm delivery,
compared with 5.2% of mothers delivering at term (OR 4.26, 95% CI 3.07 to 5.91). In the small number
of multiple pregnancies in which the mother had previously had a preterm birth, there was a trend
towards increased odds, but this did not reach statistical significance, and CIs were wide (OR 3.79, 95% CI
0.98 to 14.66). Women for whom this was the first pregnancy, regardless of whether this was a singleton
or a multiple birth, were not at increased risk of delivering at LMPT gestations.
TABLE 13 Characteristics of mothers of all live-born multiple births (continued )
Characteristic Term LMPT
OR (95% CI) for
LMPT p-value
Pre-pregnancy diabetes, n (%)
Yes 2 (1.5) 0 (0.0) a a
No 136 (98.6) 103 (100.0) a a
Unknown 0 (0.0) 0 (0.0) – –
Pre-pregnancy hypertension, n (%)
Yes 1 (0.7) 1 (1.0) 1.34 0.84
No 137 (99.3) 102 (99.0) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
a Unable to calculate as a result of separation of data.
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A large number of women delivering singletons reported having had chronic health problems during
pregnancy (39.0% of LMPT singleton births and 31.2% of term births). Those reporting chronic health
problems had increased odds of LMPT birth (OR 1.41, 95% CI 1.17 to 1.70; p< 0.001) compared with
those who did not. Among mothers having multiple births, the proportion was similar for LMPT (33.0%)
and term (32.6%) groups.
Specifically, pre-pregnancy diabetes and pre-pregnancy hypertension were associated with LMPT delivery
in singleton pregnancies [OR 4.36, 95% CI 2.00 to 9.52 (p< 0.01), and OR 2.56, 95% CI 1.25 to 5.20,
respectively]. The numbers of women having multiple pregnancies who had suffered from either of these
conditions prior to becoming pregnant were too small to be suitable for analysis.
The characteristics of live-born singleton babies, including those with congenital anomalies, are shown in
Table 14. The birth characteristics of 923 LMPT and 980 term-born singleton babies are compared. There
were no statistically significant differences in the number of male babies or in the proportion of first-born
infants. There were twice as many congenital anomalies in the LMPT group, but this difference did
not reach statistical significance. LMPT babies were significantly more likely to have been affected by
intrauterine growth restriction (OR 1.95, 95% CI 1.51 to 2.51; p= 0.001). Compared with spontaneous
vaginal deliveries, LMPT babies were more likely to be born following pre-labour CSs (OR 2.17, 95% CI
1.67 to 2.81; p< 0.001) and significantly less likely to have an assisted vaginal delivery (OR 0.71, 95% CI
0.54 to 0.93; p= 0.014).
There were 207 LMPT and 275 live term-born infants from multiple pregnancies and their birth characteristics
are shown in Table 15. As for singletons, there were no statistically significant differences in gender or in the
proportion of first-born infants. Although a significant difference is seen for congenital anomalies, with LMPT
TABLE 14 Characteristics of all live-born singleton infants
Characteristic Term LMPT
OR (95% CI) for
LMPT p-value
N (%) 980 (51.5) 923 (48.5) – –
Birthweight (g), median (range) 3420 (1980 to 5160) 2480 (1120 to 4960) – –
Male sex, n (%) 503 (51.3) 512 (55.5) 1.18 (0.99 to 1.41) 0.07
Major congenital anomalies, n (%) 8 (0.8) 16 (1.7) 2.14 (0.91 to 5.03) 0.08
Birthweight below the 10th fetal
percentile, n (%)
113 (11.5) 187 (20.3) 1.95 (1.51 to 2.51) 0.001
First born, n (%)
Yes 437 (44.6) 434 (47.0) 1.12 (0.93 to 1.34) 0.24
No 537 (54.8) 478 (51.8) Baseline –
Unknown 6 (0.6) 11 (1.2) – –
Mode of delivery, n (%)
Spontaneous vaginal 616 (62.9) 524 (56.8) Baseline –
Assisted vaginal 167 (17.0) 101 (10.9) 0.71 (0.54 to 0.93) 0.014
CS, during labour 89 (9.1) 99 (10.7) 1.31 (0.96 to 1.78) 0.089
CS, not in labour 108 (11.0) 199 (21.6) 2.17 (1.67 to 2.81) < 0.001
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having increased odds of being affected (OR 9.59, 95% CI 1.17 to 78.56; p= 0.035), this must be interpreted
with caution because of the small numbers and very wide CIs. In contrast to singleton births, multiples were
more likely to be delivered by CS after the onset of labour but, similar to singletons, the odds of assisted
vaginal delivery in the LMPT group were reduced compared with spontaneous vaginal delivery (OR 0.40,
95% CI 0.21 to 0.75; p= 0.004).
Stillbirths
There were 16 recruited stillbirths in the LMPT group and three in the term group. The very small numbers
of stillbirths occurring within the study period, and even smaller number of recruits in this group, means
that meaningful analysis of the data collected for these mothers and their babies was not possible.
However, the characteristics of the participating mothers and their stillborn infants are detailed in Table 16.
There were 15 singleton stillbirths in the LMPT group and two in the term group. There was one stillborn
infant in each group that was from a twin pregnancy. There were no stillbirths in higher-order multiple
births and in no case were both twins stillborn.
One mother consented to participate in the study following the birth of her baby that was known to have
died in utero, but, when contacted at a later date to arrange an interview, she was too distressed to
participate. Therefore, data for this case were available only from the mother’s maternity records and some
data items were missing.
One stillbirth was the result of elective feticide in a twin pregnancy at 33 weeks’ gestation. This baby was
included in the study, as the birth fulfilled the eligibility criteria. Documentation at the time of the feticide
suggested that the decision for this course of action was taken because of antenatal detection of multiple
fetal anomalies, but no further details were available about the nature of these anomalies.
TABLE 15 Characteristics of all live-born infants from multiple births
Characteristic Term LMPT
OR (95% CI) for
LMPT p-value
N (%) 275 (57.1) 207 (42.9) – –
Birthweight (g), median (range) 2720 (1250 to 4120) 2200 (1098 to 3390) – –
Male sex, n (%) 148 (53.8) 97 (46.9) 0.76 (0.53 to 1.09) 0.13
Major congenital anomalies, n (%) 1 (0.4) 7 (3.4) 9.59 (1.17 to 78.56) 0.035
Birthweight below the 10th fetal
percentile, n (%)
117 (42.6) 73 (35.3) 0.74 (0.51 to 1.07) 0.11
First born, n (%)
Yes 126 (45.8) 106 (51.2) 1.24 (0.86 to 1.78) 0.24
No 149 (54.2) 101 (48.8) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Mode of delivery, n (%)
Spontaneous vaginal 65 (23.6) 50 (24.2) Baseline –
Assisted vaginal 65 (23.6) 20 (9.7) 0.40 (0.21 to 0.75) 0.004
CS, during labour 39 (14.2) 57 (27.5) 1.90 (1.10 to 3.29) 0.022
CS, not in labour 106 (38.5) 80 (38.7) 0.98 (0.61 to 1.57) 0.94
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TABLE 16 Maternal and infant characteristics for all stillborn infants
Characteristics Term LMPT
Maternal characteristics
N (%) 3 (15.6) 16 (84.2)
Age at time of baby’s birth (years), n (%)
< 20 0 (0.0) 2 (12.5)
20–24 0 (0.0) 5 (31.3)
25–29 1 (33.3) 4 (25.0)
30–34 2 (66.7) 3 (18.8)
≥ 35 0 (0.0) 2 (12.5)
Unknown 0 (0.0) 0 (0.0)
Ethnicity, n (%)
White 3 (100.0) 10 (62.5)
Mixed 0 (0.0) 0 (0.0)
Asian or Asian British 0 (0.0) 5 (31.3)
Black or black British 0 (0.0) 0 (0.0)
Chinese or other ethnic group 0 (0.0) 0 (0.0)
Unknown 0 (0.0) 1 (6.3)
Cohabitation, n (%)
Living as part of a couple 2 (66.7) 13 (81.3)
Single 1 (33.3) 2 (12.5)
Unknown 0 (0.0) 1 (6.3)
Consanguineous relationship, n (%)
Yes 0 (0.0) 0 (0.0)
No 3 (100.0) 15 (93.7)
Unknown 0 (0.0) 1 (6.3)
Highest educational qualification, n (%)
Degree or equivalent – codes 4 and 5 2 (66.7) 4 (25.0)
A level or equivalent – code 3 0 (0.0) 2 (12.5)
GCSE grades A–C or equivalent – code 2 1 (33.3) 6 (37.5)
GCSE grade D or below or equivalent – codes 1 and 0 0 (0.0) 3 (18.8)
Unknown 0 (0.0) 1 (6.3)
Occupational status during pregnancy, n (%)
Managerial and professional – codes 1 and 2 1 (33.3) 3 (18.8)
Intermediate – codes 3, 4 and 5 1 (33.3) 3 (18.8)
Routine and manual (%) – codes 6 and 7 1 (33.3) 2 (12.5)
Never worked or unemployed – code 8 0 (0.0) 0 (0.0)
Looking after family – code 9 0 (0.0) 7 (43.8)
Unknown 0 (0.0) 1 (6.3)
continued
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TABLE 16 Maternal and infant characteristics for all stillborn infants (continued )
Characteristics Term LMPT
BMI at booking, n (%)
Normal 1 (33.3) 6 (37.5)
Underweight 0 1 (6.3)
Overweight 2 (66.7) 5 (31.3)
Obese 0 3 (18.8)
Not known 0 1 (6.3)
Previous preterm delivery, n (%)
Yes 0 (0.0) 3 (18.8)
No 3 (100.0) 13 (81.2)
Unknown 0 (0.0) 0 (0.0)
Primigravida, n (%)
Yes 0 (0.0) 2 (12.5)
No 3 (100.0) 13 (81.3)
Unknown 0 (0.0) 1 (6.3)
Any chronic health problem, n (%)
Yes 1 (33.3) 6 (37.5)
No 2 (66.7) 10 (62.5)
Unknown 0 (0.0) 0 (0.0)
Smoking during pregnancy, n (%)
Yes 1 (66.7) 5 (31.3)
No 2 (33.3) 10 (62.5)
Unknown 0 (0.0) 1 (6.3)
Recreational drug use during pregnancy, n (%)
Yes 0 (0.0) 0 (0.0)
No 3 (100.0) 15 (93.8)
Unknown 0 (0.0) 1 (6.3)
First born, n (%)
Yes 1 (33.3) 4 (25.0)
No 2 (66.7) 12 (75.0)
Unknown 0 (0.0) 0 (0.0)
Mode of delivery, n (%)
Spontaneous vaginal 1 (33.3) 11 (68.8)
Assisted vaginal 1 (33.3) 2 (12.5)
CS, during labour 1 (33.3) 2 (12.5)
CS, not in labour 0 0 (0.0)
Unknown 0 1 (6.3)
Infant characteristics
n (%) 3 (15.8) 16 (84.2)
Male sex, n (%) 0 (0.0) 12 (75.0)
Major congenital anomalies, n (%) 0 (0.0) 0 (0.0)
Birthweight below tenth fetal percentile, n (%) 1 (33.3) 6 (37.5)
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Discussion
In singleton pregnancies, previous preterm birth and pre-pregnancy health were factors that were
associated with the highest odds of delivering at LMPT gestation. Khatibi et al.144 found that increased
maternal pre-pregnancy BMI increased the risk of both early and late preterm delivery. In contrast,
this current study found decreased odds of LMPT delivery in obese mothers.
Women with diabetes or hypertension that originated prior to pregnancy were at particular risk. Carter
et al.145 also found an increase in late preterm birth among women with pre-gestational diabetes mellitus.
Catalano and Sacks146 suggest that the risk of intrauterine death at term, even in women with well-controlled
diabetes, is significant, but whether the risk is different in those with chronic rather than pregnancy-related
disease is not clear. Kase et al.147 reported that one-third of women with chronic hypertensive disease
delivered before 37 weeks’ gestation, with more than half of these being in the late preterm period. There is
only limited evidence regarding management of women with chronic diseases in pregnancy and the relative
benefits and risks associated with early delivery. Among the other reported illnesses, a very large range of
problems was cited, including conditions with a very wide spectrum of severity such as ‘depression’,
‘back problems’ and ‘asthma’. No relationship between chronic disease and multiple LMPT birth were
demonstrated, but the number of multiple pregnancies was relatively small.
In this study we saw a larger proportion of congenital anomalies in both singletons and multiples in the
LMPT group than in the term-born group. Although this was not a statistically significant finding, it is
possible that the differences would reach significance if examined in a larger cohort. Intrauterine growth
restriction was more common in the LMPT infants and it is likely that, for many of these babies, their poor
growth would have been the indication for early delivery.
Conclusions
Key findings
l There was an inverse relationship between mothers’ highest education level and odds of LMPT birth in
both singleton and multiple pregnancies, with the lowest educational group being at highest risk.
l Mothers of Asian origin had increased odds of LMPT delivery than in those women whose ethnicity
was white.
l Living as part of a couple during pregnancy was associated with lower odds of LMPT delivery than
being single.
l Previous preterm delivery was associated with a fourfold increase in the odds of LMPT delivery
compared with delivery at term.
l Maternal hypertension and diabetes originating prior to pregnancy were associated with two and four
times increased odds of delivering at LMPT gestations, respectively, compared with term births.
l LMPT babies are more likely to be affected by intrauterine growth restriction than those born at term.
Strengths and limitations
The population-based nature of the study and inclusion of 80% of eligible mothers allowed recruitment
from a socially and culturally diverse population. In addition, our study was able to recruit a large
proportion of all births of twins and higher multiples. However, although study information was available
in multiple languages for women from ethnic minorities, for the most part those with a limited
understanding of English chose not to participate and this may have influenced our results with respect to
analyses based on ethnicity.
We have identified an association between LMPT singleton delivery and previous preterm delivery,
although from our data we are unable to determine whether this increased risk is related to previous LMPT
birth or previous delivery at lower gestations.
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In our study, information about specific pre-pregnancy diseases and any other chronic illnesses was
ascertained by self-report at interview. It is well recognised that self-report may lead to either under- or
over-reporting of conditions, although this effect is likely to occur in both study groups. No attempt has
been made to determine the severity of these problems, but further subclassification of the conditions with
respect to the likelihood of impact on pregnancy outcomes may be helpful.
Implications for practice
Although there is currently limited evidence for interventions to prevent preterm birth, our findings suggest
that targeted counselling and/or care for a number of groups at risk of delivering at LMPT gestations
may be appropriate. These include women who are likely to have difficulties accessing medical care,
such as those with lower levels of education and those from ethnic minority communities. Women with
longstanding chronic diseases may also benefit from enhanced medical surveillance or input to minimise
the impact of their disease during pregnancy and optimise outcomes. However, the efficacy of targeted
counselling and/or surveillance has not yet been tested and would require evaluation.
A number of sociodemographic factors were found to be associated with LMPT birth in both singletons
and multiples. The impact and implications for these in singleton births are discussed in detail in a
following section.
Future research
Further investigation of common and important pre-pregnancy medical conditions is warranted to clarify
factors that place women at increased risk of LMPT delivery and determine whether targeted or general
counselling, interventions and education can improve pregnancy outcomes for specific groups. Currently,
information is limited about factors influencing spontaneous onset of labour at LMPT gestations and the
role that maternal medical conditions play in this. There also remains a paucity of data about pregnancies
in which pre-existing disease exerts an influence on the progress of pregnancy or well-being of the baby
either directly, or by precipitating or exacerbating pregnancy-related complications. Exploration of this is
necessary to guide obstetric decision-making in situations in which either expectant management or
early delivery is an option, but the optimal course of action is uncertain.
Complications of pregnancy and obstetric intervention
Objectives
l To describe the frequency and type of pregnancy-related complications affecting women who go on to
deliver at LMPT gestations.
l To compare pregnancy-related complications in women delivering at LMPT gestations with those
delivering at term.
l To describe the frequency of assisted reproductive techniques (ARTs), obstetric investigations and
interventions in women delivering at LMPT gestations and compare these with women delivering
at term.
Methods
Detailed data about each mother’s pregnancy, obstetric interventions during pregnancy, administration of
antenatal steroids and induction of labour were extracted from her maternity records. Information about
ARTs for this pregnancy was obtained from the interview with the mother.
Details of the statistical methods are given in Data management and analyses.
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Measures
Pregnancy-related data collection was focused upon exploration of the impact of several key factors on the
incidence of LMPT birth. Clinical factors affecting the mother and/or the fetus during pregnancy or labour
were explored.
Maternal complications included pre-eclampsia, infection, gestational diabetes and prolonged rupture of
membranes (PROM). Pre-eclampsia was defined as proteinuric hypertension with or without other
symptoms. Prolonged rupture of the membranes was considered to be significant if the time between
membrane rupture and delivery was > 24 hours. Maternal systemic infection during pregnancy was
defined as illness when positive cultures were obtained from the mother’s blood. During labour, raised
maternal C-reactive protein (CRP) levels of > 5mg/l or pyrexia of > 37.5 °C were regarded as clinical
evidence of maternal systemic infection and/or chorioamnionitis.
Complications affecting the fetus included intrauterine FGR, abnormalities of umbilical Doppler studies,
meconium staining of the liquor, abnormalities on cardiotocography (CTG) and umbilical cord prolapse.
Fetal growth restriction was defined using the GROW software. As umbilical vessel Doppler studies are
performed only in pregnancies in which there are concerns about placental insufficiency and effects on
fetal growth or fetal well-being, this investigation would have been indicated in only a limited proportion
of women. Abnormal umbilical Doppler studies were defined as those in which the end-diastolic flow in
the umbilical arteries was determined to be absent or reversed. We did not collect data regarding the
length of time these findings were present or whether the findings were constant or intermittent in nature.
Many different abnormalities can affect the results of CTG during labour. We collected data for all possible
abnormalities including fetal tachycardia, early, late or variable decelerations of the fetal heart rate,
sustained fetal bradycardia and other abnormalities not specified. However, CTG is not performed in all
women during labour. When it was clear that no cardiotocographic trace could be obtained, either
because CTG was not performed or for other reasons, this was documented.
Data collected about ARTs included information about a range of techniques: ovulation induction using
clomifene, follicle-stimulating hormone or other means, intrauterine insemination, donor insemination, in
vitro fertilisation, intracytoplasmic sperm injection and reversal of sterilisation. However, because of the
number of women having ARTs was small, the different methods were not separated for analysis.
Details about amniocentesis, if performed, were recorded, together with the reason for performing the
investigation (maternal age, suspected chromosomal or other anomaly) and whether the results were
normal or abnormal. In the case of chorionic villous sampling (CVS), we recorded whether the result
was normal or abnormal.
A complete course of antenatal steroids was defined as either two doses of betamethasone, 12 hours
apart, or two doses of dexamethasone, 24 hours apart. An incomplete course was defined as one dose of
either drug. The date and time of the last dose prior to delivery were recorded and whether or not
multiple courses had been administered.
Results
Maternal and fetal complications occurring during pregnancy or labour are shown in Table 17 for 938
LMPT deliveries and 982 term deliveries. Stillbirths and pregnancies in which fetal anomalies were
diagnosed, either antenatally or in the neonatal period, are included.
Maternal complications
Women with systemic infection during pregnancy were no more likely to deliver at LMPT gestations than
at term. However, when a raised CRP level was documented during labour, this was associated with odds
of LMPT delivery that were 11 times greater than the odds of delivering at term (OR 11.85, 95% CI
3.62 to 38.79; p< 0.001). In contrast, women with a documented temperature of > 37.5 °C during labour
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TABLE 17 Complications of pregnancy and labour in all singleton deliveries
Complication Term LMPT OR (95% CI) for LMPT p-value
Maternal complications during pregnancy
N (%) 982 (51.2) 938 (48.9) – –
Systemic infection, n (%)
Yes 3 (0.3) 5 (0.5) 1.77 (0.42 to 7.41) 0.44
No 972 (99.0) 917 (97.8) Baseline –
Unknown 7 (0.7) 16 (1.7) – –
Pre-eclampsia, n (%)
Yes 36 (3.7) 128 (13.7) 4.16 (2.84 to 6.10) < 0.001
No 940 (95.7) 803 (85.6) Baseline –
Unknown 6 (0.6) 7 (0.87) – –
Gestational diabetes, n (%)
Yes 31 (3.2) 41 (4.4) 1.41 (0.87 to 2.26) 0.16
No 949 (96.6) 893 (95.2) Baseline –
Unknown 2 (0.2) 4 (0.4) – –
Prolonged rupture of membranes > 24 hours, n (%)
Yes 70 (7.1) 217 (23.1) 3.91 (2.94 to 5.21) < 0.001
No 900 (91.7) 713 (76.0) Baseline –
Unknown 12 (1.2) 8 (0.9) – –
Maternal complications during labour
Raised CRP level of > 5mg/l, n (%)
Yes 3 (0.3) 33 (3.5) 11.85 (3.62 to 38.79) < 0.001
No 943 (96.0) 875 (93.3) Baseline –
Unknown 36 (3.7) 30 (3.2) – –
Raised temperature > 37.5 °C, n (%)
Yes 45 (4.6) 55 (5.9) 1.30 (0.87 to 1.95) 0.20
No 931 (94.8) 875 (93.3) Baseline –
Unknown 6 (0.6) 8 (0.9) – –
Fetal complications
Fetal growth restriction < 10th percentile,b n (%)
Yes 113 (11.5) 193 (20.6) 1.99 (1.55 to 2.56) < 0.001
No 869 (88.5) 745 (79.4) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Abnormal umbilical Doppler studies, n (%)
Yes 2 (0.2) 25 (2.7) 13.4 (3.17 to 56.80) < 0.001
No 980 (99.8) 913 (97.3) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
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were no more likely to deliver early. These results must be interpreted with caution. CRP level is generally
regarded as a reasonably sensitive biochemical marker of the presence of infection, but is not measured in
all women, so this finding is likely to reflect a group of women in whom infection was suspected. We do
not have data for women in whom a CRP was measured, but was not found to be elevated, or for those
in whom it was never measured. Modest fever of > 37.5 °C is less sensitive than a raised CRP level and can
be caused by other, non-pathological, factors such as the ambient environmental temperature or the use
of epidural anaesthesia in labour. Had data collection been limited to a more extreme value for mothers’
temperature, this may have produced different results.
Pre-eclampsia was also associated with increased odds of LMPT delivery, with affected women being four
times more likely to delivery LMPT than at term (OR 4.16, 95% CI 2.84 to 6.10; p< 0.001). In addition,
women who delivered LMPT infants were more likely than those delivering at term to have experienced
rupture of the amniotic membranes > 24 hours prior to delivery. Gestational diabetes affected < 5% of
women in each group and was not associated with increased odds of LMPT delivery compared with
delivery at term.
Fetal complications
Fetal growth restriction and abnormal antenatal umbilical Doppler studies are closely related and are both
likely to lead to decisions to deliver an affected infant prematurely. It is, therefore, not a surprising finding
that, in this study, using univariable analysis, both were associated with increased odds of LMPT delivery
[FGR: OR 1.99, 95% CI 1.55 to 2.56 (p< 0.001); abnormal Doppler: OR 13.4, 95% CI 3.17 to 56.80
(p< 0.001)]. Fetal growth restriction is likely to be the more reliable measure of the two, as it is impossible
to know, with any degree of certainty, how many mothers in either group would have had abnormal
studies if these had been performed. The uncertainty and the effect of small numbers are reflected in wide
CIs for this measure.
Cardiotocographic abnormalities of any kind were common in both LMPT and term deliveries, with > 40%
of all women in each group having some documented CTG abnormality during labour. However,
abnormalities were more commonly documented in LMPT deliveries and this was associated with increased
odds of LMPT delivery (OR 1.28, 95% CI 1.07 to 1.54; p< 0.007) compared with deliveries at term.
TABLE 17 Complications of pregnancy and labour in all singleton deliveries (continued )
Complication Term LMPT OR (95% CI) for LMPT p-value
Meconium-stained liquor, n (%)
Yes 129 (13.1) 43 (4.6) 0.32 (0.22 to 0.45) < 0.001
No 844 (86.0) 886 (94.5) Baseline –
Unknown 9 (0.9) 9 (1.0) – –
CTG abnormality, n (%)
Yes 427 (43.5) 466 (49.7) 1.28 (1.07 to 1.54) 0.007
No 555 (56.5) 472 (50.3) Baseline –
Unknown 0 (0.0) 0 (0.0) – –
Umbilical cord prolapse, n (%)
Yes 0 (0.0) 4 (0.4) a a
No 978 (99.6) 931 (99.3) a a
Unknown 4 (0.4) 3 (0.3) – –
a Unable to calculate as a result of separation of data.
b Fetal growth restriction calculated using the GROW software.
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Meconium staining of the liquor was significantly less common in LMPT deliveries (OR 0.32, 95% CI
0.22 to 0.45; p< 0.001), which is an expected finding, as fetal distress associated with the passage of
meconium in utero is principally a concern for women during labour at term, and in particular for
post-term births (> 41 weeks’ gestation).
Umbilical cord prolapse was seen in only four (0.4%) LMPT deliveries and in no term deliveries, and so
further analysis was not possible for this variable.
Assisted reproductive techniques and obstetric intervention
Table 18 shows the numbers of pregnancies that were the result of ARTs, and the number that required
obstetric investigation or intervention in terms of amniocentesis, CVS or administration of ANSs for
threatened preterm delivery and induction of labour. All mothers, including those delivering multiples,
stillbirths and infants with congenital anomalies, are included. This comprised 1041 mothers delivering
LMPT and 1120 delivering at term.
There were 47 (4.5%) births following ARTs in the LMPT group and 67 (6%) in the term group. This
difference was not statistically significant. There were also no differences between the groups in the
number of women undergoing amniocentesis or CVS during their pregnancy. Both investigations were
carried out in only very small numbers of women; this was particularly true for CVS, and CIs were wide.
As expected, the number of women receiving ANSs was significantly higher in the LMPT group (26.2%),
although a small proportion (1.4%) of mothers who went on to deliver at ≥ 37 weeks’ gestation had been
given corticosteroids for anticipated preterm delivery at some stage in their pregnancy (OR 24.63, 95% CI
14.75 to 41.12; p> 0.001). Induction of labour was less common in mothers who delivered their babies at
LMPT gestations.
TABLE 18 Obstetric investigations and interventions
Investigation/intervention Term LMPT OR (95% CI) for LMPT p-value
Number of mothers, N (%) 1120 (51.8) 1041 (48.2) – –
Assisted reproductive techniques, n (%)
Yes 67 (6.0) 47 (4.5) 0.74 (0.51 to 1.10) 0.13
No 1053 (94.0) 994 (95.5) Baseline –
Amniocentesis, n (%)
Yes 14 (1.3) 17 (1.6) 1.32 (0.65 to 2.59) 0.45
No 1103 (98.5) 1017 (97.7) Baseline –
Unknown 3 (0.3) 7 (0.7) – –
CVS, n (%)
Yes 1 (0.01) 5 (0.5) 5.39 (0.63 to 46.24) 0.12
No 1110 (99.1) 1029 (98.9) Baseline –
Unknown 9 (0.79) 7 (0.7) – –
Administration of ANSs, n (%)
Yes 16 (1.4) 273 (26.2) 24.63 (14.75 to 41.12) < 0.001
No 1100 (98.2) 762 (73.2) Baseline –
Unknown 4 (0.4) 6 (0.6) – –
Induction of labour, n (%)
Yes 304 (27.1) 232 (22.3) 0.77 (0.63 to 0.94) 0.009
No 812 (72.5) 806 (77.4) Baseline –
Unknown 4 (0.4) 3 (0.3) – –
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Discussion
We saw higher rates of LMPT delivery in women with prolonged rupture of the amniotic membranes.
Other researchers have also identified PROM as being more common in LMPT deliveries.148,149 Labour has
often been induced between 34 and 37 weeks’ gestation in women in the hope of avoiding problems in
the neonate. However, the results of the recently published PPROMEXIL (Preterm Prelabour Rupture Of
Membranes Expectant Management versus Induction of Labour) trial150 suggest that induction of labour
carries no benefit over expectant management. Pre-eclampsia is another common reason for medically
indicated delivery, when the well-being of the fetus is in jeopardy because of maternal illness. Although
delivery may be indicated at any time during pregnancy for very severe disease, the report of the
HYpertension and Pre-eclampsia Intervention Trial At Term (HYPITAT) trial151 recommends induction of
labour at 37 weeks’ gestation in women with mild pre-eclampsia. There is little evidence to suggest that
earlier delivery for pre-eclampsia improves outcomes for either the mother or the baby.152 An increase
in LMPT birth in mothers with pre-eclampsia has been reported, but in our study we sought only to
determine the presence, not the severity, of pre-eclampsia. In contrast to others,145 we found no increased
risk of LMPT birth in women with gestational diabetes.
Cardiotocographic abnormalities were detected in large numbers of women in both groups. It is possible that
this finding was affected by a degree of bias, as women in whom preterm delivery is anticipated are more
likely to be hospitalised prior to delivery and, therefore, are more likely to undergo CTG at this time. In
addition, although efforts were made to distinguish those women in whom CTG had been performed and
was normal from those in whom CTG was not carried out, this proved difficult. It is possible that CTG was not
carried out in a substantial proportion of the large number of women in whom no abnormality was reported,
and it cannot be presumed that CTG would be normal in these women. Further analysis of the more severe
abnormalities that might be expected to adversely affect the fetus may be more discriminating.
Fetal growth restriction was commoner in LMPT deliveries and, in a large proportion of these, is likely to have
been the main indication for early delivery. As expected, this is reflected in a larger proportion of women in
this group having abnormal antenatal umbilical Doppler studies. The documented rates are likely to be an
underestimate of the occurrence of abnormal Doppler studies, as it is likely that FGR was not identified
antenatally in some women,153 who, therefore, may not have undergone Doppler ultrasonography.
Conclusions
Key findings
l Pregnancies ending in LMPT delivery are more likely to have been affected by PROM, pre-eclampsia
and FGR than are pregnancies that continue to term.
Implications for practice
The results of this study highlight for obstetric clinicians the increased likelihood of LMPT delivery in
pregnancies complicated by pre-eclampsia, FGR and infection. Both expectant management and early
delivery carry competing risks, with the risk of stillbirth at one end of the spectrum and the risk of neonatal
morbidity at the other. As the optimal time for delivery has not yet been determined, options for
management of these women at this stage of pregnancy should be approached with careful consideration
of all factors.
Strengths and limitations
We have collected a wide range of obstetric information about mothers delivering at LMPT gestations
and the in utero well-being of babies in order to determine factors that are associated with LMPT birth.
We have shown that LMPT delivery is more common in pregnancies affected by complications. It was,
however, beyond the scope of this study to explore the decision-making processes of obstetric teams that
led to LMPT delivery in those in whom delivery was elective or semielective, and this is likely to play a
crucial part in rates of LMPT birth and variation in these.
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Future research
There is a need for further research into the management of complicated pregnancies at LMPT gestations
and, in particular, to define optimum management of women who develop pre-eclampsia. The role of
infection and inflammation in LMPT delivery and the value of clinical markers in guiding decisions to deliver
require clarification.
There have been few studies of the outcomes of pregnancies affected by common complications with the
aim of identifying the point at which the risk of in utero demise exceeds the risk of neonatal morbidity and
thus justifies LMPT delivery. Exploration is needed to allow more detailed understanding of the obstetric
decisions that lead to LMPT delivery.
Socioeconomic risk factors for late and moderately preterm birth
Background
The main objective of this study was to better understand the impact of socioeconomic risk factors on
LMPT birth at both an area and individual level. Stream 1 highlighted that almost 80% of the relative
deprivation gap in all-cause neonatal mortality is a result of premature birth and congenital anomalies.
Understanding the link between deprivation and preterm birth is vital in order to identify interventions to
reduce preterm birth in the future. One key way of doing this is to unpick socioeconomic inequalities in
health seen at an area level by exploring individual socioeconomic risk factors.
Both area-level factors of socioeconomic risk and single individual measures of income and education have
been shown to be associated with very preterm delivery in the UK5 and other developed countries.13
However, there has been less exploration of its effect specifically at later gestations.
When socioeconomic factors are explored in most analyses, there is a focus on attributing socioeconomic
differences to variations in lifestyle and health-related behaviours. These single measures of education or
income do not allow exploration of the multidimensional nature of socioeconomic risk. Individuals with
equivalent education or income may have considerably different available resources (house ownership, car
ownership, access to benefits). In this analysis the focus was on understanding the impact of socioeconomic
risk factors on LMPT birth from a multidimensional standpoint, exploring a range of socioeconomic
indicators. A major challenge in exploring the influence of socioeconomic deprivation on health outcomes
is how best to define the concept of ‘socioeconomic deprivation’ and identify measurable indicators.
These issues are discussed here, but with a focus on the impact of socioeconomic factors to assess the
impact of deprivation on preterm birth in the UK, rather than the impact of lifestyle and health behaviours.
Objective
l To clarify the contribution of socioeconomic deprivation in LMPT birth, and assess whether or not
area-level deprivation effects are explained by individual socioeconomic factors.
Methods
Area-level socioeconomic risk
As in stream 1, area-level socioeconomic risk was calculated using the IMD 2010.154 This measure of
multiple deprivation is made up of seven domain indices at the LSOA level, which relate to income
deprivation, employment deprivation, health deprivation and disability, education, skills and training
deprivation, barriers to housing and services, and living environment deprivation and crime. LSOAs are the
smallest areas for which these deprivation data are available; although some degree of heterogeneity will
exist within them, the small size of the areas (only 1500 residents) limits this. IMD 2010 was linked to the
LAMBS data constructed on LSOA of residence based on the mother’s postcode at the time of birth.
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These data were obtained from the ONS and linked to the maternal data by LSOA. All LSOAs in England
were ranked by deprivation score. They were then weighted by their population of births (using the
live-birth denominator data) and divided into five groups, with approximately equal populations of births in
each, from 1 (least deprived) to 5 (most deprived).
Individual-level socioeconomic risk
In order to operationalise the concept of socioeconomic risk, a multidimensional approach was taken,
aiming to encapsulate five key areas of importance: (1) education; (2) occupation; (3) income; (4) wealth;
and (5) social support. Indicators were then incorporated into the maternal interview to reflect these five
aspects of socioeconomic risk.
Education was measured by collecting information on mother’s highest qualification and also age at leaving
continuous education. Occupation was measured by both detailed questions on mother’s occupation
during pregnancy and receipt of Jobseeker’s Allowance. Mother’s socio-occupational status was then
classified using the NS-SEC (ONS143) based on the information collected in the maternal interview.
Occupations were classified into eight analytic classes, which were collapsed into managerial or professional
(classes I and II), intermediate occupations (classes III–V), routine and semiroutine occupations (classes VI
and VII), and unemployed, retired and students (class VIII). Mothers who reported that they looked after
their family full time were classified separately. Income was measured by the collection of occupation data
but also was based on household access to a car, which is thought to reflect current income. It was decided
not to ask for detailed information on personal income, as this was thought to reduce response rates.
Wealth and long-term income was measured based on whether or not the mother was a home owner.
Finally, social support was measured based on whether or not the mother was living with someone as a
couple during the majority of the pregnancy.
Sociodemographic data
Demographic data were also collected in the maternal interview including mother’s age and ethnic group.
Mother’s age was categorised into four groups: (1) < 20 years; (2) 20–29 years; (3) 30–39 years; and
(4) ≥ 40 years. Ethnic group was based on groups used in the census: white; mixed; Asian or Asian British;
black or black British; and Chinese or other ethnic group.
Statistical analyses
The aim of this work was to explore whether or not area-level socioeconomic deprivation was related
to LMPT birth and then to try to unpick any inequalities by identifying whether or not individual
socioeconomic-level factors explained observed variations.
First, univariable analyses were undertaken to explore the relationship with area-level deprivation and the
five aspects of socioeconomic risk and rate of LMPT birth. Analyses were restricted to singleton births
because differential access to fertility treatment may lead to a higher incidence of multiple births in less
deprived areas. Following univariable analysis, multivariable unconditional logistic regression was used to
examine the independent relationship between area- and individual-level socioeconomic risk factors and
LMPT and to generate adjusted ORs with their 95% CIs. Variables likely to confound the relationship
between socioeconomic position and LMPT were identified a priori based on evidence from the published
literature and the results of univariable analysis (i.e. ethnicity and maternal age).
Model building using unconditional logistic regression was then undertaken based on LMPT as the
outcome and including all five measures of individual socioeconomic risk, and area-level socioeconomic
risk. Ethnicity and maternal age were also included, as there was a priori evidence that these factors were
related to LMPT birth. Adjusted ORs were obtained for each risk factor and compared with the unadjusted
ORs to assess the relative importance of the effect to LMPT birth. The individual effect of each variable
on the fit of the data was assessed using the likelihood ratio test.
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Finally, models were fitted to compare the effect of including the SES Index of combined socioeconomic
risk with a model of the significant individual indicators to assess whether or not this combined score
accounted for a greater amount of variation in LMPT births than the individual risk factors, as it reflected a
multiplicative effect of the individual factors. These models were both adjusted for ethnicity and
maternal age.
Results
Data were available on 938 singleton LMPT births and 982 singleton term-born controls. Univariable
analyses showed area-level deprivation to be significantly associated with LMPT birth (Table 19). A total of
33.1% of LMPT infants were born to mothers living in the most deprived quintile, compared with 27.7%
of term-born infants. This equated to an increased odds of 49% of delivering LMPT for those mothers
from the most deprived quintile. All of the five individual socioeconomic risk factors were seen to be
significantly associated with gestation at birth.
TABLE 19 Socioeconomic risk factors and gestation at birth
Indicator
Term-born controls,
n (%)
LMPT births,
n (%)
Chi-squared test
p-value
Area-level deprivation quintile
1 (least deprived) 177 (18.1) 135 (14.5) 0.003
2 172 (17.6) 122 (13.1) Missing= 10
3 135 (13.8) 146 (15.7) –
4 222 (22.7) 221 (23.7) –
5 (most deprived) 271 (27.7) 309 (33.1) –
Highest educational qualification
Degree or equivalent 335 (34.1) 249 (26.6) 0.002
A level or equivalent 227 (23.1) 226 (24.1) Missing= 7
GCSE grades A–C or equivalent 252 (25.7) 267 (28.5) –
GCSE grade D or below or equivalent 164 (16.7) 193 (20.6) –
NS-SEC occupational status
Managerial or professional 286 (29.1) 222 (23.7) 0.003
Intermediate 202 (20.6) 183 (19.5) Missing= 11
Routine and manual 150 (15.3) 134 (14.3) –
Unemployed 192 (19.6) 247 (26.3) –
Looking after the home 145 (14.8) 148 (15.8) –
Cohabiting status
Living with partner 850 (86.6) 767 (81.8) 0.004
Not living with partner 131 (13.3) 170 (18.1) Missing= 2
Access to a car
Yes 775 (78.9) 668 (71.2) < 0.001
No 204 (20.8) 270 (28.8) Missing= 3
Home ownership
Owns with/without mortgage 479 (48.8) 238 (43.6) 0.027
Rents/lives rent free 503 (51.2) 526 (56.1) Missing= 3
THE LATE AND MODERATELY PRETERM BIRTH STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
76
Table 19 shows that, compared with those mothers delivering at term, mothers who delivered LMPT were
more likely to have a very low educational level (GCSE grade D or below: LMPT, 20.7%; term, 16.7%);
to be unemployed (LMPT, 26.3%; term, 19.6%); to not be living with a partner (LMPT, 18.1%; term, 13.3%);
to not own a car (LMPT, 28.8%; term, 20.4%); and to not own their own home (LMPT, 56.1%; term, 51.2%).
These socioeconomic factors were then explored in a multivariable model (excluding 25 cases with missing
information: 969 term-born controls and 926 LMPT) (Table 20). Demographic factors were included in the
model, including maternal age and ethnicity, but only ethnicity was seen to be significantly related to
LMPT birth (p= 0.0153). Adjusting for socioeconomic factors showed a considerable reduction in the
odds of being born LMPT for those mothers from the most deprived areas, from an OR of 1.49 before
adjustment to an OR of 1.13 after adjustment, and this effect was no longer significant. After adjustment
for demographic factors, the only individual factor to show a significant association with LMPT birth was
car ownership (p= 0.0227). Mothers without a car were at 37% increased odds of delivering LMPT than
those with access to a car (OR 1.37, 95% CI 1.04 to 1.79). There was no evidence of a relationship
for education (p= 0.2010), occupation (p= 0.7108), home ownership (p= 0.5914) or cohabitation
(p= 0.2734) in the multivariable model. In order to overcome the issue of correlation between the five
individual factors, a model with the combined SES Index was then compared with a model adjusting only
for car ownership (both models adjusted for maternal age and ethnicity). This showed that women from
the most deprived tertile, who were more likely to be unemployed, single parents, poorly educated and
not own a car or a house, were at 50% increased odds of delivering LMPT (OR 1.50, 95% CI 1.21 to 1.87).
However, the change in deviance for this model was smaller (χ2= 13.31 on 2 degrees of freedom) than the
change seen when adjusting for car ownership (χ2= 15.61 on 1 degree of freedom) and was not therefore
seen to explain any additional variation compared with the single indicator of car ownership.
Discussion
Key findings
l Women from the most deprived areas had a 49% higher risk of delivering LMPT than of delivering
at term.
l After adjusting for individual-level socioeconomic factors, there was no significant association with area
deprivation and LMPT birth.
l Not having access to a car had the strongest association with LMPT, with mothers at 37% increased
odds of LMPT.
l Area- and individual-level socioeconomic factors did not explain the increased odds of Asian or British
Asian women delivering an LMPT infant. Some of the apparent socioeconomic inequalities at the
univariate level may be because of this higher rate of LMPT birth among Asian or Asian British women,
who are more likely to be more deprived.
Strengths and limitations
Many research studies exploring socioeconomic inequalities in preterm birth are limited to area-level
measures of deprivation. Here it has been possible to explore both area- and individual-level
socioeconomic risk factors and assess the impact on LMPT birth with a rich source of data on these risk
factors. Almost all respondents answered the socioeconomic questions in the maternal data set and so
missing data were not a significant problem. Lack of access to a car showed the strongest relationship with
LMPT birth, but there was strong correlation between all of the five individual socioeconomic risk factors.
However, the SES Index, combining all five indicators of socioeconomic risk, did not account for any more
of the variation in LMPT risk.
Data are available only for responders to the study. Study response has been shown to be related to
socioeconomic status in a variety of studies, including the national census, and so the responders in this
study are likely to be less deprived than all eligible study participants. Therefore, the socioeconomic effects
seen here may be underestimated.
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TABLE 20 Odds ratios for LMPT compared with term-born controls for socioeconomic and demographic factors
Indicator
Unadjusted OR
p-value
Adjusted OR
p-valueOR 95% CI OR 95% CI
Area-level deprivation quintile
1 (least deprived) 1 – 0.003 1 – 0.20
2 0.93 0.67 to 1.28 – 0.91 0.65 to 1.26 –
3 1.42 1.03 to 1.96 – 1.35 0.97 to 1.89 –
4 1.31 0.98 to 1.75 – 1.06 0.77 to 1.46 –
5 (most deprived) 1.49 1.13 to 1.97 – 1.13 0.82 to 1.56 –
Highest educational qualification
Degree or equivalent 1 – 0.002 1 – –
A Level or equivalent 1.34 1.05 to 1.71 – 1.30 0.99 to 1.70 0.20
GCSE grades A–C or equivalent 1.43 1.12 to 1.81 – 1.29 0.97 to 1.71 –
GCSE grade D or below or equivalent 1.58 1.21 to 2.06 – 1.34 0.96 to 1.86 –
NS-SEC occupational status
Managerial or professional 1 – 0.002 1 – 0.71
Intermediate 1.17 0.90 to 1.53 – 1.03 0.77 to 1.37 –
Routine and manual 1.16 0.87 to 1.55 – 0.95 0.68 to 1.32 –
Unemployed 1.67 1.29 to 2.15 – 1.19 0.83 to 1.70 –
Looking after the home 1.32 0.99 to 1.76 – 0.98 0.70 to 1.38 –
Cohabiting status
Living with partner 1 0.004 1 0.27
Not living with partner 1.44 1.12 to 1.84 1.18 0.88 to 1.58
Access to a car
Yes 1 – 0.0001 1 – 0.02
No 1.54 1.04 to 1.90 – 1.37 1.04 to 1.79 –
Home ownership
Owns with/without mortgage 1 – 0.027 1 – 0.59
Rents/lives rent free 1.22 1.02 to 1.47 – 0.91 0.72 to 1.16 –
Mother’s age (years)
< 20 1 – 0.706 1 – 0.47
20–29 1.05 0.71 to 1.56 – 1.37 0.89 to 2.10 –
30–39 0.94 0.63 to 1.41 – 1.44 0.91 to 2.26 –
≥ 40 0.89 0.49 to 1.64 – 1.31 0.68 to 2.52 –
Ethnicity
White 1 – 0.028 1 – 0.025
Mixed 1.79 1.00 to 3.22 – 1.75 0.94 to 3.27 –
Asian or Asian British 1.41 1.10 to 1.80 – 1.47 1.12 to 1.92 –
Black or black British 1.16 0.77 to 1.75 – 0.99 0.63 to 1.53 –
Chinese or other ethnic group 1.24 0.54 to 2.83 – 1.51 0.64 to 3.58 –
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Implications
Socioeconomic inequalities exist in LMPT birth at both area and individual level. The effect of
socioeconomic deprivation on very preterm birth rates appears to continue into LMPT gestations. This
suggests that the burden of LMPT is greater in more deprived areas and is likely to lead to a greater
burden of mortality, morbidity and adverse long-term outcomes in these areas owing to differential rates
of LMPT birth.
In studies of socioeconomic deprivation, area measures are generally used as a proxy for individual risk.
Consequently, as in this work and a recently published Italian study,155 there appears to be no residual
influence of area-level deprivation after adjusting for individual measures, as there is often misclassification
of deprivation at the area level. However, in studies from the USA and Canada, a consistent area-level
deprivation effect has been shown even after accounting for individual-level behavioural and medical risk
factors,156,157 which suggests that there may be geographical differences in access to good health care.
Interestingly, although all of the individual socioeconomic risk factors explored showed a relationship with
LMPT birth at the univariable level, only lack of access to a car was significant after adjusting for other
variables. This socioeconomic risk factor showed a stronger association than education, occupation,
house ownership or cohabiting status. Lack of access to a car may reflect access to short-term income,
but may also reflect ability to physically access services.
These data suggest that reducing the burden of disease as a result of LMPT birth will have to involve
targeted, disease-specific preventative interventions in high-risk pregnancies. However, for low-risk groups,
population-level public health action is needed to address risk factors for preterm birth associated with
social deprivation.
Future research
The LAMBS collected rich and diverse data on socioeconomic risk, but also on lifestyle and health
behaviours, stress and work conditions. The next stage of this research will be to understand how these
factors are related to the observed socioeconomic inequalities seen here, exploring modifiable risk factors
that may reduce the incidence of LMPT birth in the future. It is likely that the relationship between low
socioeconomic group and LMPT may be explained by the clustering of lifestyle factors and health-related
behaviours among socioeconomically deprived women. Both Danish and Swedish population-based studies
have shown a reduction in the educational/socioeconomic status gradient in risk of preterm birth after
adjustment for lifestyle factors including smoking.158,159 Using data from the LAMBS we can extend these
analyses to assess the impact of these risk factors on LMPT birth and assess whether or not the effects are
similar to those seen at earlier gestations.
Neonatal outcomes in infants born late and moderately
preterm
Background
Although outcomes of very preterm (< 32 weeks’ gestation) infants have been extensively studied, there
have been few prospective studies exploring the outcomes of infants born at more mature preterm
gestations. In particular, the number of infants in the LMPT population in the UK who require neonatal
specialist care has not been clarified and there is a paucity of research into the influence of plurality on
neonatal outcomes in the preterm population in general. In the LMPT group this is potentially even more
important, as multiple births are over-represented in this population. Management of LMPT babies has,
until recently, been similar to that of term-born babies, but there has been little guidance for clinicians
with respect to the understanding of differences in the incidence of morbidity between these two groups.
We chose to study a range of important morbidities that are known to present commonly in infants born
close to term and at term, and investigations that are also commonly performed in these infants.
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Objectives
l To describe and quantify early mortality and morbidity associated with late and moderate prematurity
compared with that of infants born at ≥ 37 weeks’ gestation.
l To compare outcomes of singleton infants with those of twins and higher-order multiples born at
LMPT gestations.
Methods
Outcome data for LMPT and term-born infants were obtained from hospital records. For infants in either
group who did not require admission to a NNU, specific neonatal medical records may not have been
generated. In these cases, data were obtained from the mothers’ maternity records. For infants receiving
care in a NNU, data were extracted from the neonatal medical and nursing records and observation charts.
Clinical outcomes of live-born infants are presented for those without congenital anomalies, because of
the likelihood of anomalies having a major effect on many common outcomes, both during the neonatal
stay and at discharge. As it is known that neonatal outcomes differ between infants from singleton or
multiple pregnancies, multiple births were analysed separately from singleton births.
Measures
Neonatal data collection focused on determining the range of important short-term outcomes during the
neonatal hospital stay and at hospital discharge in LMPT compared with term-born infants. Deaths during
the neonatal period were recorded. When available, the cause of death and findings at post-mortem were
obtained. For surviving infants, the total length of hospital neonatal stay was calculated from the day of
birth to the day of discharge. For those admitted for specialist neonatal care, the number of days spent in
a NNU was recorded. For infants discharged home on the day of birth, or infants born at home, this was
recorded as 0 days. Data were obtained for congenital anomalies and for important conditions highlighted
in the literature and observed in clinical practice as those most commonly affecting this population. These
included resuscitation at delivery, respiratory outcomes and the need for respiratory support, surgical
intervention, feeding outcomes including rates of breastfeeding and nutritional support, hypoglycaemia,
jaundice, hypothermia and systemic infection.
Information collected about resuscitation included the administration of facial oxygen, intermittent
positive-pressure ventilation (IPPV) via a facemask and endotracheal intubation. IPPV via a facemask or
endotracheal tube and the use of drugs at resuscitation were classed as active resuscitation. The presence
of respiratory distress, hypoglycaemia, hypothermia, jaundice and suspected infection were documented in
babies for which this required either review by a member of the medical team or admission to a NNU. For
babies affected by these conditions, the lowest recorded blood sugar level, highest SBR level and whether
the baby required phototherapy or exchange transfusion, and the lowest temperature below 36.5 °C were
recorded. Hypoglycaemia was defined as a blood sugar level of < 2.5mmol/l and significant hypoglycaemia
as < 2.0mmol/l. Hypothermia was defined as a temperature of < 36.5 °C and severe hypothermia as a
temperature of < 36.0 °C. Active management of hypothermia was defined as intervention using a heated
mattress, incubator or overhead heater. Suspected infection was recorded for any infant who received
investigation for infection with blood cultures, urine cultures or lumbar puncture to obtain cerebrospinal
fluid for microbiological investigation. Proven infection was recorded for infants for whom a positive
culture was obtained from one of these normally sterile body fluids.
Common investigations performed in babies during the neonatal hospital stay were recorded. These
included radiological investigations [chest radiography, cranial ultrasound scan and magnetic resonance
imaging (MRI)], screening for infection, electroencephalography (EEG), chromosomal studies and any other
significant investigation.
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The summary outcomes at the time of discharge from neonatal hospital care were recorded according
to the number of days or part days for which a particular type of care or intervention was required.
Respiratory outcomes included the number of days of respiratory support including mechanical ventilation
via an endotracheal tube and non-invasive ventilation (nasal continuous positive airways pressure and
methods of biphasic non-invasive ventilation], and the number of days of oxygen therapy via incubator,
nasal cannulae or headbox. For each day, the highest level of support was recorded as follows: mechanical
ventilation > non-invasive ventilation > oxygen therapy. Nutritional outcome data collected were for the
number of days of PN administration, number of days of clear i.v. fluid administration and the day of
attaining full oral feeds (not feeding via a nasogastric tube (NGT)]. When no nutritional support was
required and the baby fed fully by bottle or breast from birth, the day of attaining full feeds was recorded
as day 0. The type of milk feed and method of feeding at hospital discharge was also recorded. For infants
receiving any maternal breast milk during their hospital stay, the last date on which breast milk was given
was recorded, together with whether or not there was exclusive breastfeeding or mixed feeding
at discharge.
Mortality and morbidity
Mortality
Deaths were uncommon in the study group, but six babies died before discharge from hospital. Of these,
five had been born at LMPT gestations and one at term, but the difference in the number of deaths
between the two groups was not statistically significant. Four deaths occurred within the first week of life,
one of which was of a term-born baby, and there were two deaths at more than 28 days of life. Table 21
shows the gestational ages of these infants at birth, the postnatal day of death and the cause of death.
Congenital anomalies
There were 23 babies in the LMPT group and nine babies in the term-born group with major congenital
anomalies or chromosomal disorders. Table 22 shows the range of congenital anomalies seen and
numbers of affected babies in both groups.
TABLE 21 Characteristics of infants dying prior to hospital discharge
Gestation at birth Postnatal day of death Cause of death
LMPT
36 weeks 1 day Hydrops fetalis
34 weeks 1 day Pulmonary hypoplasia
32 weeks 7 days Pulmonary haemorrhage
34 weeks 32 days Hypoplastic left heart syndrome
32 weeks 78 days Acute renal failure
Necrotising enterocolitis
Bowel obstruction
Septo-optic dysplasia
Term
40 weeks 4 days Hyperammonaemia
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Clinical outcomes for singletons
Table 23 shows outcomes during the neonatal hospital stay for live-born, normally formed singleton
infants. Outcomes are compared between LMPT (n= 907) and term-born infants (n= 972).
Resuscitation at birth
Compared with term-born babies, those born at LMPT gestations were more than twice as likely to require
active resuscitation at birth (RR 2.37, 95% CI 1.82 to 3.08; p< 0.001), and were four times more likely
to require endotracheal intubation (RR 4.02, 95% CI 1.85 to 8.72; p< 0.001).
Respiratory outcomes
The majority of babies in both the LMPT (84.2%) and term (98.4%) groups did not require any form of
respiratory support. However, the risk of needing mechanical ventilation and/or non-invasive respiratory
support in the LMPT group was more than twice that of infants born at term (RR 12.74, 95% CI 6.49 to
25.01; p< 0.001). Ventilatory support was required by 8.3% of LMPT infants, compared with < 1% of
term-born infants. Non-invasive support was the maximum level of respiratory support given in 4%
of LMPT infants and 0.1% of term-born infants. Oxygen therapy was required in 3.5% of LMPT infants,
compared with only 0.7% of those born at term.
TABLE 22 Types of congenital anomalies
Anomaly
Numbers of babies
Term LMPT
Oesophageal atresia and tracheo-oesophageal fistula 0 5
Gastroschisis 0 4
Hirschsprung’s disease 1 0
Cleft lip± cleft palate 2 2
Skeletal dysplasia 1 1
Congenital heart disease 0 4
Chromosomal anomaly 3 2
Congenital infection 1 1
Neural tube defect 0 1
Pulmonary hypoplasia 0 1
Other unspecified major structural abnormality or syndrome 1 2
Total 9 23
TABLE 23 Clinical outcomes for live-born singletons without congenital anomalies
Outcome Term LMPT
RR (95% CI) for
outcome p-valuea
Number of babies, n (%) 972 (51.7) 907 (48.3) – –
Deaths before discharge, n (%) 1 (0.1) 3 (0.3) – –
Any active resuscitation at birth, n (%) 72 (7.4) 159 (17.5) 2.37 (1.82 to 3.08) < 0.001
Endotracheal intubation at birth, n (%) 8 (0.8) 30 (3.3) 4.02 (1.85 to 8.72) < 0.001
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TABLE 23 Clinical outcomes for live-born singletons without congenital anomalies (continued )
Outcome Term LMPT
RR (95% CI) for
outcome p-valuea
Length of hospital stay (days), median (range) 2 (0–25) 5 (1–78)
All newborn care given on postnatal ward, n (%) 910 (93.6) 505 (55.7) 0.58 (0.55 to 0.62) < 0.001
Any care in a NNU, n (%) 43 (4.4) 402 (44.3) 9.82 (7.27 to 13.27) < 0.001
Maximum level of respiratory support
Mechanical ventilation, n (%) 8 (0.8) 75 (8.3) – –
Non-invasive respiratory support, n (%) 1 (0.1) 36 (4.0) – –
Oxygen therapy, n (%) 7 (0.7) 32 (3.5) – –
No respiratory support, n (%) 956 (98.4) 764 (84.2) – –
Ventilation and/or non-invasive respiratory
support, n (%)
9 (0.9) 107 (11.8) 12.74 (6.49 to 25.01) < 0.001
Days of ventilation and/or non-invasive
respiratory support, median (range)
3 (1–4) 2 (1–26) – –
Fluids and nutrition
i.v. fluids, n (%) 20 (2.1) 243 (26.8) 13.02 (8.33 to 20.36) < 0.001
Days of i.v. fluids, median (range) 2.5 (1 to 10) 2 (1 to 14) – –
PN, n (%) 3 (0.3) 32 (3.5) 11.43 (3.51 to 37.21) < 0.001
Days of PN, median (range) 3 (3 to 3) 5.5 (1 to 60) – –
Days to full oral suck feeds, median (range) 0 (0–19) 0 (0–95) – –
Nasogastric feeding at discharge, n (%) 0 (0.0) 3 (0.3) a a
Breastfeeding
Any breast milk given, n (%) 717 (73.8) 582 (64.2) 0.87 (0.82 to 0.92) < 0.001
Receiving breast milk at discharge, n (%) 701 (72.2) 524 (58.0) 0.80 (0.75 to 0.86) < 0.001
Exclusively breastfed at discharge, n (%) 632 (65.1) 355 (39.3) 0.60 (0.55 to 0.66) < 0.001
Investigations
Cranial ultrasound scan, n (%) 13 (1.3) 63 (7.0) 5.19 (2.88 to 9.37) < 0.001
MRI scan, n (%) 5 (0.5) 8 (0.9) 1.71 (0.56 to 5.22) 0.34
Chest radiography, n (%) 22 (2.3) 175 (19.3) 8.52 (5.52 to 13.16) < 0.001
Screening for infection, n (%) 48 (4.9) 322 (35.5) 7.19 (5.38 to 9.60) < 0.001
Morbidities
Culture-positive infection, n (%) 0 (0.0) 17 (1.9) – –
Jaundice requiring phototherapy, n (%) 6 (0.6) 199 (21.9) 35.54 (15.85 to 79.68) < 0.001
Hypothermia (temperature of < 36.0 °C), n (%) 11 (1.1) 83 (9.2) 8.09 (4.34 to 15.07) < 0.001
Hypoglycaemia (blood sugar level of
< 2.0mmol/l), n (%)
8 (0.8) 61 (6.7) 8.17 (3.93 to 16.98) < 0.001
Neonatal encephalopathy grade II/III, n (%) 4 (0.4) 4 (0.4) 1.07 (0.27 to 4.27) 0.92
a Unable to calculate as a result of separation of data.
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Nutritional outcomes
The proportion of babies requiring i.v. fluids was higher in the LMPT group than in the term-born group
(RR 13.02, 95% CI 8.33 to 20.36; p< 0.01). The use of PN was also more common in LMPT infants
(RR 11.43, 95% CI 3.51 to 37.21; p< 0.001) and the duration of i.v. fluids and nutrition use was also
greater in the LMPT group. LMPT babies took longer than their term-born counterparts to attain full oral
feeding by breast or bottle. Three infants in the LMPT group were fed via a NGT when they were
discharged from hospital, compared with no infants in the term group.
With respect to breastfeeding, LMPT infants were less likely to receive any breast milk during their
neonatal stay than infants born at term (64.2% vs. 73.8%; RR 0.87, 95% CI 0.82 to 0.92; p< 0.001). This
proportion decreased during the neonatal stay in both groups, but fell more in the LMPT babies than in
the term babies. The proportion of babies receiving any breast milk at the time of hospital discharge was
72.2% in the term group, compared with only 58% in the LMPT group. Exclusive breast milk feeding at
discharge was seen in 65.1% of the term-born babies, but in fewer than half of the LMPT babies
(65.1% vs. 39.3%; RR 0.60, 95% CI 0.55 to 0.66; p< 0.001).
Admission to neonatal unit and neonatal morbidity
Late and moderately preterm infants were almost 10 times more likely to be admitted to a NNU than
babies in the term-born group (RR 9.82, 95% CI 7.27 to 13.27; p< 0.001). They were also at significantly
higher risk of a number of common neonatal morbidities including hyperbilirubinaemia [that was of a
level requiring management with phototherapy (RR 35.54, 95% CI 15.85 to 79.68; p< 0.001)], severe
hypothermia (RR 8.09, 95% CI 4.34 to 15.07; p< 0.01) and severe hypoglycaemia (RR 8.17, 95% CI
3.93 to 16.98; p< 0.001). The incidence of neonatal encephalopathy of moderate or severe severity
(grades II and III) was similar in the two groups.
Clinical investigations performed during the neonatal stay
In general, LMPT infants were more likely to undergo investigation than term-born babies. With respect to
radiological examinations, LMPT babies were eight times more likely to have chest radiography performed
(RR 8.52, 95% CI 5.52 to 13.16; p< 0.001) than term-born babies, and were also more likely to have
had a cranial ultrasound scan performed (RR 5.19, 95% CI 2.88 to 9.37; p< 0.001). However, the number
of MRI scans did not differ between the groups.
Screening for suspected infection was carried out in more than one-third of LMPT infants, compared with
< 5% of those born at term (RR 7.19, 95% CI 5.38 to 9.60; p< 0.001). This yielded a positive culture in
only 17 LMPT infants (5% of those tested). None of the infants born at ≥ 37 weeks’ gestation had a
culture-positive infection.
Length of hospital stay
Three LMPT babies and one term-born baby died before discharge. For those infants surviving to
discharge, the total length of hospital stay was greater in the infants born LMPT.
Clinical outcomes for infants from multiple births
Table 24 shows the outcomes during the neonatal hospital stay for live-born infants without congenital
anomalies who were from multiple pregnancies. There were 200 LMPT infants and 274 infants born at
≥ 37 weeks’ gestation.
Resuscitation at birth
Compared with term-born multiples, LMPT multiples were more likely to require active resuscitation at
birth (RR 1.81 95% CI 1.18 to 2.79; p= 0.007), but were no more likely to need endotracheal intubation.
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TABLE 24 Clinical outcomes for live-born multiples without congenital anomalies
Outcome Term LMPT RR (95% CI) for outcome p-valuea
Number of babies, n (%) 274 (57.8) 200 (42.2) – –
Deaths before discharge, n (%) 0 (0.0) 0 (0.0) – –
Any active resuscitation at birth, n (%) 31 (11.3) 41 (20.5) 1.81 (1.18 to 2.79) 0.007
Endotracheal intubation at birth, n (%) 2 (0.7) 3 (1.5) 2.06 (0.35 to 12.21) 0.43
Length of hospital stay (days), median (range) 4 (1–26) 6.5 (2–35) – –
All newborn care given on postnatal ward, n (%) 251 (91.6) 114 (57.0) 0.62 (0.55 to 0.71) < 0.001
Any care in a NNU, n (%) 23 (8.4) 86 (43.0) 5.12 (3.36 to 7.81) < 0.001
Maximum level of respiratory support
Mechanical ventilation, n (%) 1 (0.4) 17 (8.5) – –
Non-invasive respiratory support, n (%) 1 (0.4) 11 (5.5) – –
Oxygen therapy, n (%) 1 (0.4) 4 (2.0) – –
No respiratory support, n (%) 271 (98.9) 168 (84.0) – –
Ventilation and/or non-invasive respiratory
support, n (%)
2 (0.7) 28 (14.0) 19.18 (4.62 to 79.70) < 0.001
Total days of ventilation and/or non-invasive
respiratory support, median (range)
1 (1–1) 2 (1–5) – –
Fluids and nutrition
i.v. fluids, n (%) 10 (3.7) 54 (27.0) 7.40 (3.86 to 14.18) < 0.001
Days of i.v. fluids, median (range) 1.5 (1–3) 2 (1–9) – –
PN, n (%) 0 (0.0) 7 (3.5) a a
Days of PN, median (range) 0 (0–0) 4 (1–9) – –
Days to full oral suck feeds, median (range) 0 (0–31) 0 (0–106) – –
Nasogastric feeding at discharge, n (%) 0 (0.0) 1 (0.5) a a
Breastfeeding
Any breast milk given, n (%) 196 (71.5) 126 (63.0) 0.88 (0.77 to 1.00) 0.058
Receiving breast milk at discharge, n (%) 177 (64.6) 107 (53.5) 0.83 (0.71 to 0.97) 0.018
Exclusively breastfed at discharge, n (%) 111 (40.5) 49 (24.5) 0.60 (0.46 to 0.80) < 0.001
Investigations
Cranial ultrasound scan, n (%) 3 (1.1) 13 (6.5) 5.94 (1.71 to 20.58) 0.005
MRI scan, n (%) 2 (0.7) 2 (1.0) 1.37 (0.19 to 9.66) 0.75
Chest radiography, n (%) 10 (3.7) 42 (21.0) 5.75 (2.96 to 11.20) < 0.001
Screening for infection, n (%) 16 (5.8) 70 (35.0) 5.99 (3.59 to 10.00) < 0.001
Morbidities
Culture-positive infection, n (%) 1 (0.36) 2 (1.00) 2.74 (0.45 to 30.08) 0.41
Jaundice requiring phototherapy, n (%) 4 (1.5) 31 (15.5) 10.62 (3.80 to 29.63) < 0.001
Hypothermia (temperature of < 36.0 °C), n (%) 7 (2.6) 13 (6.5) 2.54 (1.03 to 6.27) 0.042
Hypoglycaemia (blood sugar level of
< 2.0mmol/l), n (%)
3 (1.1) 6 (3.0) 2.28 (0.55 to 9.46) 0.15
Neonatal encephalopathy grade II/III, n (%) 0 (0.0) 0 (0.0) – –
a Unable to calculate as a result of separation of data.
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Respiratory outcomes
As was the case with singleton births, high percentages of multiples in both groups did not receive any
respiratory support (LMPT 84% and term 98.9%). Mechanical ventilation, non-invasive respiratory support
and oxygen therapy were each required by only one baby in the term-born multiples group. However,
17 babies (8.5%) of LMPT multiples were ventilated and 11 (5.5%) and 4 (2%), respectively, needed
non-invasive support and oxygen therapy. Among the multiple births, the risk of LMPT infants needing
mechanical ventilation and/or non-invasive respiratory support was significantly higher than that of infants
born at term (RR 19.18, 95% CI 4.62 to 79.70; p< 0.001). It should be noted that the small numbers for
this analysis result in wide CIs.
Nutritional outcomes
Among infants from multiple births, the number of babies requiring any kind of nutritional support was
small in both groups. No term-born infant required either PN or feeding by NGT, and only seven (3.5%)
LMPT infants required PN and only one (0.5%) required feeding by NGT. More than one-quarter of LMPT
infants required i.v. fluids, which was a significantly higher proportion than in the term-born group
(RR 7.40, 95% CI 3.86 to 14.18; p< 0.001).
There were lower rates of breastfeeding among the LMPT multiple births than in the term-born group.
A smaller percentage of LMPT than of term-born babies received any breast milk, but this difference did
not reach statistical significance. However, a similar pattern of decline as seen in the singletons led to a
significantly smaller proportion of LMPT multiples receiving breast milk at discharge (RR 0.83, 95% CI 0.71
to 0.97). Less than one-quarter of LMPT multiples were fed exclusively on the mother’s breast milk at
discharge and, compared with term-born multiples, this was a highly significant difference (RR 0.60, 95%
CI 0.46 to 0.80; p< 0.001).
Admission to neonatal unit and neonatal morbidity
Late and moderately preterm infants from multiple births were five times more likely to be admitted to a
NNU than babies in the term-born group (RR 5.12, 95% CI 3.36 to 7.81; p< 0.001). Their risk of jaundice
requiring phototherapy was also 10 times higher than that of term-born multiples (RR 10.62, 95% CI 3.80
to 29.63; p< 0.001), and they were twice as likely to have severe hypothermia (RR 2.54, 95% CI 1.03 to
6.27; p= 0.042). There was no increased risk for hypoglycaemia among LMPT multiples and neonatal
encephalopathy was not seen in any baby from a multiple birth.
Clinical investigations performed during the neonatal stay
Late and moderately preterm infants from multiple births were more likely to under chest radiography
(RR 5.75 95% CI 2.96 to 11.20; p< 0.001) and a cranial ultrasound (RR 5.94, 95% CI 1.71 to 20.58;
p< 0.001) than term-born babies. The number of MRI scans performed was the same in both groups.
Screening for suspected infection was carried out in 35% of LMPT multiples, compared with only 5.8% of
those born at term (RR 5.99, 95% 3.59 to 10.00; p< 0.001), but only two (1%) LMPT babies and one
(36%) term-born baby were subsequently found to have positive cultures.
Length of hospital stay
All live-born infants from multiple births survived until discharge from hospital, but among these infants
the average neonatal hospital stay was longer in the LMPT group than in the term-born group.
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Comparison between the outcomes of late and moderately preterm
singletons and multiples
Differences between LMPT singleton infants and those from multiples are shown in Table 25. For the majority
of outcomes, there were no differences observed between singletons and multiples in this study. Neither
group was more likely than the other to require resuscitation at birth, respiratory support or admission to a
NNU. There was less jaundice (RR 0.71, 95% CI 0.50 to 1.00; p= 0.049) and a non-significant trend towards
less hypoglycaemia (RR 0.45, 95% CI 0.20 to 1.02; p= 0.055) in the multiples than in the singletons.
Although equal numbers of babies in each group received some breast milk during their hospital stay and
at the time of discharge, multiples were significantly less likely to be exclusively breastfed at discharge than
were singletons. However, it is likely that, rather than a difference between characteristics of the babies,
this is more reflective of a difference in the ability of mothers of multiples to produce sufficient milk for all
their babies compared with mothers of singletons.
TABLE 25 Clinical outcomes for live-born LMPT singletons and twins without congenital anomalies
Outcome Singletons Multiples RR for outcome (95% CI) p-valuea
Number of babies, n (%) 907 (81.9) 200 (18.1) – –
Deaths before discharge, n (%) 3 (0.3) 0 (0.0) a a
Any active resuscitation at birth, n (%) 159 (17.5) 41 (20.5) 1.17 (0.86 to 1.59) 0.32
Length of hospital stay, days, median (range) 5 (1 to 78) 6.5 (2 to 35) – –
Any care in a NNU, n (%) 402 (44.3) 86 (43.0) 0.97 (0.81 to 1.16) 0.74
Ventilation and/or non-invasive respiratory
support, n (%)
107 (11.8) 28 (14.0) 1.19 (0.81 to 1.75) 0.39
Total days of ventilation and/or non-invasive
respiratory support, median (range)
2 (1–26) 2 (1–5) – –
Fluids and nutrition, median (range)
Days of i.v. fluids 2 (1–14) 2 (1–9) – –
Days of PN 5.5 (1–60) 4 (1–9) – –
Days to full oral suck feeds 0 (0–95) 0 (0–106) – –
Breastfeeding, n (%)
Any breast milk given 582 (64.2) 126 (63.0) 0.98 (0.87 to 1.10) 0.76
Receiving breast milk at discharge 524 (58.0) 107 (53.5) 0.92 (0.80 to 1.06) 0.26
Exclusively breastfed at discharge 355 (39.3) 49 (24.5) 0.62 (0.48 to 0.81) < 0.001
Morbidities, n (%)
Culture-positive infection 16 (1.8) 2 (1.0) 0.57 (0.31 to 2.45) 0.45
Jaundice requiring phototherapy 199 (21.9) 31 (15.5) 0.71 (0.50 to 1.00) 0.049
Hypothermia (temperature of < 36.0 °C) 84 (9.3) 13 (6.5) 0.70 (0.40 to 1.23) 0.22
Hypoglycaemia (blood sugar level of
< 2.0mmol/l)
61 (6.7) 6 (3.0) 0.45 (0.20 to 1.02) 0.055
Neonatal encephalopathy grade II/III 4 (0.4) 0 (0.0) – –
a Unable to calculate as a result of separation of data.
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Obstetric intervention and neonatal outcomes of late and
moderately preterm singleton infants
Background
This and other studies have shown that infants born at LMPT gestations are at increased risk of adverse
outcomes in the neonatal period compared with infants born at term. These adverse outcomes span a
number of different areas. However, current understanding of these differences is limited and it is not
known to what degree poorer outcomes are related to prematurity per se or how much may be related to
problems that occur during pregnancy and subsequently lead to medically indicated preterm delivery.
We sought to compare the outcomes of infants born LMPT following spontaneous onset of labour with
the outcomes of infants delivered prior to the onset of labour as a result of intervention by obstetricians,
that is induction of labour or CS. In order to gain some information about the relative effects of obstetric
intervention and prematurity, we have also compared outcomes in these subgroups within the term-born
group of infants.
Objectives
l To determine the numbers of women in whom delivery prior to the onset of labour, at LMPT gestations
or at term, was the result of medical intervention.
l To compare the outcomes of LMPT infants born to mothers who had non-spontaneous onset of labour
with those whose mothers had spontaneous onset of labour.
Methods
Data regarding the onset of labour were obtained from the mothers’ maternity records. Data for the
outcomes of LMPT and term-born infants were obtained from hospital records as previously described.
Clinical outcomes of live-born infants without congenital anomalies are presented because of the
likelihood of antenatal diagnosis of a major congenital anomaly contributing to the decision-making with
respect to induction of labour or delivery by CS. In view of the different mechanisms leading to delivery in
singleton and multiple births, singletons only are included in these analyses. Home births are included.
Measures
Spontaneous onset of labour was recorded when the onset of uterine contractions was spontaneous and
when this led to delivery by any mode. When the onset of labour contractions was medically induced or
where delivery by CS was carried out without prior contractions, the onset of labour was classed as
non-spontaneous.
Results
Clinical outcomes of live-born LMPT and term-born babies without anomalies are shown in Tables 26 and 27,
respectively, according to whether onset of labour in the mothers was spontaneous or non-spontaneous.
Non-spontaneous onset of labour occurred in 42.1% of LMPT and 34.2% of term births. Of these, 50.5%
of LMPT infants and 31.9% of term-born infants were delivered by CS not preceded by labour. Birth
gestations for infants following spontaneous and non-spontaneous labours were similar within both groups.
LMPT infants whose mothers had not spontaneously laboured were more likely to receive resuscitation (RR
1.50, 95% CI 1.13 to 1.99; p= 0.005), to be admitted to a NNU (RR 1.37, 95% CI 1.18 to 1.58; p< 0.001)
and to require respiratory intervention with either mechanical ventilation or non-invasive respiratory support
(RR 1.89, 95% CI 1.32 to 2.72; p= 0.001) than those whose mothers had laboured spontaneously. For
those admitted, duration of NNU stay was longer (median 4 days, range 1–77 days vs. median 6 days, range
1–78 days; p< 0.001). In term-born infants there were no differences in these outcomes between medically
indicated and spontaneous preterm deliveries.
THE LATE AND MODERATELY PRETERM BIRTH STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
88
TABLE 26 Clinical outcomes of live-born singleton LMPT babies without congenital anomalies born following
spontaneous and non-spontaneous onset of labour
Outcome Spontaneous Non-spontaneous RR (95% CI) p-valuea
Number of babies, n (%) 525 (57.9) 382 (42.1) – –
Deaths before discharge, n (%) 1 (0.2) 2 (0.5) – –
Birthweight (g), median (range) 2520 (1240–3950) 2380 (1120–4960) – –
Gestation (weeks), median (range) 35+6 (32+0–36+5) 35+6 (32+0–36+5) – –
Any active resuscitation at birth, n (%) 76 (14.5) 83 (21.7) 1.50 (1.13 to 1.99) 0.005
Length of hospital stay (days), median
(range)
4 (1–74) 6 (1–78) – –
Any care in a NNU, n (%) 201 (38.3) 200 (52.4) 1.37 (1.18 to 1.58) < 0.001
Ventilation and/or non-invasive respiratory
support, n (%)
45 (8.6) 62 (16.2) 1.89 (1.32 to 2.72) 0.001
Total days of ventilation and/or non-invasive
respiratory support, median (range)
2 (1–7) 2 (1–26) – –
Mode of delivery
Spontaneous vaginal, n (%) 386 (73.5) 129 (33.7) – –
Assisted vaginal, n (%) 75 (14.3) 26 (6.8) – –
CS, during labour, n (%) 64 (12.2) 34 (8.9) – –
CS, not in labour, n (%) – 193 (50.5) – –
Unknown, n (%) – – – –
Fluids and nutrition
i.v. fluids, n (%) 113 (21.5) 130 (34.0) 1.58 (1.28 to 1.96) 0.005
Days of i.v. fluids, median (range) 2 (1–14) 2 (1–12) – –
PN, n (%) 9 (1.7) 23 (6.0) 1.36 (1.64 to 7.51) 0.001
Days of PN, median (range) 3 (1–6) 7 (1–60) – –
Days to full oral suck feeds, median
(range)
0 (0–93) 0 (0–95) – –
Morbidities
Culture-positive infection, n (%) 10 (1.9) 6 (1.6) 0.82 (0.30 to 2.25) 0.71
Jaundice requiring phototherapy, n (%) 118 (22.5) 81(21.2) 0.94 (0.73 to 1.21) 0.65
Hypothermia (temperature of < 36.0 °C),
n (%)
39 (7.4) 45 (11.8) 1.59 (1.05 to 2.39) 0.027
Hypoglycaemia (blood sugar level of
< 2.0mmol/l), n (%)
31 (5.9) 30 (7.9) 1.33 (0.82 to 2.16) 0.25
Neonatal encephalopathy grade II/III,
n (%)
2 (0.4) 2 (0.5) 1.37 (0.19 to 9.72) 0.75
a Unable to calculate as a result of separation of data.
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TABLE 27 Clinical outcomes of live-born term babies without congenital anomalies born following spontaneous
and non-spontaneous onset of labour
Outcome Spontaneous Non-spontaneous RR for outcome (95% CI) p-valuea
Number of babies, n 640 (65.8) 332 (34.2) – –
Deaths before discharge, n (%) 1 – –
Birthweight (g), median (range) 3420 (2150–4850) 3431 (1980–5160) – –
Gestation (weeks), median
(range)
40+1 (37+0–43+4) 39+5 (37+0–42+6) – –
Any active resuscitation at birth,
n (%)
44 (6.9) 28 (8.4) 1.23 (0.78 to 1.93) 0.38
Length of hospital stay (days),b
median (range)
2 (0–14) 3 (1–25) – –
Any care in a NNU, n (%) 22 (3.4) 21 (6.3) 1.84 (1.03 to 3.30) 0.04
Ventilation and/or non-invasive
respiratory support, n (%)
5 (0.8) 4 (1.2) 1.54 (0.42 to 5.71) 0.65
Total days of ventilation and/or
non-invasive respiratory support,c
median (range)
3 (1–4) 3 (2–4) – –
Mode of delivery
Spontaneous vaginal, n (%) 484 (75.6) 127 (38.3) – –
Assisted vaginal, n (%) 106 (16.6) 60 (18.1) – –
CS, during labour, n (%) 50 (7.8) 39 (11.8) – –
CS, not in labour, n (%) – 106 (31.9) – –
Unknown, n (%) – – – –
Fluids and nutrition
i.v. fluids, n (%) 10 (1.6) 10 (3.0) 1.93 (0.81 to 4.59) 0.14
Days of i.v. fluids, median
(range)
2 (1–6) 3 (1–10) – –
PN, n (%) 2 (0.3) 1 (0.3) 0.96 (0.09 to 10.6) 0.98
Days of PN, median (range) 3 (3,3) 3 (3,3) – –
Days to full oral suck feeds,
median (range)
0 (0–9) 0 (0–19) – –
Morbidities
Culture-positive infection,
n (%)
0 (0.0) 0 (0.0) a a
Jaundice requiring
phototherapy, n (%)
3 (0.5) 3 (0.9) 1.93 (0.39 to 9.51) 0.42
Hypothermia (temperature of
< 36.0 °C), n (%)
5 (0.8) 7 (2.1) 2.70 (0.86 to 8.44) 0.088
Hypoglycaemia (blood sugar
level of < 2.0mmol/l), n (%)
2 (0.3) 7 (2.1) 6.75 (1.41 to 32.32) 0.017
Neonatal encephalopathy
grade II/III, n (%)
3 (0.5) 1 (0.3) 0.64 (0.07 to 6.16) 0.70
a Unable to calculate as a result of separation of data.
b Includes home births that did not come to hospital.
c For those receiving respiratory support.
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With respect to common morbidities, hypothermia was seen more commonly in LMPT babies following
non-spontaneous onset of labour and hypoglycaemia was also more common in the non-spontaneous
group. There were no other significant differences in the morbidities explored.
Discussion
Our results show that infants born at LMPT gestations are at significantly increased risk of most adverse
neonatal outcomes compared with their term-born counterparts. This includes the need for intervention at
delivery, admission to NNUs and common morbidities. We were unable to demonstrate a statistically
significant increase in mortality in this group, although there were more deaths in the LMPT babies. Our
findings are in line with other published findings, both those from studies conducted before the LAMBS
began recruitment6,109,110,113,116,160 and those from studies have reported results during the course of this
study.161–170 Breastfeeding rates of both singletons and multiples were poor in the LMPT group and
worsened during the course of the neonatal stay .
Delivery following obstetric intervention is more likely to occur at LMPT gestations than at term.
Non-spontaneous onset of labour at LMPT gestations is associated with more neonatal morbidity than
delivery following spontaneous labour, but these associations are not present when comparisons are made
between groups of term-born infants according to the type of onset of labour. Indications for delivery have
not yet been analysed. However, in the LMPT group it is likely that a greater proportion of obstetrically
induced deliveries occur as a result of illness in either the mother or fetus. In contrast, a proportion of
deliveries beyond 37 weeks’ gestation will occur because the pregnancy has reached post-term gestation.
As there are differences between the two LMPT groups that are not present in the term-born groups, our
findings suggest that adverse outcomes in LMPT infants are related not only to the effects of prematurity
itself, but also to the indications for delivery. Further exploration of indications for delivery may reveal
groups at particularly high risk for adverse neonatal and long-term outcomes.
Conclusions
Key findings
l Infants born at LMPT gestations are at a significantly greater risk of neonatal morbidity than infants
born at term.
l For most adverse outcomes, there is no difference in the effect between singletons and multiples born
at LMPT gestations.
l Late and moderately preterm babies are less likely to receive maternal breast milk than those born
at term.
l Non-spontaneous onset of labour at LMPT gestations is associated with more neonatal morbidity than
delivery following spontaneous onset of labour.
l The effects of prematurity at LMPT gestations are compounded by effects relating to complications
leading to medically indicated delivery.
Strengths and limitations
We have recruited a large population of LMPT infants and have collected detailed data for a wide range of
outcomes. Data were collected either during the infants’ neonatal hospital stay or as soon as possible after
discharge, minimising error and missing data. However, we were unable to recruit 100% of infants and
it is possible that selection bias may have occurred if mothers of specific groups of infants declined to
participate, for example if the baby was extremely sick or so well that very early discharge from hospital
was possible. This may have led to both over- and under-estimation of effects.
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Implications for practice
There is a need to examine current practice with regard to neonatal care for LMPT babies, as these babies
have historically been cared for in a similar way to those born at term. Our findings and those of other
researchers, in identifying increased risks of multiple common and important neonatal morbidities, should
prompt consideration of whether or not current models of care are the most appropriate for this group.
It may be that a greater level of surveillance following delivery or earlier intervention in some cases may
lead to improved outcomes and shorter hospital stays, and this should be explored. Changes in clinical
practice, if required in this large group of babies, are likely to be costly in terms of both resources and
personnel, and careful planning would be needed to ensure that the highest risk groups are identified and
targeted when possible.
Observation of poorer breastfeeding rates in LMPT babies is worrying, particularly as the longer duration of
hospital stay in this group might be expected to allow greater support for mothers wishing to breastfeed
their babies. As these babies appear to constitute a group at high risk of breastfeeding failure, targeted
support in establishing and maintaining breastfeeding may lead to improvement in rates of breastfeeding
at discharge.
High rates of obstetric intervention for delivery in LMPT babies and our finding of worse outcomes in this
group suggested that greater caution may need to be exercised in determining the optimum timing for
delivery in complicated pregnancies.
Future research
Having identified a higher risk of adverse neonatal outcomes in LMPT babies, future research is required to
determine how much of this observed risk relates to immaturity and how much to the reasons for the
early delivery. In this way, it may be possible to highlight certain groups for whom there may be scope to
intervene and improve early outcomes. The identification of poorer breastfeeding rates in LMPT babies
warrants urgent work to explore the factors influencing the initiation and maintenance of breastfeeding in
this group and whether or not this can be improved with a different model of care. Ongoing work in this
group is needed to determine whether problems in the neonatal period affect very large numbers of LMPT
infants or whether they are confined to smaller, high-risk groups. Our findings of higher rates of morbidity
in infants following medically indicated delivery rather than spontaneous onset of labour suggest that the
latter explanation may be likely, with these infants forming one higher-risk group. Follow-up of the cohort
will be crucial to indicate whether or not adverse neonatal outcomes translate into adverse outcomes in
childhood and beyond.
Health and developmental outcomes at 2 years of age
following late and moderately preterm birth
Background
Follow-up of the LAMBS cohort at 2Y-CA was conducted to determine health and developmental
outcomes of infants born at LMPT gestations to guide screening, follow-up and intervention efforts and
to identify potential intervention strategies. There is a well-documented risk for adverse health,
neurodevelopmental and behavioural sequelae171–173 among children born very preterm (i.e. < 32 weeks’
gestation). Recent studies have suggested that the constellation of health and developmental problems
associated with very preterm birth extends across birth at LMPT gestations, exerting a significant but
smaller impact on long-term outcomes.174–177 However, results are inconsistent; some have reported no
difference from term-born controls178 and there appears to be a significant moderating effect of
socioeconomic risk among this group of children.175 To further existing knowledge and guide the provision
of evidence-based long-term care for children in the UK, we sought to identify the range and prevalence
of adverse outcomes following LMPT birth. In particular, we sought to determine whether or not LMPT
birth confers additional risk over socioeconomic factors alone and to identify risk factors for adverse
neurodevelopmental outcomes at 2 years of age.
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Objectives
l Explore the health and respiratory outcomes of children born LMPT at 2 years of age.
l Identify the prevalence of cognitive impairment and neurodevelopmental disability among children
born LMPT.
l Identify neonatal risk factors for neurodevelopmental disability at 2 years of age among children
born LMPT.
l Evaluate the impact of LMPT birth on behavioural outcomes at 2 years of age.
Methods
Measures
Data relating to health, respiratory, neurodevelopmental, cognitive and behavioural outcomes were
collected via parental reporting. A study questionnaire combining standard parent report measures and
additional items to address health issues associated with preterm birth was developed. To assess general
health, parents were asked to rate their children’s health in comparison with other children of the same
age using a 4-point scale (excellent, good, fair or poor). Respiratory outcomes were assessed using
forced-choice questions relating to the frequency of wheezing (never, occasionally, frequently or every
day), type (preventer or reliever) and frequency of inhaler use (never, occasionally, frequently or every day),
and prescription of steroids for wheezing (yes or no). Neurological outcomes were assessed using
forced-choice questions relating to whether or not the child had experienced seizures over the last year
(none, febrile only or neurological seizures) and prescription for anticonvulsant medication (yes or no).
To assess neurodevelopmental outcomes, parents were asked whether or not the child had been given
a diagnosis of cerebral palsy (CP) and three forced-choice items were used to assess the child’s vision,
hearing and neuromotor function. Responses were used to identify the severity of functional impairment
(none, mild, moderate, severe) within each domain. Children were classified as having neurosensory
impairment (NSI) if they had a moderate or severe impairment in any one of these three domains
(irrespective of the diagnosis of CP). These questionnaire items were designed to map onto standard
criteria for classifying neurodevelopmental outcomes at 2 years of age.179
Cognitive development was assessed using the PARCA-R, a parent questionnaire of cognitive and
language development.180,181 Raw scores were summed to provide a subscale score for non-verbal
cognition (NVC; range 0–34) and language development (range 0–124). These were then summed to
provide a total parent report composite (PRC) score (range 0–158). The PARCA-R has excellent concurrent
validity with gold standard developmental tests and PRC scores of < 49 have good diagnostic utility, with
≥ 80% sensitivity and specificity, for identifying very preterm children with developmental delay at 2 years
of age.180,181 Therefore, PRC scores of < 49 were used to identify children with suspected developmental
delay in the present study. If fewer than four items were missing on the NVC scale, these items were
replaced by the average NVC item score at the individual level. If more than five items were missing from
the PARCA-R NVC scale, these children were excluded (n= 6). For 21 children whose first language was
not English and whose parent was unable to complete the language section of the questionnaire,
summary scores were not computed but cognitive impairment was classified using the NVC subscale alone,
from which scores of < 22 were used to identify developmental delay corresponding with NVC scores of
< 2.5th percentile of the term-born group. Classifications of cognitive impairment were combined with the
NSI classification to determine the proportion of children with composite neurodevelopmental disability
(defined as a moderate/severe impairment in vision, hearing, motor or cognitive function).179
Behavioural outcomes were measured using the BITSEA,182 a norm-referenced parent report screener for
social–emotional development and behavioural problems in children aged 1–3 years. The problem subscale
comprises 31 items to assess problems such as aggression, defiance, hyperactivity, negative emotionality,
anxiety and withdrawal, from which a summed total problem score is computed, with higher scores
indicating greater problems. The competence subscale comprises 11 items to assess social–emotional
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abilities such as empathy, prosocial behaviours and compliance, from which a total competence score is
computed, with lower scores indicating lesser competence. Behaviour problems (problem scores ≥ 75th
percentile) and delayed social–emotional competence (competence scores ≤ 15th percentile) were
identified using published age- and gender-specific norm-referenced cut-off points.182 The questionnaire
also comprises two questions to elicit level of parental concern about their child’s socioemotional and
language development. The BITSEA has good test–retest reliability, inter-rater reliability and internal
consistency, and positive screens have been shown to predict behaviour problems and psychiatric disorders
at school age in both term-born and very preterm children.182,183
Statistical analyses
Non-response at 2 years was investigated separately for LMPT and term-born children. The risk of
non-response was calculated using Poisson regression with robust SEs for maternal and infant characteristics
listed in Table 28. To assess the effect of LMPT birth on long-term outcomes, RRs with 95% CIs are presented
for the risk of adverse outcomes in the LMPT group compared with the term-born controls. RRs adjusted for
sex, corrected age at assessment and socioeconomic status are also presented. When adjustment resulted in
separation this has been noted and estimates are not provided. For the BITSEA scores, the mean difference
with 95% CIs between term-born and LMPT children is presented using a linear model both crude and after
adjustment for corrected age, socioeconomic status and sex. To identify predictors of adverse outcomes in
LMPT children, univariable associations with neurodevelopmental disability were calculated. To identify
independent risk factors, a multivariable model was then constructed selecting variables with a p-value of
< 0.2 in the univariable analysis, (excluding IMD quartile because of its correlation with the SES Index score)
into a model selection procedure using backwards stepwise selection. The final model chosen was that in
which all included variables had a p-value of < 0.05.
Results
Two-year follow-up rates
At 2Y-CA, seven (0.6%) LMPT children had died, the parents of eight (0.7%) had withdrawn them from
the study and two (0.2%) children had moved into closed foster care precluding ongoing follow-up. Of
the remaining 1113 LMPT children eligible for follow-up at 2 years, the parents of two (0.2%) refused to
complete a study questionnaire, and we did not receive follow-up data from the parents of 460 (41.3%)
children, despite numerous attempts to contact them. Thus, follow-up data were ultimately received for
651 (58.5%) infants born LMPT (Figure 10); excluding deaths, this equates to a follow-up rate of 58.0% of
the total LMPT cohort.
Of term-born infants, two (0.2%) had died, the parents of 16 (1.3%) children had withdrawn them from
the study, and the parents of two (0.2%) had moved abroad, leaving 1235 children eligible for follow-up
at 2Y-CA. Of these term-born infants, the parents of three (0.2%) infants refused to complete a study
questionnaire, and we did not receive follow-up data from the parents of 461 (37.3%) children. The
parents of 771 returned questionnaires, equating to a follow-up rate of 62.4% (see Figure 10) of eligible
term-born children and, excluding deaths, 61.5% of the term-born cohort recruited. For all subsequent
analyses, infants with major congenital anomalies were excluded; this equated to 638 responders in the
LMPT group and 765 among the term-born controls.
Analysis of non-responders
Previous research has shown that non-responders to follow-up in preterm cohorts typically have
higher medical and socioeconomic risk than those who respond to study questionnaires or formal
evaluations.185,186 To examine the effect of loss to follow-up on outcomes at 2 years, maternal and infant
characteristics of non-responders were analysed for both LMPT and term-born children (see Table 28).
Among infants born LMPT, all the maternal characteristics examined were significantly associated with
non-response to follow-up at 2 years. Specifically, mothers who did not respond to follow-up were more
likely to be younger (i.e. aged < 25 years), to have higher socioeconomic risk and poorer mental and
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general health, to be of non-white ethnic origin and not to speak English. The greatest risk was associated
with socioeconomic deprivation, with those with medium- and high-risk SES Index scores being,
respectively, 1.8 (95% CI 1.4 to 2.4) and 3.1 (95% CI 2.8 to 3.9) times more likely than those with low
risk to be non-responders (see Table 28). Of all the infant characteristics examined, not receiving any
breast milk at discharge was the only significant factor associated with non-response; this is likely to be a
marker of higher social risk among those mothers not completing study questionnaires.
Analysis of factors associated with non-response in term-born controls produced similar results in terms of
maternal characteristics, with non-responders more likely to be younger (aged < 25 years) or older mothers
(aged ≥ 35 years), to have higher socioeconomic risk and to be of non-white ethic origin and not to speak
English. However, there was no association with response to follow-up in terms of mothers’ self-reported
general and mental health. Again, the greatest risk was associated with socioeconomic deprivation, with
those with medium- and high-risk SES Index scores being, respectively, 1.7 (95% CI 1.3 to 2.1) and 2.8
(95% CI 2.3 to 3.4) times more likely than those with low risk to be non-responders. As in the LMPT
group, not receiving any breast milk at discharge was significantly associated with non-response. In
addition, mothers who gave birth to more than one baby and mothers of babies born at lower gestational
age or of low birthweight were more likely to be non-responders (see Table 28).
Discussion
The factors associated with non-response were similar between the groups and indicate that
non-responders to follow-up at 2 years were more likely to be from families with higher demographic
risk and socioeconomic deprivation. As these factors are associated with poor neurodevelopmental
outcomes, the results presented hereafter may underestimate the true prevalence of adverse outcomes in
the LMPT and term-born populations; however, the effect of this is likely to be similar between groups.
Our later discussion and conclusions have thus been tempered accordingly.
LMPT (32 – 36 weeks)
1340 live births approached
Recruited live births (n = 1130)
6-month follow-up
784/1118 (70.1%)
12-month follow-up
704/1114 (63.2%)
24-month follow-up
651/1113 (58.5%)
Postal, n = 607 (93.3%)
Telephone, n = 21 (3.2%)
Online, n = 23 (3.5%)
Died, n = 6
Withdrawn, n = 4
Foster care, n = 2
Died, n = 1
Withdrawn, n = 3
Died, n = 0
Withdrawn, n = 1
Died, n = 0
Withdrawn, n = 6
Moved abroad, n = 2
Died, n = 2
Withdrawn, n = 3
Died, n = 0
Withdrawn, n = 7
Term-born controls
(≥ 37 weeks)
1583 live births approached
Recruited live births (n = 1255)
6-month follow-up
940/1250 (75.2%)
12-month follow-up
858/1242 (69.1%)
24-month follow-up
771/1235 (62.4%)
Postal, n = 689 (89.4%)
Telephone, n = 37 (4.8%)
Online, n = 45 (5.6%)
FIGURE 10 Follow-up rates and retention of the LAMBS cohort to 2Y-CA.
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Health, respiratory and neurological outcomes
Among those without congenital anomalies, health and respiratory outcomes for LMPT infants and
term-born controls are shown in Table 29. RRs for adverse outcomes among LMPT infants are reported
both unadjusted and adjusted for sex and SES Index (low, middle and high risk).
Overall, LMPT infants were at 2.4 times (95% CI 1.4 to 3.8 times) increased risk of poorer parent-reported
general health than infants born at term. Notably, this increase was not evidenced in terms of ‘poor’
health, but instead there was an excess of LMPT infants reported as having ‘fair’ health. A similar pattern
of results was evidenced for respiratory outcomes. Although LMPT infants did not have frequent wheeze
more often than infants born at term (RR 0.89, 95% CI 0.45 to 1.75; p= 0.72), there was an excess of
LMPT infants with occasional wheeze (29% vs. 20%) and a reduction in the proportion who were
reported as never wheezing compared with infants born at term (69% vs. 78%). Similarly, although more
LMPT infants had been prescribed an inhaler by 2 years of age (RR 1.38, 95% CI 1.10 to 1.73; p= 0.005),
they did not have a higher rate of frequent inhaler use than term-born infants (RR 0.77 95% CI 0.39 to
1.55; p= 0.47); there was an increase only in occasional inhaler use, and LMPT infants had not been
prescribed more corticosteroids than term-born controls, indicating no excess of severe respiratory
problems. Similarly, there was no excess of neurological sequelae in LMPT infants: they were no more likely
than term-born infants to have had seizures in the past year or to have been prescribed anticonvulsant
medication (see Table 29). Adjustment for potential confounders of the association between outcomes and
LMPT birth did not alter the statistical significance of results for any health, respiratory or neurological
outcome (see Table 29).
Discussion
Taken together these results indicate that there is an excess of mild health problems among infants born
LMPT and that severe adverse health outcomes are as rare among this group as they are in the general
population. These findings are commensurate with other recent population-based studies of long-term
outcomes in children born LMPT in which an increase in mild health and respiratory problems has been
observed.167,174,187 This contrasts with the well-documented outcomes of very preterm infants in which
there is a significantly increased risk for severe respiratory and neurological problems.171,188 Increases in
even mild health problems should not be underestimated, as these can have a significant impact at the
population level given the large numbers of babies born LMPT.7,174,189 Whether the observed increase in
inhaler use reflects a true increase in respiratory symptoms or a potential prescription bias among preterm
children requires elucidation with detailed clinical studies to confirm the validity of these parent reports.
However, others have demonstrated impaired lung function at school age in children born LMPT,174,187
suggesting that these children may be at risk of respiratory problems. Further detailed studies of long-term
respiratory function are needed to better define outcomes in this area. Later follow-up of this cohort will
also enable an investigation of the long-term functional significance of these findings.
Neurodevelopmental outcomes
Neurodevelopmental outcomes for LMPT and term-born children are shown in Table 30. RRs were
adjusted for potential confounders (sex, corrected age and SES Index) when possible.
As in the term-born population, the prevalence of moderate/severe NSI was very low, with < 1% of LMPT
children having functional hearing, visual or neuromotor impairment. When RRs could be computed, these
showed no significant difference from term-born controls. When these were combined as a composite
measure, overall there was a significantly increased risk for NSI among LMPT children compared with
controls (1.6% vs. 0.3%; RR 6.00; 95% CI 1.32 to 27.28). Among the LMPT group, no parents reported
that their child had received a diagnosis of CP compared with 0.5% of the term-born population
(see Table 30).
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TABLE 29 Health, respiratory and neurological outcomes at 2Y-CA in LMPT and term-born infants
Outcome
Term
(n= 765)
LMPT
(n= 638)
Unadjusted Adjusteda
RR (95% CI) p-value RR (95% CI) p-value
General health
Poor health,b n (%) 2.35
(1.44 to 3.84)
0.001 2.26
(1.38 to 3.70)
0.001
Excellent 468 (61.2) 358 (56.1) – – – –
Good 274 (35.8) 234 (36.7) – – – –
Fair 22 (2.9) 44 (6.9) – – – –
Poor 1 (0.1) 1 (0.2) – – – –
Missing – 1 (0.2) – – – –
Respiratory outcomes
Frequent wheeze,c n (%) 0.89
(0.45 to 1.75)
0.729 0.85
(0.43 to 1.68)
0.64
Never 594 (77.7) 439 (68.8) – – – –
Occasionally 152 (19.9) 183 (28.7) – – – –
Frequently 16 (2.1) 11 (1.7) – – – –
Every day 3 (0.4) 3 (0.5) – – – –
Missing – 2 (0.3) – – – –
Uses an inhaler, n (%) 1.38
(1.10 to 1.73)
0.005 1.36
(1.09 to 1.70)
0.007
Uses a preventer 8 (1.1) 4 (0.6) – – – –
Uses a reliever 90 (11.8) 108 (16.9) – – – –
Uses both 19 (2.5) 23 (3.6) – – – –
Missing 1 (0.1) – – – – –
Frequent inhaler use,d n (%) 0.77
(0.39 to 1.55)
0.47 0.73
(0.37 to 1.46)
0.38
Never 653 (85.4) 515 (80.7) – – – –
Occasionally 84 (11.0) 107 (16.8) – – – –
Frequently 7 (0.9) 5 (0.8) – – – –
Every day 13 (1.7) 8 (1.3) – – – –
Missing 8 (1.1) 3 (0.5) – – – –
Steroids used, n (%) 47 (6.2) 49 (7.7) 1.25
(0.85 to 1.84)
0.26 1.21
(0.82 to 1.80)
0.33
Neurological outcomes
Seizures in past year,e n (%) 1 (0.1) 2 (0.3) 2.41
(0.22 to 26.49)
0.473 2.31
(0.22 to 24.22)
0.49
Prescribed anticonvulsant, n (%) 2 (0.3) 1 (0.2) 0.60
(0.05 to 6.60)
0.676 0.52
(0.05 to 4.97)
0.57
a Adjusted for infant sex and SES Index (low, middle, high risk).
b General health reported as fair or poor (vs. excellent or good).
c Frequent wheeze classified if frequently/every day (vs. never/occasionally).
d Frequent inhaler use classified if frequently/every day (vs. never/occasionally).
e Does not include febrile seizures.
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Cognitive problems were more frequent, in general, and there was a significantly increased risk of
cognitive impairment, which was present in 16% of LMPT children compared with 10% of term-born
children (RR 1.56, 95% CI 1.18 to 2.06). There was also a significant difference in mean PARCA-R scores
between LMPT children and controls (term: mean 94.5, SD 33.3; LMPT: mean 88.9, SD 36.0; unadjusted
mean difference –5.61, 95% CI –9.28 to -1.95, p= 0.003; adjusted mean difference –4.16, 95% CI –7.70
to -0.63, p= 0.021). The distribution of PRC scores was similar in both the LMPT and term-born children,
but there appeared to be a general shift to the left, resulting in an excess of LMPT children with scores
below the cut-off point for cognitive impairment (Figure 11).
When cognitive impairment was combined with NSI, LMPT children were at significantly increased risk of
moderate/severe neurodevelopmental disability compared with term-born controls (RR 1.57, 95% CI 1.19
to 2.07). This was almost exclusively the result of cognitive impairment, with only two additional LMPT
children and one additional control having neurodevelopmental disability over cognitive impairment alone
(see Table 30). The adjusted RR for neurodevelopmental disability was 1.42 (95% CI 1.08 to 1.86).
Discussion
Although these results indicate that there is a significantly increased risk of functional NSIs in LMPT
children compared with those born at term, these were rare and affected only 1.6% of LMPT children.
This represents a marked reduction in adverse neurosensory outcomes compared with children born very
preterm and extremely preterm.171,188 The rate of CP was also higher among term-born controls than those
born LMPT (0.5% vs. 0%, respectively). However, the statistical significance of this could not be assessed
given the low prevalence. Moreover, diagnoses were reported by parents and not confirmed in this
sample. Given that CP diagnoses often become clinically apparent only at this age, additional cases of mild
CP may become evident at later stages of follow-up.
TABLE 30 Neurodevelopmental outcomes at 2Y-CA in LMPT and term-born infants
Neurodevelopmental
outcome
Term
(n= 765)
LMPT
(n= 638)
Unadjusted Adjusteda
RR (95% CI) p-value RR (95% CI) p-value
Composite outcomes
NSI,b n (%) 2 (0.3) 10 (1.6) 6.00
(1.32 to 27.28)
0.021 – –
Neurodevelopmental disability,c
n (%)
77 (10.1) 101 (15.9) 1.57
(1.19 to 2.07)
0.001 1.42
(1.08 to 1.86)
0.011
Domains of impairment
Hearing impairment, n (%) 9 (0.0) 3 (0.5) – – – –
Vision impairment, n (%) 9 (0.0) 2 (0.3) – – – –
Motor impairment, n (%) 2 (0.3) 5 (0.8) 3.00
(0.58 to 15.41)
0.19 – –
CP, n (%) 4 (0.5) 0 (0.0) – – – –
Cognitive impairment,d n (%) 76 (10.0) 99 (15.6) 1.56
(1.18 to 2.06)
0.002 1.41
(1.07 to 1.85)
0.013
a Adjusted for chronological age at assessment (age bands: 18–23 months, 24–29 months, ≥ 30 months), sex and SES
Index (low, middle, high risk).
b NSI is classified as when the child has a moderate or severe impairment in hearing, vision or motor function.
c Neurodevelopmental disability is classified as when the child has a moderate or severe impairment in either hearing,
vision, motor or cognitive function.
d Cognitive impairment is classified as when the child had a PARCA-R PRC score of < 49.
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In contrast, 16% of LMPT children had moderately to severely delayed cognitive development, compared
with 10% of term-born controls. Thus, although the RR (1.6) was lower than for NSI (6.00), the absolute
impact of cognitive difficulties is likely to be greater at a population level given the higher prevalence
of these outcomes. Early cognitive difficulties are an important indicator of an individual’s childhood
achievement and future life chances.190 Moreover, cognitive problems in very preterm children have been
shown to persist throughout childhood and adolescence and to have a profound impact on academic
attainment and the need for special educational intervention.191,192 Thus, it might be predicted that LMPT
children will have higher rates of special educational needs and poor school performance as shown in
recent studies.9,175
Historically, cognitive problems in very preterm children have proven difficult to ameliorate and numerous
neonatal and early developmental interventions have met with limited success; even when these show
early benefits, these are rarely sustained beyond the period of intervention delivery.193 However, a number
of studies, including the large-scale US Infant Health and Development Program (IHDP), have reported
beneficial effects of intervention for relatively larger babies with birthweight of 2001–2500 g, which may
suggest that LMPT infants could benefit from early intervention.194–197 Olds et al.198 have identified
particular benefit from interventions in families of low socioeconomic status. It is not clear to what extent
cognitive problems identified at 2 years represent impaired function or developmental delays and whether
or not there is the potential for catch-up over the preschool years. Longer-term follow-up of this cohort is
needed to determine how these cognitive problems evolve over time and the long-term significance of
these early outcomes for later educational attainment. The efficacy of early intervention programmes
requires investigation in this population. Given the size of the LMPT population, intervention and follow-up
for all may be prohibitive in terms of the cost and resources required. Thus, it is important to identify an
at-risk subgroup in order to target resources to those in greatest need. As such, we also investigated risk
factors for adverse neurodevelopmental outcomes among LMPT children.
Risk factors for neurodevelopmental disability in children born late and
moderately preterm
In order to identify children at greatest risk of adverse outcomes, we explored the association of obstetric
and neonatal factors with the presence of neurodevelopmental disability at 2Y-CA. As shown in Table 31,
children whose mothers were of non-white ethnic origin, non-English speaking or of higher socioeconomic
risk, or who smoked or took recreational drugs during pregnancy, or who had pre-pregnancy hypertension
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FIGURE 11 Frequency distribution of PARCA-R PRC scores in LMPT and term-born children. Higher scores indicate
better cognitive development. The vertical line indicates the cut-off point for identifying cognitive impairment.
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TABLE 31 Univariable associations with neurodevelopmental disability at 2Y-CA among children born late and
moderately preterm
Variable
n (%) with neurodevelopmental disability
RR (95% CI) p-valueRisk factor present Risk factor absent
Obstetric factors
Mother’s age (years)
< 20 4 (20.0) 97 (16.0) 1.39 (0.54 to 3.59) 0.49
20–24 19 (21.6) 82 (15.5) 1.50 (0.88 to 2.56) 0.14
25–29 26 (14.4) 75 (16.8) Baseline –
30–34 26 (12.1) 75 (18.2) 0.84 (0.51 to 1.40) 0.51
≥ 35 26 (21.1) 75 (14.9) 1.47 (0.90 to 2.41) 0.13
Non-white ethnic group 29 (23.2) 72 (14.4) 1.61 (1.10 to 2.37) 0.015
Non-English-speaking at home 22 (27.5) 79 (14.6) 1.88 (1.24 to 2.84) 0.003
SES Index
Low risk 20 (7.1) 81 (23.5) Baseline –
Medium risk 37 (19.2) 64 (14.7) 2.71 (1.62 to 4.53) < 0.001
High risk 44 (29.0) 57 (12.0) 4.10 (2.51 to 6.69) < 0.001
Conceived via infertility
treatment
1 (1.85) 100 (17.4) 0.11 (0.02 to 0.75) 0.024
Pre-pregnancy diagnosed
diabetes
4 (19.1) 97 (16.0) 1.19 (0.48 to 2.93) 0.70
Pre-pregnancy diagnosed
hypertension
7 (46.7) 94 (15.3) 3.04 (1.72 to 5.39) < 0.001
Smoked during pregnancy 32 (25.2) 69 (13.8) 1.85 (1.27 to 2.68) 0.001
Alcohol drank during pregnancy 40 (14.1) 61 (17.7) 0.79 (0.55 to 1.15) 0.22
Recreational drugs used during
pregnancy
6 (50.0) 95 (15.4) 3.24 (1.79 to 5.88) < 0.001
Pre-eclampsia 25 (26.9) 76 (14.2) 1.89 (1.27 to 2.81) 0.002
Infection (positive culture) during
pregnancy
11 (24.4) 86 (15.2) 1.61 (0.93 to 2.80) 0.089
Gestational diabetes 5 (21.7) 96 (15.8) 1.38 (0.62 to 3.06) 0.43
Pre-labour rupture of membranes
>24 hours prior to delivery
21 (17.2) 80 (15.8) 1.09 (0.70 to 1.69) 0.70
Antinatal corticosteroids given 24 (13.9) 77 (16.9) 0.82 (0.54 to 1.26) 0.37
Labour induced 27 (20.3) 74 (14.9) 1.37 (0.92 to 2.04) 0.12
Raised CRP level during labour 7 (29.2) 94 (15.6) 1.84 (0.96 to 3.53) 0.067
Normal vaginal delivery 48 (15.2) 53 (17.0) 0.89 (0.63 to 1.28) 0.54
Cord pH of ≤ 7.1 5 (25.0) 96 (15.8) 1.55 (0.70 to 3.46) 0.28
Absent or reversed end diastolic
flow
5 (19.2) 96 (16.0) 1.21 (0.54 to 2.71) 0.65
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TABLE 31 Univariable associations with neurodevelopmental disability at 2Y-CA among children born late and
moderately preterm (continued )
Variable
n (%) with neurodevelopmental disability
RR (95% CI) p-valueRisk factor present Risk factor absent
Neonatal factors
Male 79 (23.4) 22 (7.6) 3.10 (1.98 to 4.84) < 0.001
Gestational age (weeks)
36 52 (19.2) 49 (13.7) Baseline –
35 19 (11.5) 82 (17.7) 0.60 (0.37 to 0.98) 0.041
34 16 (14.8) 85 (16.7) 0.77 (0.46 to 1.29) 0.32
33 9 (19.2) 92 (15.8) 1.00 (0.53 to 1.89) 0.99
32 5 (13.5) 96 (16.2) 0.70 (0.30 to 1.65) 0.42
Multiple birth 11 (10.3) 90 (17.3) 0.60 (0.33 to 1.07) 0.085
Birthweight
> 10th percentile for
gestation and sex
87 (15.7) 14 (19.4) Baseline –
> third and ≤ 10th percentile
for gestation and sex
8 (20.0) 93 (15.8) 1.28 (0.67 to 2.45) 0.46
≤ third percentile for
gestation and sex
6 (18.8) 95 (15.9) 1.20 (0.57 to 2.53) 0.64
Fetal growth restrictiona 25 (17.2) 76 (15.7) 1.10 (0.73 to 1.65) 0.66
APGAR score of < 5 at 5 minutes 0 (0) 101 (16.2) – –
Resuscitated at birth 28 (24.8) 73 (14.2) 1.75 (1.19 to 2.57) 0.005
Any respiratory support receivedb 18 (21.4) 83 (15.3) 1.40 (0.89 to 2.21) 0.14
Neonatal seizures 0 (0) 101 (16.1) – –
Intracranial abnormalityc 1 (20.0) 100 (16.1) 1.25 (0.21 to 7.27) 0.81
Jaundice requiring phototherapy 4 (8.3) 97 (16.7) 0.48 (0.19 to 1.26) 0.14
Antibiotics given 39 (18.8) 92 (15.9) 1.18 (0.63 to 2.20) 0.60
Any breast milk at discharged 48 (12.2) 53 (22.9) 0.53 (0.37 to 0.76) 0.001
APGAR, appearance, pulse, grimace, activity and respiration.
a Fetal growth restriction calculated using the GROW software.
b Any respiratory support includes infants who were ventilated or received non-invasive respiratory support.
c Intracranial abnormality includes grade III or IV intraventricular haemorrhage, periventricular leukomalacia and grade II or
III neonatal encephalopathy.
d Includes breast milk fed by any method.
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or pre-eclampsia were significantly more likely to have neurodevelopmental disability. Raised CRP levels
during pregnancy were also marginally associated with disability (p< 0.1). LMPT children who were
conceived via infertility treatment were less likely to have neurodevelopmental disability at 2 years. Of the
neonatal factors analysed, being male, being resuscitated at birth and not having any breast milk at
discharge were significantly associated with the risk of neurodevelopmental disability. These variables
predominantly appear to be markers of high sociodemographic risk or hypertensive disease, either before
or during pregnancy. The greatest impact was found for recreational drug use during pregnancy,
pre-pregnancy hypertension and higher SES Index, each of which as associated with a three- to fourfold
increased risk of disability.
Given the correlation between these factors, multivariable analyses were conducted to identify
independent predictors of neurodevelopmental disability in LMPT children. As shown in Table 32, eight
factors emerged as risk factors. Being male, being resuscitated at birth, having a mother who had
pre-pregnancy hypertension or pre-eclampsia or who used recreational drugs during pregnancy was
associated with a 1.5- to 2.5-fold increased risk of disability. Socioeconomic deprivation was also
independently associated with disability, with risk of disability increasing with increasing deprivation.
In addition, having a mother who did not speak English and not having had breast milk at discharge
were also associated with disability.
Discussion
These findings will aid in the identification of a subgroup of infants at high risk for disability following
LMPT birth. It should be noted that these results are likely to reflect the association with cognitive
outcomes, as 98% of LMPT children with disability were classified as such on the basis of a cognitive
impairment. The association of these factors with neurodevelopmental disability is not unexpected given
their well-documented association with both neonatal and long-term neurodevelopmental outcomes in
both term-born and preterm children. These associations are also borne out in other studies in which
resuscitation at birth, sociodemographic factors and pre-eclampsia, in particular, have been independently
associated with long-term outcomes in this population.175,199,200 Not receiving any breast milk at discharge,
either expressed or by breastfeeding, was associated with disability at 2 years. The impact of breastfeeding
on infant development has been widely reported, although the mechanisms for this association remain
unclear in both term-born and preterm infants.201,202
TABLE 32 Factors independently associated with neurodevelopmental disability at 2 years of age among children
born LMPT
Variable RR (95% CI) p-value
Male infant 2.60 (1.66 to 4.06) < 0.001
Pre-pregnancy diagnosed hypertension 2.42 (1.44 to 4.04) 0.001
SES Index
Medium risk 2.25 (1.31 to 3.85) 0.003
High risk 3.33 (2.00 to 5.57) < 0.001
Non-English-speaking 1.87 (1.20 to 2.93) 0.006
Any breast milk at discharge 0.63 (0.43 to 0.92) 0.016
Any respiratory support 1.59 (1.03 to 2.46) 0.035
Pre-eclampsia 2.16 (1.45 to 3.22) < 0.001
Recreational drugs used during pregnancy 2.39 (1.48 to 3.84) < 0.001
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Promisingly, a number of these factors may be amenable to intervention. For example, improving access to
community health-care services, supporting breastfeeding and providing developmental support for infants
born into high socioeconomic risk may serve to improve cognitive and thus neurodevelopmental outcomes;
this has been suggested by results for infants in the US IHDP, in which heavier babies, rather than those
with very low birthweight, appeared to benefit most from intervention.194,196,197 Education and intervention
strategies to minimise recreational drug use during pregnancy or provide enhanced antenatal surveillance
for these mothers may also be beneficial. The timing of delivery for mothers with pre-eclampsia may also
impact on outcomes, and efforts to target optimal timing of delivery for these babies may help to reduce
the prevalence of poor long-term outcomes. Future analyses are needed to explore the interaction of
socioeconomic factors with outcome, in more detail, to attempt to identify those children at greatest risk.
In particular, an exploration of potential interactions between the neonatal and obstetric variables
examined may aid in identifying a high-risk subgroup of children born LMPT.
Behavioural outcomes
Behavioural outcomes were assessed using the BITSEA parent report questionnaire from which both
continuous and categorical outcomes were derived for the presence of behaviour problems and delays in
socioemotional competence. Analyses are presented unadjusted and after adjustment for age, sex and
socioeconomic status (Table 33).
TABLE 33 Behavioural outcomes at 2Y-CA in LMPT and term-born children
Behavioural
outcome
Term
(n= 765)
LMPT
(n= 638) Unadjusted Adjusteda
Scale scores Mean (SD) Mean (SD)
Mean difference
(95% CI) p-value
Mean difference
(95% CI) p-value
Problem score 9.22 (6.52) 9.81 (6.58) 0.59 (–0.10 to 1.29) 0.094 0.28 (–0.38 to 0.95) 0.41
Competence score 17.20 (2.96) 16.62 (3.40) –0.58 (–0.91 to –0.25) 0.001 –0.44 (–0.77 to -0.12) 0.008
Problems or delays n (%) n (%) RR (95% CI) p-value RR (95% CI) p-value
Behaviour problems 139 (18.3) 132 (21.0) 1.15 (0.93 to 1.42) 0.20 1.07 (0.87 to 1.32) 0.52
Delayed competence 142 (18.6) 167 (26.5) 1.42 (1.17 to 1.73) < 0.001 1.36 (1.12 to 1.65) 0.002
Problems or delay 231 (30.3) 236 (37.2) 1.23 (1.06 to 1.42) 0.006 1.17 (1.01 to 1.35) 0.032
Parental concerns n (%) n (%) RR (95% CI) p-value RR (95% CI) p-value
Concerned about
behaviour
10 (1.3) 9 (1.4) 1.08 (0.44 to 2.64) 0.868 0.92 (0.38 to 2.27) 0.86
Concerned about
language
18 (2.4) 25 (3.9) 1.66 (0.92 to 3.02) 0.094 1.53 (0.85 to 2.76) 0.158
a Adjusted for chronological age at assessment (age bands: 18–23months, 24–29months, ≥ 30months), sex and SES
Index (low, middle, high risk). Higher problem scores indicate greater problems. Lower competence scores indicate lower
levels of competence.
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Although there was a trend towards higher problem scores in LMPT children (p< 0.1), there was no
statistically significant difference in the mean BITSEA problem scores. In contrast, LMPT children had
significantly lower competence scores than term-born controls both before and after adjustment for
confounders (adjusted mean difference –0.44, 95% CI –0.77 to –0.12; p= 0.008). When the BITSEA
scores were compared with age- and sex-standardised norms, overall, LMPT children were significantly
more likely to have a behaviour problem or delay, present in 37% of LMPT children, compared with 30%
of controls (adjusted RR 1.17, 95% CI 1.01 to 1.35). However, although significantly more LMPT children
had delays or deficits in socioemotional competence (adjusted RR 1.36, 1.12 to 1.65; p= 0.002), there was
no excess of behavioural problems in this group. Despite the delays in socioemotional development
observed among LMPT children, parents did not report more frequent concerns about their child’s
behaviour or language development (see Table 33).
Discussion
The BITSEA problem scale assesses internalising difficulties, externalising problems, dysregulation, atypical
behaviours and maladaptive behaviours. The results of this study indicate that children born LMPT were
not at increased risk of these problems at 2 years of age. This was a somewhat unexpected finding. Very
preterm birth (< 32 weeks) is associated with an increased risk of attention deficit/hyperactivity disorders,
emotional disorders and autism spectrum disorders,173 the cluster of which has been termed the ‘preterm
behavioural phenotype’.203 These disorders are present in around 25% of very preterm children at school
age and are considered to have a neurodevelopmental origin in this population.203 Moreover, these
problems are already evident on parent-reported behavioural screening questionnaires in the pre-school
years.204–208 If the constellation of behavioural outcomes associated with very preterm birth extends across
birth at LMPT gestations, we would expect to find increased parent-reported behaviour problems at
2 years, albeit with less severity and lower prevalence. This finding may thus be indicative of a different
behavioural profile among LMPT children from that among those born very preterm.
We did, however, find that LMPT children had delayed socioemotional development compared with
term-born peers and that this was not accounted for by the higher socioeconomic risk status of families
with LMPT children. The BITSEA competence scale assesses aspects of social relatedness that develop
early in childhood, including compliance with adult expectations and requests, attention skills, mastery
motivation, imitation and play and pro-social interactions. Delays in early socioemotional competence have
been associated with later social, emotional and behaviour problems and disorders in both preterm and
term-born children.183,207,209 Thus, although it is reassuring that early behaviour problems were not evident
at 2 years of age, the increase in poor socioemotional competence raises concerns about the risk for
longer-term problems in this population. In particular, follow-up of this cohort is needed to determine
whether these early findings are indicative of deficits in social and emotional competence and associated
risk for long-term difficulties, or whether these represent early delays from which there may be
developmental catch-up. In addition, it is well documented that parental mental health is associated
with behavioural outcomes in their offspring and with family socioeconomic status and adversity.210 The
impact of parental mental health and other maternal obstetric and neonatal factors on LMPT children’s
behavioural outcomes requires further investigation to determine whether or not services can be targeted
to subgroups of children at greatest risk. If behavioural outcomes are socially mediated to a greater extent
in LMPT children than those born very preterm, there may be potential for parenting interventions to
improve outcomes in this population.
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Conclusions
Key findings
l Parents report that children born LMPT have poorer health than children born at term and are more
likely to be prescribed inhalers. These findings are indicative of an increase in minor health conditions
and respiratory symptoms rather than severe health, respiratory or neurological outcomes.
l Children born LMPT have a six times higher risk of NSIs than children born at term. However, the
absolute impact of these impairments is minimal compared with the increased risk of cognitive
difficulties, which are present in 16% of children born LMPT.
l Late and moderately preterm children are more likely to have delayed socioemotional development at
2 years of age. Although parents do not report concern about these early delays/deficits, these may be
indicative of longer-term peer relationship difficulties and mental health problems.
l The excess of socioemotional delays in the absence of behaviour problems may be indicative of a
different behavioural profile following LMPT birth compared with children born very preterm.
l The significant increase observed in adverse health, cognitive and socioemotional outcomes is not
accounted for by the association of LMPT birth with higher socioeconomic risk.
l Risk factors for poor neurodevelopmental disability in LMPT children include high socioeconomic risk,
male sex, maternal hypertensive disease before or during pregnancy, antenatal recreational drug use
and not feeding breast milk at discharge from hospital. These factors may be amenable to intervention
for improving long-term outcomes in this population.
Strengths and limitations
Despite intensive efforts and resources directed at improving response rates to follow-up at 6, 12 and
24 months, this still remained at approximately 60%. Analysis showed that non-responders had higher
socioeconomic and demographic risk than responders, and thus we may have underestimated the true
prevalence of developmental problems in this study. Although the effect of selective dropout was similar in
both groups, we intend to carry out multiple imputations to assess the impact of non-response bias on the
prevalence of key adverse outcomes at 2Y-CA.
Given the size of the cohort, individual assessments were not possible at 2Y-CA and thus we opted to
conduct follow-up using validated parent report measures. The utility of these for identifying children with
poor longer-term outcomes requires investigation to determine the predictive validity of infant assessments
in this population. The prospective nature of this study enabled us to collect important demographic,
obstetric and neonatal information and thus we were able to adjust for the effects of socioeconomic
deprivation on developmental outcomes at 2 years. Although multivariable analyses showed that NSI,
cognitive impairment and delayed socioemotional competence were significantly increased after
adjustment for our composite SES Index, there may be a significant interaction between preterm birth and
socioeconomic factors. In particular, greater affluence and lower social risk may have a greater impact on
outcomes in the LMPT population, potentially ‘protecting’ infants from the risks conferred by LMPT birth.
As a priority, we intend to carry out further analyses to explore factors that mediate the relationship
between LMPT birth and adverse developmental outcomes and the interaction of socioeconomic factors
with the predictors of disability examined above. In addition, we intend to carry out further analyses to
determine whether or not we can identify a subgroup of LMPT children at greatest risk of adverse
outcomes in order to aid in decision-making around the time of birth and to help target follow-up and
early intervention efforts.
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Implications for practice
The results of the 2-year follow-up study may be used by obstetric practitioners in decision-making when
considering the likely long-term outcomes of delivery of pregnancies at LMPT gestations. Information
about developmental difficulties may also be used to counsel parents about the potential long-term
outcomes for their child. This may aid in shared decision-making around delivery and also in raising
awareness of the potential for long-term developmental problems, particularly in terms of cognitive and
socioemotional development. Our patient and public involvement (PPI) work has identified that parents feel
that community health-care workers lack specialist knowledge about the developmental and caregiving
needs of babies born at LMPT gestations. Thus, the results of this study may be important in informing
community paediatricians and health-care practitioners about outcomes for children born LMPT and for the
need to carry out surveillance for developmental problems among these children.
The increased prevalence of cognitive and socioemotional difficulties at 2 years may warrant follow-up
over the early years. Given the low prevalence of neurodevelopmental disorders and the size of the LMPT
population, this may be best delivered by community health-care services rather than by neonatal
services, as is currently the model of provision for children born very preterm. Low-cost alternatives to
developmental assessments may be appropriate for this population, for which parent questionnaires may
prove valuable. Enhanced antenatal surveillance for pregnant women at highest risk of pre-eclampsia and
socioeconomic deprivation and ongoing developmental and educational support for mothers post
discharge may also be beneficial for their infants who are born at LMPT gestations.
Future research
There is a need to assess the validity of the PARCA-R for predicting longer-term outcomes to determine its
use as a clinical screening measure in children born LMPT. Longer-term follow-up of this cohort will be
imperative to determine how early cognitive problems evolve over time and whether or not there is
developmental plasticity in LMPT children. This will also enable an assessment of whether or not delays in
early socioemotional development manifest as behavioural problems or peer relationship difficulties later
in childhood.
Work to evaluate the efficacy of early parenting interventions for improving cognitive and socioemotional
development in this population is needed. Given that we have identified an increase in problems in this
group at 2 years, there is a need to develop, implement and evaluate potential follow-up schemes for
families and children born LMPT that are feasible in such a large group of children. Detailed clinical studies
are warranted to further explore and validate our findings relating to an observed excess of mild
respiratory symptoms in this group of children. The impact of maternal mental health on behavioural
outcomes in this population also requires exploration.
Costs of late and moderately preterm birth
Objectives
l To determine the economic costs between birth and initial hospital discharge associated with
LMPT birth.
l To determine the economic costs between birth and 2 years associated with LMPT birth.
l To determine how the economic costs associated with LMPT birth are distributed across sectors.
l To identify how other factors, clinical and sociodemographic, constellate with LMPT birth in estimations
of economic costs.
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Methods
Measurement of resource use and costs
Relevant resource items were integrated into the perinatal and follow-up data collection instruments
described previously. The neonatal and maternal data collection forms captured a comprehensive profile of
resource use by each infant, encompassing length of stay by intensity of care, surgeries, investigations,
procedures, drugs, consumables, transfers and post-mortem examinations until final hospital discharge or
death (whichever was earliest). Resource inputs were valued using a combination of primary research,
based on established accounting methods, and data collated from secondary national tariff sets.211,212
All costs were expressed in pounds sterling and reflected values for the financial year 2010–11.
The total length of stay (total inpatient hospital days) was computed as the total number of hospital days
until first discharge to home or death. This total incorporated any hospital stays following interhospital
transfers that may have occurred. Postnatal costs for the mothers were based on the method of delivery
and costs assigned using data from the NHS Reference Costs 2010–11.212 Detailed information was
available on the interventions and feeding received by infants in the NNU including number of days on
oxygen, number of days on a ventilator, number of days of non-invasive respiratory support, number of
days of PN and number of days of i.v. fluids. A clinician involved with the study (EMB) used this daily
information on interventions and feeding to map the time spent in the NNU into days by level of neonatal
care (special, high dependency or intensive). The cost of neonatal care was calculated for each infant by
multiplying the length of stay in special care, high-dependency care or intensive care by the per diem cost
of the corresponding level of care using data from the NHS Reference Costs 2010–11.212 Non-routine
investigations excluded from these per diem costs were identified by study clinicians and these were valued
using a combination of primary and secondary costs. For situations in which these costs were not available
from national tariffs, clinicians were asked to identify the staff and material inputs required for these
investigations. Staff time was valued using the Unit Costs of Health and Social Care 2012.211 The costs of
surgeries were calculated by assignment of surgical procedures to relevant Healthcare Resource Group
(HRG) codes and application of unit costs from national tariffs.212 Transfers were recorded whenever an
infant was transported from a general hospital to a specialist hospital for neonatal critical care, from a
specialist centre to a general hospital, or from a specialist centre to a higher-level centre, and were valued
using costs from the NHS Reference Costs 2010–11.212 Post-mortem costs were based on data from
secondary sources.213 Table 34 contains for a list of resource values and their sources for the period from
birth to initial hospital discharge.
As part of the battery of research instruments completed at the follow-up points (6 months, 1 year and
2 years), the main parent was asked to complete detailed postal questionnaires about their child’s resource
utilisation over the previous period. The 6-month questionnaire covered the child’s resource utilisation
between initial hospital discharge and 6 months; the 1-year questionnaire covered the child’s resource
utilisation between 6 and 12 months; and the 2-year questionnaire covered the child’s resource utilisation
between their first and second birthdays. The questionnaires were piloted to ascertain their acceptability,
ease of comprehension and reliability and reminder letters were sent to parents to increase the response
and completion rates. The data collected from the main parent included their child’s use of hospital
inpatient, day care and outpatient services, community health and social care services, and medicines and
drugs, and also recorded adaptations to the home, provision of special equipment and parental lost
productivity attributable to the child’s health status, over the relevant time horizons. Resource inputs were
valued using a combination of primary research, based on established accounting methods, and data
collated from secondary national tariff sets211,212 (GBP, 2011 prices).
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TABLE 34 Resource valuations for the period from birth to initial hospital discharge
Resource use measures Unit cost (£) Source
Mode of delivery
Spontaneous vaginal 1206 NHS Reference Costs 2010–11212
Spontaneous vaginal and induction 1594 NHS Reference Costs 2010–11212
Forceps 1624 NHS Reference Costs 2010–11212
Forceps and induction 2116 NHS Reference Costs 2010–11212
Ventouse 1624 NHS Reference Costs 2010–11212
Ventouse and induction 2116 NHS Reference Costs 2010–11212
Ventouse and forceps 1624 NHS Reference Costs 2010–11212
Ventouse and forceps and induction 2116 NHS Reference Costs 2010–11212
Assisted breech 2178 NHS Reference Costs 2010–11212
Assisted breech and induction 2783 NHS Reference Costs 2010–11212
CS, during labour 3236 NHS Reference Costs 2010–11212
CS, not in labour 2622 NHS Reference Costs 2010–11212
Ventouse and forceps and CS 3236 NHS Reference Costs 2010–11212
Forceps and CS 3236 NHS Reference Costs 2010–11212
CS with eclampsia, pre-eclampsia or
placenta praevia
5253 NHS Reference Costs 2010–11212
Home birth 1067 Birthplace in England Collaborative Group214
Investigations
Cranial ultrasound scan 53 NHS Reference Costs 2010–11212
Electroencephalography 93 NHS Reference Costs 2010–11212
MRI 98 NHS Reference Costs 2010–11212
Chromosomal studies 589 NHS Reference Costs 2010–11212
Other investigations Various NHS Reference Costs 2010–11212
Surgery/operations, n (%) Various procedures NHS Reference Costs 2010–11212
Hospital transfer
To lower intensity 255 NHS Reference Costs 2010–11212
To higher intensity 1028 NHS Reference Costs 2010–11212
Post-mortem 620 Birthplace in England Collaborative Group214
Neonatal care
Transitional care 402 NHS Reference Costs 2010–11212
Special care 489 NHS Reference Costs 2010–11212
High-dependency care 823 NHS Reference Costs 2010–11212
Intensive care 1186 NHS Reference Costs 2010–11212
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The use of hospital-based services over the period between initial hospital discharge and 2 years included
inpatient admissions, use of hospital day-care services, paediatric outpatient department appointments,
other outpatient department appointments and visits to accident and emergency units. Inpatient
admissions over this time horizon were delineated by type and duration of neonatal or paediatric care
and valued using per diem costs extracted from the NHS Reference Costs 2010–11.212 Use of other
hospital-based care was valued by applying unit costs extracted from national tariffs.211 The use of
community-based care included routine appointments (immunisations, weight checks and developmental
checks), general practitioner (GP) or practice nurse appointments, physiotherapy contacts, walk-in
health-care centre visits and telephone calls to NHS Direct. Costs for these community-based services
were calculated by applying unit costs from national tariffs211 to resource volumes. A list of all medications
prescribed was extracted from the resource use questionnaires and items were identified for inclusion
in the economic analysis. This list included musculoskeletal, central nervous system, gastrointestinal,
infections, skin, eye, cardiovascular, respiratory, ear, nose, oropharynx and endocrine system drugs, as well
as nutrition and blood vitamins, food additives and borderline substances. NHS net prices per milligram for
these medications were obtained from the British National Formulary for Children (BNFC).215 Costs for
individual infants were estimated based on their reported doses and frequencies if these were available, or
otherwise on an assumed daily dose based on BNFC215 recommendations. Drugs cost were delineated in
terms of different child age groups when the recommended daily dosage obtained from the BNFC215 varied
by age (i.e. < 6 months, 6–12 months, 12–24 months). In estimating these costs, we assumed an average
weight of 4.3 kg for children at 1 month, 7.7 kg for children at 6 months and 11.8 kg for children at
24 months.216 Other costs captured in the study included adaptations to the home, provision of special
equipment and parental lost productivity. Adaptations to the child’s home as a result of the child’s health
status encompassed changing plugs, redecoration, heating alterations, sanitation, change of flooring,
house extensions and purchase of humidifiers and equipment to ensure child safety. Cost estimates for
these adaptations were informed by information obtained from the international electronic commerce
company Amazon (Amazon.com Inc., Seattle, WA, USA; UK version). Adaptations such as house
extensions and redecorations were guided by estimated prices provided by private building companies.
Special equipment and aids required by the LAMBS infants over the course of follow-up fell into the
following broad categories: breathing support equipment, feeding/breastfeeding equipment, chairs/
mattresses and room ventilation equipment. Unit costs for these items were informed by information
obtained from the international electronic commerce company Amazon (UK version). The costs to parents
of taking time off work to care for the infant(s) were estimated by applying gender-specific median
earnings data217 to occupational classifications derived from the self-reported employment information. A
list of resource values and their sources for the period between initial hospital discharge and 24 months is
provided in Table 35. All costs occurring beyond the first year after birth were discounted using the UK
recommended discount rate of 3.5%.220
Analysis of resource use and cost data
Maternal and neonatal characteristics and resource use items were summarised by gestational age at birth
meta-group (moderate or late preterm vs. term). Differences between groups were analysed using t-tests
for continuous variables and chi-squared test for categorical variables. Mean (SE) costs by cost category
and mean (SE) total costs were estimated by gestational age at birth status for each meta-group. Total
costs were estimated both from a NHS and Personal Social Services (PSS) perspective and from a broader
societal perspective. Cost comparisons for moderate or late preterm versus term infants were carried out
using Student’s t-tests. Differences in mean costs and their corresponding CIs were estimated for moderate
or late preterm versus term infants. Non-parametric bootstrap220 estimates based on 1000 replications were
also calculated for these differences in mean costs and their CIs.
Regression modelling was used to estimate the relationship between gestational age at birth and total
costs. The models were estimated using both ordinary least squares (OLSs) and generalised linear models
(GLMs).221 For the GLMs, a gamma distribution and log-link function for costs was selected on the basis
of its Akaike information criterion (AIC)222 statistic compared with alternative distributional forms
(e.g. Gaussian, inverse Gaussian and Poisson distributional families) and link functions (e.g. identity link
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TABLE 35 Resource valuations for the period between post initial hospital discharge and 24 months
Resource use measure Unit cost (£) Source
Hospital care
Inpatient admissions Based on HRG code NHS Reference Costs 2010–11212
Admission to day care 133 NHS Reference Costs 2010–11212
A&E visits 117 Unit Costs of Health and Social Care 2012211
Paediatric outpatient department visits 131 Unit Costs of Health and Social Care 2012211
Other outpatient department visits 163 Unit Costs of Health and Social Care 2012211
Community care
Routine 6-week check 43 NHS Reference Costs 2010–11212
Immunisations 27 NHS Reference Costs 2010–11212
Weight checks 43 NHS Reference Costs 2010–11212
Health visitor visits 43 NHS Reference Costs 2010–11212
Hearing/developmental checks 43 NHS Reference Costs 2010–11212
GP visits 36 Unit Costs of Health and Social Care 2012211
Practice nurse visits 12 Unit Costs of Health and Social Care 2012211
Community paediatrician visits 131 Unit Costs of Health and Social Care 2012211
Physiotherapy visits 35 Unit Costs of Health and Social Care 2012211
Community nurse visits 50 Unit Costs of Health and Social Care 2012211
Speech and language therapist visits 34.5 Unit Costs of Health and Social Care 2012211
Occupational therapist visits 34.5 Unit Costs of Health and Social Care 2012211
Walk-in centre contacts 38 NHS Reference Costs 2010–11212
Telephone calls to NHS Direct 28 NHS Direct: Operating Costs218
Any prescribed medications Various BNF for Children 2013–14;215 Prescription Cost
Analysis – England, 2011219
Other
Time off work Based on derived
occupational code
ONS 2011217
Provided with special equipment Various Self-report, commercial prices
Adaptations to home Various Self-report, commercial prices
A&E, accident and emergency.
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function). The modified Parks test223 was also used in an iterative manner to identify the preferred
distributional family, and the last estimable model in the processes adopted was the GLM with gamma
distribution and log-link. The first set of regression models were estimated with total NHS and PSS costs,
from birth to initial hospital discharge (or death), representing the dependent variable in all analyses.
Covariates considered in these regression analyses (referents in brackets) included gestational age birth
status [(term), moderate or late preterm]; place of delivery [(centre A, centre B), other], mode of delivery
[(spontaneous vaginal), assisted/instrumental, CS while in labour, CS not in labour]; baby status [(alive),
stillbirth, early neonatal death, late neonatal death, infant death]; multiplicity [(singleton), multiple]; gender
[(male) female]; SGA [> first decile, (≤ first decile of customised fetal weight224)]; congenital anomaly [yes,
(no)]; first born [yes, (no)]; maternal age (continuous); maternal BMI [(normal), underweight, overweight,
obese]; maternal ethnicity [(white), mixed, Asian or Asian British, black or black British, Chinese or other];
mother’s highest educational qualification [(higher degree), degree, A levels vocational level 3 and
equivalent, GCSE grades A*–C vocational level 2 and equivalent, GCSE grades D–G vocational level 1 and
below, qualification level unknown, no qualifications]; marital civil status [(living as part of a couple), not
living as part of a couple]; social class based on the mother’s occupational status [(managerial and
professional), intermediate, routine and manual, never worked and long-term unemployed, looking after
family]; home ownership [(owner-occupied), renting, living rent free]; pre-pregnancy maternal European
Quality of Life-5 Dimensions (EQ-5D)184 utility score; maternal chronic health problems [(no), yes];
socioeconomic deprivation [a composite indicator of socioeconomic deprivation for each postcode sector
was derived using the 2010 IMD, which uses census-derived indicators of income, education, employment,
environment, health and housing at small-area level]225 [(first quintile), second quintile, third quintile, fourth
quintile, fifth quintile]; maternal recreational drug use during pregnancy [(no), yes]; maternal smoking
during pregnancy [(no), yes]; previous premature birth [(no), yes]; and maternal drinking during pregnancy
[(no), yes]. Table 36 contains a list of independent variables used in the regression models.
The first model (model 1) explored the impact of infant and birth characteristics on economic costs; the
second model (model 2) included additional maternal sociodemographic and maternal lifestyle
characteristics; and the third model (model 3) built on model 2 and included two additional variables
(previous premature birth and maternal drinking during pregnancy) for which there was a high proportion
(60.1%) of missing data.
A second set of regression models was also estimated with total societal costs, from birth to 24 months
(or death), representing the dependent variable in the analyses. The first of these models (model 4)
contained all of the covariates included in model 1 except for the baby status variable and the second
model (model 5) included all of the covariates included in model 2 except for baby status and maternal
BMI. These covariates were excluded from the analyses as they precluded estimation of GLMs and we
wanted to present results for comparable models using alternative estimators. As per the birth to initial
hospital discharge analyses, the models were estimated using both OLSs and GLMs.221 Two sets of analyses
were conducted: the first used cases in which there were cost data available at all time points (complete
cases), and the second used the inverse probability weighting method226,227 (using the same set of
covariates in model 5) to adjust for the presence of censored data.
All estimates were additionally recalculated following weighting of the random sample of term births to
adjust for the oversampling of term multiple births. All analyses were estimated using Stata version 11.
Results
Descriptive statistics
The maternal and infant characteristics of the study population are presented in Table 37. Of 1376 eligible
infants born at 32–36 weeks’ gestation in the East Midlands region over the study time frame, 1146
(83%) were recruited; 1258 infants born at ≥ 37 weeks’ gestation (79% of all eligible) acted as controls.
The corresponding number of mothers who gave birth to these infants was 1041 for the LMPT group and
1120 for the term group.
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TABLE 36 Table of independent regression variables
Variable Categories for categorical variables, referent in brackets
Gestational age status (Term), late and moderately preterm
Place of delivery Neonatal service A, neonatal service B, other
Mode of delivery (Spontaneous vaginal), assisted/instrumental, CS during labour, CS not in labour
Baby status (Alive), stillbirth, early neonatal death, late neonatal death, infant death
Multiplicity (Singleton), multiple
Gender (Male), female
SGA (No), yes
Congenital anomaly (No), yes
First born (No), yes
Maternal age
Maternal BMI (Normal), underweight, overweight, obese
Maternal ethnicity (White), mixed, Asian or Asian British, black or black British, Chinese or other, not known
Highest qualification (Higher degree), degree, A Levels, vocational level 3 and equivalent, GCSE grades A*–C,
vocational level 2 and equivalent, GCSE grades D–G, vocational level 1 and below,
qualification level unknown, no qualifications, not known
Marital civil status (Living as part of a couple), not living as part of a couple
Socioeconomic
classification
(Managerial and professional occupations), intermediate occupations, routine and manual
occupations, never worked and long-term unemployed, looking after family, not known
Home ownership (Own), rent, lives rent free
EQ-5D utility score
Chronic health problems (No), yes
Deprivation score (First quintile), second quintile, third quintile, fourth quintile, fifth quintile
Recreational drugs during
pregnancy
(No), yes
Smoke during pregnancy (No), yes
Previous premature baby (No), yes
Drink during pregnancy (No), yes
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TABLE 37 Summary descriptive statistics for mothers and infants by gestational age at birth: all births
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term,
≥ 37 weeks
reweighteda p-valueb
Number of mothers 1041 1120 1120 –
Maternal age (years), mean (SD) 29.33 (5.85) 29.79 (5.96) 29.53 (5.87) 0.031
BMI, n (%)
Normal 546 (52.45) 534 (47.68%) (49.82%) 0.014
Underweight 49 (4.71) 40 (3.57) (3.81)
Overweight 262 (25.17) 290 (25.89) (26.45)
Obese 143 (13.74) 212 (18.93) (19.92)
Not known 41 (3.94) 44 (3.93) (3.93)
Ethnicity, n (%)
White 752 (72.24) 863 (77.05) (77.17) 0.013
Mixed 33 (3.17) 25 (2.23) (2.24)
Asian or Asian British 186 (17.87) 159 (14.20) (14.45)
Black or black British 54 (5.19) 60 (5.36) (4.93)
Chinese or other ethnic group 11 (1.06) 9 (0.80) (0.82)
Not known 5 (0.48) 4 (0.36) (0.41)
Marital/civil status, n (%)
Living as part of a couple 856 (82.23) 976 (87.14) (86.60) 0.12
Single 184 (17.68) 141 (12.59) (13.28)
Not known 1 (0.10) 3 (0.27) (0.12)
Age (years) completed education, mean (SD) 18.43 (2.97) 18.74 (3.08) 18.65 (3.00) 0.003
Not known, n (%) 6 (0.58) 7 (0.63) – –
Highest educational qualification, n (%)
Higher degree 95 (9.13) 134 (11.96) (10.88) 0.001
Degree 173 (16.62) 245 (21.88) (21.24)
A level 209 (20.08) 212 (18.93) (19.04)
GCSE grades A*–C 252 (24.21) 253 (22.59) (23.37)
GCSE grades D–G 111 (10.66) 88 (7.86) (8.42)
Qualification level unknown 82 (7.88) 88 (7.86) (7.93)
No qualifications 94 (9.03) 75 (6.70) (6.72)
Not known 25 (2.40) 25 (2.23) (2.43)
Occupational status during pregnancy, n (%)
Employed 609 (58.50) 738 (65.89) (65.23) < 0.001
Unemployed 123 (11.82) 84 (7.50) (8.10)
Caring for family 263 (25.26) 252 (22.50) (22.32)
Full-time student 31 (2.98) 33 (2.95) (3.04)
Long-term sick or disabled 11 (1.06) 7 (0.63) (0.71)
Not known 4 (0.38) 6 (0.54) (0.60)
continued
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TABLE 37 Summary descriptive statistics for mothers and infants by gestational age at birth: all births (continued )
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term,
≥ 37 weeks
reweighteda p-valueb
IMD deprivation score, n (%)
First quintile 179 (17.20) 255 (22.77) (22.25) < 0.001
Second quintile 196 (18.83) 237 (21.16) (21.09)
Third quintile 219 (21.04) 211 (18.84) (18.37)
Fourth quintile 232 (22.29) 205 (18.30) (18.98)
Fifth quintile 215 (20.65) 212 (18.93) (19.32)
NS-SEC, n (%)
Managerial and professional occupations 262 (25.17) 341 (30.45) (29.23) 0.001
Intermediate occupations 177 (17.00) 202 (18.04) (18.68)
Routine and manual occupations 168 (16.14) 193 (17.23) (17.11)
Never worked and long-term unemployed 165 (15.85) 124 (11.07) (11.85)
Looking after family 263 (25.26) 252 (22.50) (22.32)
Not known 6 (0.58) 8 (0.71) (0.80)
Home ownership, n (%)
Own 464 (44.57) 561 (50.09) (48.87) 0.001
Rent 514 (49.38) 493 (44.02) (44.94)
Lives rent free 60 (5.76) 66 (5.89) (6.19)
Not known 3 (0.29) 0 (0) 0 (0)
EQ-5D-3L utility score, mean (SD) 0.94 (0.14) 0.96 (0.13) 0.96 (0.13) 0.001
Chronic health problems, n (%)
No 783 (75.22) 900 (80.36) (80.63) < 0.001
Yes 255 (24.50) 219 (19.55) (19.26)
Not known 3 (0.29) 1 (0.09) (0.11)
Previous preterm baby, n (%)
No 433 (41.59) 632 (56.43) (56.04) < 0.001
Yes 192 (18.44) 59 (5.27) (5.58)
Not known 416 (39.96) 429 (38.30) (38.39)
Recreational drugs during pregnancy, n (%)
No 1017 (97.69) 1106 (98.75) (98.67) 0.002
Yes 23 (2.21) 12 (1.07) (1.21)
Not known 1 (0.10) 2 (0.18) (0.11)
Smoking during pregnancy, n (%)
No 753 (72.33) 893 (79.73) (79.26) 0.14
Yes 282 (27.09) 227 (20.27) (20.74)
Not known 6 (0.58)
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TABLE 37 Summary descriptive statistics for mothers and infants by gestational age at birth: all births (continued )
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term,
≥ 37 weeks
reweighteda p-valueb
Drinks alcohol during pregnancy, n (%)
Drinks more than 5 units per day 408 (39.19) 475 (42.41) (42.61) 0.062
Never 363 (34.87) 431 (38.48) (38.54)
Less than once per month 26 (2.50) 24 (2.14) (2.33)
1–2 days per month 10 (0.96) 5 (0.45) (0.51)
1–2 days per week 4 (0.38) 6 (0.54) (0.51)
3–4 days per week – 1 (0.09) (0.01) (0.20)
5 or more days per week 1 (0.10) 2 (0.18) (0.51)
Not known 4 (0.38) 6 (0.54) –
Number of infants 1146 1258 – –
Gestational age in completed weeks, median
(range)
35 (32–36) 39 (37–43) – –
Mean (SD) 34.93 (1.22) 39.18 (1.40) 39.59 (1.24) –
Birthweight (g), median (range) 2420 (820–4960) 3280
(520–5160)
– –
Mean (SD) 2415.99 (506.24) 3275.02
(557.18)
3418.01
(502.47)
< 0.001
Missing, n (%) 1 (0.1) – – –
Below 10th birth weight percentile at birth,
n (%)
144 (12.6) 115 (9.1) (6.9) 0.003
Below 10th fetal weight percentile at birth,
n (%)
305 (26.6) 281 (22.3) (15.8) 0.006
Male sex, n (%) 621 (54.2) 651 (51.8) (51.3) 0.002
Baby status, n (%)
Alive 1123 (98.0) 1253 (99.6) (99.6) 0.002
Stillbirth 16 (1.4) 3 (0.2) (0.2)
Early neonatal deaths (within first 7 days) 3 (0.3) 1 (0.1) (0.1)
Late neonatal death (8–28 days of life) 1 (0.1) – –
Infant death (≥ 29 days of life) 3 (0.3) 1 (0.1) (0.1)
Multiplicity, n (%)
Singleton 938 (81.9) 982 (78.1) (98.2) 0.027
Twins 196 (17.1) 276 (21.9) (1.8)
Triplets 12 (1.1) – –
Congenital anomaly, n (%) 22 (1.9) 9 (0.7) (0.7) 0.002
First born, n (%) 544 (47.5) 564 (44.8) (44.6) 0.002
EQ-5D-3L, European Quality of Life-5 Dimensions 3 levels.
a All estimates were additionally recalculated following weighting of the random sample of term births to adjust for the
oversampling of term multiple births.
b Comparisons of term vs. late and moderate preterm groups carried out using Student’s t-tests for continuous variables
and chi-squared test for categorical variables.
DOI: 10.3310/pgfar04010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 1
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Field et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
117
Comparisons of demographic characteristics of the mothers by birth status (LMPT vs. term) revealed that
there were significant differences in all characteristics with the exception of maternal age, ethnicity, maternal
recreational drug use during pregnancy and maternal drinking during pregnancy. The characteristics of the
infants are presented by gestational age status (moderately or late preterm vs. term). The mean gestational
age at birth for the combined LMPT group and for the term group was 34.9 (SD 1.2) weeks and 39.59
(SD 1.2) weeks, respectively. The proportion of singletons was 82 for the combined LMPT group and 98 for
the term group. Two per cent of the LMPT infants had a congenital anomaly compared with one for the
term group. There were significant differences in the characteristics of the infants by gestational age at birth
status (LMPT or term) across all variables with the exception of gender and whether or not the infant was
first born.
Resource use
Resource use measures and their values between birth and initial hospital discharge are summarised in
Table 38 for the comparator groups. The mean duration of the initial hospitalisation was 2.64 (SD 2.40)
days for term-born infants, whereas the LMPT infants had a substantially longer mean stay of 9.15
(SD 17.8) days (p< 0.001). LMPT infants also spent longer in the NNU on average, with a mean length
of stay of 4.45 (SD 8.79) days, compared with 0.24 (SD 1.68) days for the term-born infants (p< 0.001).
The LMPT infants also had higher rates of resource use across all other resource categories compared with
term-born infants (see Table 35).
TABLE 38 Resource use measures to initial hospital discharge by gestational age at birth status: all births
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
Number of infants 1146 1258
Mode of delivery, n (%)
Spontaneous vaginal 607 (53.0) 702 (55.8) (62.5) 0.006
Assisted/instrumental 101 (8.8) 213 (16.9) (16.8)
CS labour 158 (13.8) 129 (10.3) (9.2)
CS not in labour 279 (24.4) 214 (17.0) (11.5)
Not known 1 (0.1)
Place of delivery, n (%) < 0.001
Centre A 674 (58.8) 661 (52.5) (52.4)
Centre B 459 (40.1) 570 (45.3) (45.0)
Other 13 (1.1) 27 (2.2) (2.5)
Any active resuscitation at birth, n (%) 211 (18.4) 104 (8.3) (7.5) < 0.001
NNU admission, n (%) 494 (43.1) 67 (5.3) (4.5) < 0.001
Length of neonatal stay (days),
median (range)
0 (0–101) 0 (0–26) – –
Length of neonatal stay (days),
mean (SD)
4.45 (8.79) 0.27 (1.84) 0.24 (1.68) < 0.001
Maximum respiratory support required, n (%)
Mechanical ventilation 120 (10.5) 13 (1.0) (1.1) < 0.001
Non-invasive respiratory support 100 (8.7) 6 (0.5) (0.4) < 0.001
Nasal cannula oxygen 101 (8.8) 16 (1.3) (1.4) < 0.001
No respiratory support 942 (82.2) 1234 (98.1) (98.0) < 0.001
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TABLE 38 Resource use measures to initial hospital discharge by gestational age at birth status:
all births (continued )
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
PN, n (%) 64 (5.6) 7 (0.6) (0.6) < 0.001
i.v. fluids, n (%) 332 (29.0) 36 (2.9) (2.6) < 0.001
Length of hospital stay (days), median
(range)
5 (0–369) 2 (1 –33) – –
Mean (SD) 9.15 (17.80) 2.97 (2.48) 2.64 (2.40) < 0.001
Surgery/operations, n (%) 18 (1.6) 1 (0.1) (0.1) < 0.001
Hospital transfer, n (%)
None 1099 (95.9) 1257 (99.9) (99.9) 0.13
To lower intensity 34 (3.0) 1 (0.1) (0.0)
To higher intensity 13 (1.1) – –
Post-mortem, n (%) 10 (0.9) 3 (0.2) (0.3) < 0.001
Other investigations, n (%) 139 (12.1) 45 (3.6) (2.8) < 0.001
Number of investigations, n (%)
One 93 (8.1) 29 (2.3) (2.3) < 0.001
Two 25 (2.2) 6 (0.5) (0.3)
Three or more 21 (1.8) 10 (0.8) (0.9)
Transitional care received, n (%) 270 (23.6) 16 (1.3) (0.3) 0.003
Length of transitional care stay (days),
median (range)
0 (0 to 21) 0 (0 to 10) – < 0.001
Length of transitional care stay (days),
mean (SD)
1.44 (3.05) 0.06 (0.58) 0.02 (0.32)
Special care received, n (%) 679 (59.3) 80 (6.4) (4.6) < 0.001
Length of special care stay (days),
median (range)
0 (0 to 45) 0 (0 to 26) – < 0.001
Length of special care stay (days),
mean (SD)
3.91 (6.82) 0.24 (1.69) 0.20 (1.45)
High-dependency care received, n (%) 117 (10.2) 5 (0.4) (0.4) < 0.001
Length of high-dependency care stay
(days), median (range)
0 (0 to 307) 0 (0 to 7) – < 0.001
Length of high-dependency care stay
(days), mean (SD)
0.68 (9.40) 0.01 (0.25) 0.02 (0.28)
Intensive care received, n (%) 108 (9.4) 11 (0.9) (1.0) < 0.001
Length of intensive care stay (days),
median (range)
0 (0 to 32) 0 (0 to 4) – < 0.001
Length of intensive care stay (days),
mean (SD)
0.34 (1.92) 0.02 (0.23) 0.02 (0.26)
a All estimates were additionally recalculated following weighting of the random sample of term births to adjust for the
oversampling of term multiple births.
b Comparisons of term vs. combined late and moderate preterm groups carried out using Student’s t-tests for continuous
variables and chi-squared test for categorical variables. The Mann–Whitney U-test was used to compare medians.
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Resource use measures and their values between initial hospital discharge and 24 months are presented in
Table 39 for the comparator groups. For the period between initial hospital discharge and 6 months, the
proportion of infants using hospital-based services was significantly higher for LMPT infants than for
term-born infants for all categories of hospital services (p< 0.05). The proportion of infants accessing
community-based care services was significantly higher for LMPT infants for all categories of community
services except GP visits. The proportion of parents taking time off work to care for their child and the
proportion of infants provided with special equipment was significantly higher in the LMPT group.
The proportion of infants attending hospital day care and outpatient hospital departments between 6 and
12 months was significantly higher in the LMPT group than in the term group. The mean number of
contacts with hospital outpatient departments was significantly higher for LMPT infants than for term-born
infants. The proportion of infants using community-based immunisation services, paediatrician services,
and physiotherapy services was also significantly higher for LMPT infants over this period, as was the
proportion of infants provided with special equipment.
The proportion of infants admitted to hospital, attending a paediatric outpatient department or attending
other outpatient hospital departments between 12 and 24 months was significantly higher in the LMPT
group than in the term group. The mean number of contacts with hospital-based accident and emergency
services and other outpatient hospital departments over this period was also significantly higher in the
LMPT group, as was the mean number of contacts with GP services, community-based physiotherapy and
speech and language therapy services, and NHS Direct services.
TABLE 39 Resource use between initial hospital discharge and 24 months by gestational age at birth status:
all births
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
Post discharge to 6 months
Number of infants 781 939
Hospital care
Inpatient admissions, n (%) 230 (29.45) 162 (17.25) (16.46) < 0.001
Number of admissions, mean (SE) 0.27 (0.02) 0.16 (0.01) 0.15 (0.01) < 0.001
Cumulative inpatient length of
stay, mean (SE)
0.74 (0.10) 0.35 (0.10) 0.34 (0.11) < 0.001
Cumulative inpatient length of
stay, median (IQR)
0.00 (0.00) 0.00 (0.00) – –
Admission to day care, n (%) 186 (23.88) 121 (13.00) (12.08) < 0.001
Number of admissions, mean (SE) 0.25 (0.02) 0.13 (0.01) 0.12 (0.01) < 0.001
A&E visits, n (%) 199 (25.61) 176 (18.90) (18.01) < 0.001
Mean visits (SE) 0.26 (0.02) 0.18 (0.01) 0.17 (0.01) < 0.001
Other outpatient department visits,
n (%)
251 (32.35) 189 (20.28) (19.74) < 0.001
Mean visits (SE) 0.52 (0.04) 0.27 (0.02) 0.27 (0.02) < 0.001
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TABLE 39 Resource use between initial hospital discharge and 24 months by gestational age at birth status:
all births (continued )
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
Community care
Routine 6-week check, n (%) 754 (96.92) 914 (97.86) (98.32) 0.004
Immunisations, n (%) 767 (98.46) 925 (99.04) (99.05) < 0.001
Immunisations, n, mean (SE) 2.21 (0.03) 2.35 (0.03) 2.33 (0.03) 0.001
Weight checks, n (%) 736 (94.60) 880 (94.12) (94.35) 0.017
Weight checks, n, mean (SE) 5.55 (0.15) 4.91 (0.12) 4.83 (0.11) < 0.001
Health visitor visits, n (%) 733 (94.22) 854 (91.43) (91.10) < 0.001
Health visitor, mean visits (SE) 3.75 (0.12) 3.10 (0.08) 3.02 (0.08) < 0.001
GP visits, n (%) 549 (70.38) 651(69.70) (71.00) 0.089
GP, mean visits (SE) 1.47 (0.07) 1.35 (0.05) 1.32 (0.05) 0.001
Community paediatrician visits,
n (%)
44 (5.67) 29 (3.12) (3.05) < 0.001
Community paediatrician, mean
visits (SE)
0.08 (0.01) 0.04 (0.01) 0.05 (0.01) < 0.001
Physiotherapy visits, n (%) 22 (2.83) 16 (1.72) (1.29) 0.004
Physiotherapy, mean visits (SE) 0.04 (0.01) 0.03 (0.01) 0.02 (0.01) 0.001
Community nurse visits, n (%) 34 (4.38) 31 (3.33) (3.06) 0.001
Community nurse, mean visits (SE) 0.12 (0.03) 0.05 (0.01) 0.05 (0.01) < 0.001
Walk-in centre contacts, n (%) 119 (15.32) 135 (14.50) (15.00) 0.049
Walk-in centre, mean contacts (SE) 0.19 (0.02) 0.14 (0.01) 0.15 (0.01) 0.001
Telephone calls to NHS Direct,
n (%)
207 (26.68) 217 (23.31) (23.43) < 0.001
Telephone calls to NHS Direct,
mean (SE)
0.31 (0.02) 0.25 (0.02) 0.26 (0.02) < 0.001
Any prescribed medications, n (%) 411 (52.69) 467 (49.73) (50.86) 0.012
Time off work, n (%) 98 (12.55) 55 (5.86) (5.13) < 0.001
Days off work, mean (SE) 1.99 (1.02) 0.19 (0.04) 0.19 (0.04) < 0.001
Days off work, median (IQR) 0.00 (0.00) 0.00 (0.00) – –
Provided with special equipment,
n (%)
45 (5.76) 19 (2.02) (2.29) < 0.001
Adaptations to home, n (%) 6 (0.77) 9 (0.96) (0.95) < 0.001
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TABLE 39 Resource use between initial hospital discharge and 24 months by gestational age at birth status:
all births (continued )
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
6–12 months
Number of infants 703 856
Hospital care
Inpatient admissions, n (%) 92 (13.09) 89 (10.43) (11.35) 0.38
Inpatient admissions, number of
admissions, mean (SE)
0.11 (0.01) 0.08 (0.01) 0.09 (0.01) 0.005
Cumulative inpatient length of
stay, mean (SE)
0.38 (0.20) 0.11 (0.02) 0.13 (0.03) < 0.001
Cumulative inpatient length of
stay, median (IQR)
0.00 (0.00) 0.00 (0.00) – –
Admission to day care, n (%) 74 (10.53) 61 (7.13) (7.53) 0.002
Admission to day care, number of
admissions, mean (SE)
0.24 (0.03) 0.18 (0.02) 0.20 (0.02) 0.004
A&E visits, n (%) 152 (21.62) 155 (18.11) (20.28) 0.056
A&E, mean visits (SE) 0.49 (0.04) 0.42 (0.03) 0.47 (0.03) 0.18
Other outpatient department visits,
n (%)
160 (22.76) 139 (16.24) (15.88) < 0.001
Other outpatient department,
mean visits (SE)
0.55 (0.04) 0.43 (0.04) 0.44 (0.04) < 0.001
Community care
Immunisations, n (%) 622 (88.48) 710 (82.94) (85.00) 0.006
Immunisations, mean (SE) 2.05 (0.05) 2.06 (0.04) 2.12 (0.04) 0.019
Weight checks, n (%) 599 (85.21) 722 (84.35) (84.43) < 0.001
Weight checks, mean (SE) 2.64 (0.09) 2.80 (0.08) 2.84 (0.09) 0.001
Health visitor visits, n (%) 512 (72.83) 603 (70.44) (70.38) < 0.001
Health visitor, mean visits (SE) 1.97 (0.07) 1.93 (0.06) 1.96 (0.06) 0.51
Hearing/developmental checks,
n (%)
405 (57.61) 475 (55.49) (55.83) < 0.001
Hearing/developmental checks,
mean (SE)
1.31 (0.05) 1.35 (0.05) 1.37 (0.05) < 0.001
GP visits, n (%) 523 (74.40) 612 (71.50) (71.97) < 0.001
GP visits, mean visits (SE) 2.04 (0.07) 1.98 (0.06) 2.00 (0.06) 0.008
Community paediatrician visits,
n (%)
51 (7.25) 32 (3.74) (4.26) 0.001
Community paediatrician, mean
visits (SE)
0.17 (0.03) 0.11 (0.02) 0.12 (0.02) 0.002
Physiotherapy visits, n (%) 19 (2.70) 10 (1.17) (1.05) < 0.001
Physiotherapy, mean visits (SE) 0.09 (0.03) 0.04 (0.02) 0.04 (0.02) < 0.001
Community nurse visits, n (%) 27 (3.84) 22 (2.57) (2.25) 0.002
Community nurse, mean visits (SE) 0.10 (0.02) 0.07 (0.02) 0.06 (0.02) 0.001
Walk-in centre contacts, n (%) 124 (17.64) 147 (17.17) (17.87) 0.15
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TABLE 39 Resource use between initial hospital discharge and 24 months by gestational age at birth status:
all births (continued )
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
Walk-in centre, mean contacts (SE) 0.42 (0.04) 0.40 (0.03) 0.43 (0.03) 0.08
Telephone calls to NHS Direct,
n (%)
195 (27.74) 233 (27.22) (28.07) 0.11
Telephone calls to NHS Direct,
mean (SE)
0.65 (0.04) 0.64 (0.04) 0.67 (0.04) 0.036
Any prescribed medications, n (%) 330 (46.94) 405 (47.31) (47.95) 0.009
Time off work, n (%) 163 (23.19) 179 (20.91) (20.75) < 0.001
Days off work, mean (SE) 1.15 (0.27) 0.89 (0.14) 0.91 (0.15) < 0.001
Days off work, median (IQR) 0.00 (0.00) 0.00 (0.00) – –
Provided with special equipment,
n (%)
26 (3.70) 14 (1.64) (1.77) < 0.001
Adaptations to home, n (%) 3 (0.43) 9 (1.05) (1.03) < 0.001
12–24 months
Number of infants 651 771
Hospital care
Inpatient admissions, n (%) 88 (13.52) 66 (8.56) (8.39)
Number of admissions, mean (SE) 0.16 (0.02) 0.10 (0.01) 0.10 (0.01) < 0.001
Cumulative inpatient length of
stay, mean (SE)
0.89 (0.56) 0.25 (0.07) 0.28 (0.08) < 0.001
Cumulative inpatient length of
stay, median (IQR)
0.00 (0.00) 0.00 (0.00) – < 0.001
Paediatric outpatient department
visits, n (%)
123 (18.89) 102 (13.23) (14.38) –
Paediatric outpatient department,
mean visits (SE)
0.20 (0.02) 0.14 (0.01) 0.15 (0.01) < 0.001
A&E visits, n (%) 184 (28.26) 169 (21.92) (22.38) 0.001
A&E, mean visits (SE) 0.29 (0.02) 0.22 (0.02) 0.23 (0.02) < 0.001
Other outpatient department visits,
n (%)
124 (19.05) 90 (11.67) (12.36) < 0.001
Other outpatient department,
mean visits (SE)
0.20 (0.02) 0.12 (0.01) 0.13 (0.01) < 0.001
Community care
GP visits, n (%) 524 (80.49) 582 (75.49) (75.76) < 0.001
GP, mean visits (SE) 0.95 (0.03) 0.87 (0.02) 0.86 (0.02) < 0.001
Practice nurse visits, n (%) 128 (19.66) 161 (20.88) (20.51) 0.004
Practice nurse, mean visits (SE) 0.20 (0.02) 0.21 (0.02) 0.21 (0.02) 0.001
Community paediatrician visits,
n (%)
23 (3.53) 19 (2.46) (2.28) < 0.001
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TABLE 39 Resource use between initial hospital discharge and 24 months by gestational age at birth status:
all births (continued )
Variable
Late and moderate
preterm, 32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
Community paediatrician, mean
visits (SE)
0.04 (0.01) 0.03 (0.01) 0.03 (0.01) < 0.001
Physiotherapy visits, n (%) 23 (3.53) 13 (1.69) (1.76) < 0.001
Physiotherapy, mean visits (SE) 0.06 (0.02) 0.03 (0.01) 0.03 (0.01) < 0.001
Speech and language therapist
visits, n (%)
41 (6.30) 13 (1.69) (1.46) < 0.001
Speech and language therapist,
mean visits (SE)
0.09 (0.02) 0.02 (0.00) 0.02 (0.00) < 0.001
Occupational therapist visits, n (%) 8.00 (1.23) 4.00 (0.52) (0.63) 0.002
Occupational therapist, mean
visits (SE)
0.03 (0.01) 0.01 (0.01) 0.01 (0.01) 0.001
Community nurse visits, n (%) 14.00 (2.15) 22.00 (2.85) (2.91) < 0.001
Community nurse, mean visits (SE) 0.03 (0.01) 0.03 (0.01) 0.03 (0.01) 0.010
Walk-in centre contacts, n (%) 170 (26.11) 179 (23.22) (24.27) 0.007
Walk-in centre, mean contacts (SE) 0.27 (0.02) 0.23 (0.02) 0.24 (0.02) 0.005
Telephone calls to NHS Direct,
n (%)
204 (31.34) 190 (24.64) (24.82) < 0.001
Telephone calls to NHS Direct,
mean (SE)
0.32 (0.02) 0.25 (0.02) 0.26 (0.02) < 0.001
Other services, n (%) 44 (6.76) 25 (3.24) (3.37) < 0.001
Other services, mean (SE) 0.08 (0.01) 0.06 (0.02) 0.06 (0.02) 0.001
Any prescribed medications, n (%) 359 (55.15) 436 (56.55) (56.91) < 0.001
Time off work, n (%) 183 (28.11) 200 (25.94) (23.88) 0.006
Days off work, mean (SE) 2.02 (0.33) 1.19 (0.12) 1.16 (0.11) < 0.001
Days off work, median (IQR) 0.00 (2.00) 0.00 (0.50) – –
Provided with special equipment,
n (%)
17 (2.61) 14 (1.82) (1.93) < 0.001
Adaptations to home, n (%) 5 (0.77) 3 (0.39) (0.31) 0.004
A&E, accident and emergency.
a All estimates were additionally recalculated following weighting of the random sample of term births to adjust for the
oversampling of term multiple births.
b Comparisons of term vs. combined late and moderate preterm groups carried out using Student’s t-tests.
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Economic costs
Economic costs to initial hospital discharge or death (whichever was earliest) are summarised in Table 40
for LMPT infants and for term-born infants. Mean costs were significantly higher for LMPT infants than for
term-born infants across all cost categories. Mean total costs were estimated at £5533 (SE £310) for the
combined LMPT group compared with £1864 (SE £36) for infants born at term. The mean cost difference
(LMPT vs. term) was £3668 (bootstrap 95% CI £3129 to £4361; p< 0.0001).
Economic costs between initial hospital discharge and 24 months or death (whichever was earliest) are
presented in Table 41 for LMPT infants and for term-born infants by cost category and follow-up period.
For the period between initial hospital discharge and 6 months, all hospital care category costs were
significantly higher for LMPT infants. Over this period NHS and PSS costs (LMPT: £1107 vs. term: £773;
p< 0.001) and societal costs (LMPT: £1165 vs. term: £810; p< 0.001) were significantly higher for LMPT
infants than for term-born infants. For the period between 6 and 12 months, all categories of hospital care
costs were significantly higher for LMPT infants, with the exception of accident and emergency costs. All
categories of community care costs were significantly higher for LMPT infants with the exception of health
visitor and walk-in centre costs. Total NHS and PSS costs (LMPT: £798 vs. term: £682; p= 0.001) and total
societal costs (LMPT: £822 vs. term: £790; p= 0.028) remained significantly higher among LMPT infants
over this period. For the period between 12 and 24 months, total NHS and PSS (LMPT: £820 vs. term:
£289; p< 0.001) and total societal costs (LMPT: £1029 vs. term: £393; p< 0.001) remained significantly
higher among LMPT infants.
TABLE 40 Costs to initial hospital discharge by gestational age at birth status and cost category: all births
(£, 2010–11 prices)
Variable
LMPT, 32–36
weeks
Term,
≥ 37 weeks
reweighteda
Mean differenceb
(95% CI)
Bootstrapped
difference
(95% CI) p-valuec
Number of infants 1146 1258
Postnatal cost (£), mean (SE) 1985.26 (25.54) 1708.54
(19.25)
276.72 (211.76 to
341.68)
277.15 (213.68 to
342.13)
< 0.001
Neonatal cost (£), mean (SE) 3449.17
(298.51)
146.45
(27.54)
3302.71 (2714.38 to
3891.05)
3293.67 (2825.30 to
3934.87)
< 0.001
Other costs (£), mean (SE)
Transfer 19.23 (3.44) 0.02 (0.05) 19.21 (12.47 to
25.96)
18.99 (12.25 to
26.62)
< 0.001
Post-mortem 5.41 (1.70) 1.86 (0.97) 3.55 (–0.40 to 7.50) 3.56 (–0.40 to 7.50) 0.078
Surgery 46.86 (15.58) 0.81 (0.73) 46.05 (15.45 to
76.65) 19.14
46.23 (17.17 to
79.77)
0.003
Investigations 25.91 (3.48) 6.76 (1.69) 19.15 (11.40 to
26.88)
18.96 (11.55 to
26.88)
< 0.001
Total (other costs) 97.41 (17.53) 9.45 (2.49) 87.96 (53.15 to
122.76)
87.43 (56.70 to
125.35)
< 0.001
Total birth to discharge
hospital costs (£), mean (SE)
5532.62
(309.73)
1864.38.03
(36.49)
3668.24 (3055.84 to
4280.64)
3663.68 (3129.48 to
4361.64)
< 0.001
a All estimates were additionally recalculated following weighting of the random sample of term births to adjust for the
oversampling of term multiple births.
b These are comparisons of term vs. combined late and moderate preterm groups.
c Comparisons of term vs. combined late and moderate preterm groups carried out using Student’s t-tests.
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TABLE 41 Costs from initial hospital discharge to 24 months by gestational age at birth status and cost category:
responders (£, 2010–11 prices)
Variable
LMPT,
32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
Post discharge to 6 months
Number of infants 781 939
Hospital care costs (£), mean (SE)
Inpatient care 379.18 (44.36) 192.59 (36.51) 185.38 (39.68) < 0.001
Other outpatient department 84.04 (6.22) 44.71 (3.82) 43.93 (3.92) < 0.001
A&E 30.69 (2.45) 21.55 (1.74) 20.23 (1.70) < 0.001
Day care 32.70 (2.54) 16.75 (1.60) 15.55 (1.54) < 0.001
Community care costs (£), mean (SE)
Routine checks 31.57 (0.43) 33.79 (0.37) 33.83 (0.37) < 0.001
Immunisations 59.79 (0.89) 63.40 (0.73) 62.87 (0.74) 0.001
Weight checks 238.50 (6.37) 210.97 (4.99) 207.84 (4.88) < 0.001
Health visitor 161.11 (5.11) 133.49 (3.59) 129.92 (3.65) < 0.001
Other GP 52.78 (2.51) 48.74 (1.96) 47.60 (1.71) 0.001
Community paediatrician 10.30 (1.82) 6.19 (1.47) 6.43 (1.58) < 0.001
Physiotherapy 1.46 (0.38) 0.99 (0.32) 0.86 (0.33) 0.001
Community nurse 6.06 (1.55) 2.70 (0.55) 2.29 (0.50) < 0.001
Walk-in centre 7.27 (0.81) 5.34 (0.52) 5.65 (0.56) 0.001
Calls to NHS Direct 8.51 (0.65) 7.02 (0.48) 7.07 (0.49) < 0.001
Medication costs (£), mean (SE) 3.99 (0.52) 3.82 (0.90) 3.88 (1.01) 0.007
Lost earnings (£), mean (SE) 50.74 (18.43) 5.99 (1.57) 6.23 (1.66) < 0.001
Special equipment costs (£), mean (SE) 4.86 (1.95) 2.17 (1.64) 0.80 (0.51) 0.003
Adaptation costs (£), mean (SE) 1.26 (0.73) 23.78 (12.85) 29.85 (14.54) 0.001
NHS and PSS costs (£), mean (SE) 1107.95 (52.07) 792.05 (39.82) 773.32 (42.51) < 0.001
Societal costs (£), mean (SE) 1164.81 (57.18) 824.00 (42.22) 810.20 (45.22) < 0.001
6–12 months
Number of infants 703 856 856
Hospital care costs (£), mean (SE)
Inpatient care 167.66 (65.34) 67.79 (10.44) 76.97 (11.44) < 0.001
Other outpatient department 89.88 (6.82) 70.52 (6.55) 71.67 (6.91) < 0.001
A&E 57.14 (4.55) 49.16 (3.71) 55.33 (3.91) 0.18
Day care 31.84 (3.75) 23.34 (3.00) 25.95 (3.20) 0.004
Community care costs (£), mean (SE)
Immunisations 55.38 (1.24) 55.51 (1.17) 57.25 (1.20) 0.019
Weight checks 113.32 (3.82) 120.44 (3.62) 122.31 (3.70) 0.001
Health visitor 84.61 (3.04) 83.06 (2.64) 84.45 (2.79) 0.51
Hearing/developmental
checks
56.20 (2.12) 58.25 (1.97) 58.80 (2.00) 0.001
Other GP 73.52 (2.59) 71.20 (2.17) 72.08 (2.17) 0.008
Community paediatrician 22.64 (3.36) 14.07 (2.84) 16.10 (3.09) 0.002
Physiotherapy 3.17 (0.94) 1.47 (0.64) 1.48 (0.70) < 0.001
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TABLE 41 Costs from initial hospital discharge to 24 months by gestational age at birth status and cost category:
responders (£, 2010–11 prices) (continued )
Variable
LMPT,
32–36 weeks
Term,
≥ 37 weeks
Term, ≥ 37 weeks
reweighteda p-valueb
Community nurse 5.09 (1.10) 3.62 (0.80) 3.25 (0.79) 0.001
Walk-in centre 15.84 (1.47) 15.36 (1.19) 16.29 (1.24) 0.083
Calls to NHS Direct 17.96 (1.23) 17.79 (1.03) 18.50 (1.05) 0.036
Medication costs (£), mean (SE) 3.46 (0.90) 1.54 (0.21) 1.69 (0.22) < 0.001
Lost earnings (£), mean (SE) 22.56 (3.83) 76.35 (40.94)) 91.20 (45.93) 0.001
Special equipment costs (£), mean (SE) 1.78 (0.75) 0.87 (0.39) 1.00 (0.43) 0.001
Adaptation costs (£), mean (SE) 0.10 (0.07) 24.30 (14.88) 16.44 (14.02) 0.005
NHS and PSS costs (£), mean (SE) 797.72 (72.11) 653.13 (22.26) 682.10 (23.91) 0.001
Societal costs (£), mean (SE) 822.17 (72.99) 754.65 (57.20) 790.73 (62.89) 0.028
12–24 months
Number of infants 651 771 771
Hospital care costs (£), mean (SE)
Inpatient care 651.44 (494.01) 152.46 (47.99) 162.68 (51.14) < 0.001
Paediatric outpatient department 25.50 (2.19) 18.73 (1.84) 19.13 (1.83) 0.001
Other outpatient department 31.24 (2.60) 20.13 (2.11) 20.74 (2.13) < 0.001
A&E 33.04 (2.12) 25.83 (1.76) 25.50 (1.72) < 0.001
Community care costs (£), mean (SE)
Other GP 33.16 (0.91) 31.29 (0.82) 29.78 (0.78) < 0.001
Practice nurse 2.28 (0.18) 2.57 (0.18) 2.45 (0.18) 0.001
Community paediatrician 5.48 (1.28) 3.81 (1.00) 3.53 (0.99) < 0.001
Physiotherapy 2.17 (0.53) 0.88 (0.28) 0.91 (0.28) < 0.0001
Speech and language therapist 3.06 (0.54) 0.60 (0.17) 0.51 (0.15) < 0.001
Occupational therapist 0.92 (0.37) 0.37 (0.21) 0.43 (0.22) 0.001
Community nurse 1.60 (0.51) 1.61 (0.35) 1.46 (0.31) 0.010
Walk-in centre 9.76 (0.65) 8.88 (0.58) 8.97 (0.57) 0.005
Calls to NHS Direct 8.63 (0.52) 22.18 (1.47) 6.85 (0.44) < 0.001
Other services 9.62 (1.54) 4.30 (1.04) 3.91 (0.86) < 0.001
Medication costs (£), mean (SE) 1.96 (0.53) 2.29 (0.51) 2.23 (0.50) < 0.001
Lost earnings (£), mean (SE) 186.97 (40.07) 102.84 (10.92) 101.62 (11.07) < 0.001
Special equipment costs (£), mean (SE) 1.10 (0.40) 1.34 (0.53) 1.50 (0.56) 0.006
Adaptation costs (£), mean (SE) 20.68 (11.39) 0.70 (0.65) 0.83 (0.70) < 0.001
NHS and PSS costs (£), mean (SE) 819.87 (495.59) 280.74 (50.28) 289.08 (53.48) < 0.001
Societal costs (£), mean (SE) 1028.62 (497.57) 385.61 (55.88) 393.02 (59.27) < 0.001
A&E, accident and emergency.
a All estimates were additionally recalculated following weighting of the random sample of term births to adjust for the
oversampling of term multiple births.
b Comparisons of term vs. combined LMPT groups carried out using Student’s t-test.
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Economic costs from birth to 24 months or death (whichever was earliest) are presented by cost category
in Table 42 for LMPT infants and for term-born infants. The costs are presented for complete cases: that is,
for those infants in whom cost data available were available at all follow-up periods. Mean total neonatal
care costs, total hospital care costs, total NHS and PSS costs, and total societal costs were significantly
higher for LMPT infants than for term-born infants. There were no significant differences in mean total
community care costs, medication costs, lost earnings, special equipment costs, and adaption costs
between the two groups. Mean (SE) total societal costs were estimated at £8123 (£586) for the combined
LMPT group, compared with £3784 (£138) for children born at term. The mean cost difference (LMPT vs.
term) was £4340 (bootstrap 95 CI £3142 to £5568; p< .0001).
Regression models for economic costs
Birth to initial hospital discharge
Table 43 shows the results of three generalised linear regression models on total NHS and PSS costs
to initial hospital discharge or death (whichever was earliest). The first model explores the impact
of infant and birth characteristics on cost, while the second and third models also include maternal
sociodemographic and lifestyle characteristics to explore if they additionally influence initial hospitalisation
costs. Gestational age at birth status acted as the main exposure in these models. When compared with
term-born infants, model 1 shows that the mean (SE) cost ratio for LMPT infants was 2.39 (0.08). Infants
born in service B hospitals generated higher initial hospitalisation costs than those born in the service A
hospitals, with a mean (SE) cost ratio of 1.20 (0.04). As expected, the method of delivery had a significant
bearing on costs; infants born by assisted/instrumental delivery, CS during labour and CS not in labour had
TABLE 42 Costs from birth to 24 months by gestational age at birth status and cost category: complete cases
(£, 2010–11 prices)
Variable
LMPT,
32–36 weeks
Term,
≥ 37 weeks
reweighteda
Mean differenceb
(95% CI)
Bootstrapped
difference (95% CI) p-valuec
Number of infants 594 716
Neonatal care
costs, mean (SE)
3765.83
(531.84)
172.66 (39.32) 3593.17 (2546.47 to
4639.86)
3602.08 (2736.07 to
4828.16)
< 0.001
Hospital care costs,
mean (SE)
3025.75
(150.76)
2402.00 (89.16) 623.75 (271.02 to
976.48)
623.75 (312.76 to
1015.15)
0.001
Community care
costs, mean (SE)
1039.47 (22.34) 1005.24 (16.72) 34.23 (–22.35 to
90.80)
33.18 (–22.35 to
89.13)
0.23
Medication costs,
mean (SE)
7.92 (0.98) 7.99 (1.42) 0.26 (–3.69 to 3.53) 0.04 (–3.36 to 3.36) 0.96
Lost earnings,
mean (SE)
255.51 (49.08) 155.86 (21.74) 99.65 (–7.47 to
206.77)
98.73 (7.12 to
210.45)
0.06
Special equipment
costs, mean (SE)
5.11 (1.15) 3.32 (1.06) 1.79 (–1.17 to 4.75) 1.79 (–1.25 to 4.89) 0.23
Adaptation costs,
mean (SE)
23.72 (12.49) 36.70 (32.26) –12.98 (–86.90 to
60.94)
–11.96 (–97.38 to
43.78)
0.73
Total NHS and PSS
costs, mean (SE)
7838.96
(594.14)
3587.89
(124.52)
4251.07 (3085.50
to 5416.65)
4240.47 (3071.09 to
5439.71)
< 0.001
Total societal costs,
mean (SE)
8123.29
(586.42)
3783.76
(137.97)
4339.53 (3157.78
to 5521.28)
4328.64 (3142.18 to
5568.14)
< 0.001
a All estimates were additionally recalculated following weighting of the random sample of term births to adjust for the
oversampling of term multiple births.
b These are comparisons of term vs. combined LMPT groups.
c Comparisons of term vs. late and moderate preterm groups carried out using Student’s t-test for continuous variables.
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TABLE 43 Relationship between gestational age at birth and total birth to initial hospital discharge costs:
general linear model (gamma distribution with log-link)
Variable
Model 1 Model 2 Model 3
Relative
cost (SE) p> |t|
Relative
cost (SE) p> |t|
Relative
cost (SE) p> |t|
Gestational age status (reference: term)
Late and moderate preterm 2.39 (0.08) < 0.001 2.30 (0.07) < 0.001 2.15 (0.12) < 0.001
Place of delivery (reference: centre A)
Centre B 1.20 (0.04) < 0.001 1.17 (0.04) < 0.001 1.09 (0.05) 0.079
Other 1.19 (0.12) 0.101 0.97 (0.08) 0.759 0.95 (0.10) 0.65
Mode of delivery (reference: spontaneous vaginal)
Assisted/instrumental 1.31 (0.06) < 0.001 1.31 (0.05) < 0.001 1.39 (0.11) < 0.001
CS, during labour 2.10 (0.09) < 0.001 2.24 (0.09) < 0.001 2.06 (0.14) < 0.001
CS, not in labour 2.16 (0.10) < 0.001 2.26 (0.10) < 0.001 2.09 (0.12) < 0.001
Baby status (reference: alive)
Stillbirth 0.73 (0.11) 0.039 0.78 (0.12) 0.116 0.82 (0.14) 0.25
Early neonatal death 1.42 (0.61) 0.418 1.39 (0.59) 0.443 2.47 (0.43) < 0.001
Late neonatal death 0.84 (0.04) < 0.001 0.87 (0.07) 0.102 0.00 (–)
Infant death 2.79 (1.68) 0.087 2.90 (1.81) 0.088 0.72 (0.14) 0.097
Multiplicity (reference: singleton)
Multiple 0.90 (0.05) 0.079 0.83 (0.04) 0.001 0.81 (0.07) 0.012
Gender (reference: male) 0.98 (0.03) 0.503 0.99 (0.03) 0.797 0.97 (0.04) 0.47
Small for gestational agea (reference: no) 1.22 (0.07) < 0.001 1.22 (0.06) < 0.001 1.29 (0.11) 0.004
Congenital anomaly (reference: no) 5.33 (1.53) < 0.001 5.47 (1.40) < 0.001 5.52 (1.43) < 0.001
First born (reference: no) 1.06 (0.04) 0.096 1.04 (0.04) 0.242 1.04 (0.07) 0.56
Maternal age 1.00 (0.00) 0.920 1.00 (0.01) 0.81
Maternal BMI (reference: normal)
Underweight 0.96 (0.07) 0.567 0.87 (0.08) 0.14
Overweight 0.99 (0.04) 0.876 1.05 (0.07) 0.42
Obese 0.96 (0.04) 0.231 0.99 (0.05) 0.92
Maternal ethnicity (reference: white)
Mixed 1.02 (0.15) 0.892 1.04 (0.24) 0.88
Asian or Asian British 0.94 (0.04) 0.214 0.92 (0.10) 0.42
Black or black British 0.94 (0.06) 0.392 1.02 (0.13) 0.90
Chinese or other 0.93 (0.10) 0.500 1.20 (0.20) 0.27
Not known 1.02 (0.13) 0.870 0.95 (0.11) 0.66
Highest qualification (reference: higher degree)
Degree 0.93 (0.05) 0.139 0.95 (0.07) 0.46
A levels, vocational level 3 and
equivalent
0.99 (0.05) 0.809 0.97 (0.08) 0.72
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TABLE 43 Relationship between gestational age at birth and total birth to initial hospital discharge costs:
general linear model (gamma distribution with log-link) (continued )
Variable
Model 1 Model 2 Model 3
Relative
cost (SE) p> |t|
Relative
cost (SE) p> |t|
Relative
cost (SE) p> |t|
GCSE grades A*–C, vocational level 2
and equivalent
1.05 (0.07) 0.451 1.11 (0.11) 0.30
GCSE grades D–G, vocational level 1
and below
1.04 (0.08) 0.653 1.00 (0.12) 0.99
Qualification level unknown 0.96 (0.06) 0.528 1.10 (0.12) 0.35
No qualifications 1.03 (0.08) 0.736 1.03 (0.13) 0.82
Not known 1.22 (0.16) 0.145 0.87 (0.14) 0.40
Marital civil status (referent: living as part
of a couple)
1.02 (0.07) 0.773 1.07 (0.10) 0.46
NS-SEC (reference: managerial and professional occupations)
Intermediate occupations 0.98 (0.05) 0.642 1.03 (0.07) 0.62
Routine and manual occupations 0.97 (0.05) 0.601 1.04 (0.08) 0.55
Never worked and long-term
unemployed
0.99 (0.06) 0.841 1.05 (0.10) 0.58
Looking after family 0.96 (0.05) 0.468 1.04 (0.07) 0.59
Not known 0.81 (0.08) 0.039 1.02 (0.11) 0.82
Home ownership (reference: own)
Rent 1.07 (0.04) 0.055 1.03 (0.06) 0.52
Lives rent free 1.01 (0.07) 0.919 0.83 (0.12) 0.17
EQ-5D utility score 0.99 (0.12) 0.923 1.08 (0.18) 0.63
Chronic health problems (reference: no) 0.95 (0.03) 0.133 0.95 (0.05) 0.33
Deprivation score (reference: first quintile)
Second quintile 1.04 (0.04) 0.331 0.97 (0.05) 0.63
Third quintile 1.11 (0.05) 0.026 1.08 (0.08) 0.25
Fourth quintile 1.07 (0.06) 0.217 1.13 (0.10) 0.17
Fifth quintile 1.05 (0.05) 0.309 1.02 (0.09) 0.82
Recreational drugs during pregnancy
(reference: no)
1.12 (0.15) 0.416 0.98 (0.16) 0.91
Smoke during pregnancy (reference: no) 0.91 (0.04) 0.056 0.92 (0.07) 0.26
Previous premature baby (reference: no) 1.17 (0.08) 0.03
Drink during pregnancy (reference: no) 1.00 (0.05) 0.99
Constant 7.12 (0.03) < 0.001 7.11 (0.17) < 0.001 7.07 (0.26) < 0.001
n 2403 2281 958
Adjusted R2 42,224.36 40,131.38 16,599.23
a Based on fetal weight percentile of < 0.10.
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mean cost ratios of 1.31, 2.10, and 2.16, respectively, compared with the reference group of infants born
by spontaneous vaginal delivery. Infants who were SGA had a mean cost ratio of 1.22 compared with the
reference group of infants who were not SGA. Infants born with a congenital anomaly had a mean cost
ratio of 5.33 compared with the reference group of infants born without congenital anomalies. Gender
(male), whether or not the baby was first born, survival status and multiplicity did not have significant
effects on total birth to initial hospital discharge costs. The addition of maternal sociodemographic and
maternal lifestyle variables in models 2 and 3 had no significant impact on these findings.
Table 44 contains the corresponding results for the OLS regressions. Model 1 shows that, even after
controlling for infant and birth characteristics, LMPT birth increased costs by an average of £3006
(SE £234; p< 0.0001), in comparison with birth at full term. The same patterns of statistical significance
present in the corresponding GLM are found in this OLS model. Similarly, the addition of maternal
sociodemographic and maternal lifestyle variables in models 2 and 3 had no significant impact on
these findings.
TABLE 44 Relationship between gestational age at birth and total birth to initial hospital discharge costs: OLS
Variable
Model 1 Model 2 Model 3
Coefficient
(SE) p> |t|
Coefficient
(SE) p> |t|
Coefficient
(SE) p> |t|
Gestational age status (reference: term)
Late and moderate preterm 3006.44
(236.73)
< 0.001 2813.45
(195.33)
< 0.001 2396.23
(331.87)
< 0.001
Place of delivery (reference: centre A)
Centre B 647.61
(254.68)
0.011 670.24
(239.42)
0.005 437.83
(289.57)
0.13
Other 1251.14
(356.31)
< 0.001 576.12
(365.21)
0.115 204.86
(486.45)
0.67
Mode of delivery (reference: spontaneous vaginal)
Assisted/instrumental 476.88
(213.26)
0.025 453.09
(219.18)
0.039 797.6
(333.63)
0.017
CS, during labour 2335.05
(235.06)
< 0.001 2698.3
(291.28)
< 0.001 2288.85
(377.14)
< 0.001
CS not in labour 3554.03
(639.83)
< 0.001 3736.14
(703.97)
< 0.001 2407.36
(372.74)
< 0.001
Baby status (reference: alive)
Stillbirth –1538.09
(402.27)
< 0.001 –1036.85
(547.27)
0.058 –1174.17
(685.38)
0.087
Early neonatal death –5069.66
(6019.95)
0.400 –5482.15
(5791.83)
0.344 2327.38
(886.67)
0.009
Late neonatal death –435.57
(292.01)
0.136 –69.5 (685.3) 0.919 0.00(-)
Infant death 17,327.97
(13056.93)
0.185 16,560.15
(13477.4)
0.219 –1723.72
(1305.56)
0.18
Multiplicity (reference: singleton)
Multiple –964.42 (526) 0.067 –1169.74
(470.98)
0.013 –806.43
(483.75)
0.096
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TABLE 44 Relationship between gestational age at birth and total birth to initial hospital discharge costs: OLS
(continued )
Variable
Model 1 Model 2 Model 3
Coefficient
(SE) p> |t|
Coefficient
(SE) p> |t|
Coefficient
(SE) p> |t|
Gender (reference: male) 159.89
(306.52)
0.602 165.35
(302.06)
0.584 –344.12
(280.05)
0.21
Small for gestational age
(reference: no)a
750.75
(439.71)
0.088 760.29
(448.64)
0.090 1074.5
(627.41)
0.087
Congenital anomaly (reference: no) 20,847.47
(9240.88)
0.024 22,025.33
(9765.91)
0.024 17,999.29
(5310.01)
0.001
First born (reference: no) 485.23
(267.82)
0.070 342.54
(204.04)
0.093 60.92
(397.78)
0.87
Maternal age –4.96 (26.69) 0.853 –1.41 (43.31) 0.97
Maternal BMI (reference: normal)
Underweight –586.96
(522.23)
0.261 –674.68
(549.06)
0.21
Overweight –347.94
(303.08)
0.251 130.91
(355.27)
0.71
Obese –704.39
(360.31)
0.051 –235.85
(302.98)
0.43
Maternal ethnicity (reference: white)
Mixed –1314.74
(1355.45)
0.332 –641.3
(1585.53)
0.68
Asian or Asian British –14.86
(289.82)
0.959 –216.89
(457.6)
0.63
Black or black British 41 (698.33) 0.953 1574.4
(1772.62)
0.37
Chinese or other –234.88
(480.43)
0.625 784.1
(662.85)
0.23
Not known 654.12
(775.22)
0.399 –185.67
(615.76)
0.76
Highest qualification (reference: higher degree)
Degree –242.44
(293.33)
0.238 –5.18
(314.24)
0.98
A levels, vocational level 3 and
equivalent
238.34
(367.6)
0.517 11.24
(314.92)
0.97
GCSE grades A*–C, vocational
level 2 and equivalent
271.13
(356.88)
0.447 532.61
(412.15)
0.19
GCSE grades D–G, vocational
level 1 and below
1149.1
(1060.21)
0.279 508.18
(879.86)
0.56
Qualification level unknown –295.54
(427.07)
0.489 466.53
(401.05)
0.24
No qualifications 185.86
(443.23)
0.675 233.9
(626.01)
0.70
Not known 857.85
(610.14)
0.160 –248.76
(1000.89)
0.80
Marital civil status (reference: living as
part of a couple)
606.99
(870.1)
0.485 698.69
(667.36)
0.29
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TABLE 44 Relationship between gestational age at birth and total birth to initial hospital discharge costs: OLS
(continued )
Variable
Model 1 Model 2 Model 3
Coefficient
(SE) p> |t|
Coefficient
(SE) p> |t|
Coefficient
(SE) p> |t|
NS-SEC (reference: managerial and professional occupations)
Intermediate occupations –85.97
(279.29)
0.758 142.59
(302.4)
0.63
Routine and manual occupations 21.03
(292.56)
0.943 576.22
(475.32)
0.22
Never worked and long-term
unemployed
674.69
(780.38)
0.387 474.83
(501.23)
0.34
Looking after family –47.92
(315.91)
0.879 457.52
(398.87)
0.25
Not known –294.44
(676.08)
0.663 539.09
(614.68)
0.38
Home ownership (reference: own)
Rent 388.66
(231.18)
0.093 –85.67
(252.83)
0.73
Lives rent free –448.39
(726.37)
0.537 –726.56
(609.72)
0.23
EQ-5D utility score –442.12
(974.97)
0.650 1005.81
(1568.31)
0.52
Chronic health problems (reference: no) 203 (420.2) 0.629 249.31
(308.3)
0.41
Deprivation score (reference: first quintile)
Second quintile 349.86
(275.16)
0.204 20.76
(276.58)
0.94
Third quintile 951.9
(577.34)
0.099 375.34
(391.62)
0.33
Fourth quintile 194.56
(260.96)
0.456 380.15
(377.65)
0.31
Fifth quintile –72.67
(310.32)
0.815 –56.38
(431.34)
0.89
Recreational drugs during pregnancy
(reference: no)
134.92
(614.57)
0.826 –174.4
(806.73)
0.82
Smoked during pregnancy
(reference: no)
–887.12
(658.49)
0.178 –635.99
(560.96)
0.25
Previous premature baby (reference: no) 1062.72
(490.45)
0.03
Drink during pregnancy (reference: no) 180.35
(262.81)
0.49
Constant 285.73
(262.61)
0.277 574.88
(1303.54)
0.659 –724.58
(2479.41)
0.77
n 2403 2281 958
Adjusted R2 0.2162 0.2296 0.3448
a Based on fetal weight percentile of < 0.10.
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Birth to 24 months
Table 45 shows the results of two generalised linear regression models on total cost from birth to
24 months or death (whichever was earliest). The results are presented for complete cases, i.e. for those
infants for whom cost data were available at all follow-up periods. The first model (model 4) explores the
impact of infant and birth characteristics on total societal costs, while the second model (model 5) also
includes maternal sociodemographic and lifestyle characteristics to explore whether or not they additionally
influence societal costs. Gestational age at birth status acted as the main exposure in these models.
Model 4 shows that, compared with term-born infants, the mean (SE) cost ratio for LMPT birth was 1.70
(0.08). Infants born in service B hospitals generated higher initial hospitalisation costs than those born in
the service A hospitals, with a mean (SE) cost ratio of 1.12 (0.05). Infants born by assisted/instrumental
delivery, CS during labour and CS not in labour had mean cost ratios of 1.15, 1.51, and 1.74, respectively,
compared with the reference group of infants born by spontaneous vaginal delivery. Infants born with a
congenital anomaly had a mean cost ratio of 4.56 compared with the reference group of infants born
without congenital anomalies. Infants who were first born had a mean cost ratio of 1.1 compared with the
reference group of infants who were not first born. Gender (male), whether or not the baby was SGA and
multiplicity did not have significant effects on total birth to 24 months costs. The addition of maternal
sociodemographic and maternal lifestyle variables in model 5 had no significant impact on these findings.
Table 46 contains the corresponding results for the OLS regressions.
Table 47 shows the results of two generalised linear regression models on total cost from birth to
24 months or death (whichever was earliest) using the inverse probability weighting method226,227 to
account for the presence of censored data. The same two models were estimated as for the complete case
analyses (see Table 46). The same patterns of statistical significance present in model 4 for the complete
case analysis are found in model 4 for the weighted data. The addition of maternal sociodemographic and
maternal lifestyle variables in model 5 resulted in some significant effects. For example, an unknown
maternal ethnicity status resulted in a mean cost ratio of 0.69 compared with the white reference group.
Maternal occupational status reported as looking after the family was associated with reduced societal
costs to 24 months. Table 48 contains the corresponding results for the OLS regressions.
Discussion
A recent study that reviewed the published evidence on the economic consequences of LMPT birth found
sparse evidence on this topic.228 No previous published studies have, to our knowledge, estimated the
costs associated with LMPT birth in a UK setting. This study set out to estimate the economic costs
associated with LMPT birth on the basis of a prospective population-based study in a geographically
defined area of central England.
Conclusions
Key findings
l During the initial hospitalisation, LMPT infants have higher rates of resource use than term-born infants
across all hospital service resource categories.
l Mean costs are significantly higher for LMPT infants than for term-born infants across all categories of
hospital services.
l The mean cost difference between our main comparator groups (LMPT vs. term) for the period until
initial hospital discharge was £3668 (bootstrap 95% CI £3129 to £4362; p< .0001). This cost
difference was accentuated when the time horizon for the economic analysis was extended to 2 years
(cost differences for NHS £4083, PSS £34, other costs £101 and societal costs £4340).
THE LATE AND MODERATELY PRETERM BIRTH STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
134
TABLE 45 Relationship between gestational age at birth and birth to 24 months costs: general linear model
(gamma distribution with log-link) – complete cases
Variable
Model 4 Model 5
Cost ratio (SE) p> |t| Cost ratio (SE) p> |t|
Gestational age status (reference: term)
Late and moderate preterm 1.70 (0.08) < 0.001 1.72 (0.07) < 0.001
Place of delivery (reference: centre A)
Centre B 1.12 (0.05) 0.005 1.1 (0.05) 0.026
Other 0.95 (0.1) 0.627 1.03 (0.13) 0.83
Mode of delivery (reference: spontaneous vaginal)
Assisted/instrumental 1.15 (0.06) 0.009 1.17 (0.06) 0.002
CS, during labour 1.51 (0.08) < 0.001 1.49 (0.08) < 0.001
CS, not in labour 1.74 (0.1) < 0.001 1.72 (0.09) < 0.001
Multiplicity (reference: singleton)
Multiple 1.03 (0.07) 0.627 1.03 (0.07) 0.63
Gender (reference: male) 0.96 (0.04) 0.270 0.96 (0.04) 0.25
Small for gestational age (reference: no)a 1.08 (0.07) 0.213 1.08 (0.06) 0.16
Congenital anomaly (reference: no) 4.56 (1.48) < 0.001 4.42 (1.18) < 0.001
First born (reference: no) 1.1 (0.04) 0.020 1.1 (0.05) 0.028
Maternal age 1.01 (0.00) 0.072
Maternal ethnicity (reference: white)
Mixed 1.04 (0.16) 0.80
Asian or Asian British 0.93 (0.07) 0.30
Black or black British 1.04 (0.13) 0.72
Chinese or other 1.32 (0.18) 0.03
Not known 0.69 (0.12) 0.028
Highest qualification (reference: higher degree)
Degree 0.99 (0.06) 0.92
A levels, vocational level 3 and equivalent 1.06 (0.07) 0.41
GCSE grades A*–C, vocational level 2 and equivalent 1.06 (0.09) 0.49
GCSE grades D–G, vocational level 1 and below 0.95 (0.09) 0.60
Qualification level unknown 1.08 (0.1) 0.40
No qualifications 1.01 (0.11) 0.94
Not known 1 (0.22) 0.99
Marital civil status (reference: living as part of a couple) 0.87 (0.06) 0.038
NS-SEC (reference: managerial and professional occupations)
Intermediate occupations 0.97 (0.06) 0.55
Routine and manual occupations 1.07 (0.08) 0.36
Never worked and long-term unemployed 0.94 (0.07) 0.39
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TABLE 45 Relationship between gestational age at birth and birth to 24 months costs: general linear model
(gamma distribution with log-link) – complete cases (continued )
Variable
Model 4 Model 5
Cost ratio (SE) p> |t| Cost ratio (SE) p> |t|
Looking after family 0.88 (0.07) 0.09
Not known 0.75 (0.17) 0.20
Home ownership (reference: own)
Rent 1.07 (0.06) 0.23
Lives rent free 1.09 (0.1) 0.35
EQ-5D utility score 0.78 (0.12) 0.10
Chronic health problems (reference: no) 0.94 (0.04) 0.15
Deprivation score (reference: first quintile)
Second quintile 1.08 (0.06) 0.17
Third quintile 1.06 (0.07) 0.37
Fourth quintile 1.02 (0.07) 0.81
Fifth quintile 1.09 (0.08) 0.25
Recreational drugs during pregnancy (reference: no) 0.98 (0.14) 0.86
Smoked during pregnancy (reference: no) 1.11 (0.08) 0.159
Constant 7.96 (0.05) < 0.001 7.91 (0.24) < 0.001
n 1310 1310
AIC 24,854.06 24,893.99
a Based on fetal weight percentile of < 0.10.
TABLE 46 Relationship between gestational age at birth and total birth to 24 months costs: OLS – complete cases
Variable
Model 4 Model 5
Coefficient (SE) p> |t| Coefficient (SE) p> |t|
Gestational age status (reference: term)
LMPT 2849.72 (330.08) < 0.001 2923.23 (340.99) < 0.001
Place of delivery (reference: centre A)
Centre B 663.18 (290.98) 0.023 569.49 (297.32) 0.05
Other 162.96 (516.51) 0.752 223.4 (659.21) 0.73
Mode of delivery (reference: spontaneous vaginal)
Assisted/instrumental 605.84 (295.97) 0.041 703.43 (294.25) 0.01
CS, during labour 2152.88 (385.27) < 0.001 1952.1 (424.43) < 0.001
CS, not in labour 3143.88 (575.15) < 0.001 2905.82 (703.63) < 0.001
Multiplicity (reference: singleton)
Multiple 571.21 (594.65) 0.337 523.82 (592.83) 0.37
Gender (reference: male) –238.42 (284.75) 0.403 –265.84 (331.38) 0.42
Small for gestational agea (reference: no) 569.58 (463.99) 0.220 672.68 (457.53) 0.14
Congenital anomaly (reference: no) 19,210.29
(7614.32)
0.012 19,197.8 (7291.8) 0.009
First born (reference: no) 368.74 (328.21) 0.261 494.44 (328.1) 0.13
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TABLE 46 Relationship between gestational age at birth and total birth to 24 months costs: OLS – complete cases
(continued )
Variable
Model 4 Model 5
Coefficient (SE) p> |t| Coefficient (SE) p> |t|
Maternal age 93.2 (49.61) 0.06
Maternal ethnicity (reference: white)
Mixed 59.75 (2289.7) 0.97
Asian or Asian British –382.05 (438.67) 0.38
Black or black British 2286.8 (2868.13) 0.42
Chinese or other 1223.63 (646.08) 0.05
Not known –1286.54 (737.4) 0.08
Highest qualification (reference: higher degree)
Degree 453.73 (365.68) 0.21
A levels, vocational level 3 and equivalent 783.94 (452.23) 0.08
GCSE grades A*–C, vocational level 2 and
equivalent
564.54 (475.57) 0.23
GCSE grades D–G, vocational level 1 and below 1402.66 (1551.93) 0.36
Qualification level unknown 250.72 (638.87) 0.69
No qualifications 762 (733.08) 0.29
Not known 84.75 (1132.25) 0.94
Marital civil status (reference: living as part of a couple) –957.4 (646.8) 0.13
NS-SEC (reference: managerial and professional occupations)
Intermediate occupations –264.08 (371.96) 0.47
Routine and manual occupations 451.3 (583.1) 0.43
Never worked and long-term unemployed –715.64 (575.48) 0.21
Looking after family –932.63 (614.4) 0.12
Not known –1472.1 (997.3) 0.14
Home ownership (reference: own)
Rent 647.71 (431.4) 0.13
Lives rent free 654.94 (632.71) 0.30
EQ-5D utility score –1777.27
(1672.07)
0.28
Chronic health problems (reference: no) –251.48 (498.62) 0.61
Deprivation score (reference: first quintile)
Second quintile 482.39 (380.1) 0.20
Third quintile 456.52 (557.57) 0.41
Fourth quintile 8.61 (407.49) 0.98
Fifth quintile 199.87 (540.81) 0.71
Recreational drugs during pregnancy (reference: no) 127.57 (949.43) 0.89
Smoked during pregnancy (reference: no) 459.54 (483.82) 0.34
Constant 2475.13 (386.56) < 0.001 535.75 (2488.64) 0.83
n 1310 1310
Adjusted R2 0.2778 0.2998
a Based on fetal weight percentile of < 0.10.
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TABLE 47 Relationship between gestational age at birth and birth to 24 months costs: general linear model
(gamma distribution with log-link), inverse probability weighted
Variable (unit)
Model 4 Model 5
Cost ratio (SE) p> |t| Cost ratio (SE) p> |t|
Gestational age status (reference: term)
Late and moderate preterm 1.65 (0.08) < 0.001 1.67 (0.08) < 0.001
Place of delivery (reference: centre A)
Centre B 1.11 (0.05) 0.016 1.08 (0.05) 0.09
Other 1.00 (0.11) 0.971 1.1 (0.15) 0.51
Mode of delivery (reference: spontaneous vaginal)
Assisted/instrumental 1.16 (0.08) 0.024 1.16 (0.07) 0.01
CS, during labour 1.52 (0.09) < 0.001 1.49 (0.09) < 0.001
CS, not in labour 1.73 (0.1) < 0.001 1.71 (0.09) < 0.001
Multiplicity (reference: singleton)
Multiple 1.13 (0.09) 0.140 1.11 (0.08) 0.17
Gender (reference: male) 0.96 (0.04) 0.329 0.96 (0.04) 0.35
Small for gestational agea (reference: no) 1.05 (0.06) 0.413 1.07 (0.06) 0.26
Congenital anomaly (reference: no) 4.47 (1.46) < 0.001 4.50 (1.31) < 0.001
First born (reference: no) 1.12 (0.05) 0.014 1.11 (0.06) 0.03
Maternal age 1.01 (0.00) 0.09
Maternal ethnicity (reference: white)
Mixed 0.88 (0.15) 0.43
Asian or Asian British 0.94 (0.06) 0.34
Black or black British 1 (0.11) 0.97
Chinese or other 1.25 (0.16) 0.09
Not known 0.69 (0.1) 0.01
Highest qualification (reference: higher degree)
Degree 0.99 (0.06) 0.89
A levels, vocational level 3 and equivalent 1.07 (0.08) 0.37
GCSE grades A*–C, vocational level 2 and equivalent 1.08 (0.1) 0.39
GCSE grades D–G, vocational level 1 and below 0.9 (0.09) 0.29
Qualification level unknown 1.09 (0.1) 0.35
No qualifications 0.98 (0.11) 0.88
Not known 1.14 (0.33) 0.64
Marital civil status (reference: living as part of a couple) 0.93 (0.07) 0.33
NS-SEC (reference: managerial and professional occupations)
Intermediate occupations 0.97 (0.06) 0.67
Routine and manual occupations 1.04 (0.08) 0.64
Never worked and long-term unemployed 0.95 (0.08) 0.55
Looking after family 0.85 (0.07) 0.04
Not known 0.8 (0.16) 0.25
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TABLE 47 Relationship between gestational age at birth and birth to 24 months costs: general linear model
(gamma distribution with log-link), inverse probability weighted (continued )
Variable (unit)
Model 4 Model 5
Cost ratio (SE) p> |t| Cost ratio (SE) p> |t|
Home ownership (reference: own)
Rent 1.09 (0.06) 0.12
Lives rent free 1.08 (0.1) 0.41
EQ-5D utility score 0.8 (0.11) 0.11
Chronic health problems (reference: no) 0.94 (0.04) 0.20
Deprivation score (reference: first quintile)
Second quintile 1.08 (0.07) 0.23
Third quintile 1.06 (0.07) 0.39
Fourth quintile 1.02 (0.08) 0.82
Fifth quintile 1.08 (0.08) 0.31
Recreational drugs during pregnancy (reference: no) 1.18 (0.2) 0.32
Smoke during pregnancy (reference: no) 1.02 (0.07) 0.78
Constant 7.96 (0.05) < 0.001 7.89 (0.24) < 0.001
n 1310 1310
AIC 45,007.86 45,026.75
a Based on fetal weight percentile of < 0.10.
TABLE 48 Relationship between gestational age at birth and total birth to 24 months costs: OLS, inverse
probability weighted
Variable
Model 4 Model 5
Coefficient (SE) p> |t| Coefficient (SE) p> |t|
Gestational age status (reference: term)
Late and moderate preterm 2590.13 (298.65) < 0.001 2687.85 (308) < 0.001
Place of delivery (reference: centre A)
Centre B 603.13 (283.01) 0.033 459.85 (284.09) 0.10
Other 228.01 (637.28) 0.721 271.02 (775.9) 0.72
Mode of delivery (reference: spontaneous vaginal)
Assisted/instrumental 594.69 (353.2) 0.092 677.75 (331.85) 0.04
CS, during labour 2145.89 (417.96) < 0.001 1964.81 (440.47) < 0.001
CS, not in labour 3129.18 (510.89) < 0.001 2904.41 (641.87) < 0.001
Multiplicity (reference: singleton)
Multiple 334.77 (412.93) 0.418 1025.23 (608.72) 0.09
Gender (reference: male) 1158.28 (648.8) 0.074 –290.74 (335.99) 0.38
Small for gestational agea (reference: no) –205.6 (267.77) 0.443 468.38 (434.28) 0.28
Congenital anomaly (reference: no) 18,945.89
(7182.38)
0.008 19,105.01
(7076.49)
0.007
continued
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TABLE 48 Relationship between gestational age at birth and total birth to 24 months costs: OLS, inverse
probability weighted (continued )
Variable
Model 4 Model 5
Coefficient (SE) p> |t| Coefficient (SE) p> |t|
First born (reference: no) 446.71 (312.44) 0.153 512.91 (324.59) 0.11
Maternal age 75.15 (42.62) 0.07
Maternal ethnicity (reference: white)
Mixed –1069.04 (1603.89) 0.50
Asian or Asian British –340.33 (411.43) 0.40
Black or black British 1410.5 (1688) 0.40
Chinese or other 871.35 (643.08) 0.17
Not known –1596.68 (734.38) 0.03
Highest qualification (reference: higher degree)
Degree 447.5 (373.72) 0.23
A levels, vocational level 3 and equivalent 807.38 (431.17) 0.06
GCSE grades A*–C, vocational level 2 and
equivalent
753.11 (487.08) 0.12
GCSE grades D–G, vocational level 1 and below 939.04 (1217.42) 0.44
Qualification level unknown 363.03 (626.09) 0.56
No qualifications 618.47 (720.22) 0.39
Not known 702.8 (1501.19) 0.64
Marital civil status (reference: living as part of a
couple)
–474.06 (506.58) 0.35
NS-SEC (reference: managerial and professional occupations)
Intermediate occupations –271.81 (391.55) 0.48
Routine and manual occupations 56.96 (551.7) 0.91
Never worked and long-term unemployed –683.91 (533.95) 0.20
Looking after family –993.27 (578.7) 0.08
Not known –1198.81 (885.51) 0.17
Home ownership (reference: own)
Rent 770.74 (387.29) 0.04
Lives rent free 635.45 (568.31) 0.26
EQ-5D utility score –1213.95 (1140.8) 0.28
Chronic health problems (reference: no) –256.26 (411.92) 0.53
Deprivation score (reference: first quintile)
Second quintile 465.48 (411.43) 0.25
Third quintile 494.82 (543.18) 0.36
Fourth quintile 81.36 (413.29) 0.84
Fifth quintile 234.19 (483.66) 0.62
Recreational drugs during pregnancy (reference: no) 1661.19 (1189.57) 0.16
Smoked during pregnancy (reference: no) –70.56 (415.8) 0.86
Constant 2470.45 (323.2) < 0.001 705.93 (1996.84) 0.72
n 1310 1310
Adjusted R2 0.2748 0.2953
a Based on fetal weight percentile of < 0.10.
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Strengths and limitations
The main strengths of this study lie in the fact that it was based on a large geographically determined
prospective population cohort, included a term comparison group and captured a comprehensive profile of
resource use, encompassing use of hospital inpatient, day care and outpatient services, community health
and social care services, medicines and drugs, adaptations to the home, provision of special equipment
and parental lost productivity between birth and 2 years. Furthermore, the rigorous costing methodology
applied followed national guidance for health economic evaluation purposes.220,229
A number of caveats need to be borne in mind by readers. First, because the study was based in the
geographical area of the East Midlands, it may not be representative of the UK population as a whole.
Nevertheless, as we were able to collect information about the numbers of infants that were not recruited,
together with baseline denominators in terms of ‘all births’, it has still been possible to create reasonable
estimates for the population, which should be suitable for generalisation. Second, our study considered
only hospitalisation costs during the period between birth and initial hospital discharge, whereas a broader
societal perspective for economic costs over this initial time horizon might also appropriately consider costs
borne by parents and informal carers. A recent structured review of the economic costs associated with
preterm birth highlighted the importance of non-health-care costs associated with the initial period of
hospitalisation, such as parental travel costs and those associated with lost parental productivity, and it is
likely that these categories of costs are relevant to some families and carers of children born either
moderately or late preterm.230 Third, the study covered a time horizon of birth to 2 years, whereas a longer
time horizon could have captured the economic consequences of potential longer-term sequelae, such as
physical, neuropsychological and behavioural difficulties. The economic consequences of LMPT birth are
likely to be ongoing in infants with long-term adverse sequelae and it is possible that the need for special
educational support in this group is substantial but not yet fully recognised.
Implications for practice
Compared with birth at full term, LMPT birth is associated with significant additional costs during the
period of the initial hospitalisation and over the first 2 years of life. Clinical decision-makers and budgetary
and service planners should recognise the overall economic impact of LMPT birth in their service planning,
as well as the potential contribution of clinical and sociodemographic factors to future public sector and
broader societal costs. The results of our study should be considered for use within economic evaluations
of preventative or treatment interventions for LMPT birth, or as inputs to studies attempting to model the
economic costs of preterm birth throughout childhood.
The two neonatal services involved in this study generated significantly different costs associated with the
care of LMPT babies. This is mirrored in clinical differences reported in previous sections. Rationalising
the approach to care could result in very significant saving given that there are around 40,000 births each
year in the UK at LMPT gestations.
Challenges and lessons learned from conducting the Late And
Moderately preterm Birth Study
Improving response rates
Obtaining responses to postal questionnaires from parents of participating children was challenging and
time-consuming. At recruitment, we asked parents for details of an additional contact to improve
opportunities for follow-up, since we believed that this would be a very mobile population. Although this
is a tried and tested approach to maximising follow-up, we had only limited success with this strategy from
the outset, as large numbers of mothers did not feel comfortable in providing additional contact details of
friends or relatives. This appeared to be related to the perceived nuisance caused to people by unwanted
or irrelevant calls and may reflect disquiet with the ease with which multiple agencies are now able to
contact individuals, with or without explicit consent. However, this reluctance on the part of participants
reduced our ability to follow up a number of children beyond the neonatal period.
DOI: 10.3310/pgfar04010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 1
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Field et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
141
Families with young children are busy and have limited time to complete postal questionnaires, particularly
when their children reach 1 or 2 years of age and both parents may again be working. In order to
maximise our chances of contacting families who had failed to return postal questionnaires, we used
telephone, text messaging and e-mail. We found a preference among some families for completing the
questionnaire on the telephone, and these interviews also provided the opportunity to check contact
details regularly.
The use of these additional methods of follow-up necessitated a review of administrative staffing, because
of the time-consuming nature of this personal and individualised contact. Additional members of staff
were employed at various points during the course of the study. This was necessary both to maximise
opportunities for contacting parents and to allow a high degree of flexibility in the timing of calls to
families, of which many expressed a wish to be telephoned to complete questionnaires at particular times
of the day or evening.
We also faced a challenge related to new technology in that parents were often reluctant to respond to
calls to their mobile phones or landlines that were displayed on their handset as ‘blocked call’ or ‘withheld
number’. Mobile telephones were therefore purchased for use by study team members solely for the
purpose of contacting families for which this appeared to be a difficulty. Text messaging was also possible
and proved highly successful in avoiding this problem.
During the follow-up phase of the LAMBS, we received a number of requests from parents who wished to
complete follow-up questionnaires in an online format. We therefore introduced this option at the 2-year
follow-up, providing a web link via e-mail for individuals who expressed the desire to use this. A number
of parents took advantage of this opportunity and these, together with telephone interviews, increased
our response rate by five individuals at 2 years.
At the 6-month follow-up, parents had to contact the research team to complete their questionnaire by
telephone interview. However, by the time of the 12-month follow-up questionnaire, with the additional
staff, we were able to routinely contact them to ‘chase’ missing questionnaires and offer telephone
interview or online completion. Therefore, from that point onwards, we were operating a true mixed mode
approach in response to these identified needs. The introduction of additional methods in response to
parents’ wishes appears to have had a positive effect, as our greatest loss to follow-up was in the first
6 months and contact has been more consistently maintained since that stage (see Figure 10). For each
change or addition to methods of contacting parents, approval was sought from the REC and the
participating NHS trusts.
Recruitment and follow-up for ethnic groups
Barriers caused by lack of availability of interpreters for mothers who had limited knowledge of English
were a significant issue. Although information sheets were translated into all the common local languages,
these were rarely used and parents instead chose either to rely on family members who spoke English or,
more often, to decline participation. This is a substantial challenge in areas in which there is a high ethnic
minority population. When face-to-face communication was possible, with or without the support of
family members, this proved sufficient to allow understanding of the study at the recruitment stage.
However, obtaining responses from these families to written questionnaires was often difficult. Telephone
conversations were extremely challenging and often had to be abandoned when adequate understanding
could not be assured. However, response rates among ethnic minority families were generally improved by
offering telephone interviews.
Maintaining the cohort
In order to maintain interest in the study among participating families, we felt that it was necessary to
have some means of communicating on a more informal basis. However, funding limitations precluded
more regular postal correspondence.
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The advent of social media has provided both opportunities and challenges for longitudinal research in
young families. Facebook is a popular avenue of communication among young parents, and we sought to
capitalise on this by creating a LAMBS Facebook group. However, in order to be of use to the research
team, this required, and continues to require, a high level of input to maintain an active, informative site
that maintains the interest of participants without compromising their privacy.
In order to thank mothers for their involvement in the study at the recruitment stage, following the
interview, each mother was given a cotton bag displaying the LAMBS logo. This was designed to maintain
awareness of the study and encourage parents to remember that they were participating. Birthday cards
were sent to children at 1, 2 and 3 years. A colourful picture sheet with stickers was included with the
questionnaire at 2 years and a suggestion made that this was used to occupy the child while parents
completed the questionnaire. This proved extremely popular with parents and the study Facebook page
was used by a number of mothers to respond with thank-you messages to the study team for this and for
their child’s birthday cards.
Patient and public involvement
Engaging young parents and families with small children proved extremely challenging. It had been our
intention to develop a ‘panel’ of parent advisors from those participating in the study. We envisaged that
this group would attend regular but infrequent meetings and would use e-mail to comment on study
documentation, provide feedback on the conduct of the study and guide the research team on areas for
future research. However, although a considerable number of parents expressed interest in acting in this
role during telephone conversations with members of the study team, we were unable to identify any
parents who said that they would be willing to attend meetings, despite the fact that travel and child care
expenses were offered. All parents who were approached indicated that they would not have sufficient
time to devote to this. All indicated that they would be willing to engage in e-mail correspondence to help
with this. However, when e-mails were distributed, responses were not received.
We then chose, instead, to use our Facebook page as a means of engaging parents. We initially invited
them to attend a ‘coffee morning’ to give feedback on the study and provided a play specialist to entertain
the children if they wished to bring them. Although approximately 10 parents indicated that they would
attend, only two mothers came. Nevertheless, they provided very helpful comment and feedback. Parents
who were unable to attend suggested that we posted questions on the Facebook page. This was much
more successful and, in response to specific questions posted on the page, a number of responses were
received and some discussion between parents was also generated. Although these efforts came too late
to have an effect on the LAMBS conduct, input from these parents has been extremely helpful in providing
guidance in prioritising areas for future work according to parents’ needs.
Summary
Over recent years there has been increasing concern about the short- and long-term outcomes of babies
born LMPT. Historically, these babies have constituted a relatively understudied group, with the largest
proportion of studies originating in North America since 2006. Subsequently, in the UK there have been a
number of retrospective studies exploring outcomes in this group using data from large regional and
national cohort studies. However, the LAMBS is the first UK population-based study of its kind, from a
birth cohort designed with the specific aim of exploring issues associated with birth at these gestations.
We recruited a high proportion of all LMPT births, together with a control group of a similar number of
babies born at ≥ 37 weeks’ gestation, and examined a wide range of risk factors and outcomes; these
included maternal health, socioeconomic status and lifestyle factors, neonatal and early childhood
outcomes and associated health-care costs. In doing so, we have identified a number of factors that confer
an increased risk of delivery at LMPT gestations. These relate mainly to low levels of maternal education,
socioeconomic deprivation and maternal health before and during pregnancy. For infants born LMPT,
compared with their term-born counterparts, we have shown significantly increased risk for a range of
adverse neonatal outcomes. These include the requirement for specialist neonatal care and prolonged
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neonatal hospital stay associated with increased neonatal morbidity. Furthermore, we have shown that an
increased risk of problems persists into infancy and early childhood, with a greater proportion of children
born LMPT experiencing health, cognitive and socioemotional difficulties.
Our findings support the findings of retrospective studies both in the USA and in the UK that these infants
represent a group that is at higher risk than previously appreciated. Although LMPT babies experience less
severe illness than infants born before 32 weeks’ gestation, they constitute a much larger group and
represent around 75 of all preterm births. The effects of even modestly increased morbidity in such a large
proportion of infants should not be underestimated in terms of the health and social care services required
to support them as they grow older. As might be expected, given the increased incidence of problems in
this group, we have also been able to demonstrate significantly increased costs associated with their care
in the first 2 years of life.
A large proportion of LMPT birth occurs as a result of a decision on the part of obstetric clinicians.
Decision-making in complicated pregnancies has been, to a great extent, based on the premise that
outcomes for LMPT babies did not differ substantially from those of term-born infants. The findings of
previous studies, and those from the LAMBS, suggest that this perception has been erroneous, and this
necessitates further exploration of the factors that influence such decisions. The view that LMPT birth was
relatively ‘benign’ has meant that few researchers have pursued exploration of the optimal time of delivery
at LMPT gestations in which pregnancy is complicated by problems such as hypertensive disease of
pregnancy and pre-eclampsia. However, our results suggest that delivery associated with these conditions
may have effects for babies that extend beyond the neonatal period. We have begun to explore whether
these adverse effects are related to immaturity owing to early delivery or the effects of maternal illness, but
this requires further requires investigation and clarification.
The detailed information that we have collected relating to the antenatal, perinatal, neonatal and
childhood periods places us in a position to explore the relationship between early factors and later
outcomes in greater depth, and this will be a priority. Such exploration is required to identify modifiable
risk factors and to inform guidance about the management of women and their babies affected by either
spontaneous or medically indicated delivery.
Our cohort will provide an ideal opportunity for long-term follow-up in this group of children to determine
whether or not they remain at increased risk at school age and whether this risk remains static or changes
with time. As the risks of LMPT birth constitute a newly recognised entity, few studies have the capacity to
monitor the outcomes for these individuals into later childhood and adolescence, and to relate these
outcomes to influences during the antenatal and perinatal periods and the early years. As children grow
and develop within different family and educational settings, these two environments will exert an
influence on the long-term outcomes and it will be important to identify further factors that set those with
adverse outcomes apart. Our ongoing aim is to capture the progress of these children in order to identify
potential mechanisms that may be amenable to modification to optimise management at every point and
maximise the potential of young people following LMPT birth.
THE LATE AND MODERATELY PRETERM BIRTH STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
144
Chapter 4 Discussion
This programme of work was originally conceived in recognition of the huge impact of prematurity onindividuals, the NHS and society in general. The focus of research, at the time of the application, had
been very much one of optimising the management of mothers presenting in preterm labour and dealing
with the consequences of very preterm birth. This situation continues.
Preterm birth is a major problem, with implications across many aspects of health and social care, and
hence it seemed important to try to focus on key aspects of the topic as a whole trying to:
1. understand how the impact of prematurity differed across the UK as it was clear that routine statistics
were compromised by a number of aspects regarding how they were collected and presented
2. understand better the drivers and impact of LMPT births – who are the major contributors to the
socioeconomic burden
3. explore avenues that might provide a means of preventing preterm birth – despite its economic
importance there is still no credible primary prevention strategy.
We were funded to carry out the first two strands of work and these have been successfully completed.
Many of the findings of the stream focused on better understanding childhood mortality are already being
implemented. The work of the LAMBS, as well as the detailed findings, offers routes to improved care of
these babies at lower costs for the NHS as well the opportunity to prevent some of the long-term
consequences of prematurity. However, both streams of work repeatedly flag the association between
premature birth and deprivation both in relation to the occurrence of premature babies and their on-going
problems. There are also clear indications that, despite our tendency to categorise preterm birth into
different groups (extreme, very, LMPT), there is almost certainly a continuum of risk with many shared
aetiological influences. Therefore, although continuing to deal with preterm babies in the most appropriate
fashion remains a priority, the lack of a primary prevention strategy should command no less attention.
Impact
Our work on understanding socioeconomic inequalities in infant mortality has provided important
information regarding ways to tackle these inequalities and to improve the future monitoring of
socioeconomic inequalities in the UK, both at a national and at a regional level. This work has been
disseminated through publications,20,33,52,62,231,232 workshops with directors of public health and
presentations at relevant national and international conferences.
The work targeting LMPT births was completed just 3 months before the end of the grant and just
9 months before submission of this report. As a result, the work on LMPT birth will continue to be refined
in terms of publications and influence on policy from this point on (the end of 2013). Nonetheless, there
have already been a number of important publications189,233–236 and to date there have already been
approximately 40 ‘engagement activities’ at which lessons from the work have been shared with both
parents and relevant health professionals. Presentations have been given to national and international
conferences to academics, midwives, obstetricians, neonatologists, health-care commissioners and
policy-makers involved in provision of care for babies in the UK and internationally. At a local level we have
fed back the findings of our work on mortality rates directly to Midlands-based directors of public health.
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Synergies
Our work focused on important topics around the common theme of preventing mortality and morbidity
in early life. Subsequently, this was supported by the CMO’s report for 2012 (published October 2013),
which makes a very similar case for a change in policy towards prevention in order to deal with a range of
challenges in childhood.237
Additional synergy between the research streams was seen, as socioeconomic influences emerged strongly
in both streams as perhaps offering the most obvious way in which to impact early childhood mortality
and morbidity. The most obvious biological link to socioeconomic status, seen in both streams of work,
related to the risk of preterm birth, which in the CMO’s 2012 report was estimated to cost the country
£2.48B per year. However, we have identified the impact of socioeconomic factors to be far wider,
including in relation to the risk of certain major congenital anomalies occurring, the nature of the
population most likely to generate LMPT babies and its influence on the long-term development of
children born LMPT.
The impact of ethnicity and cultural beliefs was also seen across both streams of work. Increased rates of
stillbirth, LMPT birth and, through congenital anomalies, infant deaths have been demonstrated. Within
the LAMBS cohort, recruitment showed differential participation according to ethnic group. These findings
are probably mediated in a number of ways, including through decreased access to health-care resources,
language difficulties and the effects of consanguinity. We were, however, unable to explore the effects of
cultural and religious beliefs in these populations.
Key findings
Key issues that have emerged include:
1. There are widening socioeconomic inequalities in infant mortality. Approximately 70% of all infant
deaths are the result of either preterm birth or a major congenital abnormality. These causes explain
the majority of the deprivation gap.
2. Among women from the most deprived areas, the risk of preterm birth is double that of the least
deprived groups in society.
3. Although responsible for < 1% of all births, babies born before 24 weeks’ gestation account for
20% of infant mortality.
4. The recording of babies born before 24 weeks’ gestation as live births shows very marked differences
around the country, as if such babies subsequently die their deaths are registered. In contrast, babies
born dead at this gestation are not included at all in routine statistics.
5. Although rates of severe congenital anomalies in utero were similar across all deprivation groups, women
from the most deprived areas are significantly less likely to opt for termination than the least deprived,
resulting in a significantly greater number of babies born alive with a serious congenital anomaly in the
most deprived groups in society. The reason(s) for the differential rate of termination is not clear.
6. Risk of LMPT birth is greatest in the most deprived groups within society.
7. Compared with children born at term, babies born LMPT are at increased risk of poorer health and
developmental outcomes, particularly delayed cognitive and socioemotional development.
8. The risk of adverse outcomes of children born LMPT is amplified by socioeconomic factors, with the
greatest risk being for those born to the most deprived families.
9. Developmental surveillance and early intervention may be beneficial for LMPT infants at greatest risk,
including those born to mothers with high antenatal and social risk.
10. During the first 24 months of life, each child born LMPT generates approximately £3500 of additional
health and societal costs and around 40,000 such babies are born each year in the UK.
11. We identified significant differences in the average in-hospital costs generated by the two neonatal
services involved in this study while caring for LMPT babies.
DISCUSSION
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Patient and public involvement
Throughout the time that the programme of work was under way the team developed a range of alliances
in relation to PPI, and this enthusiastic involvement of patients and the public benefited our research
strongly. These were primarily:
1. A close working relationship with the national charities Bliss (‘for babies born too small, too soon,
too sick’) and SANDS.
2. A whole range of interactions with families from the large cohorts involved in the LAMBS. These
included face-to-face meetings in small groups, e-mail forums and a Facebook group.
In relation to this programme of work, the parents have been particularly helpful in planning interactions to
maximise follow-up. However, as results started to emerge they were also very helpful in planning and
supporting applications for further research, including the Research for Patient Benefit (RfPB)-funded LAMBS-II.
Our experiences of trying to engage with parents directly (as opposed to the charities, which could be
approached on a more structured basis) taught us that it was necessary to tailor our approach to meet
their needs. We thought we had done just that in our early attempts to meet small groups of parents.
However, it was only later, when meetings were arranged in soft-play centres that catered fully for the
needs of young children and their parents in a familiar, safe and relaxed setting, that we achieved the
higher numbers we were hoping for. It is our intention to continue to use this approach/setting in future
PPI engagement events and we have developed good links with these venues to support our future events.
We have experimented with the use of social media in an attempt to seek wider engagement but the
group attracted to this type of approach tended to be the better educated middle-class families rather than
those from the otherwise hard-to-reach groups we intended to target.
The work was disseminated to a lay audience through the incorporation of the findings of socioeconomic
inequalities in infant mortality into a series of Health Infancy Roadshows for parents held at children’s
centres aiming to convey the main risk factors for infant mortality to pregnant women and teenage
mothers living in deprived areas with high rates of infant mortality. Findings have also been disseminated
to a lay audience including interviews for television (‘Central News’ on BBC1), radio (including ‘The Today
Programme’ on BBC Radio 4; BBC Radio Leicester) and national newspapers (the Guardian, The Times and
the Mirror).
Limitations
We have highlighted methodological issues relating to the research in the relevant earlier sections.
However, the following points merit particular emphasis:
1. The results from the LAMBS cohort represent the earliest analysis from this aspect of the programme.
More detailed analysis has since been carried out.238
2. Maintaining high rates of follow-up in neonatal studies has been an increasing problem in the UK for
the last 10 years. Although the rates achieved here were acceptable, they were less than we would
have liked to have achieved and occurred despite the use of multiple methods of ascertainment. We
will subsequently publish a more detailed analysis of the potential impact on the findings of those
‘lost to follow-up’. It seems clear that parents are more likely to accept face-to-face ‘assessment’ with
feedback than questionnaire-based follow-up.
3. Despite the recurring theme of socioeconomic status in relation to both streams, it was only in relation
to the LAMBS cohort that individual-level data were available. The lack of individual data in the routine
data sources is likely to have reduced the size of the associations that were detected.
4. Given the large contribution of ethnic minorities to the population within the area in which the LAMBS
was conducted, our results may not be fully generalisable to all parts of the UK.
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The findings of one stream of work centred on improving understanding of routine statistics relating to
early childhood mortality rates and these results have already influenced some aspects of policy.
The various outcomes indicated that unadjusted figures, even for geographically defined populations,
needed guarded interpretation unless they were adjusted for key confounders. Some of the necessary
adjustments could be made relatively easily, for example by applying government area-level indices
of deprivation to adjust for ‘social mix’. However, variation in the practice of deciding whether the most
immature babies are born alive or dead is much more complex to deal with. These complexities are far
more testing when the population being considered is that from an individual trust, as opposed to a
geographically defined population, as the trust population will have been subject to a whole range of
biases related to not only geography but also the nature of its services. This makes ‘fair comparison’
to other apparently similar trusts very complex.
In 2012, a number of the original programme grant applicants successfully bid, as part of a co-operative,
to take on the work of the Healthcare Quality Improvement Partnership’s maternal, neonatal and infant
(mortality and morbidity) clinical outcome review programme (MNI-CORP). The relevant individuals lead on
the perinatal aspects of the work and have already modified the data set to facilitate adjustment for the
confounding influences identified by the work of the programme grant. It is intended in addition that
future reports of the MNI-CORP will focus on commissioning group populations rather than trusts,
although we acknowledge that initially both types of output will be required in order to provide some
continuity with previous work.
In relation to the LAMBS cohort, the early results have highlighted a number of important findings that will
almost certainly impact policy and practice in the next 3–5 years. In relation to decisions to deliver ‘at-risk
pregnancies’ at these gestations, early indications are that the outlook for most babies is good, but that
for some groups (we are currently focusing on those in which maternal hypertensive disease was the
reason for early delivery being considered) the chances of ‘developmental delay’ being present as the child
grows are increased. Hence the findings will be important to obstetricians managing women in which early
delivery is seen as a reasonable treatment option.
In the neonatal period the size of the LMPT population means that LMPT infants consume significant
resources either within the NNU or on the postnatal ward. It emerged from this study, which involved
primarily two large neonatal services, that there were very diverse approaches to management that led to
quite different patterns of resource use (the difference was significant). There are clearly important savings
that could be made from rationalising the care of these babies that will be informed by the results of
our studies.
It is in relation to the later development of these babies that probably the most important findings are
emerging. It appears that babies born to the most affluent families have a reduced risk of significant
developmental problems at 2 years of age compared with those babies born to mothers from more
deprived backgrounds. One approach to dealing with this finding would be to try to manage delivery
based on the mother’s socioeconomic status; however, this seems totally impractical. A more realistic option
would be to view such developmental delay as ‘preventable’ and to screen and instigate early intervention
in children at greatest risk for adverse outcomes. Although such an approach has largely failed in very
preterm children, we have identified that the pattern of behavioural difficulties in LMPT children appears to
be different. The findings from some intervention studies in more mature babies would suggest that such an
approach could alter the developmental trajectory of these children.
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Implications for practice
1. Continued exploration of socioeconomic inequalities in neonatal mortality and stillbirth would facilitate
greater understanding of associated socioeconomic inequalities in health, both nationally and at a
local level.
2. Commissioners and others responsible for clinical governance should be cautious when reviewing
unadjusted early-life mortality rates, particularly when these relate to individual trusts.
3. Monitoring of inequalities in infant mortality by specific cause in the future would be facilitated by
high-quality data collection at a national level.
4. When more sophisticated analysis is not possible, the exclusion of babies of < 24 weeks’ gestation from
routine analyses would be a sensible compromise.
5. Neonatal services should consider the care they offer to babies born LMPT to ensure that it is
appropriate to their needs and the risks that they face.
6. For women considering delivery of their baby at a LMPT gestation, evidence indicates that:
i. There is an increased risk of developmental problems, but that increased risk is very small.
ii. The risk of developmental problems appears to differ depending on the reason for LMPT delivery.
The nature of the developmental problems affecting these babies appears to be primarily cognitive,
social and emotional.
iii. The nature of the developmental problems seen in children born at LMPT gestations is different from
that seen in babies born very preterm and hence approaches to follow-up, assessment and support
need to reflect these differences.
Future research
As a result of this programme of work a range of new research questions emerged and funding to pursue
some of these has already been sought or is in place:
l Understanding the socioeconomic variation in termination rates following detection of a severe
congenital anomaly during pregnancy (University of Leicester PhD studentship). This will allow full
investigation of the variation identified here with the aim of making recommendations for appropriate
improvements in care.
l Understanding decision-making regarding the interpretation of signs of life at the limit of viability to
identify how to reduce variation in practice across the UK and inequalities in access to financial benefits
for parents (a funded NIHR Career Development fellowship).
l Longer-term follow-up of the LMPT cohort to determine how early cognitive and socioemotional
problems evolve over time and whether or not there is developmental plasticity in LMPT children.
This will also enable an assessment of whether delays in early socioemotional development manifest as
behaviour problems or peer relationship difficulties later in childhood.
l Evaluate the efficacy of early parenting interventions for improving cognitive and socioemotional
development in the LMPT population.
l Evaluating the efficacy and acceptability of developmental screening and follow-up in children born
LMPT (NIHR RfPB-funded study).
l Develop, implement and evaluate potential follow-up schemes for families and children born LMPT.
l Investigation of ways in which rates of premature birth can be prevented.
l Understanding obstetric decision-making regarding delivery at LMPT gestations.
l Investigation of the most appropriate approach to the neonatal care of babies born LMPT.
l Investigation of strategies to alter the developmental trajectory of at-risk LMPT children.
l Development of strategies to support breastfeeding in babies born LMPT.
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Appendix 1 The Late And Moderately preterm
Birth Study maternal interview
1.1 Surname 
1.2 First name 
1.3 Address 
1.4 Postcode 
LAMBS – Late And Moderately preterm Birth Study 
Maternal interview 
1. Personal Details 
1.7 NHS number 
1.8 Date of birth 1 9 / / Age OR 
1.6 Hospital number 
1.9 Height 
years 
1.10 Weight pre-pregnancy 
cm OR  in 
st lb kg OR 
Survey ID: 
. 
LAMBS Maternal Interview V 2  06 August 2009 
2.1 Surname 
2.2 First name 
2.3 Address 
2.4 Postcode 
2. Contact Details of Close Relave 
1.5 Telephone number 
2.5 Telephone number 
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3. Ethnicity 
3.1 In which country were you born?  
3.2 How long have you lived in the UK? 
3.3 What is your ethnic group? A1 Brish 
A2 Irish 
A3 Other White background 
B1 White and Black Caribbean 
B2 White and Black African 
B3 White and Asian 
B4 Other Mixed background 
C1 Indian 
C2 Pakistani 
C3 Bangladeshi 
C4 Other Asian background 
D1 Caribbean 
D2 African 
D3 Other Black background 
E1 Chinese 
E2 Other background 
A White 
B Mixed 
C Asian or Asian Brish 
D Black or Black Brish 
E Chinese or other ethnic group 
3.4 What language do you usually 
speak at home? 
4. Marital Status 
4.1 What is your marital status? 
Divorced 
Single, never married 
Married 
Separated 
Widowed 
Civil Partnership 
4.2 Were you living with someone as  
a couple during the majority of your 
pregnancy? 
No 
Yes 
years months 
Unsure 
Not disclosed by parcipant 
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5. Educaon 
5.1 How old were you when you 
completed connuous full me 
education? 
years 
5.2 Now, thinking about all the 
qualiﬁcations you may have, from 
this list please tell me the highest 
qualiﬁcations which you have 
obtained 
 
Highest qualiﬁcaon overall, not just 
those from any recent courses.  
Please enter code from ﬂash card 
Please enter further details in box below if necessary 
6. Occupaon 
6.1 Please look at this card and tell 
me which best describes your 
situation during your pregnancy: 
 If self-employed/employed or on 
maternity leave:  
 6.2 What was the full tle of your 
main job? 
 
Please enter code from ﬂash card 
6.4 How many employees did you 
care for? 
 
6.5 Was this your only job? 
 
No 
Yes If No:  
 6.6 Did you have two or more jobs at 
the same me? 
 
No 
Yes 
6.7 Did you change jobs during your 
pregnancy? 
 
6.8 During which months of your 
pregnancy did you work? 
 
1 2 3 4 5 6 7 8 9 
6.9 In which month of pregnancy did 
you plan to give up work? 
 6.10 Did you ﬁnish earlier than 
expected for reasons relang to your 
pregnancy? 
 
No 
Yes 
6.11 What  was the reason? 
 
More than one change 
One change 
No 
weeks  gestation 
6A. Occupaon During  this Pregnancy 
6.3 Were you a manager? 
 
No 
Yes 
If yes: 
If yes: 
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The next quesons are about your hours of work. 
6.12 In the weeks before you ﬁnished work, how many hours, including overme, did you usually 
work on average each week? (Month-by-month, if possible) 
6B. Hours of Work 
Less than 15 
15 to less than 30 
30 to less than 40 
40 and over 1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
6.13 Did you reduce your hours for 
reasons relang to your pregnancy? 
 
No 
Yes 
6.15 Did you do shi work in your 
main job? 
 
6C. Working Condions 
The next quesons are about your working condions: 
6.14 what was the reason? 
 
Occasionally 
Most of the me 
Never 
6.16 Did you ever work night shis? 
 Occasionally 
Most of the me 
Never 
In your work: 
 
6.17 Did you usually stand for more 
than 3 hours per day? 
 
No 
Yes 
6.18 Did you work on an assembly 
line? 
 
No 
Yes 
6.19 Did your work involve heavy 
liing? (carrying loads of 20lb/10kg 
or more) 
 
No 
Yes 
6.20 Did your work involve 
strenuous physical acvity? 
 
No 
Yes 
If yes:  
If yes: 
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6.21 Did your work involve any direct 
contact with: 
Please ck all that apply 
 
Solvents 
Glues/adhesives 
Cleaning agents 
Paint spraying 
Colour mixing soluons 
Other chemicals 
6.22 Did you ﬁnd your work boring? 
 
No 
Yes 
6.23 Was your workplace: 
Please ck one from each category 
Temperature 
 
Noise 
 
Cleanliness 
 Cold 
Warm 
Hot 
Very Hot 
Variable 
Quiet 
Background noise 
Noisy 
Very noisy 
Clean 
Dirty 
Very dirty 
7. Income and Living Condions 
With regard to your ﬁnancial and home situation: 
7.1 How well would you say you are 
managing ﬁnancially these days? 
 
Please enter code from ﬂash card 
7.2 Do you (or your partner) receive 
any of the following tax credits or 
beneﬁts? 
Please ck all that apply 
 
Income Support 
Employment and support allowance 
Housing beneﬁt 
Council tax beneﬁt 
Jobseekers allowance 
Working tax credit 
Severe disablement allowance 
Child tax credit 
Disability premium 
Maternity allowance 
Statutory maternity pay 
Surestart maternity grant 
7.3 How many cars or vans are 
owned or available for use by one or 
more members of your household? 
(include any company car or van if 
available for private use) 
 
7.4 Does your household own or rent 
the accommodation? 
Please ck one box only 
 
Owns outright 
Owns with a mortgage or loan 
Pays part rent and part mortgage 
Rents 
Lives rent free 
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8. General Health 
8.1 Please think back over the last 
12 months about how your health 
has been.  Compared to people of 
your own age, would you say that 
your health has on the whole been: 
 
Excellent 
Good 
Fair 
Poor 
Very poor 
8.2 Please indicate which statements 
best describe your own health state 
before you became pregnant: 
 
Please enter code from ﬂash card: 
Mobility 
Self-care 
Usual acvies 
Pain/discomfort 
Anxiety/depression 
8.5 When did you last visit the 
denst? 
 
8.4 How oen do you generally visit 
the denst? 
 Within the last 6 months 
6-12 months ago 
>12 months ago 
9. Family History 
Do you have any family history of the 
following: 
 
No 
Yes (please specify) 
No 
Yes (please specify) 
9.1 Major congenital anomalies in 1st 
degree relave? 
 
9.2 Babies that have died within the 
ﬁrst 6 months of life? 
 
9.3 Are your family and your baby’s 
father’s family related in any way 
prior to marriage? 
 
No 
Yes 
8.3 Do you have any chronic health 
problems?  
(eg. Asthma, thyroid problems, 
epilepsy, etc) 
 
 
No 
Yes (please specify) 
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10. Past Obstetric History 
10.1 Was this your ﬁrst pregnancy? No 
Yes 
10.2 How long is it since your last 
pregnancy? 
(Give date of birth or terminaon of 
last pregnancy) 
/ / 
10.4 Have you ever received 
treatment for inferlity? 
No 
Yes 
10.5 If yes, what type of treatment 
was this? 
Ovulaon Inducon 
Intrauterine Inseminaon (IUI) 
Donor Inseminaon (DI) 
In vitro Ferlisaon (IVF) Own eggs 
Donor eggs 
Intracytoplasmic Sperm 
Injecon (ICSI) 
Own eggs 
Donor eggs 
Reversal of Sterilisaon 
10.6 Was this pregnancy a result of 
inferlity treatment? 
No 
Yes 
11. This Pregnancy 
11A. Antenatal Care 
11.1 Was this pregnancy planned? No 
Yes 
11.2 How many weeks pregnant were 
you when you ﬁrst contacted your 
midwife or doctor about this 
pregnancy? 
weeks 
11.3 During this pregnancy, were 
most of your antenatal appointments 
with: 
GP 
Midwife 
Hospital 
Unspeciﬁed 
Clomiphene 
FSH 
Other  (please specify) 
Unspeciﬁed 
Unspeciﬁed 
Other (please specify) 
Partner’s sperm 
Donor sperm 
Unspeciﬁed 
(if No, then go to Secon 11) 
If No: 
10.6 Have you had any babies 
prematurely in the past? 
No 
Yes (please enter gestaon(s)) 
10.3 Have you ever had any 
treatment to your cervix? 
No 
Yes 
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11B. Sexual History 
11.4 Once you realised you were 
pregnant, did you have vaginal 
intercourse during your pregnancy? 
No 
Yes 
11.5 During which months of your 
pregnancy did this connue? 1 2 3 4 5 6 7 8 9 
11.7 Did you stop for any of the 
following reasons?  
Please ck all that apply 
Pain 
Bleeding 
On medical advice 
Other (please specify) 
11C. Medicaons During Pregnancy 
11.8 What tablets, medications, ointments or creams did you use during pregnancy (excluding beauty 
products)? 
For each drug ask: 
1. When did you take this? 
2. Was this prescribed for you? Prescibed 
 No Yes 
1 2 3 4 5 6 7 8 9  a. Iron 
 b. Folic acid 
 c. 
 d. 
 e. 
 f. 
 g. 
 h. 
 j. 
 i. 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
Month of pregnancy 
 
11.6 Did you stop at any point? No 
Yes 
If yes: 
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11.9 Did you take any recreaonal 
drugs during your pregnancy  
(eg. Ecstasy, crack, cocaine, heroin, 
LSD, amphetamines, cannabis, other) 
No 
Yes 
If yes, what did you take and when 
did you take these? 
 a.  
 b.  
 c. 
 d. 
 e. 
 f. 
 g. 
 h. 
 j. 
 i. 
1 2 3 4 5 6 7 8 9 
Month of pregnancy 
 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
11D. Tobacco 
11.10 Have you ever smoked as much 
as one cigaree a day for as long as a 
year? 
No 
Yes 
11.11 Between the date of your last 
menstrual period and your delivery, 
did you smoke as much as one 
cigaree per day? 
No 
Yes 
11.12 During which months of your 
pregnancy? 
1 2 3 4 5 6 7 8 9 
Show Flash card to indicate names and types of drugs 
If yes: 
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11.13 On average, how many 
cigarees (or equivalent) per day 
each month during your pregnancy? 
One small cigar = 2 cigarees 
One large cigar = 3 cigarees 
1oz pipe tobacco = 28 cigarees 
Month  
 
No of cigarees  
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
11.14 Have you ever chewed as much 
as one betel nut/quid/paan per day 
for as long as a year? 
No 
Yes 
11.15 Between the date of your last 
menstrual period and your delivery, 
did you chew as much as one betel 
nut/quid/paan per day? 
No 
Yes 
11.16 During which months of your 
pregnancy? 
1 2 3 4 5 6 7 8 9 
11.17 Was this: With tobacco 
Without tobacco 
Both with and without tobacco 
Not known 
If yes,  
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11E. Alcohol 
11.18 Do you ever drink alcohol? 
Don’t forget special occasions; include 
home-brewed beer or wine etc. 
11.19 Did you drink at all during this 
pregnancy? 
Don’t forget special occasions; include 
home-brewed beer or wine etc. 
No 
Yes 
11.20 During which months of your 
pregnancy? 1 2 3 4 5 6 7 8 9 
Month of pregnancy 
 
11.21 Approximately how many units 
per week did you drink during each 
month?  
Show ﬂash card to illustrate units 
Month  
 
Units 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
No 
Yes 
11.22 Did you drink more than 5 
units per day? 
Never 
Less than once per month 
1-2days per month 
1-2 days per week 
3-4 days per week 
5 or more days per week 
If yes:  
DOI: 10.3310/pgfar04010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 1
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Field et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
179
11F. Diet 
11.23 Would you describe yourself 
as a vegetarian? 
No 
Yes 
11.24 Are you a vegan? No 
Yes 
Never Less than 
once/month 
1-2 days 
/month 
1-2 days 
/week 
3-4 days 
/week 
5 or more 
days/week 
11.26 How many days a week , on 
average , during your pregnancy did 
you eat the following types of food? 
Please ck all that apply 
11.27 Fresh fruit 
11.28 Fresh vegetables or salad 
vegetables 
11.29 Oily ﬁsh (salmon, mackerel, 
trout etc) 
11.30 Red meat (beef, lamb) 
11.31 In the past 12 months have 
you personally been forced to buy 
cheaper food so that you could pay 
for other things you needed? 
No 
Yes 
11.32 How many days a week on 
average do you have 5 porons of 
fruit or vegetables? 
11.33 In the past 12 months have you 
personally gone without fruit and 
vegetables oen so that you could 
pay for the things you needed? 
No 
Yes 
11.25 Do you ever eat: 
Please ck all that apply 
Meat 
Fish 
Animal products eg milk, cheese 
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11G. Caﬀeine 
During your pregnancy how many 
mes each day, on average, did you 
consume the following? 
11.34 Freshly brewed coﬀee (not decaf) 
11.35 Instant coﬀee (not decaf) 
11.36 Tea (not fruit, herbal or decaf) 
11.37 Hot chocolate 
11.38 Cola (regular or diet) 
11.39 Energy drinks (eg Red Bull) 
11.40 Bar of chocolate 
11.41 ‘Over the counter’ medications 
containing caﬀeine (eg ProPlus) 
Never Less than 
1/day 
1 2-3 3-4 4-5 >5 
11H. Stress 
The following questions are about stressful events that can happen at any me. Please could you tell 
me if any of the following events or problems happened to you during your pregnancy?   
(Please ascertain months in queson) 
11.42 Did you suﬀer a serious illness, 
injury or assault? 
1 2 3 4 5 6 7 8 9 
11.43 Did close relaves suﬀer a 
serious illness, injury or assault? 
11.44 Did a close family member die? 
11.45 Did you have a separaon from 
your husband/partner due to 
relaonship diﬃcules? 
11.46 Did you have a serious 
problem with a relave, close friend 
or neighbour? 
11.47 Were you sacked or made 
redundant from your place of work 
or unsuccessful in seeking 
employment? 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
DOI: 10.3310/pgfar04010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 1
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Field et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
181
11.52 Midwife’s inials  
11.53 Midwife’s 
notes/comments:  
11.48 Did you have a major ﬁnancial 
crisis? 
11.49 Was something you valued lost 
or stolen? 
11.50 Did you have any other sort of 
crisis? (Emergency situaon, problems 
with police etc) 
11.51 Is there anything else that 
happened during your pregnancy 
that you felt was relevant? (House 
move etc) 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 6 7 8 9 
Please specify: 
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Appendix 2 The Late And Moderately preterm
Birth Study 6-month questionnaire
LAMBS — Late And Moderate preterm Birth Study
Parent Questionnaire at 6 months
Your baby’s details
Your baby’s first name Your baby’s surname or family name
Address
Postcode
If your baby’s name or address is different from those shown on the enclosed letter, 
please enter the correct information below.
Your baby’s date of birth (dd/mm/yyyy)
/ /
Your details
Your name
Your relationship to the baby (e.g. mother, father)
Date questionnaire completed (dd/mm/yyyy)
/ /
This questionnaire contains nine questions about your baby at 6 months of age.
Any personally identifiable information you tell us will not be passed on to any third party, 
or used for any purpose other than contacting you about the study.
If you would prefer to answer the questions by telephone, or you 
require any help with completing this questionnaire, please phone us 
on 0116 252 5456 or email lambs@leicester.ac.uk
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1. Routine health care
This question is about routine visits to your GP or health visitor for normal health care, 
not because your baby is unwell.
2. Additional health care
Have you taken your baby for any of the following routine health care appointments 
since discharge from hospital after birth, and if so, how many times?
Routine appointment Attended? If yes, how many times?
Routine 6-week check
Routine immunisations
Routine weight check
Routine Health Visitor visit
NoYes
NoYes
NoYes
NoYes
—
This question is about other contact with health professionals that is not listed above.
Has your baby used any of the following types of additional health care since discharge from 
hospital after birth, and if so, how many times?
GP or Practice Nurse appointments because of illness NoYes
Type of additional health care Used? If yes, how many times?
Hospital Accident and Emergency department (A&E) NoYes
Hospital outpatients clinic NoYes
Admission to hospital or children’s day care unit NoYes
Community paediatrician NoYes
Physiotherapy NoYes
Community nurse NoYes
Walk-in health care centre NoYes
Telephone call to NHS Direct (0845 4647) NoYes
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Has your baby been admitted to hospital as a day patient or as an in-patient since discharge 
from hospital after birth?
3. Hospital admissions and operations
Yes – please list your baby’s hospital admissions below
No – go to next question
4. Medicines and drugs
Has your baby been prescribed any medicines or drugs since discharge from hospital after 
birth?
Yes – please list your baby’s prescribed medicines and drugs below
No – go to next question
If you know the dose, please enter this next to the name of the medication
If your baby had an operation, please state the type of operation under reason for admission
Name of hospital
(specify ward if known) Reason for admission
Number 
of nights
Name of medication Number of days medication taken
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Has your baby’s health meant that you or your partner have had to take time off work, 
or been unable to work since your baby’s discharge from hospital after birth?
5. Time off work
Yes – please complete the following information about you and your partner
No – go to next question
How many days have you taken off work because of your baby’s health?
What is your current occupation?
How many hours do you usually work in a week?
What is your estimated loss of earnings (£)?
How many days has your partner taken off work because of your baby’s health?
What is your partner’s current occupation?
How many hours does your partner usually work in a week?
What is your partner’s estimated loss of earnings (£)?
If you do not have a current partner, please go to the next question
You
Your partner
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Has your baby’s health meant that you have bought, hired or been provided with 
any special equipment since your baby’s discharge from hospital after birth?
6. Special equipment
Yes – please list the equipment below
No – go to next question
For each item, please state whether it was borrowed, bought or hired. If the equipment 
was borrowed, tell us who it was borrowed from (e.g., hospital, local authority, friends). 
If it was bought or hired, indicate approximately how much the equipment cost you.
Has your baby’s health meant that you have had any changes made to your home 
since your baby’s discharge from hospital after birth?
7. Changes to your home
Yes – please list the changes below
No – go to next question
Examples of special equipment include special feeding equipment, portable nebulizer, 
oxygen equipment
Who provided or paid for it?Type of special equipment Approximate cost to you (£)
Who paid for it?Type of change to your home Approximate cost to you (£)
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Has your baby’s health meant that you or your family spend extra money on everyday outgoings?
8. Other costs
Yes – please list the additional costs below
No – go to next question
Food or milk NoYes
Item Extra money required?
Additional
cost (£)
Cost of visiting hospital or GP NoYes
Child care NoYes
Help with housework NoYes
Telephone bills NoYes
Utility bills NoYes
Therapies for baby NoYes
Other expenses (please specify) NoYes
This does not include expected costs, only extra costs that you have incurred as a result of 
your baby’s health. For example, you may have had to buy a special formula milk.
For each item, please estimate the additional cost incurred since your baby’s discharge 
from hospital after birth. For example, for Telephone Bills, this would mean the cost of 
the extra calls to the doctor, not your total bill.
Is there anything else that you would like to tell us about your baby’s health since his or her 
discharge from hospital after birth, or about your family situation? If so, please give details.
9. Any other information
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Thank you for completing this questionnaire.
Please return it to us in the Freepost envelope provided. No stamp is required.
As part of the LAMBS follow-up, we will send you another questionnaire when your baby 
is 12 months old. We hope that you will continue to participate in this study to help to 
provide us with information for the future care of babies.
Thank you
If you would like to know more about LAMBS, or you need any help with completing this 
questionnaire, please telephone us on 0116 252 5456 or email lambs@leicester.ac.uk
Or you can write to us at:
Department of Health Sciences
University of Leicester
22-28 Princess Road West
LEICESTER
LE1 6TP
Contact us
About LAMBS
LAMBS is a population-based study on late and moderately preterm birth (babies born at 
32 to 36 weeks of pregnancy). These babies make up 6 to 7 per cent of all births in the UK 
and 75% of all preterm births.
The study aims to identify risk factors contributing to preterm delivery of babies born in 
Leicestershire and Nottinghamshire, and to provide information about the short- and 
long-term outcomes of babies born at this preterm gestation.
This knowledge is important to highlight areas where changes in care around the time of 
birth and in early life may improve babies' outcomes.  We also hope to learn more about 
what sorts of health and educational support is needed for children and young adults with 
problems.
LAMBS is funded by the National Institute for Health Research and is sponsored by the 
University Hospitals of Leicester NHS Trust.
LAMBS is one of The Infant Mortality & Morbidity Studies (TIMMS), a collaborative group of 
national and regional research projects based at the University of Leicester. For more 
information, visit our website:
www.le.ac.uk/timms
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Appendix 3 The Late And Moderately preterm
Birth Study 12-month questionnaire
LAMBS — Late And Moderate preterm Birth Study
Parent Questionnaire covering from 7-12 months
This questionnaire contains eleven questions about you and your baby’s health and 
development during the past 6 months.
If you would prefer to answer the 
questions by telephone, or you 
require any help with completing this 
questionnaire, please phone us on 
0116 252 5456 or email 
lambs@leicester.ac.uk
[sticker placeholder]
Any personal information you tell us will not be passed on to any third party, or used 
for any purpose other than contacting you about the study.
The majority of these questions are tick-box format, so the questionnaire will probably  only 
take you about 10 minutes to complete.
Your name
Your relationship to the baby (e.g. mother, father)
Date questionnaire completed (dd/mm/yyyy)
/ /
Your baby’s details
Your baby’s first name Your baby’s surname or family name
Your address
Postcode
We just want to check that we have your names spelt correctly, and that our contact 
information is up to date.
Your telephone number:
Your email address:
Landline: Mobile:
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1. Your baby’s development
We’d like to know how your baby’s skills are developing. All babies progress at different rates, 
and how well your baby is doing now won’t necessarily reflect how well he or she continues to 
do in the future.
Please tick the relevant box to answer the questions below about your baby’s current abilities.
Question
Can your baby control his or her head movements?
Can your baby sit up on his or her own, without any support?
Can your baby pick up objects with his or her right hand?
Yes No Don’t
know
Can your baby use both hands to hold onto a big object (e.g. a cup)?
Can your baby pick up objects with his or her left hand?
Can your baby pull him or herself up from sitting to a standing
position?
Can your baby walk more than 10 steps without any support
(i.e. without holding on to anyone or anything)?
Can your baby walk around furniture if he or she is holding on to it?
Does your baby make any babbling sounds – noises that sound like
speech (e.g “Da-da”, “Ma-ma-ma” etc)?
Does your baby say any words yet?
If yes, please give an example of the sort of words your baby uses
If yes, please give details
Do you think that your baby has any difficulties with his or her vision?
If yes, please give details
Do you think that your baby has any difficulties with his or her vision?
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2. Routine health care
This question is about routine visits to your GP or health visitor for normal health care, not 
because your baby is unwell.
We are looking at whether the number or type of appointments varies across the study area, and 
whether the babies born early are asked to attend more routine appointments to monitor them.
Have you taken your baby for any of the following routine health care appointments 
since MONTH, YEAR, and if so, how many times?
Routine appointment
How many times?
Routine immunisations
Routine weight check
Routine Health Visitor appointment
0 1-5 6-10 11-15 More than 15
Routine hearing/developmental check-up 
3. Additional health care
This question is about other contact with health professionals that is not listed above.
We’re using this information to look at whether babies born early need to use local health 
services more than their term counterparts.
Has your baby used any of the following types of additional health care since MONTH, YEAR, 
and if so, how many times?
GP or Practice Nurse appointments because of illness
Type of additional health care
How many times?
Hospital Accident and Emergency department (A&E)
Hospital outpatients clinic
Admission to hospital or children’s day care unit
Community paediatrician
Physiotherapy
Community nurse
Walk-in health care centre
Telephone call to NHS Direct (0845 4647)
0 1-5 6-10 11-15 More than 15
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If you know the dose, please enter this next to the name of the medication. If the medication
is ongoing or ‘as necessary’, please enter the date that the medication was given to you.
4. Medicines and drugs
Has your baby taken any medicines or drugs (that have been prescribed to them by a doctor) 
since MONTH?
Yes – please list your baby’s prescribed medicines and drugs below
No – go to next question
Name of medication Number of days or start date
Has your baby’s health meant that you have bought, hired or been provided with any more or 
different special equipment since MONTH, YEAR?
6. Special equipment
Yes – please list the equipment below
No – go to next question
For each item, please state whether it was borrowed, bought or hired. If the equipment 
was borrowed, tell us who it was borrowed from (e.g., hospital, local authority, friends). 
If it was bought or hired, please indicate approximately how much the equipment cost 
you.
Examples of special equipment include special feeding equipment, portable nebulizer, 
oxygen equipment
Who provided or paid for it?Type of special equipment Approximate cost to you (£)
Has your baby been admitted to hospital as a day patient or as an in-patient since MONTH, 
YEAR?
5. Hospital admissions and operations
Yes – please list your baby’s hospital admissions below
No – go to next question
If your baby had an operation, please state the type of operation under reason for admission
Name of hospital
(specify ward if known) Reason for admission (since MONTH, YEAR)
Number 
of nights
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Having to make alterations to your house is a huge upheaval, so we’d like to know if your baby’s 
health has affected you in this way.
Has your baby’s health meant that you have had any more or different changes made to your 
home since MONTH, YEAR?
7. Changes to your home
Yes – please list the changes below
No – go to next question
Who paid for it?Type of change to your home Approximate cost to you (£)
Has your baby’s health meant that you or your family spend extra money on everyday outgoings?
8. Other costs
Yes – please list the additional costs below
No – go to next question
Food or milk NoYes
Item Extra money required?
Additional
cost (£)
Cost of visiting hospital or GP NoYes
Child care NoYes
Help with housework NoYes
Telephone bills NoYes
Utility bills NoYes
Therapies for baby NoYes
Other expenses (please specify) NoYes
This does not include the expected costs of having a baby at home, only extra money that 
you have needed to spend because your baby has been ill or had some special need. For 
example, you may have had to leave other children with a minder for longer than normal so 
that you could take your baby to hospital.
For each item, please estimate the extra costs that you have had since MONTH, YEAR. 
For example, for Telephone Bills, this would mean the cost of the extra calls to the doctor, 
not your total bill.
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Has your baby’s health meant that you or your partner have had to take time off work, 
or been unable to work since MONTH, YEAR?
9. Your work
Yes – please complete the following information about you and your partner
No – go to next question
How many days have you taken off work because of your baby’s health?
What is your occupation at present?
How many hours do you usually work in a week?
What is your estimated loss of earnings (£)?
How many days has your partner taken off work because of your baby’s health?
If you have a current partner, what is their occupation at present?
How many hours does your partner usually work in a week?
What is your partner’s estimated loss of earnings (£)?
If you do not have a current partner, please go to the next question
We are interested in how much of a financial impact your baby’s health has on you and your 
family. 
We are asking about your current occupation and working patterns in order to find out if, 
perhaps, parents would benefit from more out-of-hours medical services being available.
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10. Your general health
You may remember that when your baby was born we asked you some questions about your 
health before the pregnancy.
I have no problems walking about
Mobility
I have some problems walking about
I am confined to bed
Please use the tick boxes below to indicate which of the three statements in each group best 
describe how you feel about your health at the moment.
I have no problems washing and dressing myself
Self-care
I have some problems washing and dressing myself
I am not able to wash or dress myself
I have no problems going about my usual activities
Usual activities
I have some problems going about my usual activities
I am not able to perform my usual activities
I do not suffer from pain or discomfort
Pain or discomfort
I suffer from a moderate amount of pain or discomfort
I suffer from extreme pain or discomfort
I am not anxious or depressed
Anxiety or depression
I am moderately anxious or depressed
I am extremely anxious or depressed
Is there anything else that you would like to tell us about your baby’s health since MONTH, 
YEAR, or about your family situation? If so, please give details.
11. Any other information
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LAMBS 7-12 month parent questionnaire · v1 · August 2010
FSC 
logo 
place-
holder
If you would like to know more about LAMBS, or you need any help with completing this 
questionnaire, please telephone us on 0116 252 5456 or email lambs@leicester.ac.uk
Contact us
About LAMBS
LAMBS is a population-based study on late and moderately preterm birth (babies born at 
32 to 36 weeks of pregnancy). These babies make up 6 to 7 per cent of all births in the UK 
and 75% of all preterm births.
The study aims to identify risk factors contributing to preterm delivery of babies born in 
Leicestershire and Nottinghamshire, and to provide information about the short- and 
long-term outcomes of babies born at this preterm gestation.
This knowledge is important to highlight areas where changes in care around the time of 
birth and in early life may improve babies' outcomes.  We also hope to learn more about 
what sorts of health and educational support is needed for children and young adults with 
problems.
LAMBS is funded by the National Institute for Health Research and is sponsored by the 
University Hospitals of Leicester NHS Trust
LAMBS is one of The Infant Mortality & Morbidity Studies (TIMMS), a collaborative group of 
national and regional research projects based at the University of Leicester. For more 
information, visit out website:
www.le.ac.uk/timms
Thank you for completing this questionnaire.
Please return it to us in the Freepost envelope provided. No stamp is required.
Thank you
We will be in contact again with a LAMBS update when your baby is 18 months old. The next 
questionnaire will be sent when your baby is 2 years old. This will be particularly important 
as it will concentrate mainly on your baby’s health and development. We hope that you will 
continue to participate in this study to help to provide us with information for the future care 
of babies.
Or you can write to us at:
Department of Health Sciences
University of Leicester
22-28 Princess Road West
LEICESTER
LE1 6TP
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Appendix 4 The Late And Moderately preterm
Birth Study obstetric data collection form
1.1 Surname 
1.2 First name 
1.3 Address 
1.4 Postcode 
LAMBS – Late And Moderately preterm Birth Study 
Maternal Data Collecon 
 MATERNAL DATA 
1.6 NHS number 
1.7 Date of birth 1 9 / / Age OR 
1.5 Hospital number 
years 
Survey ID: 
1. Mother’s Details 
A1 Brish 
A2 Irish 
A3 Other White background  
B1 White and Black Caribbea n 
B2 White and Black African  
B3 White and Asian 
B4 Other Mixed background  
C1 Indian 
C2 Pakistani 
C3 Bangladeshi 
C4 Other Asian background 
D1 Caribbean 
D2 African 
D3 Other Black background  
E1 Chinese 
E2 Other background 
A White 
B Mixed 
C Asian or Asian Brish  
D Black or Black Brish  
E Chinese or other ethnic group 
1.8 Ethnicity 
LAMBS Maternal Data Collecon V 1  06 August 2009 Unsure 
Not disclosed by parcipant 
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2. General Medical History 
2.1 Does the mother suﬀer from any 
chronic condions (diagnosed prior 
to this pregnancy)?   
Please ck all that apply Other  (specify)  
Diabetes  
Hypertension  
Autoimmune Disorder  
Using the convenon (live births + sllbirths ) + (aborons), write the number of such births the 
woman has had, including this pregnancy (eg. 4 + 2)  NB. Please count births not pregnancies. 
3.1 Number of live births and 
sllbirths including this pregnancy 
+ 
3.2 Number of spontaneous aborons 
3.3 Number of medical terminations 
of pregnancy 
3.4 Number of preterm births 
1.9 Name of GP 
1.10 Address 
1.11 Postcode 
3. Past Obstetric History 
2.2 Has the mother had any 
treatment to the cervix in the past? 
Yes 
No 
Other  (specify)  
Laser  
Cone biopsy  
Not known  
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4. This Pregnancy 
4.1 Date of booking 2 0 / / 
4.2 Height at booking 
4.3 Weight at booking 
cm OR  in 
st lb kg OR . 
4.4 BMI at booking 
4.5 Haemoglobin at booking g/dl . 
4.6 Number of reviews by a doctor 
or midwife (excluding scans) 
4.7 Expected date of delivery: 
 
 
2 0 / / By dang scan: 
By Dates: 2 0 / / 
4.8 Was an ultrasound dang 
scan performed? 
No 
Yes 
4.9 Was an ultrasound 
anomaly scan performed? 
No 
Yes 
4.11 Ultrasound scan ﬁndings: 
Major anomalies(please specify)  
Fetal growth restricon  
Minor anomalies (please specify)  
Other (please specify)  
4.10 Was a nuchal scan 
performed? 
No 
Yes 
4A. Booking 
4B. Ultrasound Scans 
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4C. Amniocentesis / Chorionic Villous Sampling 
4.12 Was amniocentesis performed? No  
Yes, due to maternal age  
Yes, suspected chromosomal anomaly  
Yes, suspected other anomaly  
Yes, other (please specify)  
4.13 Result of amniocentesis: 
4.15 Were antenatal corticosteroids 
given? 
No  
Not known  
Complete course  
Incomplete course  
Mulple courses  
4.16 Date and me of last antenatal 
corcosteroid course: 2 0 / / : 
Normal  
Major abnormality (please specify)  
Minor abnormality (please specify)  
4.17 Were antenatal dopplers 
measured? 
No  
Yes  
Not known  
4.18 Date of last measurement: 2 0 / / 
4.19 Result: Normal  
Absent end diastolic ﬂow  
Reversed end diastolic ﬂow  
4.14 Was CVS performed? No 
Yes Normal  
Abnormal (please specify)  
4E. Antenatal Dopplers 
4D. Antenatal Steroids 
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In the week prior to delivery did the mother receive any of the following drugs? 
No  
Yes  
Not known  
4.20 Anbiocs (not including cover 
for LSCS) 
No  
Yes  
Not known  
4.21 Tocolycs 
No  
Yes  
Not known  
4.22 Anhypertensives 
No  
Yes  
Not known  
4.23 Andepressants 
No  
Yes  
Not known  
4.24 Regular opiates (excluding those 
given in labour) 
No  
Yes  
Not known  
4.25 Recreaonal drugs 
4.26 Other drugs (please specify) 
Were any of the following present between 23+0 weeks of gestaon and delivery? 
Yes (please specify organisms; indicate weeks in grid below)  
No  
Not known  
23 24 25 26 27 28 29 30 31 32 
33 34 35 36 37 38 39 40 41 42 
4.27 Systemic infecon (+ve blood 
culture) 
4F. Drugs During Pregnancy 
4G. Pregnancy Complicaons 
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4.29 Urinary tract infecon (+ve MSU) 
4.28 Genital infecon (+ve vaginal 
swab) 
Yes (please specify organisms; indicate weeks in grid below)  
No  
Not known  
23 24 25 26 27 28 29 30 31 32 
33 34 35 36 37 38 39 40 41 42 
Yes (please specify organisms; indicate weeks in grid below)  
No  
Not known  
23 24 25 26 27 28 29 30 31 32 
33 34 35 36 37 38 39 40 41 42 
4.30 Proteinuric hypertension 
Yes (please indicate weeks in grid below)  
Yes  
Not known  
23 24 25 26 27 28 29 30 31 32 
33 34 35 36 37 38 39 40 41 42 
4.31 Fetal growth restricon (<10th 
cenle) 
No  
Yes  
Not known  
4.32 Pre-labour rupture of 
membranes 
No  
No  
2 0 / / 
Not known  
4.33 Gestaonal diabetes No  
Yes  
Not known  
4.34 Other condions developing 
during this pregnancy 
No 
Yes (please specify) 
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5. Labour and Delivery 
5.1 Was delivery preceded by 
labour? (any contracons including 
niggling. ie. Health Professional felt 
contracons) 
No 
Yes 
Not known  
Were any of the following present 
during labour: 
5.2 Spontaneous rupture of 
membranes Yes >24 hours before delivery 
Yes ≤24 hours before delivery 
No 
5.3 Evidence of maternal infecon: 
5.4 Abnormal fetal scalp pH 
No 
Yes 
Not known 
Maternal fever     
No 
Not known 
Yes 
Raised maternal CRP 
No 
Yes 
Not monitored 
Not known 
5.5 Meconium stained liquor No 
Yes 
Not known 
5.6 CTG abnormality  
Please ck all that apply  Fetal tachycardia  
Early deceleraons in fetal heart rate  
Late deceleraons in fetal heart rate  
Sustained fetal bradycardia  
Other (please specify) 
None 
5.7 Cord prolapse No 
Yes 
5.9 Was labour induced? 
Fetal compromise  (please specify) 
No 
Maternal compromise  (please specify) 
Maternal choice  (please specify) 
Other (please specify) 
Yes 
Not known 
. Temperature 
Variable deceleraons in fetal heart rate  
Post dates 
5.8 Other fetal or maternal 
complication (please specify) 
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5.10 Length of labour : First stage 
: Second stage 
5.11 Time between membrane 
rupture and delivery (indicate 
shortest me: 
At delivery 
<24 hours 
<48 hours 
<96 hours 
<1 week 
≥1 week 
5.12 Place of delivery Leicester Royal Inﬁrmary 
Leicester General Hospital 
Queens Campus NUH 
City Campus NUH 
St Mary’s Hospital Melton 
Other (please specify) 
5.13 Intended place of delivery Leicester Royal Inﬁrmary 
Leicester General Hospital 
Queens  Campus NUH 
City Campus NUH 
St Mary’s Hospital Melton 
Other (please specify) 
5.14 Method of delivery Spontaneous vaginal 
Forceps 
Ventouse 
Assisted breech 
Caesarean secon labouring 
Caesarean secon not in labour 
Not known 
Home 
Home 
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5.15 Indicaon for caesarean secon: 
Fetal compromise (please specify) 
Maternal compromise (please specify) 
Maternal choice (please specify) 
Other (please specify) 
Not known 
Previous CS 
5.16 Caesarean secon performed 
with:  
5.18 Cord bloods  Tick if cord bloods not done 
Tick if source of blood gases not known 
. 
Arterial 
. 
pH 
mbe 
pCO2 
pO2 
. 
. 
. 
Venous 
. 
. 
. 
5.17 Infant condion at birth: 
Apgar score at 1 minute 
Apgar score at 5 minutes 
5.19 Midwife’s inials  
5.20 Midwife’s notes/comments:  
Epidural anaesthec 
Spinal block 
Not known 
General anaesthec 
Epi-spinal 
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Appendix 5 The Late And Moderately preterm
Birth Study neonatal data collection form
1.1  Surname 
1.2  First name 
1.3  Address 
1.4  Postcode 
LAMBS – Late And Moderately preterm Birth Study 
Neonatal Data Collecon 
 MATERNAL DATA 
1.6  NHS number 
1.7  Date of birth 1 9 / / Age OR 
1.5  Hospital number 
years 
Survey ID: 
1. Mother’s Details 
LAMBS Neonatal Data Collecon V 1  06 August  2009 
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 NEONATAL DATA 
6. Baby’s Details 
6.1  Surname 
6.2  First name 
6.3  Address 
6.4  Postcode 
6.6  NHS number 
6.5  Hospital number 
6.7  Date and me of birth 2 0 / / : 
6.8  Birth weight g cenle 
6.9  Head circumference cenle 
6.10  Gestaon at birth (weeks + days) 
cm 
+ 
6.11  Birth order and mulplicity of 
6.12  For mulple births: Monochorionic  
Dichorionic  Diamnioc  
Monoamnioc  
6.13  Sex 
Male  
Female  
Unknown  
Indeterminate  
6.14 Is this baby involved in any 
other research study or trial? 
No  
Yes (please specify)  
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7.3  Were drugs or volume 
replacement given at resuscitaon? 
Please ck all that apply 
Sodium bicarbonate  
Adrenaline  
Saline  
Blood  
Naloxone  
Other (please specify)  
8. Place of postnatal care 
7. Resuscitaon at Delivery 
7.1  Did the baby require 
resuscitaon at delivery ?  
Please ck all that apply 
No acve support required  
Facial oxygen  
Intubaon  
Bag / T piece and mask  
7.2  Apgar scores 
  
at 1 minute  
at 5 minutes  
at 10 minutes  
If No, where did the baby receive 
postnatal care?  
Please ck all that apply and give 
length of stay for each 
8.1 Was all of the baby’s postnatal 
care from delivery to discharge 
given on the postnatal ward? 
No  
Yes  
If Yes, please give total length of 
postnatal ward stay. 
8.2  Date of discharge from postnatal ward to home 2 0 / / 
Glucose / Dextrose  
Postnatal ward   
Transional care  
Neonatal unit  
Other (please specify)  
Days / hours 
(please circle) 
Days / hours 
(please circle) 
Days / hours 
(please circle) 
Days / hours 
(please circle) 
Days / hours (please circle) 
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9.3 What was the reason for the 
medical review?  
9.2 Did the baby require review by a 
doctor/ANNP from the neonatal 
team (excluding routine baby check)?  
No  
Yes  
Hypoglycaemia  
Jaundice  Max SBR 
Respiratory distress  
Hypothermia  Lowest temp 
Poor feeding  
Neonatal absnence syndrome  
Seizures  
IUGR  cenle 
Cyanoc / dusky episode  
Congenital anomaly, antenatally diagnosed (please specify ) 
Other (please specify)  
. 
9.4 Condion(s) requiring review by 
a doctor/ANNP:  
Please ck all that apply 
9.1 Did the baby have a routine baby 
check on the postnatal ward?  Yes  
9.5 Did the baby require any 
laboratory blood tests on the 
postnatal ward? 
No  
. Lowest blood sugar 
Not known  
Haemocue  
BM or similar  
Lab test  
Method  
Yes  
Congenital anomaly, new postnatal ﬁnding (please specify)  
Suspected infecon  
No  
9. Medical Management on postnatal / Transional Care Ward 
Planned following antenatal concerns / neonatal alert   
Clinical concern postnatally   
Low birth weight  
Prematurity  
Heart murmur  
9.3 Did the baby require more than 
one review by a doctor/ANNP?  
No  
Yes  
Day of life 
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Did the baby require any of the following intervenons on the postnatal ward?   
9.6 Feeding    
Please ck all that apply 
Change from breast to bole feeding  
Cup feeds  
Nasogastric tube feeding  
9.7  Temperature management 
Please ck all that apply 
Heated maress  
Overhead heater  
Incubator  
9.11 Phototherapy No  
Yes  days 
9.12 Oral medicaons No  
Yes (please specify)  
9.15 Intravenous ﬂuids/ 
medications  
Please ck all that apply 
No  
9.8 Observaons 4hrly or more 
frequently 
No  
Yes  
9.9 Regular blood sugar  
monitoring 
No  
Yes  
days 
9.10 Regular bilirubin monitoring No  
Yes  days 
days 
Blood  
CSF  
Urine  
Other (please specify)  
9.13 Infecon screen 
Please ck all that apply 
Blood  
LP  
Urine   
CXR   
No 
Yes 
9.14 Were cultures posive? 
Please ck all that apply 
Other (please specify)  
Anbiocs  
Other (please specify)   
days Fluids  
days 
Yes 
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10.6 Reason for admission 
Cyanoc episode  
. Lowest blood sugar 
Jaundice  Max SBR 
Respiratory distress  
Hypothermia  . Lowest temp 
Poor feeding  
Neonatal absnence syndrome  
Seizures  
Phototherapy Yes  
Phototherapy No   
Exchange transfusion Yes  
Exchange transfusion No   
IUGR  cenle 
Evidence of encephalopathy  0 I II III N/K Grade 
Likely cause: 
Suspected infecon  Culture negave 
Culture posive 
Blood  
CSF  
Urine  
Other (please specify)  
Other (please specify)  
10. Neonatal Unit Admission 
Theatre  
Congenital anomaly, antenatally diagnosed (please specify)  
Congenital anomaly, new postnatal diagnosis (please specify) 
10.2 Hospital of ﬁrst admission 
10.5 Admied from: Home  
Labour ward  
Transional care  
Postnatal ward  
Other hospital (please specify)  
10.3 Hospital of this admission 
Other (please specify)  
10.4 Date and me of admission 2 0 / / : 
Hypoglycaemia  
No 
Yes 
10.1 Was the baby ever admied to a neonatal unit?  Please go to Queson 11 
APPENDIX 5
NIHR Journals Library www.journalslibrary.nihr.ac.uk
214
Did the baby require any of the following investigations during the neonatal stay?   
11.1 Cranial ultrasound scan No 
Yes 
11.1.1 Intraventricular Haemorrhage (IVH) 
11.1.2 Periventricular leukomalacia (PVL) 
Highest level of IVH 
recorded? 
LEFT 
None 
(Grade I or II: bleeding into 
ventricle; Grade III or IV: 
enough bleeding to 
distend ventricle) 
Did the haemorrhage 
extend to the 
parenchyma? 
Yes 
No 
Yes 
No 
Grade I or II 
Grade III or IV 
RIGHT 
None 
Grade I or II 
Grade III or IV 
Was there any 
isolated parenchymal 
change not caused by 
haemorrhage? 
Yes 
No 
Yes 
No 
LEFT RIGHT 
11.2 EEG No 
Yes Normal  
Abnormal  
11.3 MRI No 
Yes Normal  
Abnormal  11.4 Chromosomal studies No 
Yes Normal  
Abnormal  
11.5 Chest X-ray No 
Yes Normal  
Abnormal  Pneumonia  
RDS  
Pneumothorax  
Other (please specify)  
11.6 Other investigation 
(please specify) 
Normal  
Abnormal  
10.7 Temperature on admission . 
10.8 Were anbiocs given?  
(Enter 0 if none given) 
days 
10.9 Were any other drugs given?  
(please specify)  
10.10 Did the baby require surgery? No  
Yes (please specify)  
11. Invesgaons 
DOI: 10.3310/pgfar04010 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 1
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Field et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
215
13. Discharge Details 
13.2 Discharged to: (name of hospital, 
home , death etc) 
13.3 Diagnoses on discharge  1. 
 2. 
 3. 
 4. 
 5. 
13.4 Infant feeding  on discharge None 
Breast  
Formula 
Mixed 
Not known 
13.5 Method of feeding  on 
discharge 
Please ck all that apply 
Breast 
Bole  
Nasogastric tube  
Gastronomy 
Parenteral feeding 
None 
Did the baby require home 
oxygen therapy? 
Yes 
No 
Type of care (for transferred babies) 
Connuing care (includes return to home unit) 
Specialist care 
Surgical care 
Cardiac care 
Other (please specify) 
12.1 No of days in oxygen 
12.6 Date of aaining full oral feeds 
(Not NGT) 
12.4 No of days of parenteral nutrion 
12.3 No of days of non-invasive 
respiratory support 
12.2 No of days on a ventilator 
12.5 No of days of intravenous ﬂuids 
(Not TPN) 
12. Intervenons and Feeding 
13.1 Date of discharge / death 
2 0 / / 12.7 Date of last breast milk 
Enter discharge date if baby receiving 
breast milk on discharge 
2 0 / / 
2 0 / / 
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14.7 Post mortem ﬁndings 
No  
Yes, Coroner  
Yes, Hospital  
14.6 Post mortem 
14.1 Main disease or condion in  
infant 
14.2 Other diseases or condions in 
infant 
14.3 Main maternal diseases or 
condions affecng infant 
14.4 Other maternal diseases or 
condions affecng infant 
14.5 Other relevant causes  
14. Cause of death 
14.8 Midwife’s inials  
14.9 Midwife’s notes/comments:  
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